{"docstore/data": {"69c282a1-fb15-4b35-abde-72f13c724a32": {"__data__": {"id_": "69c282a1-fb15-4b35-abde-72f13c724a32", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b27c940-f4e5-4bec-9b9d-a6f03bdebab8", "node_type": "1", "metadata": {}, "hash": "b8b134b5ddc8a560d699c9755450303b6fe112c1ec886ead6558469d9c4b5292", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Reproduction, Vol.33, No.9 pp. 1636\u20131644, 2018\nAdvanced Access publication on August 7, 2018\ndoi:10.1093/humrep/dey258\nORIGINAL ARTICLE Embryology\nArti\ufb01cial oocyte activation with SrCl2\nor calcimycin after ICSI improves\nclinical and embryological outcomes\ncompared with ICSI alone: results of\na randomized clinical trial\nMohamed Fawzy1,*, Mai Emad1, Ali Mahran2, Mohamed Sabry3,\nAhmed N. Fetih4, Hazem Abdelghafar3, and Salah Rasheed3\n1IbnSina IVF Centre, IbnSina Hospital, Sohag 15322, Egypt 2Department of Dermatology, Venereology and Andrology, Faculty of Medicine,\nAssiut University, AG 71515, Egypt 3Department of Obstetrics and Gynecology, Sohag University, Sohag 82524, Egypt 4Department of\nObstetrics and Gynecology, Faculty of Medicine, Assiut University, AG 71515, Egypt\n*Correspondence address. IVF Laboratory Director (IbnSina and Banoon IVF Centres), IbnSina Hospital, 146El Aref Square, Sohag, Egypt.\nTel: +20-101-112-2286; E-mail: drfawzy001@me.com\nSubmitted on February 28, 2018; resubmitted on June 30, 2018; accepted on July 9, 2018\nSTUDY QUESTION: Are pregnancy and birth rates affected by arti\ufb01cial oocyte activation (AOA) with SrCl2 or calcimycin after ICSI for\ncouples with male-factor infertility linked to abnormal sperm morphology or for couples with previous ICSI cycles of unexplained low fertiliza-\ntion or inadequate fertilization associated with impaired oocyte morphology?\nSUMMARY ANSWER: AOA with either SrCl2 or calcimycin can improve the rates of clinical pregnancy, ongoing pregnancy and live birth\ncompared with ICSI alone, and the two agents have diverse effects for different subgroups of patients.\nWHAT IS KNOWN ALREADY: ICSI is a successful treatment for infertility, but not in all individuals.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1741, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b27c940-f4e5-4bec-9b9d-a6f03bdebab8": {"__data__": {"id_": "5b27c940-f4e5-4bec-9b9d-a6f03bdebab8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "69c282a1-fb15-4b35-abde-72f13c724a32", "node_type": "1", "metadata": {}, "hash": "f8c9c5265f8122576140d9202894b61e386b93cda27e6fb08068077ad3f80783", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e66dfbeb-b6b5-41f2-bbc0-dc271d3ba486", "node_type": "1", "metadata": {}, "hash": "a25778cf58a8f108a03a86ee0ad72745904df8f075b7a66b970859047be1eb9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "WHAT IS KNOWN ALREADY: ICSI is a successful treatment for infertility, but not in all individuals. AOA has potential to overcome\ninadequate fertilization in ICSI. Calcimycin and SrCl2 are candidate agents for AOA, but their effectiveness remains to be compared.\nSTUDY DESIGN, SIZE, DURATION: This study was a randomized, open-label, three-arm, parallel-group, double-centre, superiority\ntrial conducted between April 2015 and January 2016. The study evaluated the effects of AOA with calcimycin or SrCl2 for clinical pregnancy\nrates after ICSI and included 343 couples divided into three groups.\nPARTICIPANTS/MATERIALS, SETTING, METHODS: Couples were included if they had two previous ICSI cycles of no or low fertil-\nization (0\u201330%) with unknown causes or impaired oocyte morphology. Male-factor infertility cycles (frozen\u2013thawed sperm, surgically\nretrieved sperm or ejaculates contained <10 millions spermatozoa/ml) undergoing their \ufb01rst ICSI attempt were also included if they had\n100% abnormal sperm morphology (including globozoospermia and tapered-head). Couples were randomized to undergo ICSI with SrCl2\nAOA, ICSI with calcimycin AOA or ICSI alone, with clinical pregnancy as the primary endpoint. Effect sizes were summarized as absolute rate\ndifferences (ARDs) and odds ratios (ORs), with precision evaluated by 95% CIs.\nMAIN RESULTS AND THE ROLE OF CHANCE: Both SrCl2 and calcimycin AOA improved clinical pregnancy rates compared to ICSI\nalone (49, 42 and 27%; ARD 22, 95% CI: 9\u201333; P = 0.0007 and ARD 16, 95% CI: 3\u201327; P = 0.014). SrCl2 and calcimycin AOA were also\nsuperior to ICSI alone on the rates of ongoing pregnancy (42, 36 and 23%; P = 0.0019 and P = 0.023) and live birth (40, 33 and 18%;\nP = 0.0002 and P = 0.012).", "mimetype": "text/plain", "start_char_idx": 1643, "end_char_idx": 3379, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e66dfbeb-b6b5-41f2-bbc0-dc271d3ba486": {"__data__": {"id_": "e66dfbeb-b6b5-41f2-bbc0-dc271d3ba486", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b27c940-f4e5-4bec-9b9d-a6f03bdebab8", "node_type": "1", "metadata": {}, "hash": "b8b134b5ddc8a560d699c9755450303b6fe112c1ec886ead6558469d9c4b5292", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a2ab8ad1-3de6-47ab-9195-b6fab1655249", "node_type": "1", "metadata": {}, "hash": "ccb7f8a16ac3c742faa28bdbf41570c7713da79f4215df1d0f17be0abe507e27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among couples with previous ICSI cycles of low fertilization, AOA with SrCl2 (but not with calcimycin) was super-\nior to ICSI alone for rates of clinical pregnancy (ARD 35 percentage points (pp), P = 0.0007), ongoing pregnancy (ARD 27 pp, P = 0.009) and\nlive birth (ARD 37 pp, P = 0.002). Among couples affected by male-factor infertility, AOA with calcimycin (but not with SrCl2) was superior\nto ICSI alone for rates of clinical pregnancy (ARD 22 pp, P = 0.006), ongoing pregnancy (ARD 19 pp, P = 0.013) and live birth (ARD 17 pp,\nP = 0.02).\n\u00a9 The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.\nFor Permissions, please e-mail: journals.permissions@oup.com\nLIMITATIONS, REASONS FOR CAUTION: This study was an open-label trial, and this design might have introduced bias, although ran-\ndomization methods were used. The study did not include a longitudinal follow-up, so further evidence is required to demonstrate the safety\nof AOA.\nWIDER IMPLICATIONS OF THE FINDINGS: The decision to use SrCl2 or calcimycin for AOA after ICSI may depend on whether the\nactivation failure originates in the oocyte or the sperm.\nSTUDY FUNDING/COMPETING INTEREST(S): The study received no funding and the authors have no con\ufb02icts of interest to\ndeclare.\nTRIAL REGISTRATION NUMBER: NCT02424214.\nTRIAL REGISTRATION DATE: 22 April 2015.\nDATE OF FIRST PATIENT\u2019S ENROLMENT: 27 April 2015.\nKey words: oocyte activation / calcium ionophore / calcium oscillation / failed fertilization / male factor infertility\nIntroduction\nIVF and ICSI are effective treatments for infertility (Palermo et al.,\n1992; Steptoe and Edwards, 1992; Kissin et al., 2014). Successful fertil-\nization requires oocyte activation, which depends on a proper inter-\naction between the gametes (Yeste et al., 2016).", "mimetype": "text/plain", "start_char_idx": 3380, "end_char_idx": 5240, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a2ab8ad1-3de6-47ab-9195-b6fab1655249": {"__data__": {"id_": "a2ab8ad1-3de6-47ab-9195-b6fab1655249", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e66dfbeb-b6b5-41f2-bbc0-dc271d3ba486", "node_type": "1", "metadata": {}, "hash": "a25778cf58a8f108a03a86ee0ad72745904df8f075b7a66b970859047be1eb9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8d4c2fdc-774f-40a3-ab88-6349f7521ed2", "node_type": "1", "metadata": {}, "hash": "a7bb26fe4fcf13868896a8c72979575f86df7d6507804e1cfb1d89c5bf23e207", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Successful fertil-\nization requires oocyte activation, which depends on a proper inter-\naction between the gametes (Yeste et al., 2016). Activation failure\nresults in poor fertilization rates (Flaherty et al., 1998; Cheng et al.,\n2011; Clift and Schuh, 2013).\nOocyte activation triggers a cascade of events including Ca2+ oscilla-\ntion, leading to fertilization and embryo development (Yeste et al.,\n2016). In animal models, the duration, amplitude and frequency of Ca2+\noscillation affect the normal oocyte activation and embryo development\n(Sfontouris et al., 2015). The precise mechanisms underlying oocyte\nactivation remain elusive. A likely mechanism is that the phospholipase\nC zeta (PLC\u03b6) of a fertilizing spermatozoon produces inositol-1,4,5-\ntrisphosphate within the oocyte which interacts with receptors in the\nendoplasmic reticulum, causing Ca2+ oscillation (Ridgway et al., 1977;\nSteinhardt et al., 1977; Miyazaki et al., 1992, 1993; Wassarman et al.,\n2001; Ducibella et al., 2002; Saunders et al., 2002; Horner and Wolfner,\n2008; Kashir et al., 2010; Amdani et al., 2013; Nomikos et al., 2013;\nEscof\ufb01er et al., 2014). Reports suggest that abnormal sperm morphology\nreduces the rates of fertilization and implantation (De Vos et al., 2003;\nLu et al., 2012; Greco et al., 2013). The oocyte also contributes to the\nactivation events via identi\ufb01ed and unidenti\ufb01ed factors (Tesarik et al.,\n2002; Eldar-Geva et al., 2003; Heindryckx et al., 2005, 2008; Combelles\net al., 2010; Yelumalai et al., 2015).\nArti\ufb01cial oocyte activation (AOA) can repair a defective activation\n(Yeste et al., 2016), improving ICSI outcomes (Montag et al., 2012).", "mimetype": "text/plain", "start_char_idx": 5104, "end_char_idx": 6749, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8d4c2fdc-774f-40a3-ab88-6349f7521ed2": {"__data__": {"id_": "8d4c2fdc-774f-40a3-ab88-6349f7521ed2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a2ab8ad1-3de6-47ab-9195-b6fab1655249", "node_type": "1", "metadata": {}, "hash": "ccb7f8a16ac3c742faa28bdbf41570c7713da79f4215df1d0f17be0abe507e27", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dfdb4dee-1cea-4ada-9e45-246ce22679a3", "node_type": "1", "metadata": {}, "hash": "d7a41bae187ebdb19d79ae6d5a27fc8ec06de81f0d58094d4e75f73ff4a5b4d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Arti\ufb01cial oocyte activation (AOA) can repair a defective activation\n(Yeste et al., 2016), improving ICSI outcomes (Montag et al., 2012).\nMechanical, electrical and chemical activation serve as AOA methods\n(Vanden Meerschaut et al., 2012; 2014). Chemical AOA is the prominent,\nand it induces either a single, prolonged wave or pulsatile waves of intracy-\ntoplasmic Ca2+ (Yeste et al., 2016; Murugesu et al., 2017). Calcimycin,\nionomycin, puromycin and 6-dimethylaminopurine increase membrane\npermeability to extracellular Ca2+, inducing a single, prolonged Ca2+ wave\n(Rybouchkin et al., 1997; Ebner et al., 2015; Yeste et al., 2016). Strontium\nchloride (SrCl2), phorbol esters or anhydrous alcohol release the Ca2+\nfrom the endoplasmic reticulum in pulsatile waves (Kline and Kline, 1992;\nKishikawa et al., 1999; Kim et al., 2014; Yeste et al., 2016).\nAOA with calcimycin or SrCl2 can improve outcomes for ICSI cycles\nof impaired fertilization (Yanagida et al., 2006; Chen et al., 2010; Kim\net al., 2014; Murugesu et al., 2017). Variable studies including retro-\nspective designed analyses, historical comparisons or relatively under-\npowered studies have synthesized this evidence. Most of the studies\nhave only examined calcimycin AOA, although SrCl2 has shown poten-\ntial for AOA (Kim et al., 2014; Yeste et al., 2016). Recently, Lu et al.\n(2018) showed that SrCl2 AOA cannot provoke calcium oscillation or\nparthenogenic division for human oocytes. However, Lu et al. used\nin vitro matured oocytes or oocytes characterized by smooth endo-\nplasmic reticulum. In addition, there has been no comparative rando-\nmized clinical trial (RCT) to evaluate the relative effectiveness of\ncalcimycin and SrCl2.", "mimetype": "text/plain", "start_char_idx": 6613, "end_char_idx": 8313, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dfdb4dee-1cea-4ada-9e45-246ce22679a3": {"__data__": {"id_": "dfdb4dee-1cea-4ada-9e45-246ce22679a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8d4c2fdc-774f-40a3-ab88-6349f7521ed2", "node_type": "1", "metadata": {}, "hash": "a7bb26fe4fcf13868896a8c72979575f86df7d6507804e1cfb1d89c5bf23e207", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22f950e8-96aa-44db-8f2d-9064b09f3238", "node_type": "1", "metadata": {}, "hash": "18b4f26f868177e6af49cc0721393a3bcedb88a48929483d3fc0b0e0976e4a3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In addition, there has been no comparative rando-\nmized clinical trial (RCT) to evaluate the relative effectiveness of\ncalcimycin and SrCl2. Whether the sperm or the oocyte is most\nresponsible for the activation defects remains unidenti\ufb01able from a\nclinical perspective (Murugesu et al., 2017).\nTo address these questions, we compared SrCl2 and calcimycin\nAOA with each other and with ICSI alone in this prospective RCT,\nidentifying the rate of clinical pregnancy as a primary endpoint. To\ndetermine whether the sperm or the oocyte is most responsible, infer-\ntile couples included were those undergoing ICSI cycles for previous\nlow fertilization (<30%) but normal semen parameters or \ufb01rst ICSI\ncycles for male-factor infertility with abnormal sperm morphology.\nMaterials and Methods\nTrial design\nThe study adopted a randomized, open-label, three-arm, parallel-group,\ndouble-centre, superiority trial design (NCT02424214, registered at www.\nClinicalTrials.gov). Two private IVF facilities in Egypt (Ibnsina IVF Centre,\nSuhag and Banoon IVF Centre, Asyut) conducted the trial. The trial included a\nscreening period of 18 months (from the time of getting the consent to the\nstart of assignment of participants). Research instructors disclosed the details\nto eligible couples. From January to April 2015, research instructors recalled\nparticipants for randomization and enrolment. The \ufb01rst couple was recruited\non 30 April 2015, and the last oocyte retrieval was performed on 17 January\n2016. Participants provided written informed consent. The ethics committees\nof the centres approved the study (Number 09; 02/2013). Independent\nexperts and safety committees oversaw this study.\nParticipants\nWomen were 18\u201340 years of age with a BMI of <31 kg/m2. Inclusion cri-\nteria were deliberately broad to include couples with two previous ICSI\ncycles of no or low fertilization (0\u201330%) or with male-factor infertility\n1637\nSrCl2 and calcimycin regulate oocyte activation\nundergoing their \ufb01rst ICSI cycle.", "mimetype": "text/plain", "start_char_idx": 8173, "end_char_idx": 10166, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "22f950e8-96aa-44db-8f2d-9064b09f3238": {"__data__": {"id_": "22f950e8-96aa-44db-8f2d-9064b09f3238", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dfdb4dee-1cea-4ada-9e45-246ce22679a3", "node_type": "1", "metadata": {}, "hash": "d7a41bae187ebdb19d79ae6d5a27fc8ec06de81f0d58094d4e75f73ff4a5b4d2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9127de41-169c-44c0-bb99-52552eb02d47", "node_type": "1", "metadata": {}, "hash": "57844f9fc4bd890f31f85e35b890e8474cc783ec866362424aabcd649aa8d022", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We classi\ufb01ed previous cycles of low fertiliza-\ntion as \u2018unexplained low fertilization\u2019 or as \u2018low fertilization associated with\nimpaired oocyte morphology\u2019, but within normal sperm limits. Impaired\nmorphology of oocytes, according to the Istanbul Consensus, was non-\nconformity with the following de\ufb01nition: a spherical structure in a uniform\nzona pellucida with a uniform translucent cytoplasm free of inclusions and\nwith a size-proper polar body (Alpha Scientists in Reproductive Medicine\nand ESHRE Special Interest Group of Embryology, 2011). The male-factor\ninfertility cycles (frozen\u2013thawed sperm, surgically retrieved sperm or ejacu-\nlates containing <10 million spermatozoa/ml) undergoing their \ufb01rst ICSI\nattempt had 100% abnormal sperm morphology (including globozoospermia\nand tapered-head). Couples had primary infertility with no previous com-\npleted pregnancy or abortion. Exclusion criteria were couples with endo-\nmetriosis, thin endometrial lining or pinhead sperm defects.\nRandomization and masking\nUsing an online randomization tool (http://www.openepi.com/Random/\nRandom.htm), independent data managers assigned participants to SrCl2\nAOA, calcimycin AOA or ICSI alone with a 1:1:1 allocation ratio. Block\nrandomization was performed to ensure equal representation of couples\nin the study groups. Each allocation was sealed in a sequentially numbered,\nopaque envelope. On 27 April 2015, independent instructors recorded\neach envelope number in each woman\u2019s case-record \ufb01le. On Day 21 of\nthe cycle preceding ICSI, research instructors opened the envelope and\nassigned the participant to the relevant group. Immediately, the instructors\ntransferred the allocation result to the laboratory team, keeping gynaecol-\nogists and participants unaware of the result until the embryo transfer.\nStimulation protocol, embryo transfer and\nluteal-phase support\nPituitary\ndownregulation\nwas\nattainable\nby\nsubcutaneous\nGnRH-a\n(Decapeptyl 0.1 mg, Ferring, Saint-Prex, Switzerland) from Day 21 of the\ncycle preceding ICSI.", "mimetype": "text/plain", "start_char_idx": 10167, "end_char_idx": 12188, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9127de41-169c-44c0-bb99-52552eb02d47": {"__data__": {"id_": "9127de41-169c-44c0-bb99-52552eb02d47", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22f950e8-96aa-44db-8f2d-9064b09f3238", "node_type": "1", "metadata": {}, "hash": "18b4f26f868177e6af49cc0721393a3bcedb88a48929483d3fc0b0e0976e4a3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "313092a6-84e7-4afa-8cc2-765cfc933e7e", "node_type": "1", "metadata": {}, "hash": "c07f903e2d4d8463224bb8e8e55a565ba1865e9786a8c8805ce91228f207cec3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "On Day 2 of the ICSI cycle, women received\n225\u2013300 IU of rFSH (Gonal-F, Merck Serono) and hMG injections\n(Menogon, Ferring) with a 2:1 ratio, with the dose adjusted according to\nthe response. When three follicles measured 18 mm diameter, \ufb01nal matur-\nation was induced by 10 000 IU human chorionic gonadotropin (hCG,\nChoriomon, IBSA, Lugano, Switzerland). Oocytes were collected 37 h\nlater and the metaphase II (MII) were inseminated by ICSI (Palermo et al.,\n1992). On Day 5, speci\ufb01ed clinicians followed a standard protocol, trans-\nferring one to two blastocysts for each woman. For luteal phase support,\nwomen began intramuscular progesterone (100-mg, Prontogest, IBSA)\nfrom the day after oocyte retrieval to the 12th week of gestation, unless\nthe biochemical pregnancy test was negative.\nSperm preparation, oocyte retrieval,\ndenudation and ICSI\nFresh, frozen\u2013thawed and surgically retrieved sperm were prepared at\nroom\ntemperature\nby\ndensity-gradient\ncentrifugation\n(PureSperm,\nNidacon, M\u00f6lndal, Sweden) (Bj\u00f6rndahl et al., 2010). Samples were then\nwashed and incubated in AllGrade Wash medium (LifeGlobal, Guilford,\nCT, USA). Follicles were aspirated into, and handled in, Global HEPES\nmedium (LifeGlobal) at 37\u00b0C, using a tube warmer. With chemical and\nmechanical tools (80 IU hyaluronidase, LifeGlobal; Denudation Pipette,\nVitrolife, G\u00f6teborg, Sweden), oocytes were denuded at 39 h after hCG.\nImmediately, ICSI was performed at 37\u00b0C, in Global HEPES (LifeGlobal).", "mimetype": "text/plain", "start_char_idx": 12189, "end_char_idx": 13656, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "313092a6-84e7-4afa-8cc2-765cfc933e7e": {"__data__": {"id_": "313092a6-84e7-4afa-8cc2-765cfc933e7e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9127de41-169c-44c0-bb99-52552eb02d47", "node_type": "1", "metadata": {}, "hash": "57844f9fc4bd890f31f85e35b890e8474cc783ec866362424aabcd649aa8d022", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed0c1021-ee70-49c6-ba2b-6e7f2f54239b", "node_type": "1", "metadata": {}, "hash": "158a57f78671b3b386222546011fd07779b561cdad5104ed9d0a6eea04344f7c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Immediately, ICSI was performed at 37\u00b0C, in Global HEPES (LifeGlobal).\nCulture protocol and embryo scoring\nIn the two centres and across the study, laboratory variables were con-\ntrolled using: only Minc-1000 incubators (Cook, USA); Global Total medium\n(LifeGlobal); 37 \u00b1 0.1\u00b0C culture temperature veri\ufb01ed by a thermocouple\n(Chino, Tokyo, Japan); 7.25 \u00b1 0.02 pH validated weekly by a blood gas ana-\nlyser (Epocal, Ottawa, Canada); group culture of three oocytes; 15 \u03bcl\nmedium droplet in micro-droplet dish (Vitrolife) overlaid by 5 ml oil (NidOil,\nNidacon); continuous culture from Day 0 through Day 5/6, without medium\nrenewal; premixed gas (7.5% CO2, 5% O2 and 87.5% N2); and the same\nbatches of disposables. Fertilization check and embryo grading were\nperformed on Days 1, 3 and 5 of culture (Alpha Scientists in Reproductive\nMedicine and ESHRE Special Interest Group of Embryology, 2011).\nInterventions\nImmediately after ICSI, AOA was performed and comprised incubation for\n1 h in 10 mM SrCl2 (Sigma, St Louis, MO, USA) diluted in Global Total\nmedium or incubation for 20 min in a commercial calcimycin (Cult-active\nCa-Ionophore; Gynemed, Lensahn, Germany). AOA droplets were 200 \u03bcl\neach in 60-mm dishes (353652, BD Falcon, USA) overlaid with 10 ml oil\n(NidOil) and were equilibrated overnight at 37\u00b0C and in an atmosphere of\n7.5% CO2, 5% O2, and 87.5% N2 (pH 7.25 \u00b1 0.02).\nStudy outcomes\nThe primary endpoint was clinical pregnancy rate (positive heartbeat on\nultrasonography at \u22654 weeks after ET).", "mimetype": "text/plain", "start_char_idx": 13586, "end_char_idx": 15089, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed0c1021-ee70-49c6-ba2b-6e7f2f54239b": {"__data__": {"id_": "ed0c1021-ee70-49c6-ba2b-6e7f2f54239b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "313092a6-84e7-4afa-8cc2-765cfc933e7e", "node_type": "1", "metadata": {}, "hash": "c07f903e2d4d8463224bb8e8e55a565ba1865e9786a8c8805ce91228f207cec3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "414ef5b0-c94e-417f-a3b3-0b36c2bf27f5", "node_type": "1", "metadata": {}, "hash": "f918afa12bf5e9b9812d391e6b949b5554111276c95d13a7103f83911d50786f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Study outcomes\nThe primary endpoint was clinical pregnancy rate (positive heartbeat on\nultrasonography at \u22654 weeks after ET). Secondary endpoints included the\nrates of (i) fertilization (fertilized oocytes with two pronuclei per MII\noocyte injected); (ii) high-quality embryos on Day 3 (seven or eight blasto-\nmeres of equal-size and <10% fragmentation by volume); (iii) formed\nblastocyst on Day 5/6 from fertilized oocytes; (iv) high-quality blastocysts\n(blastocysts \u22653.1.1 grade, per fertilized oocyte); (v) biochemical pregnancy\n(positive b-hCG at \u226514 days following ET); (vi) ongoing pregnancy (preg-\nnancy following week 12 of gestation); (vii) multiple pregnancy (\u2265two\nfoetuses with a heartbeat); (viii) implantation (sacs with a heartbeat);\n(ix) miscarriage (pregnancy loss before gestational week 12); and (x) live birth\n(viable neonate at \u226530 weeks of gestation).\nStatistical analysis\nPrevious cycles of low fertilization for women younger than 40 years of age\nshowed a 16% clinical pregnancy rate (Murugesu et al., 2017). This trial was\npowered to detect a 14% rise in pregnancy rate (16\u201330%) with 80% power\nat 5% signi\ufb01cance level, requiring 342 participants (114 per arm) to undergo\nSrCl2 AOA, calcimycin AOA or ICSI alone and reach the primary endpoint.\nAn alternative was to enrol up to 450 women, to allow for any signi\ufb01cant\ndropout. The independent data and safety committees performed an\ninterim analysis at 343 participants, advising that no more enrolment is\nneeded. Data were analysed using binomial logistic regression with log link,\none-way ANOVA, Fisher\u2019s exact and Chi-square tests where appropriate.\nBetween-clinician and between-embryologist differences were controlled by\nFleiss\u2019 Kappa analysis (McHugh, 2012). Results are reported as an intention-\nto-treat and per indication analyses and are presented as an absolute rate\ndifference (ARD), odds ratio (OR) with 95% CI) or means with SD where\nappropriate.", "mimetype": "text/plain", "start_char_idx": 14964, "end_char_idx": 16897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "414ef5b0-c94e-417f-a3b3-0b36c2bf27f5": {"__data__": {"id_": "414ef5b0-c94e-417f-a3b3-0b36c2bf27f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed0c1021-ee70-49c6-ba2b-6e7f2f54239b", "node_type": "1", "metadata": {}, "hash": "158a57f78671b3b386222546011fd07779b561cdad5104ed9d0a6eea04344f7c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "077bfbfb-a750-4d40-8b7f-e924c0fca8ef", "node_type": "1", "metadata": {}, "hash": "680d577072bfc88d612dd7290f238e65c69d7ee3b42ef4ecbc4fe043946af835", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results are reported as an intention-\nto-treat and per indication analyses and are presented as an absolute rate\ndifference (ARD), odds ratio (OR) with 95% CI) or means with SD where\nappropriate. P < 0.05 was regarded as statistically signi\ufb01cant. All analyses\nwere performed using SPSS (version 22, IBM. Armonk, NY, USA).\nResults\nBetween 27 April 2015 and 17 January 2016, we recruited 343 partici-\npants (SrCl2 AOA = 115, calcimycin AOA = 113 and ICSI alone = 115)\n1638\nFawzy et al.\nafter excluding 49 (Fig. 1). Patient and cycle characteristics were similar\nin the three groups (Table I).\nOverall (Table II), the clinical pregnancy rate was signi\ufb01cantly higher\nwith SrCl2 and calcimycin AOA than with ICSI alone (49, 42 and 27%;\nARD 22, 95% CI: 9\u201333 and ARD 16, 95% CI: 3\u201327). SrCl2 and calci-\nmycin AOA also signi\ufb01cantly increased the biochemical pregnancy rate\ncompared with ICSI alone. The ongoing pregnancy rate was consider-\nably higher with SrCl2 and calcimycin AOA than with ICSI alone (42,\n36 and 23%; ARD 19, 95% CI: 7\u201330 and ARD 14, 95% CI: 2\u201325). The\nimplantation rate was signi\ufb01cantly also higher with SrCl2 and calcimycin\nAOA than with ICSI alone (32, 28 and 18%; ARD 14, 95% CI: 5\u201323\nand ARD 10, 95% CI: 2\u201319). These results culminated in signi\ufb01cantly\nhigher rates of live birth for SrCl2 and calcimycin AOA than for ICSI\nalone (40, 33 and 18%; ARD 22, 95% CI: 10\u201333 for SrCl2 and ARD\n14, 95% CI: 3\u201325).", "mimetype": "text/plain", "start_char_idx": 16702, "end_char_idx": 18121, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "077bfbfb-a750-4d40-8b7f-e924c0fca8ef": {"__data__": {"id_": "077bfbfb-a750-4d40-8b7f-e924c0fca8ef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "414ef5b0-c94e-417f-a3b3-0b36c2bf27f5", "node_type": "1", "metadata": {}, "hash": "f918afa12bf5e9b9812d391e6b949b5554111276c95d13a7103f83911d50786f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e2cffb51-6705-45a5-8c71-300537442fc5", "node_type": "1", "metadata": {}, "hash": "69387985a201c2e06c4353a0a2cef6228913f754147ea1f9725054263ef1725f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The rates of cancelled transfer, chemical preg-\nnancy, miscarriage and multiple pregnancy were similar between the\ngroups. Both SrCl2 and calcimycin AOA resulted in similar rates of\nongoing pregnancy, implantation and live birth (Supplementary\nTable SV).\nAmong couples with previous low fertilization, SrCl2 AOA signi\ufb01cantly\nimproved the clinical pregnancy rate compared with ICSI alone (ARD\n35, 95% CI: 15\u201352; Supplementary Table SI) or calcimycin AOA (ARD\n30, 95% CI: 10\u201347; Supplementary Table SV), whereas calcimycin AOA\nand ICSI alone were comparable (ARD 5, 95% CI:\u221214 to 24;\nSupplementary Table SI). SrCl2 AOA was superior to ICSI alone regard-\ning the rates of biochemical pregnancy, ongoing pregnancy and implant-\nation, resulting in a higher live birth rate (ARD 37, 95% CI: 16\u201353;\nSupplementary Table SI). SrCl2 AOA was also superior to calcimycin\nAOA, resulting in higher rates of ongoing pregnancy and live birth (ARD\n22, 95% CI: 2\u201340 and ARD 26, 95% CI: 6\u201344; Supplementary\nTable SV). Only the implantation rate was signi\ufb01cantly higher with calci-\nmycin AOA than with ICSI alone (Supplementary Table SI).\nAmong couples of male-factor infertility with abnormal sperm, calci-\nmycin AOA signi\ufb01cantly improved the clinical pregnancy rate com-\npared with ICSI alone (ARD 22, 95% CI: 6\u201336; Supplementary\nTable SII), whereas SrCl2 AOA and ICSI alone were comparable\n(ARD 12, 95% CI:\u22123 to 26). Calcimycin AOA was superior to ICSI\nalone regarding the rates of biochemical pregnancy, clinical pregnancy\n115 women who produced 1180 \nMII oocytes were assigned to \nthe control group (no chemical \nactivation post-ICSI).\n115 women who produced\n1377 MII oocytes were \nassigned to intervention \ngroup I (oocyte activation \n-\nfor 60 min post\n2\nSrCl\nusing \nICSI).", "mimetype": "text/plain", "start_char_idx": 18122, "end_char_idx": 19881, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e2cffb51-6705-45a5-8c71-300537442fc5": {"__data__": {"id_": "e2cffb51-6705-45a5-8c71-300537442fc5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "077bfbfb-a750-4d40-8b7f-e924c0fca8ef", "node_type": "1", "metadata": {}, "hash": "680d577072bfc88d612dd7290f238e65c69d7ee3b42ef4ecbc4fe043946af835", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "379a9310-5e98-4b2f-ae48-0445af362347", "node_type": "1", "metadata": {}, "hash": "b2d4539b3e08cf1767a03ac13c4ca96ef7b51996289b36b788360a85073ddfed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "115 women who produced\n1377 MII oocytes were \nassigned to intervention \ngroup I (oocyte activation \n-\nfor 60 min post\n2\nSrCl\nusing \nICSI).\n392 women were \nassessed for eligibility \n360 women were eligible, of whom 17 decided to freeze all embryos before \nrecruitment.\nTherefore, 343 were assigned to three groups and produced 3867 MII oocytes \n32 women were excluded\n- 18 declined to participate \n- 4 had diabetes \n- 6 had endometriosis\n- 4 had poor endometrium\n115 women were included \nin the analysis, of whom \n108 reached Day 5 transfer.\n- 4 women had poor \nembryo development \nand did not reach \ntransfer  \n- 1 woman developed \nOHSS and had her\nembryos frozen\n- 2 women were lost to \nfollow-up \n- 9 women had poor \nembryo development \nand did not reach \ntransfer  \n- 2 women developed \nOHSS and had their\nembryos frozen\n- 1 woman was lost to \nfollow-up \n115 women were included \nin the analysis, of whom \n103 reached Day 5 transfer.\n113 women who produced 1310 \nMII oocytes were assigned to \nintervention group II (oocyte \nactivation using calcimycin for \n20 min post-ICSI).\n- 10 women had poor \nembryo development \nand did not reach \ntransfer  \n- 1 woman developed \nOHSS and had her\nembryos frozen\n- 3 women were lost to \nfollow-up \n113 women were included \nin the analysis, of whom 99\nreached Day 5 transfer.\nFigure 1 Study \ufb02ow diagram.\n1639\nSrCl2 and calcimycin regulate oocyte activation\nand ongoing pregnancy, implantation, live birth and live-birth implant-\nation, whereas SrCl2 AOA and ICSI alone were comparable, as were\nSrCl2\nand\ncalcimycin\nAOA\nwere\ncomparable\n(Supplementary\nTables SII and SV).\nSrCl2 AOA resulted in signi\ufb01cantly greater rates of fertilization, top-\nquality embryo and compaction on Day 3, blastocyst development,\nhigh-quality blastocysts and cryopreservation compared with ICSI\nalone (all P < 0.0001; Table III).", "mimetype": "text/plain", "start_char_idx": 19743, "end_char_idx": 21587, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "379a9310-5e98-4b2f-ae48-0445af362347": {"__data__": {"id_": "379a9310-5e98-4b2f-ae48-0445af362347", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e2cffb51-6705-45a5-8c71-300537442fc5", "node_type": "1", "metadata": {}, "hash": "69387985a201c2e06c4353a0a2cef6228913f754147ea1f9725054263ef1725f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c9ecd9e-f8c2-4149-ad2a-89586ba81f78", "node_type": "1", "metadata": {}, "hash": "3988073230a48c09d79efb4348a8cd2ff7f091f7428a4da98d4702bd0a96b73f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Calcimycin AOA also resulted in sig-\nni\ufb01cantly higher rates of fertilization, blastocyst formation and cryo-\npreservation compared with ICSI alone (P = 0.003, P = 0.026 and\nP < 0.0001; Table III). The embryological outcomes for the subgroup\nanalyses are shown in Supplementary Tables SIII and SIV.\nDiscussion\nTo our knowledge, this RCT is the \ufb01rst to compare SrCl2 and calcimy-\ncin AOA after ICSI to ICSI alone for cycles of previous low fertilization\nor male-factor infertility. Overall, this trial demonstrated signi\ufb01cantly\nhigher rates of clinical pregnancy and live birth for either SrCl2 or calci-\nmycin AOA after ICSI compared with ICSI alone, whereas SrCl2 and\ncalcimycin AOA were comparable. Our \ufb01ndings concur with a recent\nmeta-analysis (Murugesu et al., 2017).\nAmong couples with previous ICSI cycles of low fertilization, SrCl2\nAOA was more effective than ICSI alone, whereas calcimycin AOA\nwas comparable to ICSI alone. In this subgroup, neither sperm entry\nnor ICSI appears suf\ufb01cient to initiate the oocyte activation. This is likely\nto relate the activation defects to the oocyte (Miyara et al., 2003;\nEbner et al., 2006; Xing et al., 2011; Kilani and Chapman, 2014).\nReports suggest that ICSI with SrCl2 AOA appears to stimulate pulsa-\ntile waves of Ca2+ oscillation from the endoplasmic reticulum during\nfertilization and further development (Kline and Kline, 1992; Kishikawa\net al., 1999; Kim et al., 2014; Yeste et al., 2016). Although SrCl2 AOA\ndid not show signs of Ca2+ oscillation or parthenogenetic division for\nin-vitro matured oocytes (Lu et al., 2018), this situation may differ from\nthe MII oocytes undergoing ICSI with AOA.", "mimetype": "text/plain", "start_char_idx": 21588, "end_char_idx": 23240, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c9ecd9e-f8c2-4149-ad2a-89586ba81f78": {"__data__": {"id_": "6c9ecd9e-f8c2-4149-ad2a-89586ba81f78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "379a9310-5e98-4b2f-ae48-0445af362347", "node_type": "1", "metadata": {}, "hash": "b2d4539b3e08cf1767a03ac13c4ca96ef7b51996289b36b788360a85073ddfed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4556a9c6-e12f-431a-8f42-f10218602d30", "node_type": "1", "metadata": {}, "hash": "729877181817ee206b5ff2a16205dbf831634f058879e4fa7054daed9558d2ba", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Therefore, given its\npotential to improve ICSI outcomes, further studies are required to\nidentify whether SrCl2 AOA activates the oocyte by Ca2+ oscillation\nor other mechanisms.\nFor calcimycin AOA and previous ICSI cycles of low fertilization, our\n\ufb01ndings showed that calcimycin AOA and ICSI alone were compar-\nable. Our results can be explained as calcimycin might be less effective\nthan SrCl2 because it induces a single Ca2+ wave that is not converted\ninto oscillation. Although our observations contradict a recent meta-\nanalysis (Murugesu et al., 2017) yet concur with an earlier one\n(Sfontouris et al., 2015), the conclusions from the meta-analyses seem\nto be not substantial due to the heterogenous designs of their studies.\nTherefore, calcimycin AOA appears to be not bene\ufb01cial for ICSI cycles\nwith previous impaired fertilization, but normal sperm parameters.\nAmong couples with male-factor infertility, calcimycin AOA was\nsuperior to SrCl2 AOA or ICSI alone. It is likely that when the problem\nresults from male-factor infertility, Ca2+ oscillation is functional in the\noocyte, but it has insuf\ufb01cient stimulation by the ICSI alone with\naffected sperm (Vanden Meerschaut et al., 2013; Ferrer-Buitrago et al.,\n2018). Calcimycin AOA provides additional Ca2+ in\ufb02ux from the\n...................................................................................\n...............\n.......................\n..........................\n.............................................................................................................................................................................................\nTable I Baseline characteristics by trial group.\nArti\ufb01cial oocyte activation (AOA) groups\nSrCl2 AOA\nCalcimycin AOA\nControl (no AOA)\n(n = 115)\n(n = 113)\n(n = 115)\nAge (years): mean \u00b1 SD\n31 \u00b1 5.1\n32.4 \u00b1 5.2\n32 \u00b1 5.2\nBMI (kg/m2): mean \u00b1 SD\n28.4 \u00b1 2.7\n28.4 \u00b1 2.7\n28.3 \u00b1 2.7\nDuration of infertility (years): mean \u00b1 SD\n6 \u00b1 2.7\n6 \u00b1 2.5\n6 \u00b1 2.", "mimetype": "text/plain", "start_char_idx": 23241, "end_char_idx": 25197, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4556a9c6-e12f-431a-8f42-f10218602d30": {"__data__": {"id_": "4556a9c6-e12f-431a-8f42-f10218602d30", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c9ecd9e-f8c2-4149-ad2a-89586ba81f78", "node_type": "1", "metadata": {}, "hash": "3988073230a48c09d79efb4348a8cd2ff7f091f7428a4da98d4702bd0a96b73f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dfbafac1-47dc-49d4-856b-d18e0c6cf151", "node_type": "1", "metadata": {}, "hash": "0a6be7eadadd013b16a3348a513b1e4e9daea3c4cd414790f9c9736a58b61bff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7\n28.4 \u00b1 2.7\n28.3 \u00b1 2.7\nDuration of infertility (years): mean \u00b1 SD\n6 \u00b1 2.7\n6 \u00b1 2.5\n6 \u00b1 2.2\nBasal FSH (IU/L): mean \u00b1 SD\n6 \u00b1 1.2\n6 \u00b1 1.3\n6 \u00b1 2\nAntral follicle count: mean \u00b1 SD\n15.0 \u00b1 2.2\n14.0 \u00b1 2.1\n14.3 \u00b1 2.3\nTotal FSH/hMG: mean \u00b1 SD\n2245 \u00b1 244\n2294 \u00b1 195\n2264 \u00b1 227\nImpaired-fertilization cycles:\nPrevious fertilization failure: n (%)\n7 (6)\n5 (4)\n7 (6)\nPrevious low fertilization (<30%) with average oocyte quality: n (%)\n14 (12)\n13 (12)\n12 (11)\nPrevious low fertilization (<30%) associated with impaired oocyte quality: n (%)\n26 (23)\n27 (23)\n24 (21)\nMale-factor infertility cycles:\nFrozen\u2013thawed sperm of affected-morphology samples: n (%)\n22 (19)\n24 (21)\n23 (20)\nSurgically retrieved sperm of affected-morphology samples: n (%)\n19 (17)\n21 (19)\n22 (19)\nGlobozoospermia: n (%)\n4 (3)\n3 (3)\n5 (4)\n100% tapered-head sperm: n (%)\n23 (20)\n20 (18)\n22 (19)\nNumber of oocytes collected: mean \u00b1 SD\n14 \u00b1 9.4\n13 \u00b1 9.1\n12 \u00b1 8.0\nNumber of mature oocytes: mean \u00b1 SD\n13 \u00b1 6.5\n12 \u00b1 8.0\n11 \u00b1 6.2\nNumber of embryos transferred: mean \u00b1 SD\n1.7 \u00b1 0.5\n1.6 \u00b1 0.5\n1.6 \u00b1 0.5\nComparison of the differences between the three groups was performed by one-way ANOVA and the chi-square test where appropriate.\n1640\nFawzy et al.\nsurrounding medium, boosting the initiation of Ca2+ oscillation (Yeste\net al., 2016).", "mimetype": "text/plain", "start_char_idx": 25108, "end_char_idx": 26389, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dfbafac1-47dc-49d4-856b-d18e0c6cf151": {"__data__": {"id_": "dfbafac1-47dc-49d4-856b-d18e0c6cf151", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4556a9c6-e12f-431a-8f42-f10218602d30", "node_type": "1", "metadata": {}, "hash": "729877181817ee206b5ff2a16205dbf831634f058879e4fa7054daed9558d2ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d0443bed-a471-4bba-9f65-453c6d965e51", "node_type": "1", "metadata": {}, "hash": "7191b0caab0f55cfa74e5f5436861ea4f3dd85b13629d1fb2c0747f4ac519f0e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1640\nFawzy et al.\nsurrounding medium, boosting the initiation of Ca2+ oscillation (Yeste\net al., 2016). In this situation, SrCl2 may have less effect because the\ndefect is not with the Ca2+ oscillation machinery itself, just the initi-\nation of oscillation. Our observations concur with a recent meta-\nanalysis (Murugesu et al., 2017) as it also included cycles with affected\nsperm function. Therefore, calcimycin AOA appears promising for\nICSI cycles with abnormal sperm morphology.\nRegarding embryo development, AOA with SrCl2 or calcimycin gave\nsigni\ufb01cantly better results than conventional ICSI in the overall and\nsubgroup analyses. The effect sizes for SrCl2 were larger than for calci-\nmycin. Both AOA protocols were superior to ICSI alone for the\nblastocyst cryopreservation rate, suggesting that, besides the clinical\nimprovements observed, AOA might improve the cumulative preg-\nnancy rate. The improvements in embryo development could have\nresulted from restoration of Ca2+ oscillation to physiological or supra-\nphysiological status. However, the mechanisms by which this restor-\nation might have occurred are beyond this study, and whether\npossible supraphysiological Ca2+ oscillation might have epigenetic\neffects remains a subject for further investigation.\nPrevious studies (Murugesu et al., 2017) have shown that the clinical\npregnancy rate is 16% for ICSI cycles with previous low fertilization.\nThis rate appears relatively lower than that we observed in our facil-\nities and we reported for this group. In our study, the rigorous control\nfor the laboratory and clinical confounders, the relatively young age of\nwomen included (~32), and the short time of conduct seemed to be\nre\ufb02ected in the observed outcomes in the three groups.\nTo limit the sample size required, the margin of superiority was set\nat 14%, which is a relatively high. This margin was considered because\nalthough calcimycin and SrCl2 appear safe, this safety has not been\nproved unequivocally (Yeste et al., 2016).\nOur study has several strengths.", "mimetype": "text/plain", "start_char_idx": 26286, "end_char_idx": 28319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d0443bed-a471-4bba-9f65-453c6d965e51": {"__data__": {"id_": "d0443bed-a471-4bba-9f65-453c6d965e51", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dfbafac1-47dc-49d4-856b-d18e0c6cf151", "node_type": "1", "metadata": {}, "hash": "0a6be7eadadd013b16a3348a513b1e4e9daea3c4cd414790f9c9736a58b61bff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28a7fb70-a880-47ab-a0b9-3704cdf20754", "node_type": "1", "metadata": {}, "hash": "81abb5aaac263fac654817a291feea8d3e6d0dc756cf3ad375f6125f07450343", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This margin was considered because\nalthough calcimycin and SrCl2 appear safe, this safety has not been\nproved unequivocally (Yeste et al., 2016).\nOur study has several strengths. It represents, to our knowledge,\nthe \ufb01rst RCT with an appropriate sample size to compare SrCl2 to cal-\ncimycin for AOA. Although clinical pregnancy was the primary out-\ncome, ongoing pregnancy and live birth rates were also assessed. Our\n...........................................................\n........................................\n........................................\n..............................................................................................................................................................................................\nTable II Clinical Outcomes in the trial groups by intention-to-treat analysis.\nArti\ufb01cial oocyte activation (AOA)\ngroups (%)\nAbsolute rate difference,\npercentage points (95% CI)\nOdds ratio (95% CI)\nSrCl2\nAOA\n(n = 115)\nCalcimycin\nAOA\n(n = 113)\nControl\n(no AOA)\n(n = 115)\nSrCl2 to\ncontrol\nCalcimycin\nto control\nSrCl2 to\ncontrol\nCalcimycin\nto control\nCancelled transfer rate\n7/115\n(6)\n14/113\n(12)\n12/115\n(10)\n\u22124.3\n(\u221212 to 3)\n2\n(\u22126.5 to 11)\n0.56\n(0.21\u20131.47)\nP = 0.23\n1.21\n(0.54\u20132.75)\nP = 0.64\nBiochemical pregnancy rate\n62/115\n(54)\n61/113\n(54)\n39/115\n(34)\n20\n(7\u201332)\n20\n(7\u201332)\n2.28\n(1.34\u20133.88)\nP = 0.002\n2.29\n(1.34\u20133.90)\nP = 0.002\nClinical pregnancy rate\n56/115\n(49)\n48/113\n(42)\n31/115\n(27)\n22\n(9\u201333)\n16\n(3\u201327)\n2.57\n(1.48\u20134.46)\nP = 0.0007\n2.0\n(1.15\u20133.49)\nP = 0.014\nChemical pregnancy rate\n6/115\n(5)\n13/113\n(11)\n8/115\n(7)\n\u22121.", "mimetype": "text/plain", "start_char_idx": 28141, "end_char_idx": 29709, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28a7fb70-a880-47ab-a0b9-3704cdf20754": {"__data__": {"id_": "28a7fb70-a880-47ab-a0b9-3704cdf20754", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d0443bed-a471-4bba-9f65-453c6d965e51", "node_type": "1", "metadata": {}, "hash": "7191b0caab0f55cfa74e5f5436861ea4f3dd85b13629d1fb2c0747f4ac519f0e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9d74a9ed-13b3-4c0f-ad72-11d74f83b371", "node_type": "1", "metadata": {}, "hash": "4eef9566d374bc84a6f6b5a24ef72af96953326447c703df81f3c6888a3beeb6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0\n(1.15\u20133.49)\nP = 0.014\nChemical pregnancy rate\n6/115\n(5)\n13/113\n(11)\n8/115\n(7)\n\u22121.7\n(\u22128 to 5)\n5\n(\u22123 to 13)\n0.74\n(0.25\u20132.19)\nP = 0.58\n1.74\n(0.69\u20134.37)\nP = 0.24\nOngoing pregnancy rate\n48/115\n(42)\n41/113\n(36)\n26/115\n(23)\n19 (7\u201330)\n14 (2\u201325)\n2.45\n(1.38\u20134.35)\nP = 0.0019\n1.95\n(1.10\u20133.49)\nP = 0.023\nMiscarriage rate\n14/115\n(12)\n20/113\n(18)\n13/115\n(11)\n0.9\n(\u22128 to 9.4)\n6.4\n(\u22122.9 to 15.7)\n1.09\n(0.49\u20132.43)\nP = 0.84\n1.69\n(0.79\u20133.58)\nP = 0.17\nMultiple pregnancy rate\n5/115\n(4)\n4/113\n(4)\n2/115\n(2)\n2.6\n(\u22122.4 to 8.2)\n1.8\n(\u22123.1 to 7.2)\n2.57\n(0.49\u201313.5)\nP = 0.45\n2.07\n(0.37\u201311.6)\nP = 0.44\nImplantation rate\n61/190\n(32)\n52/184\n(28)\n33/182\n(18)\n14\n(5\u201323)\n10\n(2\u201319)\n2.14\n(1.31\u20133.47)\nP = 0.0019\n1.78\n(1.08\u20132.92)\nP = 0.022\nLive birth rate\n46/115\n(40)\n37/113\n(33)\n21/115\n(18)\n22\n(10\u201333)\n14\n(3\u201325)\n2.98\n(1.63\u20135.45)\nP = 0.", "mimetype": "text/plain", "start_char_idx": 29626, "end_char_idx": 30427, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9d74a9ed-13b3-4c0f-ad72-11d74f83b371": {"__data__": {"id_": "9d74a9ed-13b3-4c0f-ad72-11d74f83b371", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28a7fb70-a880-47ab-a0b9-3704cdf20754", "node_type": "1", "metadata": {}, "hash": "81abb5aaac263fac654817a291feea8d3e6d0dc756cf3ad375f6125f07450343", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f9e7d081-4d2e-4cad-bcfa-55c630269e65", "node_type": "1", "metadata": {}, "hash": "f21238277c6d53100e2fade0ca413dcbdd6b713bb0dffd6d75a80e30dfa94719", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "98\n(1.63\u20135.45)\nP = 0.0002\n2.18\n(1.18\u20134.03)\nP = 0.012\nLive-birth-implantation rate\n46/190\n(24)\n37/184\n(20)\n21/182\n(12)\n13\n(5\u201320)\n9\n(1\u201316)\n2.45\n(1.39\u20134.30)\nP = 0.0015\n1.93\n(1.08\u20133.45)\nP = 0.025\nThe logistic regression analysis veri\ufb01ed that there was no association between the primary outcome and the confounding variables including each centre\u2019s cycle characteristics, except\nfor SrCl2 AOA and Calcimycin AOA. Chemical pregnancy indicates a positive pregnancy test with no gestational sac identi\ufb01ed 15 days after the test.\n1641\nSrCl2 and calcimycin regulate oocyte activation\n...............................................................\n.................................................\n.................................................\n..........................................................................................................................................................................................................................................................\nTable III Embryological outcomes in the trial groups.\nArti\ufb01cial oocyte activation (AOA)\ngroups (%)\nAbsolute rate difference,\npercentage points (95% CI)\nOdds ratio (95% CI)\nSrCl2\nAOA (n\n= 115)\nCalcimycin\nAOA\n(n = 113)\nControl (no\nAOA)\n(n = 115)\nSrCl2 to control\nCalcimycin to\ncontrol\nSrCl2 to control\nCalcimycin to\ncontrol\nMaturation rate: MII oocytes/collected oocytes\n1377/\n1581\n(87)\n1310/1483\n(88)\n1180/1329\n(89)\n\u22121.7\n(\u22124.1 to 0.7)\n\u22120.45\n(\u22122.8 to 1.9)\n0.85\n(0.68\u20131.07)\nP = 0.16\n0.96\n(0.76\u20131.21)\nP = 0.71\nFertilization rate: 2PN oocytes/injected MII oocytes\n1168/\n1377\n(85)\n874/1310\n(67)\n720/1180\n(61)\n24\n(20\u201327)\n5.7\n(1.9\u20139.5)\n3.", "mimetype": "text/plain", "start_char_idx": 30406, "end_char_idx": 32026, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f9e7d081-4d2e-4cad-bcfa-55c630269e65": {"__data__": {"id_": "f9e7d081-4d2e-4cad-bcfa-55c630269e65", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9d74a9ed-13b3-4c0f-ad72-11d74f83b371", "node_type": "1", "metadata": {}, "hash": "4eef9566d374bc84a6f6b5a24ef72af96953326447c703df81f3c6888a3beeb6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "125ed0df-0871-4111-9472-447f458f1959", "node_type": "1", "metadata": {}, "hash": "3cd2b54abd402e9c60f3c4c0520ed2f7315a8b5e822609e73694b1d2b640eb8c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7\n(1.9\u20139.5)\n3.57\n(2.96\u20134.31)\nP < 0.0001\n1.28\n(1.09\u20131.51)\nP = 0.003\nCleavage rate: cleaved embryos/fertilized oocytes\n1134/\n1168\n(97)\n854/874\n(98)\n702/720\n(98)\n\u22120.4\n(\u22121.9 to 1.2)\n0.2\n(\u22121.3 to 1.8)\n0.86\n(0.48\u20131.53)\nP = 0.597\n1.09\n(0.5\u201372.09)\nP = 0.78\nTop-quality Day 3 embryos/fertilized oocytes\n1021/\n1168\n(87)\n513/874\n(59)\n413/720\n(57)\n30\n(26\u201334)\n1.3\n(3.5\u20136.0)\n5.16\n(4.11\u20136.48)\nP < 0.0001\n1.06\n(0.87\u20131.29)\nP = 0.59\nCompaction rate: compacted Day 3 embryos/fertilized\noocytes\n518/1168\n(44)\n212/874\n(24)\n189/720\n(26)\n18\n(14\u201322)\n\u22122\n(\u22126.3 to 2.3)\n2.24\n(1.83\u20132.74)\nP < 0.0001\n0.89\n(0.72\u20131.13)\nP = 0.36\nBlastocyst formation rate: blastocysts/fertilized oocytes\n722/1168\n(62)\n447/874\n(51)\n328/720\n(46)\n17\n(12\u201321)\n5.6\n(0.7\u201310.5)\n1.93\n(1.60\u20132.34)\nP < 0.0001\n1.25\n(1.03\u20131.52)\nP = 0.026\nHigh-quality blastocysts/fertilized oocytes\n475/1168\n(41)\n232/874\n(27)\n195/720\n(27)\n14\n(9\u201318)\n\u22120.5\n(\u22120.5 to 0.", "mimetype": "text/plain", "start_char_idx": 32012, "end_char_idx": 32898, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "125ed0df-0871-4111-9472-447f458f1959": {"__data__": {"id_": "125ed0df-0871-4111-9472-447f458f1959", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f9e7d081-4d2e-4cad-bcfa-55c630269e65", "node_type": "1", "metadata": {}, "hash": "f21238277c6d53100e2fade0ca413dcbdd6b713bb0dffd6d75a80e30dfa94719", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d9bdb48-1770-495d-ad8a-b424674f1e8d", "node_type": "1", "metadata": {}, "hash": "2f6639bab6e476c83cdb87059caf5c5e0be15eef29a8e1afb04f5cb9a18d9ea9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5\n(\u22120.5 to 0.4)\n1.85\n(1.51\u20132.26)\nP < 0.0001\n0.97\n(0.78\u20131.22)\nP = 0.806\nCryopreservation rate: vitri\ufb01ed blastocysts/fertilized oocytes\n518/1168\n(44)\n251/874\n(29)\n133/720\n(18)\n26\n(22\u201330)\n6.1\n(6\u201314)\n3.52\n(2.82\u20134.39)\nP < 0.0001\n1.7\n(1.40\u20132.26)\nP < 0.0001\n2PN, two pronuclei; MII, metaphase II.\n1642\nFawzy et al.\n\ufb01ndings provide insight into the relative suitability of SrCl2 and calcimy-\ncin for AOA for particular causes of infertility, which can improve the\noutcomes for subgroups of patients who experience poor outcomes\nof ICSI.\nOur study also has several limitations. The open-label trial design\nmight have introduced bias, although randomization, at least partly,\naddressed this possibility. The study did not include a longitudinal\nfollow-up period, so further evidence regarding the safety of AOA is\nstill required. The study included couples with different indications for\nICSI, rather than focusing on a single subgroup, but post hoc analyses\nwere performed to determine the particular effects of AOA in these\nsubgroups.\nIn conclusion, in our study population, ICSI followed by AOA with\nSrCl2 or calcimycin was associated with signi\ufb01cantly better embryo-\nlogical and clinical outcomes than ICSI alone. Calcimycin AOA appears\neffective in overcoming defects related to abnormal sperm morph-\nology, whereas SrCl2 AOA appears to improve outcomes for ICSI\ncycles characterized by previous impaired fertilization. In consideration\nof the current lack of knowledge regarding the long-term safety and\ntransgenerational effects of AOA, we do not recommend this treat-\nment for the general ICSI population. Instead, we recommend that\nmore studies are performed, to further elucidate the mechanisms that\nunderlie our \ufb01ndings, in particular those related to SrCl2 AOA.", "mimetype": "text/plain", "start_char_idx": 32885, "end_char_idx": 34648, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d9bdb48-1770-495d-ad8a-b424674f1e8d": {"__data__": {"id_": "6d9bdb48-1770-495d-ad8a-b424674f1e8d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "125ed0df-0871-4111-9472-447f458f1959", "node_type": "1", "metadata": {}, "hash": "3cd2b54abd402e9c60f3c4c0520ed2f7315a8b5e822609e73694b1d2b640eb8c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4322125-12ef-4859-a757-44962fa1d4e8", "node_type": "1", "metadata": {}, "hash": "f11714c577c7434b4064cc7707734df28ca4c9a8a30d9b8b15840aaf503867f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Instead, we recommend that\nmore studies are performed, to further elucidate the mechanisms that\nunderlie our \ufb01ndings, in particular those related to SrCl2 AOA. We\nalso recommend that a multicentre trial is conducted to identify the\ncumulative live birth rate and to assess the health of the offspring as\nprimary outcomes. Until these studies have been conducted, we rec-\nommend that AOA should be used cautiously, and the advantages and\ndisadvantages regarding its use should be weighed in each case.\nSupplementary data\nSupplementary data are available at Human Reproduction online.\nAcknowledgements\nThe authors thank the IbnSina IVF laboratory team for their dedicated\nefforts during the study, especially Dr Ahmed AlAboudy and Dr\nMostafa Ail.\nAuthors\u2019 roles\nM.F. created the concept and design of the study, was the primary\ninvestigator and wrote the article. M.E. participated in the investigation\nas well as the collection, analysis and interpretation of the data. All\nother authors participated in critically reviewing the concept upon\nwhich the study was conducted and participated in the investigation.\nAll authors critically revised the manuscript and gave their \ufb01nal\napproval of the version for publication.\nFunding\nThe research was not funded by any agency.\nCon\ufb02ict of interest\nThe authors have no con\ufb02icts of interest to declare.\nREFERENCES\nAlpha Scientists in Reproductive Medicine and ESHRE Special Interest\nGroup of Embryology. Alpha Scientists in Reproductive Medicine and\nESHRE Special Interest Group of Embryology. The Istanbul consensus\nworkshop on embryo assessment: proceedings of an expert meeting.\nHum Reprod 2011;26:1270\u20131283.\nAmdani SN, Jones C, Coward K. Phospholipase C zeta (PLC\u03b6): oocyte\nactivation and clinical links to male factor infertility. Adv Biol Regul 2013;\n53:292\u2013308.\nBj\u00f6rndahl L, Mortimer D, Barratt CLR, Castilla JA, Menkveld R, Kvist U,\nAlvarez JG, Haugen TB. A Practical Guide to Basic Laboratory Andrology.\nCambridge, UK: Cambridge University Press, 2010.", "mimetype": "text/plain", "start_char_idx": 34489, "end_char_idx": 36488, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d4322125-12ef-4859-a757-44962fa1d4e8": {"__data__": {"id_": "d4322125-12ef-4859-a757-44962fa1d4e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d9bdb48-1770-495d-ad8a-b424674f1e8d", "node_type": "1", "metadata": {}, "hash": "2f6639bab6e476c83cdb87059caf5c5e0be15eef29a8e1afb04f5cb9a18d9ea9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c2b9d7d-16a5-4164-a233-bae304d3829a", "node_type": "1", "metadata": {}, "hash": "fc5c0321ee113960ba245e2b97e5add833e59e31f51254c798cfb80eeb5bc51e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A Practical Guide to Basic Laboratory Andrology.\nCambridge, UK: Cambridge University Press, 2010.\nChen J, Qian Y, Tan Y, Mima H. Successful pregnancy following\noocyte activation by strontium in normozoospermic patients of\nunexplained infertility with fertilisation failures during previous\nintracytoplasmic sperm injection treatment. Reprod Fertil Dev 2010;\n22:852\u2013855.\nCheng D, Li J, Guo C-C, Xiong C-L. [Failed fertilization after ICSI: causes\nand countermeasures]. Zhonghua Nan Ke Xue 2011;17:1131\u20131134.\nClift D, Schuh M. Restarting life: fertilization and the transition from meiosis\nto mitosis. Nat Rev Mol Cell Biol 2013;14:549\u2013562.\nCombelles CMH, Morozumi K, Yanagimachi R, Zhu L, Fox JH, Racowsky\nC. Diagnosing cellular defects in an unexplained case of total fertilization\nfailure. Hum Reprod 2010;25:1666\u20131671.\nDe Vos A, Van De Velde H, Joris H, Verheyen G, Devroey P, Van\nSteirteghem A. In\ufb02uence of individual sperm morphology on fertilization,\nembryo morphology, and pregnancy outcome of intracytoplasmic sperm\ninjection. Fertil Steril 2003;79:42\u201348.\nDucibella T, Huneau D, Angelichio E, Xu Z, Schultz RM, Kopf GS, Fissore\nR, Madoux S, Ozil JP. Egg-to-embryo transition is driven by differential\nresponses to Ca2+ oscillation number. Dev Biol 2002;250:280\u2013291.\nEbner T, Montag M, Montag M, Van Der Ven K, Van Der Ven H, Ebner T,\nShebl O, Oppelt P, Hirchenhain J, Kr\u00fcssel J et al. Live birth after arti\ufb01cial\noocyte activation using a ready-to-use ionophore: a prospective multi-\ncentre study. Reprod Biomed Online 2015;30:359\u2013365.", "mimetype": "text/plain", "start_char_idx": 36391, "end_char_idx": 37932, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c2b9d7d-16a5-4164-a233-bae304d3829a": {"__data__": {"id_": "8c2b9d7d-16a5-4164-a233-bae304d3829a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4322125-12ef-4859-a757-44962fa1d4e8", "node_type": "1", "metadata": {}, "hash": "f11714c577c7434b4064cc7707734df28ca4c9a8a30d9b8b15840aaf503867f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3a8e8a9e-42ad-474e-bda9-68abc4364850", "node_type": "1", "metadata": {}, "hash": "3c846f4d1254783a2f0f6cb9c7d74e8acd1771b018a17edda5d6d021e7476d1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Live birth after arti\ufb01cial\noocyte activation using a ready-to-use ionophore: a prospective multi-\ncentre study. Reprod Biomed Online 2015;30:359\u2013365.\nEbner T, Moser M, Tews G. Is oocyte morphology prognostic of embryo\ndevelopmental potential after ICSI? Reprod Biomed Online 2006;12:\n507\u2013512.\nEldar-Geva T, Brooks B, Margalioth EJ, Zylber-Haran E, Gal M, Silber SJ.\nSuccessful pregnancy and delivery after calcium ionophore oocyte acti-\nvation in a normozoospermic patient with previous repeated failed fertil-\nization after intracytoplasmic sperm injection. Fertil Steril 2003;79:\n1656\u20131658.\nEscof\ufb01er J, Yassine S, Lee HC, Martinez G, Delaroche J, Coutton C,\nKaraouz\u00e9ne T, Zouari R, Metzler-Guillemain C, Pernet-Gallay K et al.\nSubcellular localization of phospholipase Cz in human sperm and its\nabsence in DPY19L2-de\ufb01cient sperm are consistent with its role in\noocyte activation. Mol Hum Reprod 2014;21:157\u2013168.\nFerrer-Buitrago M, Dhaenens L, Lu Y, Bonte D, Meerschaut F Vanden,\nSutter P De, Leybaert L, Heindryckx B. Human oocyte calcium ana-\nlysis predicts the response to assisted oocyte activation in patients\nexperiencing fertilization failure after ICSI. Hum Reprod 2018;33:\n416\u2013425.\nFlaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal fer-\ntilization after intracytoplasmic sperm injection. Hum Reprod 1998;13:\n155\u2013164.", "mimetype": "text/plain", "start_char_idx": 37783, "end_char_idx": 39130, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3a8e8a9e-42ad-474e-bda9-68abc4364850": {"__data__": {"id_": "3a8e8a9e-42ad-474e-bda9-68abc4364850", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c2b9d7d-16a5-4164-a233-bae304d3829a", "node_type": "1", "metadata": {}, "hash": "fc5c0321ee113960ba245e2b97e5add833e59e31f51254c798cfb80eeb5bc51e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ee1c34f8-f078-44ea-9049-7b9e0bb54e1c", "node_type": "1", "metadata": {}, "hash": "68c403f284cadbc4f5b6a3ed59f74b58b45a90d103ba4a9ef6bf265485e4d8e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Flaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal fer-\ntilization after intracytoplasmic sperm injection. Hum Reprod 1998;13:\n155\u2013164.\nGreco E, Scarselli F, Fabozzi G, Colasante A, Zavaglia D, Alviggi E, Litwicka\nK, Varricchio MT, Minasi MG, Tesarik J. Sperm vacuoles negatively affect\noutcomes in intracytoplasmic morphologically selected sperm injection\nin terms of pregnancy, implantation, and live-birth rates. Fertil Steril\n2013;100:379\u2013385.\n1643\nSrCl2 and calcimycin regulate oocyte activation\nHeindryckx B, De Gheselle S, Gerris J, Dhont M, De Sutter P. Ef\ufb01ciency of\nassisted oocyte activation as a solution for failed intracytoplasmic sperm\ninjection. Reprod Biomed Online 2008;17:662\u2013668.\nHeindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option for\nsperm- or oocyte-related fertilization failure: assisted oocyte activation\nfollowing\ndiagnostic\nheterologous\nICSI.\nHum\nReprod\n2005;20:\n2237\u20132241.\nHorner VL, Wolfner MF. Transitioning from egg to embryo: triggers and\nmechanisms of egg activation. Dev Dyn 2008;237:527\u2013544.\nKashir J, Heindryckx B, Jones C, De Sutter P, Parrington J, Coward K.\nOocyte activation, phospholipase C zeta and human infertility. Hum\nReprod Update 2010;16:690\u2013703.\nKilani S, Chapman MG. Meiotic spindle normality predicts live birth in patients\nwith recurrent in vitro fertilization failure. Fertil Steril 2014;101:403\u20136.\nKim JW, Kim SD, Yang SH, Yoon SH, Jung JH, Lim JH. Successful pregnancy\nafter SrCl2 oocyte activation in couples with repeated low fertilization\nrates following calcium ionophore treatment. Syst Biol Reprod Med 2014;\n60:177\u2013182.", "mimetype": "text/plain", "start_char_idx": 38975, "end_char_idx": 40592, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee1c34f8-f078-44ea-9049-7b9e0bb54e1c": {"__data__": {"id_": "ee1c34f8-f078-44ea-9049-7b9e0bb54e1c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3a8e8a9e-42ad-474e-bda9-68abc4364850", "node_type": "1", "metadata": {}, "hash": "3c846f4d1254783a2f0f6cb9c7d74e8acd1771b018a17edda5d6d021e7476d1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "250ffe8d-017a-47da-b440-3bdeb2faf3ac", "node_type": "1", "metadata": {}, "hash": "c066fb1ab19d20c3bd7407e2a47522cd0b25d647de245c2a088c1e56ea865528", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Successful pregnancy\nafter SrCl2 oocyte activation in couples with repeated low fertilization\nrates following calcium ionophore treatment. Syst Biol Reprod Med 2014;\n60:177\u2013182.\nKishikawa H, Wakayama T, Yanagimachi R. Comparison of oocyte-\nactivating agents for mouse cloning. Cloning 1999;1:153\u2013159.\nKissin DM, Jamieson DJ, Bar\ufb01eld WD. Monitoring health outcomes of\nassisted reproductive technology. N Engl J Med 2014;371:91\u201393.\nKline D, Kline JT. Repetitive calcium transients and the role of calcium in\nexocytosis and cell cycle activation in the mouse egg. Dev Biol 1992;149:\n80\u201389.\nLu Y, Gao H, Li B, Zheng Y, Ye Y, Qian Y, Xu C, Huang H, Jin F. Different\nsperm sources and parameters can in\ufb02uence intracytoplasmic sperm\ninjection outcomes before embryo implantation. J Zhejiang Univ Sci B\n2012;13:1\u201310.\nLuYReddyRBuitragoMFVander Jeught MNeupaneJDe VosWHVan Den\nAbbeelELiermanSDe SutterPHeindryckxB2018Strontium fails to induce\nCa2+ release and activation in human oocytes despite the presence of\nfunctional TRPV3 channelsHum Reprod Open31\u201311\nMcHugh ML. Interrater reliability: the kappa statistic. Biochem Med 2012;\n22:276\u2013282.\nMiyara F, Aubriot FX, Glissant A, Nathan C, Douard S, Stanovici A, Herve\nF, Dumont-Hassan M, LeMeur A, Cohen-Bacrie P et al. Multiparameter\nanalysis of human oocytes at metaphase II stage after IVF failure in non-\nmale infertility. Hum Reprod 2003;18:1494\u20131503.\nMiyazaki S, Shirakawa H, Nakada K, Honda Y. Essential role of the inositol\n1,4,5-trisphosphate receptor/Ca2+ release channel in Ca2+ waves and Ca2\n+ oscillations at fertilization of mammalian eggs.", "mimetype": "text/plain", "start_char_idx": 40415, "end_char_idx": 42008, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "250ffe8d-017a-47da-b440-3bdeb2faf3ac": {"__data__": {"id_": "250ffe8d-017a-47da-b440-3bdeb2faf3ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ee1c34f8-f078-44ea-9049-7b9e0bb54e1c", "node_type": "1", "metadata": {}, "hash": "68c403f284cadbc4f5b6a3ed59f74b58b45a90d103ba4a9ef6bf265485e4d8e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2724d647-5b6a-4b3b-9b98-8f518e8d11d7", "node_type": "1", "metadata": {}, "hash": "8f15ed3bc99623d3c321d4fe10951580ce15f7a91c287ff5439b20b81069eb2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dev Biol 1993;158:62\u201378.\nMiyazaki S, Yuzaki M, Nakada K, Shirakawa H, Nakanishi S, Nakade S,\nMikoshiba K. Block of Ca2+ wave and Ca2+ oscillation by antibody to\nthe inositol 1,4,5-trisphosphate receptor in fertilized hamster eggs.\nScience 1992;257:251\u2013255.\nMontag M, K\u00f6ster M, van der Ven K, Bohlen U, van der Ven H. The bene\ufb01t\nof arti\ufb01cial oocyte activation is dependent on the fertilization rate in a\nprevious treatment cycle. Reprod Biomed Online 2012;24:521\u2013526.\nMurugesu S, Saso S, Jones BP, Bracewell-Milnes T, Athanasiou T, Mania A,\nSerhal P, Ben-Nagi J. Does the use of calcium ionophore during arti\ufb01cial\noocyte activation demonstrate an effect on pregnancy rate? A meta-\nanalysis. Fertil Steril 2017;108:468\u2013482.e3.\nNomikos M, Kashir J, Swann K, Lai FA. Sperm PLC\u03b6: from structure to\nCa2+ oscillations, egg activation and therapeutic potential. FEBS Lett\n2013;587:3609\u20133616.\nPalermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after\nintracytoplasmic injection of single spermatozoon into an oocyte. Lancet\n1992;340:17\u201318.\nRidgway EB, Gilkey JC, Jaffe LF. Free calcium increases explosively in acti-\nvating medaka eggs. Proc Natl Acad Sci USA 1977;74:623\u2013627.\nRybouchkin AV, De Sutter P, Van Der Straeten F, Dhont M, Quatacker J.\nFertilization and pregnancy after assisted oocyte activation and intracyto-\nplasmic sperm injection in a case of round-headed sperm associated with\nde\ufb01cient oocyte activation capacity. Fertil Steril 1997;68:1144\u20131147.", "mimetype": "text/plain", "start_char_idx": 42009, "end_char_idx": 43475, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2724d647-5b6a-4b3b-9b98-8f518e8d11d7": {"__data__": {"id_": "2724d647-5b6a-4b3b-9b98-8f518e8d11d7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "250ffe8d-017a-47da-b440-3bdeb2faf3ac", "node_type": "1", "metadata": {}, "hash": "c066fb1ab19d20c3bd7407e2a47522cd0b25d647de245c2a088c1e56ea865528", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b178f845-2267-44fa-a1ac-3cd03cb59397", "node_type": "1", "metadata": {}, "hash": "3d13fcc8a0b3ffb029ca6c493101909e134676a7efbc3bc1eb6f80592248cf4b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertil Steril 1997;68:1144\u20131147.\nSaunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM,\nSwann K, Lai FA. PLC zeta: a sperm-speci\ufb01c trigger of Ca(2+) oscilla-\ntions in eggs and embryo development. Development 2002;129:3533\u2013\n3544.\nSfontouris IA, Nastri CO, Lima MLS, Tahmasbpourmarzouni E, Raine-Fenning\nN, Martins WP. Arti\ufb01cial oocyte activation to improve reproductive out-\ncomes in women with previous fertilization failure: a systematic review and\nmeta-analysis of RCTs. Hum Reprod 2015;30:1831\u20131841.\nSteinhardt R, Zucker R, Schatten G. Intracellular calcium release at fertiliza-\ntion in the sea urchin egg. Dev Biol 1977;58:185\u2013196.\nSteptoe PC, Edwards RG. Birth after the reimplantation of a human\nembryo. Arch Pathol Lab Med 1992;116:321.\nTesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modi\ufb01ed intra-\ncytoplasmic sperm injection technique to overcome sperm-borne and\noocyte-borne oocyte activation failures. Fertil Steril 2002;78:619\u2013624.\nVanden Meerschaut F, Leybaert L, Nikiforaki D, Qian C, Heindryckx B, De\nSutter P. Diagnostic and prognostic value of calcium oscillatory pattern ana-\nlysis for patients with ICSI fertilization failure. Hum Reprod 2013;28:87\u201398.\nVanden Meerschaut F, Nikiforaki D, De Gheselle S, Dullaerts V, Van Den\nAbbeel E, Gerris J, Heindryckx B, De Sutter P. Assisted oocyte activa-\ntion is not bene\ufb01cial for all patients with a suspected oocyte-related acti-\nvation de\ufb01ciency. Hum Reprod 2012;27:1977\u20131984.", "mimetype": "text/plain", "start_char_idx": 43443, "end_char_idx": 44907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b178f845-2267-44fa-a1ac-3cd03cb59397": {"__data__": {"id_": "b178f845-2267-44fa-a1ac-3cd03cb59397", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Ebner (2004).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2724d647-5b6a-4b3b-9b98-8f518e8d11d7", "node_type": "1", "metadata": {}, "hash": "8f15ed3bc99623d3c321d4fe10951580ce15f7a91c287ff5439b20b81069eb2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod 2012;27:1977\u20131984.\nVanden Meerschaut F, Nikiforaki D, Heindryckx B, De Sutter P. Assisted\noocyte activation following ICSI fertilization failure. Reprod Biomed Online\n2014;28:560\u2013571.\nWassarman PM, Jovine L, Litscher ES. A pro\ufb01le of fertilization in mammals.\nNat Cell Biol 2001;3:E59\u2013E64.\nXing X, Zhao H, Li M, Sun M, Li Y, Chen ZJ. Morphologically abnormal\noocytes not capable of fertilization despite repeated strategies. Fertil\nSteril 2011;95:2435.e5\u20137.\nYanagida K, Morozumi K, Katayose H, Hayashi S, Sato A. Successful preg-\nnancy after ICSI with strontium oocyte activation in low rates of fertiliza-\ntion. Reprod Biomed Online 2006;13:801\u2013806.\nYelumalai S, Yeste M, Jones C, Amdani SN, Kashir J, Mounce G, Silva SJM\nDa, Barratt CL, McVeigh E, Coward K. Total levels, localization patterns,\nand proportions of sperm exhibiting phospholipase C zeta are signi\ufb01-\ncantly correlated with fertilization rates after intracytoplasmic sperm\ninjection. Fertil Steril 2015;104:561\u2013568.e4.\nYeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activation de\ufb01-\nciency: a role for an oocyte contribution? Hum Reprod Update 2016;22:\n23\u201347.\n1644\nFawzy et al.", "mimetype": "text/plain", "start_char_idx": 44878, "end_char_idx": 46037, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2d028516-59a7-40b6-bf83-6df150680417": {"__data__": {"id_": "2d028516-59a7-40b6-bf83-6df150680417", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ea66c1a-91b3-4442-9f5e-fc78966c9ca7", "node_type": "1", "metadata": {}, "hash": "00b1ce219f19d790f3c3eac2a852d8add5776ef48e82749e245a37988c82d8ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vol.:(0123456789)\n1 3\nhttps://doi.org/10.1007/s10815-022-02467-3\nEMBRYO BIOLOGY\nEffect of\u00a0A23187 ionophore treatment on\u00a0human blastocyst \ndevelopment\u2014a sibling oocyte study\nIleana\u00a0Mateizel1\u200a \u00a0\u00b7 Samuel\u00a0Santos\u2011Ribeiro2\u00a0\u00b7 Ingrid\u00a0Segers1\u00a0\u00b7 Koen\u00a0Wouters1\u00a0\u00b7 Shari\u00a0Mackens1\u00a0\u00b7 Greta\u00a0Verheyen1\nReceived: 4 October 2021 / Accepted: 15 March 2022 \n\u00a9 The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022\nAbstract\nPurpose\u2002 To investigate whether treatment with commercially available ready-to-use A23187 ionophore (GM508-CultActive) \nimproves embryo development outcome in patients with a history of embryo developmental problems.\nMethods\u2002 This is a uni-center prospective study in which sibling oocytes of patients with embryos of poor quality on day 5 \nin the previous cycle were treated or not with CultActive.\nResults\u2002 Two hundred forty-seven metaphase II (MII) oocytes from 19 cycles performed between 2016 and 2019 were \nincluded in the study. After ICSI, the sibling oocytes were assigned to the treatment group or to the control group, following \nan electronically generated randomization list. A number of 122 MII were treated with CultActive and 125 MII had no treat-\nment and were assigned to the control group. No difference in fertilization rate (p\u2009=\u20090.255) or in the capacity of embryos to \nreach good quality on day 5 (p\u2009=\u20090.197) was observed between the two groups. The utilization rates defined as the number of \nembryos transferred or cryopreserved per mature oocyte (p\u2009=\u20090.438) or per fertilized oocytes (p\u2009=\u20090.299) were not significantly \ndifferent between the treated group and the control group.\nConclusion\u2002 The results of the current study do not support the use of CultActive in cases with embryo developmental \nproblems.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1788, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7ea66c1a-91b3-4442-9f5e-fc78966c9ca7": {"__data__": {"id_": "7ea66c1a-91b3-4442-9f5e-fc78966c9ca7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2d028516-59a7-40b6-bf83-6df150680417", "node_type": "1", "metadata": {}, "hash": "0449614766c3e220d9f1c41fd0af3af658956a45ff725ed2c6f06055bb160224", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ccade27f-a9d5-44bd-b5cc-439350da0245", "node_type": "1", "metadata": {}, "hash": "5df1adea3d4dedd72307f71b61708ca1adf3765888ac3abde26c59906e5363f8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusion\u2002 The results of the current study do not support the use of CultActive in cases with embryo developmental \nproblems.\nKeywords\u2002 Assisted oocyte activation\u00a0\u00b7 A23187 ionophore\u00a0\u00b7 CultActive\u00a0\u00b7 Blastocyst development\nIntroduction\nThe development of the preimplantation human embryo \nbegins with fertilization of the oocyte followed by succes-\nsive cell divisions and cell differentiation events that lead to \nthe formation of the blastocyst able to implant in the endo-\nmetrial tissue.\nFor fertilization to take place, the sperm should pro-\nvide factors necessary to induce calcium oscillations in \nthe ooplasm and consequently to activate the oocyte. This \nsperm-derived oocyte-activating factor, identified as phos-\npholipase C zeta [1, 2], catalyzes the hydrolysis of phos-\nphatidylinositol 4,5-bisphosphate (PIP2) leading to the \ngeneration of diacylglycerol (DAG) and inositol triphosphate \n(IP3) [3]. The IP3 binds to its receptors on the membrane \nof the endoplasmic reticulum and induces calcium release \ninto the cytoplasm that will generate \u00adCa2+ oscillations [4] \nnecessary for oocyte fertilization and embryo development \n[5]. These oscillations will last for several hours and modu-\nlate essential processes leading to oocyte activation: cortical \ngranule exocytosis, block to polyspermy, cell cycle resump-\ntion, and recruitment of maternal mRNA [6, 7].\nThe absence of \u00adCa2+ oscillations leads to failed or poor \noocyte fertilization, as in the cases of globozoospermia or \nspermatozoa of poor quality where the lack of the sperm \noocyte activation factor is considered responsible [8, 9]. The \nuse of \u00adCa2+ ionophores, such as ionomycin or calcimycin \n(A23187) during the ICSI procedure artificially increases the \nlevel of intracytoplasmic \u00adCa2+, allowing the events of fertili-\nzation to take place (assisted oocyte activation, AOA).", "mimetype": "text/plain", "start_char_idx": 1661, "end_char_idx": 3516, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ccade27f-a9d5-44bd-b5cc-439350da0245": {"__data__": {"id_": "ccade27f-a9d5-44bd-b5cc-439350da0245", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ea66c1a-91b3-4442-9f5e-fc78966c9ca7", "node_type": "1", "metadata": {}, "hash": "00b1ce219f19d790f3c3eac2a852d8add5776ef48e82749e245a37988c82d8ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc9d926e-b13a-4130-b44b-72f8a883bd72", "node_type": "1", "metadata": {}, "hash": "ad37175222b592593b31c8a94274750e42442250db36345f2abd10ea44531b64", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As a \nconsequence, ionomycin is being used in assisted reproduc-\ntive technologies (ART) for cases of previously low or total \nabsence of fertilization after insemination by ICSI.\n *\t Ileana Mateizel \n\t\nileana.mateizel@uzbrussel.be\n1\t\nVrije Universiteit Brussel (VUB), Universitair Ziekenhuis \nBrussel (UZBrussel), Brussels IVF, Laarbeeklaan 101, \n1090\u00a0Brussels, Belgium\n2\t\nInstituto Valenciano de Infertilidade de Lisboa (IVI Lisboa), \nLisboa, Portugal\n/ Published online: 31 March 2022\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\nAn alternative use of \u00adCa2+ ionophores in ART has also \nbeen reported for cases with embryo developmental prob-\nlems [10, 11]. Experiments on mice oocytes showed that \neach of the processes leading to oocyte activation has dif-\nferent requirements in terms of the number of \u00adCa2+ oscil-\nlations necessary for both their initiation and completion \n[12]. Artificial modulation of the amplitude, frequency, and \nduration of \u00adCa2+ oscillations was shown to impact embryo \ndevelopment and have a considerable effect on the post-\nimplantation period [13\u201315]. In addition, it was reported that \nmouse oocyte activation and embryonic development might \nbe mediated by the total summation of \u00adCa2+ peaks during \nthe oscillation period [16\u201318]. As a consequence, A23187 \nionophore (in a ready-to-use, commercially available form \nGM508-CultActive) was used as a strategy to improve \nembryonic development in cases experiencing pronuclear \n[10] or embryonic arrest [11].\nIn the latter study, however, one major limitation was \nthe choice of the control group represented by the previ-\nous cycle of the patient. To overcome this shortcoming, we \ndesigned a prospective study in which sibling oocytes of \npatients with embryos of poor quality on day 5 in the pre-\nvious cycle were treated or not with GM508-CultActive.", "mimetype": "text/plain", "start_char_idx": 3517, "end_char_idx": 5380, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc9d926e-b13a-4130-b44b-72f8a883bd72": {"__data__": {"id_": "dc9d926e-b13a-4130-b44b-72f8a883bd72", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ccade27f-a9d5-44bd-b5cc-439350da0245", "node_type": "1", "metadata": {}, "hash": "5df1adea3d4dedd72307f71b61708ca1adf3765888ac3abde26c59906e5363f8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "92c3cc89-4e8f-4c44-9843-381553d9b8f7", "node_type": "1", "metadata": {}, "hash": "22e70c0a3f2c7a108544796a351e79f5eb10c507a7c00b67f20f1fa1d0b324df", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To overcome this shortcoming, we \ndesigned a prospective study in which sibling oocytes of \npatients with embryos of poor quality on day 5 in the pre-\nvious cycle were treated or not with GM508-CultActive. \nThis study would allow a more accurate investigation of the \nactual influence of the A23187 ionophore on the develop-\nment of embryos derived from the same oocyte cohort as \nthe untreated controls.\nMaterials and\u00a0methods\nStudy population\nICSI cycles performed in our center between January 2016 \nand 2019 were included in the study. Patients were eligible \nfor inclusion in the study if they had undergone at least one \nprevious ICSI cycle in our center with either day 5 transfer \nof embryos of moderate or poor quality or no transfer on day \n5 due to insufficient embryo quality. Therefore, all patients \npresented in the previous cycle only embryos of moderate \nand/or poor quality on day 5. Every patient was included \nonly once. Patients with poor fertilization (<\u200930%) or failed \nfertilization in the previous cycle were excluded from the \nstudy. Cycles with surgically retrieved spermatozoa, egg \nrecipient cycles, in\u00a0vitro maturation cycles, and preimplan-\ntation genetic testing cycles were also excluded. The study \nhas the approval of the Ethical Committee in UZ Brussel (nr \nB.U.N. 143,201,628,846).\nOvarian stimulation and\u00a0oocyte retrieval\nThe ovarian stimulation was performed using either \nhighly purified urinary menotropin (Menopur, Ferring \nPharmaceuticals A/S, Denmark) or recombinant FSH (Pur-\negon, Elonva, Pergoveris, Merck Sharp & Dohme, USA; \nGonal F, Merck, Germany) in combination with either a \nGnRH antagonist (Orgalutran, Merck Sharp & Dohme, \nUSA; Cetrotide\u00ae, Merck, Germany) or agonist (Suprefact, \nAventis Pharma, Germany; Gonapeptyl, Ferring, Switzer-\nland; Decapeptyl, Ipsen Pharma Biotech, France) for pitui-\ntary downregulation.", "mimetype": "text/plain", "start_char_idx": 5175, "end_char_idx": 7045, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92c3cc89-4e8f-4c44-9843-381553d9b8f7": {"__data__": {"id_": "92c3cc89-4e8f-4c44-9843-381553d9b8f7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc9d926e-b13a-4130-b44b-72f8a883bd72", "node_type": "1", "metadata": {}, "hash": "ad37175222b592593b31c8a94274750e42442250db36345f2abd10ea44531b64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "38ddb3f4-a255-491a-9f3d-09bbc8cb50ad", "node_type": "1", "metadata": {}, "hash": "49db64ecfe668e563ec354c2b88d21880fefe176247aa8fe182ed3fd33e9375c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Final oocyte maturation and ovulation \nwere triggered as soon as at least 3 follicles\u2009\u2265\u200917\u00a0mm were \nvisible on transvaginal pelvic ultrasound. Oocyte retrieval \n(OR) was carried out by vaginal ultrasound-guided puncture \nof the ovarian follicles approximately 36\u00a0h after ovulation \ntriggering.\nOocyte retrieval and\u00a0ICSI\nFollowing oocyte retrieval, the cumulus-oocyte-complexes \n(COCs) were placed in Origio\u00aeFert\u2122 medium (Cooper \nSurgical, USA) at 6% \u00adCO2/5% \u00adO2 and 37\u00a0\u00b0C until ICSI pro-\ncedure. The COC denudation was performed in group in a \n100\u00a0\u03bcl ICSICumulase\u00ae drop (Cooper Surgical, USA) cov-\nered with Ovoil (Vitrolife, Sweden). The mature oocytes \n(Metaphase II) were injected in 5\u00a0\u03bcl Quinn\u2019s AdvantageTM \nMedium with Hepes (In-Vitro Fertilization, Inc., Cooper \nSurgical, USA).\nTreatment intervention\nFor the ionophore treatment, the GM508-CultActive bicar-\nbonate-buffered reagent (CultActive) containing an undis-\nclosed concentration of A23187 ionophore (ready-to-use \nA23187 ionophore; Gynemed, Germany, CE labeled) was \nused. For this, 60-cm Petri dishes (353,652, Falcon) were \nprepared as follows: one drop of 30\u00a0\u03bcl CultActive and 2 \ndrops of 40\u00a0\u03bcl Origio\u00aeSequential Cleav\u2122 (Cooper Surgi-\ncal, USA) for each mature oocyte, for a maximum of three \nmature oocytes treated in one dish. The dishes were covered \nwith Ovoil (Vitrolife, Sweden) and placed in the incubator \nfor at least 4\u00a0h at 6% \u00adCO2/5% \u00adO2 and 37\u00a0\u00b0C use to allow \nmedia equilibration prior to use.\nImmediately after ICSI, the sibling oocytes were assigned \nto the treatment group or to the control group, based on an \nelectronically generated randomization list.", "mimetype": "text/plain", "start_char_idx": 7046, "end_char_idx": 8686, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "38ddb3f4-a255-491a-9f3d-09bbc8cb50ad": {"__data__": {"id_": "38ddb3f4-a255-491a-9f3d-09bbc8cb50ad", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "92c3cc89-4e8f-4c44-9843-381553d9b8f7", "node_type": "1", "metadata": {}, "hash": "22e70c0a3f2c7a108544796a351e79f5eb10c507a7c00b67f20f1fa1d0b324df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "742cb966-58c8-4dca-8664-567488fadda6", "node_type": "1", "metadata": {}, "hash": "6b8bab730ea0daa7918dc7f35e6ec2959e0d4acb176f637c46a6a34199deb3c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Immediately after ICSI, the sibling oocytes were assigned \nto the treatment group or to the control group, based on an \nelectronically generated randomization list. The oocytes in \nthe control group were placed directly in Origio\u00aeSequential \nCleav\u2122 medium (see below).\nIn the treatment group, the inseminated oocytes were \nincubated for 15\u00a0min in pre-equilibrated CultActive drops, \nfollowed by two consecutive washing steps in the 40\u00a0\u03bcl drops \nof Origio\u00aeSequential Cleav\u2122 medium. The treated oocytes \nwere further cultured in similar conditions as the ones from \nthe control group (no CultActive treatment after ICSI).\n1226\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\nEmbryo culture and\u00a0evaluation\nFollowing ICSI, the inseminated oocytes (both from treated \nand control groups) were cultured in\u00a0vitro at 37\u00a0\u00b0C in an \natmosphere of 6% \u00adCO2, 5% \u00adO2, and 89% \u00adN2 in individual \n25\u00a0\u03bcl droplets of culture media (Origio\u00aeSequential Cleav\u2122 \nuntil day 3 and Origio\u00aeSequential Blast\u2122 from day 3 until \nday 5/6, Cooper Surgical, USA) covered with oil (Ovoil, \nVitrolife).\nFertilization was assessed 16\u201318\u00a0h after ICSI by the pres-\nence of two pronuclei (PN). On day 3, the embryos were \nevaluated for the number and symmetry of blastomeres, \npercentage of fragmentation, vacuolization, granulation, \nand multinucleation. On day 5, the blastocysts were scored \naccording to the grading system by Gardner and School-\ncraft (1999) [19]. Based on all these parameters, an embryo \nquality score (EQ) was assigned to each embryo based on \na predefined algorithm, defining four categories: excellent, \ngood, moderate, or poor as previously described [20].\nRegarding day 3 embryos: excellent embryos had at least \nseven blastomeres with cell stage-specific blastomere size \nsymmetry and had\u2009\u2264\u200910% fragmentation.", "mimetype": "text/plain", "start_char_idx": 8522, "end_char_idx": 10342, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "742cb966-58c8-4dca-8664-567488fadda6": {"__data__": {"id_": "742cb966-58c8-4dca-8664-567488fadda6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38ddb3f4-a255-491a-9f3d-09bbc8cb50ad", "node_type": "1", "metadata": {}, "hash": "49db64ecfe668e563ec354c2b88d21880fefe176247aa8fe182ed3fd33e9375c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0c864224-e32a-40ae-94e7-f2890c44213b", "node_type": "1", "metadata": {}, "hash": "552e10ca4e6aa77c7f29abf58d38712903034b39ae25554c55158ba820fe6694", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Regarding day 3 embryos: excellent embryos had at least \nseven blastomeres with cell stage-specific blastomere size \nsymmetry and had\u2009\u2264\u200910% fragmentation. Good embryos had \nat least six blastomeres and/or\u2009\u2264\u200920% fragmentation and/or \nblastomeres with stage-specific cell size symmetry. Moder-\nate embryos had at least four cells and/or 20\u201350% fragmen-\ntation (with or without a combination of vacuoles or granu-\nlation) and/or multinucleation in\u2009\u2264\u200950% of the blastomeres, \nand/or large differences in cell size. Embryos considered \nto be of poor quality had less than four cells and/or\u2009>\u200950% \nfragmentation and/or multinucleation in\u2009>\u200950% of the blas-\ntomeres (with or without a combination of vacuoles) [20].\nRegarding day 5 embryos, the following parameters were \nused to define the blastocyst quality score: (i) the expansion \nstage, (ii) the number of cells joining the blastulation, and \n(iii) the appearance of the trophectoderm (TE) and inner \ncell mass (ICM). Excellent blastocysts were expanded with \nTE type A and ICM type A or B. Good blastocysts were \nfull or expanded with a TE type B and ICM type A or B. \nModerate quality was obtained in either early blastocysts or \nfull/expanded blastocysts with a type C TE or ICM. Poor-\nquality embryos were scored as such if they were arrested, \ncompacted, fragmented, degenerated, or lacked a TE or ICM \n[20].\nEmbryo transfer and\u00a0cryopreservation\nFresh embryos were considered eligible for transfer if they \nreached at least moderate quality and eligible for freezing \nif they reached at least good quality. The embryo with the \nbest quality from the cohort was chosen for embryo transfer \n(ET), irrespective of the group they belong to. Each cycle \nhad either a fresh ET or a \u201cfreeze-all\u201d policy when, due \nto medical reasons (risk of OHSS, progesterone rise at the \nday of ovulation triggering, thin endometrium), the embryos \nwere cryopreserved for later use.", "mimetype": "text/plain", "start_char_idx": 10188, "end_char_idx": 12103, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0c864224-e32a-40ae-94e7-f2890c44213b": {"__data__": {"id_": "0c864224-e32a-40ae-94e7-f2890c44213b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "742cb966-58c8-4dca-8664-567488fadda6", "node_type": "1", "metadata": {}, "hash": "6b8bab730ea0daa7918dc7f35e6ec2959e0d4acb176f637c46a6a34199deb3c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "810af72d-1fdc-4708-912c-df80f4d07f96", "node_type": "1", "metadata": {}, "hash": "971ccdb77ab8200dfececb248a1d9228033b75bcaca89c4aaf16b54466b4460f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Outcome parameters\nThe main outcome of the study was the utilization rate \ndefined as the total number of embryos transferred and cry-\nopreserved per fertilized oocyte. Additional embryological \nparameters such as fertilization rate and embryo quality, as \nwell as clinical outcome, were also reported.\nStatistical analysis\nGroup sample sizes of at least 121 MII in the control group \nand at least 121 MII in the treatment group to detect a dif-\nference in embryo utilization rate between the groups from \n15 to 30%, with 80% power. The outcome measures were \ncompared using logistic generalized estimating equations \n(GEE) regression analysis in order to account for the fact \nthat multiple oocytes were derived from the same treatment \ncycle. The statistical analysis was performed in Stata version \n13.1 and p-values below 0.05 were considered statistically \nsignificant.\nResults\nThe patient characteristics and the distribution of the base-\nline cycle characteristics are presented in Table\u00a01. Cou-\nples included in the study presented male factor indication \n(n\u2009=\u20097), female factor indication (n\u2009=\u20096; age indication (3), \nPCOS (n\u2009=\u20091), tubal (n\u2009=\u20091), and endometriosis (n\u2009=\u20091)), \nand unexplained infertility (n\u2009=\u20096). Mean female age was \n35.3\u2009\u00b1\u20095.5\u00a0years (range of 26\u201343\u00a0years).\nThe embryological data are presented in Table\u00a02. In 19 \ncycles, a total number of 301 COCs were retrieved (mean \n13.05\u2009\u00b1\u200910.5), of which 247 (82%) were mature (MII). After \nICSI, 122 MII were treated with CultActive and 125 MII \nhad no treatment and were assigned to the control group. \nFertilization rate did not differ significantly between the \ntwo groups (85.2% vs. 79.2%, respectively; p\u2009=\u20090.255). The \ncapacity of fertilized oocytes to develop into good quality \nembryos (excellent and good) on day 3 was not significantly \ndifferent between the treatment and the control group (65.4% \nvs.", "mimetype": "text/plain", "start_char_idx": 12104, "end_char_idx": 13983, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "810af72d-1fdc-4708-912c-df80f4d07f96": {"__data__": {"id_": "810af72d-1fdc-4708-912c-df80f4d07f96", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0c864224-e32a-40ae-94e7-f2890c44213b", "node_type": "1", "metadata": {}, "hash": "552e10ca4e6aa77c7f29abf58d38712903034b39ae25554c55158ba820fe6694", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d749b2d-ca04-4e8d-8ee1-a08241d44271", "node_type": "1", "metadata": {}, "hash": "ddfc4d7e6c27c7bf80922ab15ed8b7849b8a86640fde317e517fe90371b9f0c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The \ncapacity of fertilized oocytes to develop into good quality \nembryos (excellent and good) on day 3 was not significantly \ndifferent between the treatment and the control group (65.4% \nvs. 70.7%, respectively; p\u2009=\u20090.281). Similarly, no significant \ndifference was observed in the blastulation rate (40.4% vs. \n38.3%; p\u2009=\u20090.758) or in the capacity of embryos to reach \ngood quality (excellent and good) on day 5 (11.5% vs. \n18.2%; p\u2009=\u20090.197) between the two groups.\nThe utilization rates per mature oocyte (13.9% vs. 17.6%; \np\u2009=\u20090.438) or per fertilized oocytes (16.3% vs. 22.2%; \np\u2009=\u20090.299) were not significantly different between the Cul-\ntActive group and the control group.\n1227\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\nTable\u202f1\u2002 \u2009General patient and cycle characteristics\nOAT, oligoasthenotheratospermia; PCOS, polycystic ovary syndrome; COC, cumulus-oocyte-complex. Semen parameters represent values before capacitation; MII, metaphase II oocyte; 2PN, \nfertilized oocytes; ET, embryos transferred; EC, embryos cryopreserved\nCultActive-treated group\nControl group\nPatient\u2019s age\nInfertility\nSuppression type\nSperm concen-\ntration (mil/ml)\n% progressive and \nnon-progressive \nmotility\nNr COC\nNr MII\nNr 2PN\nNr ET\nNr EC\nNr MII\nNr 2PN\nNr ET\nNr EC\n1\n37\nOAT\nAntagonist\n28.6\n61\n16\n7\n5\n1\n0\n8\n7\n0\n0\n2\n29\nIdiopathic\nAntagonist\n58.5\n42\n4\n2\n1\n0\n0\n2\n2\n1\n0\n3\n26\nOAT\nAntagonist\n13.", "mimetype": "text/plain", "start_char_idx": 13791, "end_char_idx": 15193, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d749b2d-ca04-4e8d-8ee1-a08241d44271": {"__data__": {"id_": "1d749b2d-ca04-4e8d-8ee1-a08241d44271", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "810af72d-1fdc-4708-912c-df80f4d07f96", "node_type": "1", "metadata": {}, "hash": "971ccdb77ab8200dfececb248a1d9228033b75bcaca89c4aaf16b54466b4460f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "73cfdaac-2817-44d3-88ca-5cb100cd4607", "node_type": "1", "metadata": {}, "hash": "670987858b1e116514eea9671683e7f961eb1557d1ff782e1ae24973363dc33f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5\n42\n4\n2\n1\n0\n0\n2\n2\n1\n0\n3\n26\nOAT\nAntagonist\n13.5\n58\n12\n6\n4\n0\n0\n6\n6\n0\n2\n4\n40\nOAT\nAntagonist\n38.7\n30\n5\n2\n0\n3\n2\n0\n1\n5\n36\nIdiopathic\nAntagonist\n80.5\n86\n17\n8\n7\n0\n1\n9\n8\n0\n3\n6\n28\nIdiopathic\nAntagonist\n57.5\n60\n15\n8\n6\n0\n1\n7\n1\n0\n1\n7\n30\nPCOS\nAntagonist\n120.5\n16\n48\n24\n20\n0\n3\n24\n19\n0\n4\n8\n37\nOAT\nAgonist\n0.24\n17\n6\n3\n3\n1\n0\n3\n3\n1\n0\n9\n32\nIdiopathic\nAntagonist\n76.0\n48\n9\n4\n4\n0\n0\n5\n3\n0\n0\n10\n33\nEndometriosis\nAntagonist\n13.5\n34\n12\n6\n5\n1\n0\n6\n5\n0\n0\n11\n35\nTubal\nAgonist\n114.0\n77\n10\n5\n4\n0\n0\n5\n3\n0\n0\n12\n33\nIdiopathic\nAntagonist\n57.35\n32\n7\n4\n4\n1\n0\n3\n3\n0\n1\n13\n43\nAge\nAntagonist\n38.4\n48\n6\n3\n3\n1\n0\n3\n1\n1\n0\n14\n41\nAge\nAntagonist\n10.1\n23\n10\n5\n4\n0\n1\n5\n4\n0\n1\n15\n43\nOAT\nAntagonist\n0.66\n74\n5\n3\n3\n1\n1\n2\n2\n0\n0\n16\n28\nOAT\nAntagonist\n0.", "mimetype": "text/plain", "start_char_idx": 15147, "end_char_idx": 15842, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73cfdaac-2817-44d3-88ca-5cb100cd4607": {"__data__": {"id_": "73cfdaac-2817-44d3-88ca-5cb100cd4607", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d749b2d-ca04-4e8d-8ee1-a08241d44271", "node_type": "1", "metadata": {}, "hash": "ddfc4d7e6c27c7bf80922ab15ed8b7849b8a86640fde317e517fe90371b9f0c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37ef2460-25ca-480c-bebc-7854784c7e25", "node_type": "1", "metadata": {}, "hash": "e49ac8fc855080e1496f052b986f5bccbfe8b507bd7a6310685fb4209e2eb6d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "66\n74\n5\n3\n3\n1\n1\n2\n2\n0\n0\n16\n28\nOAT\nAntagonist\n0.34\n27\n12\n6\n6\n1\n1\n6\n6\n0\n2\n17\n42\nAndrologic\nAgonist\n32.7\n71\n13\n6\n6\n0\n1\n7\n6\n1\n1\n18\n37\nIdiopathic\nAntagonist\n21.8\n37\n31\n15\n14\n0\n1\n16\n14\n0\n2\n19\n41\nAge\nAgonist\n32.6\n12\n10\n5\n5\n0\n0\n5\n4\n0\n0\n1228\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\nFrom the 19 cycles, 11 were planned as fresh ET and \neight as a freeze-all strategy. From the fresh ET group, two \ncycles had no ET due to poor embryo quality. Regarding the \nfreeze-all group, in one cycle, no embryos were vitrified due \nto insufficient quality.\nThe clinical outcome from the fresh ET cycles and from \nthe first frozen embryotransfer cycle of each patient from \nthe freeze-all group is presented in Table\u00a03: seven single \nETs were performed with embryos only from the Cul-\ntActive-treated group, six single ETs and one double ET \nwith embryos only from the control group, and two ETs \nperformed with mixed embryos. Seven deliveries were \nreported, with four, two, and one delivery in each category, \naccordingly. No major malformations at delivery were \nreported. Data on the weight and height of the seven new-\nborns is presented in Table\u00a03.\nDiscussion\nThe aim of the present prospective study was to investi-\ngate if \u00adCa2+ ionophore treatment with commercially avail-\nable ready-to-use A23187 ionophore (GM508-CultActive) \nimproves embryo utilization rate in patients with a history of \nembryo developmental problems.", "mimetype": "text/plain", "start_char_idx": 15795, "end_char_idx": 17234, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37ef2460-25ca-480c-bebc-7854784c7e25": {"__data__": {"id_": "37ef2460-25ca-480c-bebc-7854784c7e25", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "73cfdaac-2817-44d3-88ca-5cb100cd4607", "node_type": "1", "metadata": {}, "hash": "670987858b1e116514eea9671683e7f961eb1557d1ff782e1ae24973363dc33f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "61c9b673-6b4d-42fc-aed0-f09247eccfbc", "node_type": "1", "metadata": {}, "hash": "1fde3675be667bbfe74acc8514496a02f4f77d041368f21be8b74fe1584a57cb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For this purpose, sibling \nmature oocytes were treated or not with CultActive and the \nTable\u202f2\u2002 \u2009Comparison of \nembryological data between the \nCultActive-treated group and \nthe control group\nFertilization is given as normally fertilized oocytes (2PN), oocytes with one (1PN) or three pronuclei \n(3PN), degenerated oocytes or not fertilized after ICSI. P value\u2009<\u20090.05 is significant\nCultActive-treated group\nControl group\nP value\nNo of MII\n122\n125\nFertilization/MII (%)\n2PN\n104/122 (85.2)\n99/125 (79.2)\n0.255\n1PN\n6/122 (4.9)\n5 (4.0)\n3PN\n2/122 (1.6)\n5 (4.0)\nDegenerated\n5/122 (4.1)\n4 (3.2)\nNot fertilized\n5/122 (4.1)\n12/125 (9.6)\nEmbryo quality day 3/2PN (%)\nExcellent\u2009+\u2009good\n68/104 (65.4)\n70/99 (70.7)\n0.281\nModerate\u2009+\u2009poor\n36/104 (34.6)\n29/99 (29.3)\nDay 3 cell number\n\u2009<\u20096\n27\n19\n6\u20137\n27\n24\n\u2009=\u20098\n24\n27\n\u2009>\u20098\n22\n23\n\u2009=\u20098\u2009+\u2009\u2009>\u20098\n46\n50\nCompacting\n4\n4\nDegenerated\n0\n2\nDay 5 evaluations\nBlastocyst formation\nBl1\n18\n11\nBl2\n8\n11\nBl3\n8\n10\nBl4\n8\n6\nTotal blastocyst formation/2PN (%)\n42/104 (40.4)\n38/99 (38.3)\n0.758\nEmbryo quality day 5/2PN (%)\nExcellent\u2009+\u2009good\n12/104 (11.5)\n18/99 (18.2)\n0.197\nModerate\u2009+\u2009poor\n92/104 (88.5)\n81/99 (81.", "mimetype": "text/plain", "start_char_idx": 17235, "end_char_idx": 18358, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "61c9b673-6b4d-42fc-aed0-f09247eccfbc": {"__data__": {"id_": "61c9b673-6b4d-42fc-aed0-f09247eccfbc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "37ef2460-25ca-480c-bebc-7854784c7e25", "node_type": "1", "metadata": {}, "hash": "e49ac8fc855080e1496f052b986f5bccbfe8b507bd7a6310685fb4209e2eb6d2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5312a7ad-636c-4078-af63-39f3029a489f", "node_type": "1", "metadata": {}, "hash": "72626177ba1cf100a8b10a34a955fac363713c6aaff455a08f09daf06982158c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5)\n18/99 (18.2)\n0.197\nModerate\u2009+\u2009poor\n92/104 (88.5)\n81/99 (81.8)\nNr of embryos transferred\n7\n4\nNr of embryos cryopreserved on day 5\n6\n9\nNr of embryos cryopreserved on day 6\n4\n9\nUtilized embryos (nr of embryos transferred \nand cryopreserved)\n17\n22\nUtilization rate per nr of MII (%)\n17/122 (13.9)\n22/125 (17.6)\n0.438\nUtilization rate per nr of 2PN (%)\n17/104 (16.3)\n22/99 (22.2)\n0.299\n1229\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\nembryo development at cleavage and blastocyst stage was \nevaluated. Our results showed that CultActive treatment is \nnot associated with improved embryo development or uti-\nlization rate.\nOur data are in contradiction with the previous reports of \nEbner et\u00a0al. [11] and Lv et\u00a0al. [21]. Both studies published \nincreased blastocyst formation after treatment with A23187 \nionophore. In both studies, the oocytes were incubated imme-\ndiately after ICSI in A23187 solution for 15\u00a0min, but is not \nclear if the same concentration of ionophore was used by the \ntwo groups. While Lv et\u00a0al. used 5\u00a0\u03bcmol/l A23187, Ebner \net\u00a0al. [11] used (similar to our protocol) CultActive with an \nundisclosed concentration of ionophore. In addition, both \nstudies use the previous cycle of the patient as a control. \nBy doing this, the possible effect of different stimulation \nprotocols and/or possible differences in quality of culture \nsystems between cycles or intra-individual cycle-to-cycle \ndifferences was underestimated. Moreover, Ebner et\u00a0al. [11] \nrecruited patients from five centers. To overcome these prob-\nlems, we designed a single-center sibling oocyte study. Only \npatients with poor embryo quality on day 5 in the previous \ncycle performed in our center were included.", "mimetype": "text/plain", "start_char_idx": 18296, "end_char_idx": 20020, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5312a7ad-636c-4078-af63-39f3029a489f": {"__data__": {"id_": "5312a7ad-636c-4078-af63-39f3029a489f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "61c9b673-6b4d-42fc-aed0-f09247eccfbc", "node_type": "1", "metadata": {}, "hash": "1fde3675be667bbfe74acc8514496a02f4f77d041368f21be8b74fe1584a57cb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be4e86ba-4445-4e41-aeef-b2dc7b8e4bb9", "node_type": "1", "metadata": {}, "hash": "d1a70c9bbb633464f497e6590acb54c114044b5eee6c4112a89236643151b5ed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To overcome these prob-\nlems, we designed a single-center sibling oocyte study. Only \npatients with poor embryo quality on day 5 in the previous \ncycle performed in our center were included. In addition, \nsimilar culture conditions were used for both cycles in all \npatients, but six patients had a different stimulation protocol \ncompared to their previous cycle. Recently, data on embryo \nmorphokinetics following the use of CultActive on sibling \noocytes were reported [22]. The study based on a cohort of \n78 ICSI patients showed significantly improved fertilization \nand utilization rates. Our findings contradict these results and \nmay be explained by differences in patient cohorts, embryo \ntransfer protocol, and/or the way data are reported. Shebl \net\u00a0al. [22] included patients with a suspected fertilization \nproblem, which was not the case in our cohort. Contrary to \nour policy (ET on day 5 only and blastocyst vitrification on \nday 5/6), Shebl et\u00a0al. [22] performed blastocyst transfer and \nvitrification on day 4 or 5. These differences can have an \nimpact on final embryo quality and consequently on utiliza-\ntion rates as different laboratories may have different criteria \nfor transfer and vitrification. No clear description of the cri-\nteria to define an embryo\u2019s eligibility for transfer or vitrifica-\ntion was mentioned by Shebl et\u00a0al. [22]. In addition, there \nis a difference in the way the utilization rate was reported: \nper number of fertilized oocytes (2PN) in our dataset and \nper number of embryos in culture to day 5 in the report of \nShebl et\u00a0al. [22]. We consider that, when looking at the effect \nof a treatment on embryo developmental potential, the best \napproach is to perform the analysis per normally fertilized \noocyte.", "mimetype": "text/plain", "start_char_idx": 19830, "end_char_idx": 21589, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "be4e86ba-4445-4e41-aeef-b2dc7b8e4bb9": {"__data__": {"id_": "be4e86ba-4445-4e41-aeef-b2dc7b8e4bb9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5312a7ad-636c-4078-af63-39f3029a489f", "node_type": "1", "metadata": {}, "hash": "72626177ba1cf100a8b10a34a955fac363713c6aaff455a08f09daf06982158c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b86abf3e-2938-4a17-8ec1-1536958dc992", "node_type": "1", "metadata": {}, "hash": "22a4e363a1f8c4b8e326cb9f8ec1115555a80843415f90a9beda8075f671ae71", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[22]. We consider that, when looking at the effect \nof a treatment on embryo developmental potential, the best \napproach is to perform the analysis per normally fertilized \noocyte.\nThe signaling events involved in oocyte activation pro-\ncesses, triggered by the sperm, rely on factors from the \nTable\u202f3\u2002 \u2009Clinical and neonatal outcome from the fresh ET cycles and from the first frozen-thawed cycle of each patient from the Freeze All \ngroup\n*\u200a1 single ET and 1 double ET (clinical pregnancy with 1 vanishing twin)\n1230\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\noocyte, like PIP2, DAG, or IP3. This suggests that, besides \nthe sperm, the oocyte also plays a role in oocyte activation. \nThe couples included in this study represent a rather hetero-\ngeneous population regarding the cause of infertility. Unfor-\ntunately, due to the limited number of patients included, the \nimpact of CultActive treatment on embryological outcomes \nin different infertility subgroups could not be evaluated.\nThe present study includes patients with sperm capable of \nat least initiating oocyte activation as proven by fertilization \nand early cleavage rates observed in the present and previous \ncycle. Based on our data, the extra \u00adCa2+ present transiently \nin the cytoplasm due to ionophore exposure has no impact \non blastocyst development. Nevertheless, it should be worth \nmentioning that all transfers of embryos originated following \nthe CultActive led to a clinical pregnancy.\nOne of the most frustrating aspects of an IVF clinic is the \ntransfer of a blastocyst of lower quality or lack of blastocysts \nfor transfer, in cycles with proven fertilization. Understand-\nably, the use of A23187 ionophore to overcome this situa-\ntion is tempting. However, little is known about the impact \nof intracellular \u00adCa2+ manipulation in human oocytes. Until \nnow, no adverse neonatal events were reported following \n\u00adCa2+ ionophore treatment [23\u201325]. From our series, no \nmajor malformations were described from the four babies \nborn following transfer with embryos from the CultActive \ngroup, results that are in line with our previous report [24].", "mimetype": "text/plain", "start_char_idx": 21409, "end_char_idx": 23564, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b86abf3e-2938-4a17-8ec1-1536958dc992": {"__data__": {"id_": "b86abf3e-2938-4a17-8ec1-1536958dc992", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be4e86ba-4445-4e41-aeef-b2dc7b8e4bb9", "node_type": "1", "metadata": {}, "hash": "d1a70c9bbb633464f497e6590acb54c114044b5eee6c4112a89236643151b5ed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d797fbb-abfe-4f1d-b653-f6daa4b72e96", "node_type": "1", "metadata": {}, "hash": "5905ab8354017b82127b510448c9d1a68942291dc564524006d691e1d2b09856", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "From our series, no \nmajor malformations were described from the four babies \nborn following transfer with embryos from the CultActive \ngroup, results that are in line with our previous report [24].\nThe results reported here should be confirmed in a larger \nsize study. Before more research is performed, the use of \n\u00adCa2+ ionophore in ART should be limited to strict indica-\ntions, where its benefit has been proven, as in cases of globo-\nzoospermia or previously failed or low fertilization [26, 27].\nThe main strength of our study is its prospective, sibling \noocyte nature that allows us to evaluate the impact of Cul-\ntActive on embryo development within the same treatment \ncycle, and the fact that all cycles and previous cycles were \nperformed in a single center. The limitation of our study is \nthe small number of patients included.\nIn conclusion, the results of the current study do not sup-\nport the use of CultActive in cases with embryo develop-\nmental problems.\nAcknowledgements\u2002 The authors wish to thank the clinical embryolo-\ngists, medical doctors, and laboratory technologists of the Brussels IVF \ncenter from Universitair Ziekenhuis Brussel (UZBrussel).\nDeclarations\u2002\nConflict of interest\u2002 The authors declare no competing interests.\nReferences\n\t 1.\t Saunders CM, Larman MG, Parrington J, Cox LJ, Royse J, \nBlayney ML, Swann K, Lai FA. PLC zeta: a sperm-specific trigger \nof Ca(2+) oscillations in eggs and embryo development. Develop-\nment. 2002;129(15):3533\u201344.\n\t 2.\t Swann K, Larman MG, Saunders CM, Lai FA. The cytosolic \nsperm factor that triggers Ca2+ oscillations and egg activation \nin mammals is a novel phospholipase C: PLCzeta. Reproduction. \n2004;127:431\u20139.\n\t 3.\t Yeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activa-\ntion deficiency: a role for an oocyte contribution? Hum Reprod \nUpdate. 2016;22(1):23\u201347.", "mimetype": "text/plain", "start_char_idx": 23366, "end_char_idx": 25215, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d797fbb-abfe-4f1d-b653-f6daa4b72e96": {"__data__": {"id_": "5d797fbb-abfe-4f1d-b653-f6daa4b72e96", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b86abf3e-2938-4a17-8ec1-1536958dc992", "node_type": "1", "metadata": {}, "hash": "22a4e363a1f8c4b8e326cb9f8ec1115555a80843415f90a9beda8075f671ae71", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0ba2cd55-02f4-497a-b257-f653fa5534a7", "node_type": "1", "metadata": {}, "hash": "b7df18a966bb8138f8a4b03f26f7cda755887d1be2bc80dc6f30f47b54e726e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod \nUpdate. 2016;22(1):23\u201347. https://\u200bdoi.\u200borg/\u200b10.\u200b1093/\u200bhumupd/\u200b\ndmv040.\n\t 4.\t Whitaker M. Calcium at fertilization and in early development. \nPhysiol Rev. 2006;86(1):25\u201388. https://\u200bdoi.\u200borg/\u200b10.\u200b1152/\u200bphysr\u200bev.\u200b\n00023.\u200b2005.\n\t 5.\t Jones KT. Intracellular calcium in the fertilization and devel-\nopment of mammalian eggs. Clin Exp Pharmacol Physiol. \n2007;34(10):1084\u20139. https://\u200bdoi.\u200borg/\u200b10.\u200b1111/j.\u200b1440-\u200b1681.\u200b2007.\u200b\n04726.\n\t 6.\t Schultz RM, Kopf GS. Molecular basis of mammalian egg activa-\ntion. Curr Top Dev Biol. 1995;30:21\u201362. https://\u200bdoi.\u200borg/\u200b10.\u200b1016/\u200b\ns0070-\u200b2153(08)\u200b60563-3.\n\t 7.\t Amdani SN, Jones C, Coward K. Phospholipase C zeta (PLC\u03b6): \noocyte activation and clinical links to male factor infertility. Adv \nBiol Regul. 2013;53(3):292\u2013308. https://\u200bdoi.\u200borg/\u200b10.\u200b1016/j.\u200bjbior.\u200b\n2013.\u200b07.\u200b005.\n\t 8.\t Yoon SY, Jellerette T, Salicioni AM, Lee HC, Yoo MS, Coward \nK, et\u00a0al. Human sperm devoid of PLC, zeta 1 fail to induce Ca2+ \nrelease and are unable to initiate the first step of embryo develop-\nment. J Clin Invest. 2008;118:3671\u201381. https://\u200bdoi.\u200borg/\u200b10.\u200b1172/\u200b\nJCI36\u200b942.\n\t 9.\t Heytens E, Parrington J, Coward K, Young C, Lambrecht S, Yoon \nSY, Fissore RA, Hamer R, et\u00a0al.", "mimetype": "text/plain", "start_char_idx": 25178, "end_char_idx": 26384, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0ba2cd55-02f4-497a-b257-f653fa5534a7": {"__data__": {"id_": "0ba2cd55-02f4-497a-b257-f653fa5534a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d797fbb-abfe-4f1d-b653-f6daa4b72e96", "node_type": "1", "metadata": {}, "hash": "5905ab8354017b82127b510448c9d1a68942291dc564524006d691e1d2b09856", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9511df57-7527-409c-bf41-71f91c4acfcd", "node_type": "1", "metadata": {}, "hash": "1c2b3070f4d90d456e5bfbb92c8b43908af11512a1f8a8981f12eb0f1c2e4d9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "9.\t Heytens E, Parrington J, Coward K, Young C, Lambrecht S, Yoon \nSY, Fissore RA, Hamer R, et\u00a0al. Reduced amounts and abnormal \nforms of phospholipase C zeta in spermatozoa from infertile men. \nHum Reprod. 2009;24:2417\u201328. https://\u200bdoi.\u200borg/\u200b10.\u200b1093/\u200bhumrep/\u200b\ndep207.\n\t10.\t Darwish E, Magdi Y. A preliminary report of successful cleav-\nage after calcium ionophore activation at ICSI in cases with \nprevious arrest at the pronuclear stage. Reprod Biomed Online. \n2015;31(6):799\u2013804. https://\u200bdoi.\u200borg/\u200b10.\u200b1016/j.\u200brbmo.\u200b2015.\u200b08.\u200b012.\n\t11.\t Ebner T, Oppelt P, W\u00f6ber M, Staples P, Mayer RB, Sonnleitner U, \nBulfon-Vogl S, Gruber I, Haid AE, Shebl O. Treatment with Ca2+ \nionophore improves embryo development and outcome in cases \nwith previous developmental problems: a prospective multicenter \nstudy. Hum Reprod. 2015;30(1):97\u2013102. https://\u200bdoi.\u200borg/\u200b10.\u200b1093/\u200b\nhumrep/\u200bdeu285.\n\t12.\t Ducibella T, Huneau D, Angelichio E, Xu Z, Schultz RM, Kopf \nGS, Fissore R, Madoux S, Ozil JP. Egg-to-embryo transition is \ndriven by differential responses to Ca(2+) oscillation number. Dev \nBiol. 2002;250(2):280\u201391.\n\t13.\t Ozil JP, Huneau D. Activation of rabbit oocytes: the impact \nof the Ca2+ signal regime on development. Development. \n2001;128(6):917\u201328.\n\t14.\t Malcuit C, Kurokawa M, Fissore RA. Calcium oscillations and \nmammalian egg activation. J Cell Physiol. 2006;206(3):565\u201373.", "mimetype": "text/plain", "start_char_idx": 26286, "end_char_idx": 27661, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9511df57-7527-409c-bf41-71f91c4acfcd": {"__data__": {"id_": "9511df57-7527-409c-bf41-71f91c4acfcd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ba2cd55-02f4-497a-b257-f653fa5534a7", "node_type": "1", "metadata": {}, "hash": "b7df18a966bb8138f8a4b03f26f7cda755887d1be2bc80dc6f30f47b54e726e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c8d95f87-9983-4190-8f04-e6a3383aef78", "node_type": "1", "metadata": {}, "hash": "a7c49d0ee6dad7257b4d2ec513655dd553d4530b5c8091cbe89877b373393252", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Malcuit C, Kurokawa M, Fissore RA. Calcium oscillations and \nmammalian egg activation. J Cell Physiol. 2006;206(3):565\u201373. \nhttps://\u200bdoi.\u200borg/\u200b10.\u200b1002/\u200bjcp.\u200b20471.\n\t15.\t Machaty Z. Signal transduction in mammalian oocytes during \nfertilization. Cell Tissue Res. 2016;363(1):169\u201383. https://\u200bdoi.\u200borg/\u200b\n10.\u200b1007/\u200bs00441-\u200b015-\u200b2291-8.\n\t16.\t Ozil JP, Banrezes B, T\u00f3th S, Pan H, Schultz RM. Ca2+ oscilla-\ntory pattern in fertilized mouse eggs affects gene expression and \ndevelopment to term. Dev Biol. 2006;300(2):534\u201344. https://\u200bdoi.\u200b\norg/\u200b10.\u200b1016/j.\u200bydbio.\u200b2006.\u200b08.\u200b041.\n\t17.\t T\u00f3th S, Huneau D, Banrezes B, Ozil JP. Egg activation is the \nresult of calcium signal summation in the mouse. Reproduction. \n2006;131(1):27\u201334. https://\u200bdoi.\u200borg/\u200b10.\u200b1530/\u200brep.1.\u200b00764.\n\t18.\t Ferrer-Buitrago M, Bonte D, De Sutter P, Leybaert L, Heindry-\nckx B. Single Ca2+ transients vs oscillatory Ca2+ signaling for \n1231\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232\n1 3\nassisted oocyte activation: limitations and benefits. Reproduction. \n2018;155(2):105\u201319. https://\u200bdoi.\u200borg/\u200b10.\u200b1530/\u200bREP-\u200b17-\u200b0098.\n\t19.\t Gardner DK, Schoolcraft WB. In-vitro culture of human blasto-\ncysts. In: Jansen R, Mortimer D, editors. Towards reproductive \ncertainty: fertility and genetics beyond 1999.", "mimetype": "text/plain", "start_char_idx": 27539, "end_char_idx": 28826, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c8d95f87-9983-4190-8f04-e6a3383aef78": {"__data__": {"id_": "c8d95f87-9983-4190-8f04-e6a3383aef78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9511df57-7527-409c-bf41-71f91c4acfcd", "node_type": "1", "metadata": {}, "hash": "1c2b3070f4d90d456e5bfbb92c8b43908af11512a1f8a8981f12eb0f1c2e4d9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d55f06d0-be41-4ce7-b7c3-d262425ecf5c", "node_type": "1", "metadata": {}, "hash": "7c3e8c9f39fb71e7a235d42524a92fcb3c48fc06f5d3af2282dab847e7d154ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In-vitro culture of human blasto-\ncysts. In: Jansen R, Mortimer D, editors. Towards reproductive \ncertainty: fertility and genetics beyond 1999. Carnforth: Parthe-\nnon Press; 1999. p. 378\u201388.\n\t20.\t De Munck N, Santos-Ribeiro S, Mateizel I, Verheyen G. \nReduced blastocyst formation in reduced culture volume. J Assist \nReprod Genet. 2015;32(9):1365\u201370. https://\u200bdoi.\u200borg/\u200b10.\u200b1007/\u200b\ns10815-\u200b015-\u200b0541-z.\n\t21.\t Lv M, Dan Zhang D, He X, Chen B, Li Q, Ding D, Hao Y, Xue \nR, Ji D, et\u00a0al. Artificial oocyte activation to improve reproductive \noutcomes in couples with various causes of infertility: a retro-\nspective cohort study. Reprod Biomed Online. 2020;40(4):501\u20139. \nhttps://\u200bdoi.\u200borg/\u200b10.\u200b1016/j.\u200brbmo.\u200b2020.\u200b01.\u200b001.\n\t22.\t Shebl O, Trautner PS, Enengl S, Reiter E, Allerstorfer C, Rech-\nberger T, Oppelt P, Ebner T. Ionophore application for artificial \noocyte activation and its potential effect on morphokinetics: a sib-\nling oocyte study. J Assist Reprod Genet. 2021;38(12):3125\u201333. \nhttps://\u200bdoi.\u200borg/\u200b10.\u200b1007/\u200bs10815-\u200b021-\u200b02338-3.\n\t23.\t Miller N, Biron-Shental T, Sukenik-Halevy R, Klement AH, Sha-\nrony R, Berkovitz A. Oocyte activation by calcium ionophore and \ncongenital birth defects: a retrospective cohort study. Fertil Steril. \n2016 1;106(3):590\u20136.\u00a0https://\u200bdoi.\u200borg/\u200b10.\u200b1016/j.\u200bfertn\u200bstert.\u200b2016.\u200b04.\u200b\n025\n\t24.", "mimetype": "text/plain", "start_char_idx": 28682, "end_char_idx": 30012, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d55f06d0-be41-4ce7-b7c3-d262425ecf5c": {"__data__": {"id_": "d55f06d0-be41-4ce7-b7c3-d262425ecf5c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c8d95f87-9983-4190-8f04-e6a3383aef78", "node_type": "1", "metadata": {}, "hash": "a7c49d0ee6dad7257b4d2ec513655dd553d4530b5c8091cbe89877b373393252", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f832c886-a6df-4832-95bc-0064c562b0e6", "node_type": "1", "metadata": {}, "hash": "b1e2da354980861b181b74c8ccc2c7e36bdf45552f38185537d04fb07c3205dd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "https://\u200bdoi.\u200borg/\u200b10.\u200b1016/j.\u200bfertn\u200bstert.\u200b2016.\u200b04.\u200b\n025\n\t24.\t Mateizel I, Verheyen G, Van de Velde H, Tournaye H, Belva F. \nObstetric and neonatal outcome following ICSI with assisted \noocyte activation by calcium ionophore treatment. J Assist \nReprod Genet. 2018;35(6):1005\u201310. https://\u200bdoi.\u200borg/\u200b10.\u200b1007/\u200b\ns10815-\u200b018-\u200b1124-6.\n\t25.\t Li B, Zhou Y, Yan Z, Li M, Xue S, Cai R, Fu Y, Hong et\u00a0al. \nPregnancy and neonatal outcomes of artificial oocyte activation \nin patients undergoing frozen-thawed embryo transfer: a 6-year \npopulation-based retrospective study. Arch Gynecol Obstet. 2019 \nOct;300(4):1083\u201392. https://\u200bdoi.\u200borg/\u200b10.\u200b1007/\u200bs00404-\u200b019-\u200b05298-3\n\t26.\t Moaz MN, Khattab S, Foutouh IA, Mohsen EA. Chemical activa-\ntion of oocytes in different types of sperm abnormalities in cases \nof low or failed fertilization after ICSI: a prospective pilot study. \nReprod Biomed Online. 2006;13(6):791\u20134. https://\u200bdoi.\u200borg/\u200b10.\u200b\n1016/\u200bs1472-\u200b6483(10)\u200b61025-5.\n\t27.\t Heindryckx B, De Gheselle S, Gerris J, Dhont M, De Sutter P. \nEfficiency of assisted oocyte activation as a solution for failed \nintracytoplasmic sperm injection. Reprod Biomed Online. \n2008;17(5):662\u20138. https://\u200bdoi.\u200borg/\u200b10.\u200b1016/\u200bs1472-\u200b6483(10)\u200b\n60313-6.\nPublisher's Note\u2002 Springer Nature remains neutral with regard to \njurisdictional claims in published maps and institutional affiliations.", "mimetype": "text/plain", "start_char_idx": 29949, "end_char_idx": 31314, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f832c886-a6df-4832-95bc-0064c562b0e6": {"__data__": {"id_": "f832c886-a6df-4832-95bc-0064c562b0e6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mateizel (2022).pdf", "node_type": "4", "metadata": {}, "hash": "972adfa6629ef0dad0063778059e5f4b81abd3add82c0f2edf1d226c483c5c79", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d55f06d0-be41-4ce7-b7c3-d262425ecf5c", "node_type": "1", "metadata": {}, "hash": "7c3e8c9f39fb71e7a235d42524a92fcb3c48fc06f5d3af2282dab847e7d154ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Publisher's Note\u2002 Springer Nature remains neutral with regard to \njurisdictional claims in published maps and institutional affiliations.\n1232\nJournal of Assisted Reproduction and Genetics (2022) 39:1225\u20131232", "mimetype": "text/plain", "start_char_idx": 31177, "end_char_idx": 31385, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "503863d1-7df0-47a8-b10d-abfd5e9778fc": {"__data__": {"id_": "503863d1-7df0-47a8-b10d-abfd5e9778fc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "91e8f0e6-bf46-483c-a399-3d5c0176a3c3", "node_type": "1", "metadata": {}, "hash": "e445e42363e0c11e07490464acafaef9ab986cb289be035caeb926dd33b560c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL ARTICLE Embryology\nAssisted oocyte activation is not\nbene\ufb01cial for all patients with a\nsuspected oocyte-related activation\nde\ufb01ciency\nF. Vanden Meerschaut*, D. Nikiforaki, S. De Gheselle, V. Dullaerts,\nE. Van den Abbeel, J. Gerris, B. Heindryckx, and P. De Sutter\nDepartment for Reproductive Medicine, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium\n*Correspondence address. De Pintelaan 185, B-9000 Ghent, Belgium. Tel: +32(0)9-332-02-89; E-mail: frauke.vandenmeerschaut@ugent.be\nSubmitted on October 4, 2011; resubmitted on December 30, 2011; accepted on February 8, 2012\nbackground: Despite the success of ICSI, total fertilization failure (TFF) still occurs in 1\u20133% of all ICSI cycles. ICSI followed by assisted\noocyte activation (ICSI-AOA) can restore fertilization, most ef\ufb01ciently in cases of sperm-related fertilization de\ufb01ciency. The indication for\nICSI-AOA is less obvious when the capacity of the sperm to activate oocytes is considered normal, as proved by a heterologous ICSI\nmodel, such as the mouse oocyte activation test (MOAT). In this study, we veri\ufb01ed whether ICSI-AOA is bene\ufb01cial for patients in\nwhom an oocyte-related activation de\ufb01ciency is suspected.\nmethods: A prospective study was conducted including patients presenting with a history of TFF or low fertilization (LF) following con-\nventional ICSI in our centre (in-house cases, n \u00bc 2) or elsewhere (out-house cases, n \u00bc 12). In all cases a sperm de\ufb01ciency was refuted by the\nMOAT. In a next treatment cycle, ICSI-AOA was performed on half of the sibling metaphase II oocytes and conventional ICSI on the rest\n(\u2018split ICSI-AOA cycle\u2019). The main outcome parameters were fertilization, pregnancy and live birth rates.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1720, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "91e8f0e6-bf46-483c-a399-3d5c0176a3c3": {"__data__": {"id_": "91e8f0e6-bf46-483c-a399-3d5c0176a3c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "503863d1-7df0-47a8-b10d-abfd5e9778fc", "node_type": "1", "metadata": {}, "hash": "ebc62abb15c8b0e35c32af1d5db7942504a073c1daa4f3a11e865e5030fb90e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b6c9359e-e0bb-4edc-9fcb-0bbc95b72897", "node_type": "1", "metadata": {}, "hash": "104befb894d484952a69cbc636f186d7603fac9afa6a0e9042d58e93b17f1474", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The main outcome parameters were fertilization, pregnancy and live birth rates.\nresults: Overall, ICSI-AOA was able to improve fertilization rates in couples with a suspected oocyte-related fertilization problem, with\na mean fertilization rate of 74.2% following ICSI-AOA compared with 43.5% following conventional ICSI (P , 0.001). Cumulative pregnancy\nrate and live birth rate per cycle were 35.7 and 14.3%, respectively. Considering the out-house patients only, fertilization rates with ICSI-AOA\nwere higher in couples with previous TFF than with conventional ICSI (P , 0.001). Interestingly, for out-house patients who had experienced\nlow, but not zero, fertilization elsewhere, ICSI-AOA could not enhance the fertilization rate. For the two in-house patients, both suffering from\nprevious LF following conventional ICSI, the ICSI-AOA procedure enhanced the mean fertilization rate (25 versus 75%, respectively).\nconclusions: For patients with a suspected oocyte-related activation de\ufb01ciency, as diagnosed by a heterologuous ICSI model, the\nindication for ICSI-AOA still remains debatable. Our data show that ICSI-AOA is very ef\ufb01cient in patients with a suspected oocyte-\nrelated activation de\ufb01ciency and previous TFF after conventional ICSI. In contrast, when there was a history of LF in another centre, one\nshould be careful and test the ef\ufb01ciency of ICSI-AOA on half of the sibling oocytes, because ICSI-AOA is not always bene\ufb01cial for patients\nwith previous LF and a suspected oocyte-related activation de\ufb01ciency. For these patients, a split ICSI-AOA cycle using sibling oocytes can\nhelp to distinguish between a molecular oocyte-related activation de\ufb01ciency and a previous technical or other biological failure. Moreover,\nthis split ICSI-AOA strategy enables us to set the appropriate strategy for future treatment cycles. Further research with larger groups of\npatients is now required.", "mimetype": "text/plain", "start_char_idx": 1641, "end_char_idx": 3538, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b6c9359e-e0bb-4edc-9fcb-0bbc95b72897": {"__data__": {"id_": "b6c9359e-e0bb-4edc-9fcb-0bbc95b72897", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91e8f0e6-bf46-483c-a399-3d5c0176a3c3", "node_type": "1", "metadata": {}, "hash": "e445e42363e0c11e07490464acafaef9ab986cb289be035caeb926dd33b560c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "974739ea-45fd-4a59-8e36-0ccf64d95e9a", "node_type": "1", "metadata": {}, "hash": "2bb8b69d92f5f3aa3ad972ad5f15b61c8da5df33dbcc55d94710487ff6fe23e3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Moreover,\nthis split ICSI-AOA strategy enables us to set the appropriate strategy for future treatment cycles. Further research with larger groups of\npatients is now required.\nKey words: failed fertilization / oocyte activation de\ufb01ciency / assisted oocyte activation / ionophore / mouse oocyte activation test\nIntroduction\nICSI is used in two-thirds of the arti\ufb01cial reproduction technology\n(ART) cycles in European fertility clinics (Mouzon et al., 2010). ICSI\nwas developed in the early 1990s and millions of couples suffering\nfrom severe male infertility or previously failed IVF conceived by this\ntechnique. On average, ICSI leads to fertilization rates of approximate-\nly 70\u201380% (Palermo et al., 2009). Unfortunately, total fertilization\n& The Author 2012. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.\nFor Permissions, please email: journals.permissions@oup.com\nHuman Reproduction, Vol.27, No.7 pp. 1977\u20131984, 2012\nAdvanced Access publication on May 2, 2012\ndoi:10.1093/humrep/des097\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \nfailure (TFF) still occurs in \u224f1\u20133% of all ICSI cycles and can recur in\nsubsequent cycles (Flaherty et al., 1995; Esfandiari et al., 2005). Failure\nof oocyte activation is considered to be the main cause of fertilization\nfailure following conventional ICSI (Liu et al., 1995; Flaherty et al.,\n1998; Rawe et al., 2000). Less common causes include failed sperm\nhead decondensation, premature sperm chromatin condensation,\nspindle defects or sperm aster defects and incorrect sperm injection\n(Swain and Pool, 2008).", "mimetype": "text/plain", "start_char_idx": 3363, "end_char_idx": 5050, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "974739ea-45fd-4a59-8e36-0ccf64d95e9a": {"__data__": {"id_": "974739ea-45fd-4a59-8e36-0ccf64d95e9a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6c9359e-e0bb-4edc-9fcb-0bbc95b72897", "node_type": "1", "metadata": {}, "hash": "104befb894d484952a69cbc636f186d7603fac9afa6a0e9042d58e93b17f1474", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "efc9f392-1475-43b0-8278-fec560307071", "node_type": "1", "metadata": {}, "hash": "1989ffdbb0d1a204c082718e3815342d8e94a851aa2025282e5eb4ae84c9f44e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Less common causes include failed sperm\nhead decondensation, premature sperm chromatin condensation,\nspindle defects or sperm aster defects and incorrect sperm injection\n(Swain and Pool, 2008). Furthermore, fertilization failure can be\ncaused by technical problems, a limited availability of mature or mor-\nphologically normal oocytes, a lack of motile spermatozoa or severe\nforms of teratozoospermia, such as globozoospermia (Yanagida\net al., 2004; Dam et al., 2007).\nWhen a mammalian oocyte is activated, the \ufb01rst observed cytoplas-\nmic event is an increase in intracellular calcium concentration. The\ninitial calcium increase (trigger) starts within a few minutes of\nsperm\u2013oocyte fusion in IVF, whereas following ICSI this trigger is pro-\nvoked immediately during the injection of the sperm by the arti\ufb01cial\ncalcium in\ufb02ux from the surrounding injection medium (Tesarik et al.,\n2000). This trigger is followed by a typical pattern of calcium oscilla-\ntions which are crucial for normal fertilization and further embryo de-\nvelopment (Ducibella et al., 2002; Parrington et al, 2007; Kashir et al.,\n2010). Substantial evidence suggests that these calcium oscillations are\nthe result of the release of the sperm phospholipase C zeta (PLCz)\ninto the oocyte cytosol (Saunders et al., 2002; Kashir et al., 2010).\nDuring \ufb01nal oocyte maturation, the ability to generate calcium oscilla-\ntions is developed within the oocyte. This means that successful fertil-\nization also depends on the inherent quality and cytoplasmic maturity\nof the oocyte (Ajduk et al., 2008). Hence, both the sperm and the\noocyte play a role in the oocyte activation mechanism, fertilization\nand further embryo development: the sperm by supplying the\nprotein PLCz and the oocyte by its responsiveness to PLCz and down-\nstream molecular pathways (Tesarik and Mendoza, 1999).\nIn our centre, a diagnostic test was developed to distinguish sperm-\nfrom oocyte-related causes of fertilization failure (Rybouchkin et al.,\n1996).", "mimetype": "text/plain", "start_char_idx": 4857, "end_char_idx": 6845, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "efc9f392-1475-43b0-8278-fec560307071": {"__data__": {"id_": "efc9f392-1475-43b0-8278-fec560307071", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "974739ea-45fd-4a59-8e36-0ccf64d95e9a", "node_type": "1", "metadata": {}, "hash": "2bb8b69d92f5f3aa3ad972ad5f15b61c8da5df33dbcc55d94710487ff6fe23e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26a2a009-eee8-4aae-a523-6aed3180ace2", "node_type": "1", "metadata": {}, "hash": "87fd947d18ff198a387f5e18e811f8c80f330a8af1ce59f608c7535aaeb23906", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In our centre, a diagnostic test was developed to distinguish sperm-\nfrom oocyte-related causes of fertilization failure (Rybouchkin et al.,\n1996). The mouse oocyte activation test (MOAT) is offered to\npatients with TFF or low fertilization (LF) following conventional\nICSI. Test sperm is injected by heterologous ICSI into mouse\noocytes, followed by assessment of the percentage of oocyte activa-\ntion. The MOAT enabled the classi\ufb01cation of patients into three\ngroups (Heindryckx et al., 2008). Patients with an oocyte activation\npercentage of ,20%, being the upper limit of the negative control,\nare classi\ufb01ed as MOAT Group 1 patients. In these cases, a sperm-\nrelated activation de\ufb01ciency is extremely likely. In contrast, when\n85% or more mouse oocytes are activated, being the lower limit of\nthe positive control, patients are classi\ufb01ed as MOAT Group 3 patients.\nIn this group, a sperm de\ufb01ciency can be excluded. Less distinct are\nMOAT Group 2 patients, in which 21\u201384% of the mouse oocytes are\nactivated, pointing to either a sperm or an unknown de\ufb01ciency.\nRecently, there has been growing interest in the use of ICSI in com-\nbination with assisted oocyte activation (ICSI-AOA) in patients suffering\nfrom previous TFF or LF following conventional ICSI (Nasr-Esfahani\net al., 2010). Several activation agents, such as calcium ionophore,\nstrontium ions and electrical pulses, are ef\ufb01cient in restoring fertilization\nand pregnancy rates by arti\ufb01cially provoking calcium rises in the cyto-\nplasm of the oocyte (Yanagida et al., 1999, 2006; Eldar-Geva et al.,\n2003; Chi et al., 2004; Heindryckx et al., 2005). Others reported the\nuse of a mechanically modi\ufb01ed ICSI technique to overcome activation\nfailure (Tesarik et al. 2002; Ebner et al., 2004).", "mimetype": "text/plain", "start_char_idx": 6698, "end_char_idx": 8447, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "26a2a009-eee8-4aae-a523-6aed3180ace2": {"__data__": {"id_": "26a2a009-eee8-4aae-a523-6aed3180ace2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "efc9f392-1475-43b0-8278-fec560307071", "node_type": "1", "metadata": {}, "hash": "1989ffdbb0d1a204c082718e3815342d8e94a851aa2025282e5eb4ae84c9f44e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ada4a161-18bb-43b4-8389-4aecbcb5272b", "node_type": "1", "metadata": {}, "hash": "259b61a42833cbe0139bce4a98ad014ea8dabb0aacf5dd48be5be8e10299ce19", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Others reported the\nuse of a mechanically modi\ufb01ed ICSI technique to overcome activation\nfailure (Tesarik et al. 2002; Ebner et al., 2004). Chemical activation\nusing the ionophore ionomycin is the most commonly used method\nfor AOA, resulting in high fertilization rates (Nasr-Esfahani et al., 2010).\nIn our centre, ICSI-AOA is performed using ionomycin, which\nenables us to restore fertilization rates to normal in most patients\nwith a history of previously failed or LF (Heindryckx et al., 2005,\n2008). The current study focuses on the patients with a normal\nMOAT result, namely patients in MOAT Group 3, who are presenting\nwith TFF or LF probably caused by an oocyte-related activation pro-\nblems. Our former policy was to perform ICSI-AOA on all available\noocytes following the MOAT in most of these patients. Nevertheless,\npregnancy results were lower in this group compared with patients in\nwhom a sperm activation de\ufb01ciency (MOAT Group 1) or a diminished\noocyte activation capacity (MOAT Group 2) was found (Heindryckx\net al., 2008). To our knowledge, \u2018split activation\u2019 on part of the avail-\nable metaphase II (MII) oocytes was \ufb01rstly mentioned by Yanagida\n(2004) in a review regarding fertilization failure following ICSI. Yana-\ngida stated that \u2018split activation\u2019 could be performed when fertilization\nfailure is anticipated but did not discussed the validity of this method\nsince, at that time, no data were available on the subject. Therefore,\nsince 2006, we changed our policy for patients in MOAT Group 3 to\nverify their real bene\ufb01t of ICSI-AOA. We strongly advised convention-\nal ICSI and split ICSI-AOA on sibling oocytes. The majority of patients\nin MOAT Group 3 are referred to our centre because of a history of LF\nor TFF following conventional ICSI elsewhere.", "mimetype": "text/plain", "start_char_idx": 8309, "end_char_idx": 10086, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ada4a161-18bb-43b4-8389-4aecbcb5272b": {"__data__": {"id_": "ada4a161-18bb-43b4-8389-4aecbcb5272b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26a2a009-eee8-4aae-a523-6aed3180ace2", "node_type": "1", "metadata": {}, "hash": "87fd947d18ff198a387f5e18e811f8c80f330a8af1ce59f608c7535aaeb23906", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "41c7cc37-9e2c-4399-9756-576f752db2b2", "node_type": "1", "metadata": {}, "hash": "3b8b66ba46cd85b5d59275d4d6468aba68a16f4c9a018717bd1c7f246dcd2f5c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The majority of patients\nin MOAT Group 3 are referred to our centre because of a history of LF\nor TFF following conventional ICSI elsewhere. By the split ICSI-AOA\npolicy, we aim to distinguish between a previous coincidental LF\nrate or a real oocyte-related activation de\ufb01ciency, in order to assess\nthe necessity of AOA in these patients. According to the fertilization\noutcome of the split ICSI-AOA cycle, either conventional ICSI or\nICSI-AOA will be advised on all oocytes in the next treatment cycle.\nThe primary objective of this prospective case series is thus to\nprovide further insight into the ef\ufb01ciency of ICSI-AOA compared\nwith conventional ICSI in patients with a suspected oocyte-related\nactivation de\ufb01ciency. Furthermore, we present a diagnostic and\ntherapeutic approach based on the results of the split ICSI-AOA\ncycle for this rare but challenging group of patients.\nMaterials and Methods\nInclusion and exclusion criteria for patients\nCouples with a history of failed or LF following conventional ICSI in whom\nthe MOAT revealed a possible oocyte-related activation de\ufb01ciency\n(MOAT result .84%) were eligible to be included in this prospective\ncase series. Patients were divided into two separate groups: the out-house\npatients (referred patients) and in-house patients (own patients). All\npatients were treated in our centre from January 2006 until December\n2011. Controlled ovarian hyperstimulation was performed in all included\npatients using the short GnRH agonist protocol. This protocol consisted\nof daily injections of triptorelin (0.1 mg) starting on Day 3 of the cycle, fol-\nlowed by gonadotrophin stimulation (112.5\u2013300 IU) from Day 5 of the\ncycle. Gonadotrophin stimulation was performed with recombinant FSH\nor HMG. In each case ICSI-AOA was performed on half of the MII\noocytes, if six or more MII oocytes were available. Patients with less\nthan six MII oocytes available at retrieval were excluded from the analysis,\nbecause in such cases the agreement was to perform ICSI-AOA on all\nof their available MII oocytes. Main end-points were fertilization rate,\npregnancy rate and live birth rate.", "mimetype": "text/plain", "start_char_idx": 9946, "end_char_idx": 12066, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "41c7cc37-9e2c-4399-9756-576f752db2b2": {"__data__": {"id_": "41c7cc37-9e2c-4399-9756-576f752db2b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ada4a161-18bb-43b4-8389-4aecbcb5272b", "node_type": "1", "metadata": {}, "hash": "259b61a42833cbe0139bce4a98ad014ea8dabb0aacf5dd48be5be8e10299ce19", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a13aff0d-bdfe-4bd9-ae63-74a5b03e906d", "node_type": "1", "metadata": {}, "hash": "b405c5ac96e9da205c8da8d4dafe9ae67c9bbbf275f2028b0f15afff716deccc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Main end-points were fertilization rate,\npregnancy rate and live birth rate.\n1978\nMeerschaut et al.\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \nMOAT\nMII mouse oocytes were collected from B6D2 F1 hybrid female mice after\novulation induction by 10 IU pregnant mare\u2019s serum gonadotrophin\n(PMSG,\nFolligonw,\nIntervet, Boxmeer,\nThe\nNetherlands),\nfollowed\n46\u201348 h later by 10 IU hCG (Chorulonw, Intervet, Boxmeer, The Neth-\nerlands). MII oocytes were collected 13\u201314 h following hCG adminis-\ntration. Culture and handling media were potassium simplex optimized\nmedium\n(KSOM)\nand\nKSOM-HEPES\nrespectively,\nboth\ncontaining\n0.2 mmol/l glucose and supplemented with 0.4% w/v bovine serum\nalbumin (BSAw, MP Biochemicals, Asse-Relegem, Belgium). Cumulus\ncells were removed by a brief exposure to 200 IU hyaluronidase/ml.\nInjection of immobilized frozen-thawed spermatozoa using piezo pulses\nwas performed at 15\u2013178C in KSOM-HEPES supplemented with 20%\nfetal bovine serum (FBSw, Gibco BRL, Carlsbad, USA). Four experimental\ngroups were set up: (i) ICSI with patients spermatozoa; (ii) ICSI with\ndonated\nspermatozoa\nwith\nproven\nfertilization\ncapacity\n(positive\ncontrol); (iii) sham ICSI (negative control) and (iv) non-manipulated\noocytes (medium control) to exclude spontaneous parthenogenetic\nactivation. Next, the oocytes were put in culture and 1 day later the\npercentage of oocyte activation was determined by examining the\nnumber of 2-cell embryos versus the number of surviving injected oocytes.\nAOA and outcome\nWhen six or more MII oocytes were available, ICSI-AOA was performed\non half of the sibling MII oocytes.", "mimetype": "text/plain", "start_char_idx": 11990, "end_char_idx": 13653, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a13aff0d-bdfe-4bd9-ae63-74a5b03e906d": {"__data__": {"id_": "a13aff0d-bdfe-4bd9-ae63-74a5b03e906d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "41c7cc37-9e2c-4399-9756-576f752db2b2", "node_type": "1", "metadata": {}, "hash": "3b8b66ba46cd85b5d59275d4d6468aba68a16f4c9a018717bd1c7f246dcd2f5c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "21fd8d04-e738-42b2-9895-3495f2019d60", "node_type": "1", "metadata": {}, "hash": "0ebed2ecc7a5297beb50c19c0bdc242add0268683c81c33f8f5277061d829b7d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "AOA and outcome\nWhen six or more MII oocytes were available, ICSI-AOA was performed\non half of the sibling MII oocytes. When an odd number of oocytes was\navailable, ICSI-AOA was chosen for half plus one of the oocytes.\nICSI-AOA was performed at least 6 h after oocyte retrieval, as previously\ndescribed by Heindryckx et al. (2008). Brie\ufb02y, a spermatozoon was\ninjected into the oocyte using conventional ICSI together with a small\namount of 0.1 mol/l CaCl2 (corresponding to the diameter of the\noocyte). Thereafter, the oocytes were incubated for 30 min at 378C in\na 6% CO2 air atmosphere. Next, the oocytes were exposed to a\ncalcium ionophore (10-mM ionomycin, I9657, Sigma-Aldrich, Bornem,\nBelgium) for 10 min. Following this ionophore exposure, the oocytes\nwere washed with Cook Cleavage medium (Cook Ireland Ltd, Limerick,\nIreland) and were incubated again. After another 30 min, the calcium iono-\nphore treatment was repeated for 10 min. Finally, the oocytes were\nwashed and incubated overnight. Fertilization was evaluated 16 h after\nthe ICSI procedure. Normal fertilized oocytes showed two pronuclei\nand two polar bodies. The fertilization rate was de\ufb01ned by the number\nof normally fertilized oocytes compared with the total number of injected\nand surviving MII oocytes. Embryo transfer was carried out on Day 2 or\n3. Pregnancy rate was de\ufb01ned by the number of clinical pregnancies (ges-\ntational sac with fetal heartbeat at 6\u20137 weeks) as a proportion of the\nnumber of fresh cycles. Birth rates were de\ufb01ned as the number of live\nborn babies compared with the proportion of clinical pregnancies.\nStatistical analysis\nThe student\u2019s t-test, x2 test or Fisher\u2019s exact test were used for statistical\nanalysis where appropriate using the Statistical Package for the Social\nSciences (SPSSw Statistics 19, IBM Corp., NY, USA).", "mimetype": "text/plain", "start_char_idx": 13534, "end_char_idx": 15358, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "21fd8d04-e738-42b2-9895-3495f2019d60": {"__data__": {"id_": "21fd8d04-e738-42b2-9895-3495f2019d60", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a13aff0d-bdfe-4bd9-ae63-74a5b03e906d", "node_type": "1", "metadata": {}, "hash": "b405c5ac96e9da205c8da8d4dafe9ae67c9bbbf275f2028b0f15afff716deccc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "15a7e983-14ef-4d0e-a5ea-1c0eea2d0a2e", "node_type": "1", "metadata": {}, "hash": "350d3f92cd633b59253f960047df8a67e70b91d43881ba6fb683efef6c02dd14", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A P-value , 0.05\nwas considered statistically signi\ufb01cant.\nResults\nMOAT results and inclusion of patients\nFrom January 2006 until December 2011, 74 MOATs were performed\nin our centre. MOAT Group 1 (sperm de\ufb01ciency con\ufb01rmed) accounted\nfor 17.6% of the results and MOAT Group 2 (sperm de\ufb01ciency sus-\npected) accounted for 16.2%. MOAT Group 3 (no sperm de\ufb01ciency)\nwas con\ufb01rmed in 66.2% of the cases. The reasons for exclusion\nwere the renouncement of any further treatment, signing up for\noocyte donation and conventional ICSI or ICSI-AOA on all of the\navailable oocytes (the latter options were taken at the request of\nthe patient; see Fig. 1).\nDemographics, fertility history and semen\ncharacteristics\nThe mean age of the included women was 31.6 +3.73 years. The age\nof the two in-house patients was 30.0 and 30.2 years. The out-house\npatients were split into two groups regarding (i) a history of TFF\n(n \u00bc 5) or (ii) a history of LF (n \u00bc 7) following conventional ICSI.\nThe mean age in the TFF group was 33.4 +3.05 years compared\nwith 31.3 +4.23 years in the LF group (P \u00bc 0.365). Thirteen of the\nincluded women were of Caucasian descent and one couple\nwas Arab. Semen characteristics and fertility treatment history are\npresented in Table I.\nOverall fertilization and pregnancy rates\nFollowing conventional ICSI 43.5% of the oocytes were fertilized,\nwhereas following ICSI-AOA the fertilization rate increased to\n74.2% (P , 0.001). In total, 14 split ICSI-AOA cycles were performed\nin this study population. As a result of these split ICSI-AOA cycles, \ufb01ve\npregnancies were achieved (overall pregnancy rate: 35.7%), of which\ntwo ended in the birth of a healthy singleton (overall live birth rate:\n14.3%) and one pregnancy is still ongoing.", "mimetype": "text/plain", "start_char_idx": 15359, "end_char_idx": 17097, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "15a7e983-14ef-4d0e-a5ea-1c0eea2d0a2e": {"__data__": {"id_": "15a7e983-14ef-4d0e-a5ea-1c0eea2d0a2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "21fd8d04-e738-42b2-9895-3495f2019d60", "node_type": "1", "metadata": {}, "hash": "0ebed2ecc7a5297beb50c19c0bdc242add0268683c81c33f8f5277061d829b7d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a8b5af39-dbfa-41be-9c26-8b3e490104d6", "node_type": "1", "metadata": {}, "hash": "683e28a7b5573667ebeeaf739a4effb31e45e5f31c6d8582a9a3109809bfa0f8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The fertilization history,\nresults and outcome are presented in Table II.\nIn-house cases with a history of LF rates\nTwo in-house cases (Cases 1 and 2) are included in this study (Supple-\nmentary Table SI). Both cases showed LF in previous ICSI cycles.\nICSI-AOA was shown to be bene\ufb01cial, with a mean fertilization rate\nof 75.0% for ICSI-AOA compared with 25.0% for conventional ICSI\nFigure 1 Overview of the MOAT results from January 2006 until\nDecember 2011 and subsequent inclusion of study patients.\nIndication for assisted oocyte activation\n1979\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \non sibling oocytes (P , 0.01). In one patient (Case 2) an ongoing\npregnancy was achieved and a healthy singleton was born.\nOut-house cases with a history of TFF\nFive out-house patients (Cases 3\u20137) consulted our centre with a history\nof TFF in one or more ICSI cycles (Supplementary Table SII). Overall,\nICSI-AOA was bene\ufb01cial, with a mean fertilization rate of 72.7% (24/\n33) for ICSI-AOA compared with 25.0% (7/28) for conventional ICSI\n(P , 0.001). One of these patients had a miscarriage following the\ntransfer of a single ICSI-AOA embryo.\nOut-house patients with a history of LF rates\nSeven out-house patients (Cases 8\u201314) were referred to our centre\nwith a history of LF in one or more ICSI cycles (Supplementary\nTable SIII). The previous mean fertilization rate was 21.4%. Overall,\nICSI-AOA was not bene\ufb01cial, with a mean oocyte fertilization rate\nof 75.0% (39/52) compared with 60.4% (29/48) for conventional\nICSI (P \u00bc 0.118). Three patients became pregnant during this split\nICSI-AOA cycle. One pregnancy ended in a miscarriage, one resulted\nin the birth of a healthy singleton and one pregnancy is still ongoing.", "mimetype": "text/plain", "start_char_idx": 17098, "end_char_idx": 18870, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a8b5af39-dbfa-41be-9c26-8b3e490104d6": {"__data__": {"id_": "a8b5af39-dbfa-41be-9c26-8b3e490104d6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15a7e983-14ef-4d0e-a5ea-1c0eea2d0a2e", "node_type": "1", "metadata": {}, "hash": "350d3f92cd633b59253f960047df8a67e70b91d43881ba6fb683efef6c02dd14", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e4db23bb-cdaa-42e8-80d8-679cb2508099", "node_type": "1", "metadata": {}, "hash": "e3d78d5f15fe2cebd3c101b4c0c8678b4c2915aa77153110013cb7bca84037e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Three patients became pregnant during this split\nICSI-AOA cycle. One pregnancy ended in a miscarriage, one resulted\nin the birth of a healthy singleton and one pregnancy is still ongoing.\nDiagnostic and therapeutic algorithm\nFigure 2 represents a diagnostic and therapeutic algorithm based on\nthe outcomes of the above described groups. From 2003 until May\n2011, the mean fertilization rate of 13 136 ICSI cycles registered in\nour centre was 73.7 + 22.72%. The 5th, 25th, 50th and 75th percen-\ntiles were 33.3, 62.5, 76.92 and 90.0%, respectively. Based on this, in\nour centre, abnormal LF is now considered to be a recurrent fertiliza-\ntion rate of 33.3% or less. A MOAT is thus proposed when the fertil-\nization rate after ICSI is ,33.3%. According to the result of the\nMOAT, patients are classi\ufb01ed into three MOAT groups. For MOAT\nGroups 1 and 2, ICSI-AOA is performed on all oocytes. For patients\nin MOAT Group 3 with a history of TFF, ICSI-AOA is performed on\nall oocytes. For patients in MOAT Group 3 with a history of LF, a\n\u2018split ICSI-AOA cycle\u2019 is proposed. According to the fertilization\nresults of this split cycle, the decision is made to perform conventional\nICSI or ICSI-AOA on all available oocytes in future cycles.\nDiscussion\nICSI-AOA has proved to be a very ef\ufb01cient technique in cases of\nrecurrent TFF or LF rates after ICSI (Nasr-Esfahani et al., 2010).\nThe MOAT is a diagnostic tool which helps to predict the usefulness\nof ICSI-AOA in a subsequent cycle and helps to diagnose sperm-\nrelated activation de\ufb01ciencies (Rybouchkin et al., 1996; Yanagida\net al., 1999; Tesarik et al., 2002; Araki et al., 2004; Heindyckx et al.,\n2005, 2008).", "mimetype": "text/plain", "start_char_idx": 18683, "end_char_idx": 20340, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e4db23bb-cdaa-42e8-80d8-679cb2508099": {"__data__": {"id_": "e4db23bb-cdaa-42e8-80d8-679cb2508099", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a8b5af39-dbfa-41be-9c26-8b3e490104d6", "node_type": "1", "metadata": {}, "hash": "683e28a7b5573667ebeeaf739a4effb31e45e5f31c6d8582a9a3109809bfa0f8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "257b4fd6-7cf7-4fbe-a994-0f43548a5b5e", "node_type": "1", "metadata": {}, "hash": "c521e25d824f6aebf2c9e1b4b60bba4ac3d6bff616d0b3f86f76e89ffd2543ad", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ICSI-AOA with ionophore or electrical pulses is success-\nful in restoring fertilization and pregnancy rates by manipulating the\nintracellular calcium concentration (Yanagida et al., 1999; Eldar-Geva\net al. 2003; Murase et al., 2004; Heindryckx et al., 2005). To our\nknowledge, this is the \ufb01rst study to test the ef\ufb01ciency of ICSI-AOA\ncompared with conventional ICSI on sibling oocytes of patients with\na possible oocyte-related activation de\ufb01ciency, as diagnosed by the\nMOAT, namely patients in MOAT Group 3. As this technique is still\nconsidered to be experimental, research to assess the bene\ufb01cial\n.............................................................................................................................................................................................\nTable I Semen characteristics and treatment history of the included patients.", "mimetype": "text/plain", "start_char_idx": 20341, "end_char_idx": 21208, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "257b4fd6-7cf7-4fbe-a994-0f43548a5b5e": {"__data__": {"id_": "257b4fd6-7cf7-4fbe-a994-0f43548a5b5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e4db23bb-cdaa-42e8-80d8-679cb2508099", "node_type": "1", "metadata": {}, "hash": "e3d78d5f15fe2cebd3c101b4c0c8678b4c2915aa77153110013cb7bca84037e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab806ebb-2f6c-42ce-a8dc-f9e84b7471c3", "node_type": "1", "metadata": {}, "hash": "eb9167461f99038cd18173f178ee252c34c025f5f426d293c36f66a786ff22c8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As this technique is still\nconsidered to be experimental, research to assess the bene\ufb01cial\n.............................................................................................................................................................................................\nTable I Semen characteristics and treatment history of the included patients.\nSemen characteristics at MOAT\nSperm concentration\nper ml\nSperm motility\nA 1 B (%)\nSperm morphology % normal\nTreatment history\nIn-house cases (both LF)\nCase 1\n21.106\n35\n1\nIUI, IVF, ICSI\nCase 2\n58.106\n71\n4\nIUI, IVF, ICSI\nOut-house TFF\nCase 3\n14.106\n42\n5\nIUI, IVF, ICSI\nCase 4\n57.106\n47\n2\nIVF, ICSI\nCase 5\n31.106\n19\n1\nICSI\nCase 6\n,0.5.106\n0\n0\nICSI\nCase 7\n15.106\n11\n1\nICSI\nOut-house LF\nCase 8\n30.106\n56\n4\nIUI, ICSI\nCase 9\n8.106\n7\n0\nIUI, ICSI\nCase 10\n1.106\n4\n0\nIUI, ICSI\nCase 11\n29.106\n4\n2\nICSI\nCase 12\n11.106\n68\n0\nICSI\nCase 13\n14.106\n40\n7\nIUI, IVF, ICSI\nCase 14\n2.106\n23\n8\nIUI, ICSI\nTFF, total fertilization failure after previous conventional ICSI; LF, low fertilization after previous conventional ICSI (considered to be 33.3% or less, based on the 5th percentile of mean\nfertilization rates);\nIUI, intrauterine insemination;\nMOAT, mouse oocyte activation test.\n1980\nMeerschaut et al.\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \neffect of, and necessity for, ICSI-AOA in this speci\ufb01c patient group\nremains highly important.\nOwing to practical considerations, the MOAT was performed using\nfrozen-thawed human sperm.", "mimetype": "text/plain", "start_char_idx": 20850, "end_char_idx": 22378, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab806ebb-2f6c-42ce-a8dc-f9e84b7471c3": {"__data__": {"id_": "ab806ebb-2f6c-42ce-a8dc-f9e84b7471c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "257b4fd6-7cf7-4fbe-a994-0f43548a5b5e", "node_type": "1", "metadata": {}, "hash": "c521e25d824f6aebf2c9e1b4b60bba4ac3d6bff616d0b3f86f76e89ffd2543ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f125168-ec69-4b27-8e4c-845e000b0df6", "node_type": "1", "metadata": {}, "hash": "772ea7582ce688278d9d54b4eea190a83162cb35a728260ec3f219c2cb5919a1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Owing to practical considerations, the MOAT was performed using\nfrozen-thawed human sperm. Cryopreservation is widely known to\nraise impaired sperm motility and decrease fertilization rates through\ndetrimental effects on membranes, acrosomal structure and acrosin\nactivity (Cross and Hanks, 1991). Nevertheless, we consider our\nMOAT results to be reliable because only motile spermatozoa with\nthe best morphology were used for heterologous ICSI. Moreover,\ndata on fertilization and pregnancy rates after ICSI comparing fresh\nand frozen-thawed human ejaculated spermatozoa are reassuring:\nno statically signi\ufb01cant differences were found between fresh and\nfrozen-thawed sperm in fertilization rates (Kuczyn\u00b4ski et al., 2001). Fur-\nthermore, we did not \ufb01nd any differences in calcium releasing ability\nafter heterologous ICSI when fresh sperm were compared with\nfrozen-thawed sperm from the same patient (unpublished data).\nThe mean age of the 14 included women in this study is 31.6 years.\nThe age did not differ between the in-house compared with the out-\nhouse cases, neither did the age differ between the out-house group\nwith TTF in their history compared with the out-house group with\nLF in their history. Several authors have reported on the age-related\ndecline in the success of IVF/ICSI cycles. Most likely this lies in the\nprogressively diminished ovarian reserve, with a decreasing quantity\nand quality of oocytes (Broekmans et al., 2007; van Loendersloot\net al., 2010). However, in this relatively young study population, it is\nplausible that age did not yet in\ufb02uence oocyte quality.\nTwo in-house patients with previous LF rates were included in this\nstudy. It is clearly shown that ICSI-AOA was clinically and statistically\n(albeit for only two patients) bene\ufb01cial compared with conventional\nICSI for both cases. This emphasizes the presence of a real\noocyte-related activation de\ufb01ciency in these in-house patients, rather\nthan a previous technical failure.", "mimetype": "text/plain", "start_char_idx": 22288, "end_char_idx": 24255, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f125168-ec69-4b27-8e4c-845e000b0df6": {"__data__": {"id_": "9f125168-ec69-4b27-8e4c-845e000b0df6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab806ebb-2f6c-42ce-a8dc-f9e84b7471c3", "node_type": "1", "metadata": {}, "hash": "eb9167461f99038cd18173f178ee252c34c025f5f426d293c36f66a786ff22c8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "19de532f-e3f6-4a90-947d-4fe34bbf3894", "node_type": "1", "metadata": {}, "hash": "f1cfcf4c2a4e36bafb995ae7c1439db670fec6fbd65f3ce36b8a3317e3f2e068", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This emphasizes the presence of a real\noocyte-related activation de\ufb01ciency in these in-house patients, rather\nthan a previous technical failure. Unfortunately, in Case 1, although\nICSI-AOA was ef\ufb01cient in improving the fertilization rate, neither the\nsplit ICSI-AOA cycle nor two subsequent 100% ICSI-AOA cycles\nled to a pregnancy. Even after several oocyte donation cycles, no\nongoing pregnancy was achieved. So, it is clear that this patient\nsuffers from severe underlying female factor infertility, and whether\n...................................................................\n..........................................................................................................................................................................................................................................................\nTable II Fertilization and pregnancy rates before and after the split ICSI-AOA cycle.", "mimetype": "text/plain", "start_char_idx": 24111, "end_char_idx": 25029, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "19de532f-e3f6-4a90-947d-4fe34bbf3894": {"__data__": {"id_": "19de532f-e3f6-4a90-947d-4fe34bbf3894", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f125168-ec69-4b27-8e4c-845e000b0df6", "node_type": "1", "metadata": {}, "hash": "772ea7582ce688278d9d54b4eea190a83162cb35a728260ec3f219c2cb5919a1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20e9e856-9dd9-4ed5-879b-70f8d40a6b14", "node_type": "1", "metadata": {}, "hash": "ea78a72082a78b57e5725b95a80b7e4a28db90a555f382e1e84334051fa5a0ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "So, it is clear that this patient\nsuffers from severe underlying female factor infertility, and whether\n...................................................................\n..........................................................................................................................................................................................................................................................\nTable II Fertilization and pregnancy rates before and after the split ICSI-AOA cycle.\nFertilization rate before\nICSI-AOAa\nPregnancy\nrateb\nSplit cycle fertilization ratea\nPregnancy rateb\nLive birth ratec\nSource of embryos\ntransferred leading to\npregnancy\nICSI-AOA\nConventional ICSI\nIn-house LF (n \u00bc 2)\n29.3 (19.2 and 37.5) (17/58)\n0 (0/5)\n75.0 (57.1\u201388.9) (12/16)*\n25.0 (14.3\u201333.3) (4/16)*\n50.0 (1/2)\n50.0 (1/2)\n1\u00d7 mixed DETd\nOut-house TFF (n \u00bc 5)\n0 (0\u20130) (0/54)\n0 (0/15)\n72.7 (28.6\u201390.9) (24/33)\u2020\n25.0 (0.0\u2013100) (7/28)\u2020\n20.0 (1/5)\n0.0 (0/5)\n1\u00d7 AOA SETd\nOut-house LF (n \u00bc 7)\n21.4 (6.3\u201335.1) (27/126)\n0 (0/8)\n75.0 (40.0\u2013100) (39/52)\u2021\n60.4 (33.3\u201380.0) (29/48)\u2021\n42.9 (3/7)e\n14.3 (1/7)\n2\u00d7 mixed DET, 1\u00d7 AOA SET\nTotal\n17.7 (0\u201337.5) (44/248)\n0 (0/28)\n74.2 (28.6\u2013100) (75/101)$\n43.5 (0.0\u2013100) (40/92)$\n35.7 (5/14)\n14.3 (2/14)\nSee above\nAOA, assisted oocyte activation.\naValues are percentage (range) (number of normally fertilized oocytes/number of injected metaphase II oocytes).\nbValues are percentage (number of clinical pregnancies/number of fresh cycles).", "mimetype": "text/plain", "start_char_idx": 24521, "end_char_idx": 25996, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "20e9e856-9dd9-4ed5-879b-70f8d40a6b14": {"__data__": {"id_": "20e9e856-9dd9-4ed5-879b-70f8d40a6b14", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "19de532f-e3f6-4a90-947d-4fe34bbf3894", "node_type": "1", "metadata": {}, "hash": "f1cfcf4c2a4e36bafb995ae7c1439db670fec6fbd65f3ce36b8a3317e3f2e068", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a266794-ccd2-4c05-bd9e-073cae5896e3", "node_type": "1", "metadata": {}, "hash": "045ea79514703e737bc9c33f1d41d8032977aa01df50d45614d3b18979fd14e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aValues are percentage (range) (number of normally fertilized oocytes/number of injected metaphase II oocytes).\nbValues are percentage (number of clinical pregnancies/number of fresh cycles).\ncValues are percentage (number of live births/number of fresh cycles).\ndMixed DET \u00bc double embryo transfer of one ICSI-AOA embryo and one conventional ICSI embryo; AOA SET \u00bc single embryo transfer of an ICSI-AOA embryo.\neOne pregnancy is still ongoing.\n*P , 0.01 (Pearson x2 test).\n\u2020P , 0.001 (Pearson x2 test).\n\u2021P \u00bc 0.118 (Pearson x2 test).\n$P , 0.001 (Pearson x2 test).\nFigure 2 Diagnostic and therapeutic approach of patients with pre-\nvious total fertilization failure or LF rates following conventional ICSI.\nIndication for assisted oocyte activation\n1981\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \nthis infertility is strictly oocyte related or not remains debatable. Case\n2 did also bene\ufb01t from ICSI-AOA according to fertilization rate,\nalthough not as explicitly as compared with Case 1. In Case 2, a struc-\ntural oocyte defect lies at the basis of the history of the LF: as\ndescribed by Heindryckx et al. (2008), a spindle defect was suspected\nowing to (i) the absence of spindle visualization using polarized micros-\ncopy and (ii) commonly seen formation of multiple pronucleii and\nmultinucleated embryos following IVF, conventional ICSI as well as\nICSI-AOA. Previous studies on unfertilized oocytes in IVF cycles\nhave revealed the presence of abnormal spindle and interphase micro-\ntubules, indicating that de\ufb01ciencies in ooplasmic components may be a\ncause of failed fertilization (Kovacic and Vlaisavljevic, 2000; Rawe et al.,\n2000). A very interesting case was recently reported by Combelles\net al. (2010). In this case, no fertilization was seen following conven-\ntional ICSI. Subsequently, heterologuous ICSI showed a normal\nability of the husband\u2019s sperm to activate mouse oocytes.", "mimetype": "text/plain", "start_char_idx": 25805, "end_char_idx": 27753, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6a266794-ccd2-4c05-bd9e-073cae5896e3": {"__data__": {"id_": "6a266794-ccd2-4c05-bd9e-073cae5896e3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20e9e856-9dd9-4ed5-879b-70f8d40a6b14", "node_type": "1", "metadata": {}, "hash": "ea78a72082a78b57e5725b95a80b7e4a28db90a555f382e1e84334051fa5a0ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e09ab81a-5916-491b-aaba-a7d786f75136", "node_type": "1", "metadata": {}, "hash": "1a34b4ee107cc06a26c582cb61a1ba798969628ec489b5f3ef581cbc4a1b0ba8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(2010). In this case, no fertilization was seen following conven-\ntional ICSI. Subsequently, heterologuous ICSI showed a normal\nability of the husband\u2019s sperm to activate mouse oocytes. Next,\nICSI-AOA was performed on all oocytes after ICSI with half of the\nsperm from the husband and half from a donor. None of the injected\noocytes in either group was fertilized. Thus, in contrast to both our\nin-house patients, the oocyte-related activation failure in the case\ndescribed by Combelles et al. (2010) could not be rescued by\nICSI-AOA. Analysis of the cytoskeletal and chromatin organization\nof the unfertilized oocytes revealed severe cytoplasmic abnormalities\nacross the cohort of oocytes. It is obvious that further research is\nnecessary to \ufb01nd other treatment options for such patients.\nThe patients from the out-house TFF group showed a signi\ufb01cant\nbene\ufb01t from ICSI-AOA over conventional ICSI. This underlines the\nprobability of an oocyte-related activation de\ufb01ciency of unknown\nsource in this group, which can be rescued by ICSI-AOA. It is well\nknown that nuclear as well as cytoplasmic maturation is crucial for\noocytes before being able to respond properly to the sperm PLCz\nduring the fertilization process (Swain and Pool, 2008). Thus, success-\nful fertilization depends also on the inherent quality of the oocyte,\nwhich correlates strongly with successful oocyte maturation. The\nability to generate calcium oscillations requires several cytoplasmic\nchanges: reorganization of the endoplasmic reticulum (ER), an increase\nin the number of inositol-3-phosphate receptors (IP3Rs), changes in\nthe biochemical properties of the IP3Rs (sensitivity to IP3), an increase\nin the concentration of Ca2+ ions stored in ER and redistribution of\nCa2+-binding ER proteins (Goud et al., 1999; Goud et al., 2002;\nAjduk et al., 2008; Vanderheyden et al., 2009).", "mimetype": "text/plain", "start_char_idx": 27568, "end_char_idx": 29419, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e09ab81a-5916-491b-aaba-a7d786f75136": {"__data__": {"id_": "e09ab81a-5916-491b-aaba-a7d786f75136", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6a266794-ccd2-4c05-bd9e-073cae5896e3", "node_type": "1", "metadata": {}, "hash": "045ea79514703e737bc9c33f1d41d8032977aa01df50d45614d3b18979fd14e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28790530-8cfd-486c-97cc-646a7bafdb95", "node_type": "1", "metadata": {}, "hash": "1a7bfff9b8d388b0a377bb80125828996e0e24d442daeaaa5bf123af8c3e7e6d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As our ICSI-AOA\nprotocol using CaCl2 and ionomycin arti\ufb01cially provokes some\ncalcium rises in the oocyte cytoplasm, it is likely that an underlying\ncytoplasmic defect (related to the Ca2+-releasing machinery of the\noocyte) is the reason for the previous TFF in the out-house patients,\nrather than a structural cytoskeletal-related or nuclear defect.\nIn contrast to the out-house TFF group, the patients from the out-\nhouse LF group showed no signi\ufb01cant bene\ufb01t from ICSI-AOA. More-\nover, Cases 8, 9 and 13 had pregnancies, four miscarriages and one\nongoing pregnancy, with the same male partner before being referred\nto our centre. Interestingly, all but one of the out-house LF group had\nacceptable fertilization rates in our centre (considering the .33.3%\nthreshold for normal fertilization) when conventional ICSI was\napplied as part of the split cycle. This underlines even more that the\nindication for ICSI-AOA in this group should not be made implicitly\nand that a split cycle could be advised instead of 100% AOA. The\naim of the split ICSI-AOA cycle policy was thus to distinguish\nbetween a molecular oocyte-related activation de\ufb01ciency from a pre-\nvious technical or other biological failure. Nevertheless, the absence of\nbene\ufb01t from ICSI-AOA in this group leads to the assumption that\neither a previous technical (and neither an oocyte nor a sperm de\ufb01-\nciency) or an unidenti\ufb01ed temporary biological failure could have led\nto LF rates elsewhere. Although ICSI is considered to be a routine\ntechnique, it remains one of the most demanding techniques for\nembryologists to master. It is not unusual for any embryologist to ex-\nperience a dip in performance following the acquisition of pro\ufb01ciency\nin the technique. A comprehensive investigation of factors that in\ufb02u-\nence fertilization rates after ICSI, found that the ICSI embryologist\nconducting the procedure was a signi\ufb01cant predictor of success,\nwhile laboratory conditions, such as incubators or storage of eggs\nindividually versus grouped, did not affect the fertilization rates\n(Shen et al., 2003).", "mimetype": "text/plain", "start_char_idx": 29420, "end_char_idx": 31481, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28790530-8cfd-486c-97cc-646a7bafdb95": {"__data__": {"id_": "28790530-8cfd-486c-97cc-646a7bafdb95", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e09ab81a-5916-491b-aaba-a7d786f75136", "node_type": "1", "metadata": {}, "hash": "1a34b4ee107cc06a26c582cb61a1ba798969628ec489b5f3ef581cbc4a1b0ba8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "005be17c-41f3-418e-9823-d272d8fa2301", "node_type": "1", "metadata": {}, "hash": "2625a155b4d2a4c795da66f7ac074553f7ae808f37114c80f9dee280d09c953f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The factors leading to fertilization failure are complex and may\ninvolve either sperm- or oocyte-related activation de\ufb01ciencies, which\ncan be indicated by the MOAT result and overcome with ICSI-AOA\n(Heindryckx et al., 2008). It is important to keep in mind that the\nhuman PLCz has a higher activation potential compared with mouse\nPLCz on mouse oocytes (Cox et al., 2002; Ito et al., 2008). The\nlatter needs to be considered when interpreting a MOAT result,\nbecause the activation rate in mouse oocytes cannot be extrapolated\nas such to human oocytes. Furthermore, factors leading to fertilization\nfailure may also relate to cycle-speci\ufb01c parameters and the number\nand quality of the mature oocytes, as well as the availability of\nnormal motile sperm (Liu et al., 1995; Flaherty et al., 1998, Kovacic\nand Vlaisavljevic, 2000, Esfandiari et al., 2005, Swain and Pool, 2008).\nAlthough ICSI-AOA is considered a very ef\ufb01cient technique to over-\ncome fertilization failure, this is not true for all cases of fertilization\nfailure. A previous study has showed that AOA is more ef\ufb01cient to\novercome sperm-related activation de\ufb01ciencies, as diagnosed by the\nMOAT, rather than suspected oocyte-related activation de\ufb01ciencies\n(Heindryckx et al., 2008). In the study of Heindryckx et al., (2008),\npatients from all three MOAT groups were included and the main\ntreatment strategy was 100% ICSI-AOA. Since in this patient series\nonly one MOAT group 3 couple received split ICSI-AOA, the validity\nof the split ICSI-AOA strategy could not be investigated. Nevertheless,\nit was demonstrated that although fertilization rates could be restored\nby ICSI-AOA for all MOAT groups, the clinical pregnancy rates in\nMOAT Group 3 patients were lower compared with MOAT Group 1\nand 2 patients (17 versus 34 and 43%, respectively).", "mimetype": "text/plain", "start_char_idx": 31482, "end_char_idx": 33286, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "005be17c-41f3-418e-9823-d272d8fa2301": {"__data__": {"id_": "005be17c-41f3-418e-9823-d272d8fa2301", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28790530-8cfd-486c-97cc-646a7bafdb95", "node_type": "1", "metadata": {}, "hash": "1a7bfff9b8d388b0a377bb80125828996e0e24d442daeaaa5bf123af8c3e7e6d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e9b3e9e4-408c-4f03-8644-b09f80acea30", "node_type": "1", "metadata": {}, "hash": "e528d0e3783b13603cd978ddba179f43d7beacb1b3e5a79263a94a95db57989f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The latter is con-\n\ufb01rmed by the current study, with a mean pregnancy rate and birth rate\nof 35.7 and 14.3%, respectively.\nIn order to increase the ef\ufb01ciency of AOA in some subgroups of\npatients (for example, with extreme oligoasthenoteratozoospermia\nor when an oocyte factor is responsible for the failed ICSI), injection\nof PLCz cRNA or recombinant PLCz protein might offer a better\nalternative as these provide a more physiological stimulus than iono-\nphore. Furthermore, the use of ionophore is still experimental\nbecause of insuf\ufb01cient knowledge about the potential cytotoxic,\nteratogenic and mutagenic effects on embryos and offspring. In previ-\nous animal research, no adverse effects of ionomycin on in-vitro or\nin-vivo mouse embryo development were noticed, giving arguments\nin favour of the use of ionomycin (Heytens et al., 2008). On the\n1982\nMeerschaut et al.\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \ncontrary, no long-term follow-up studies of children born after\nICSI-AOA using ionomycin are yet available. Therefore, ICSI-AOA\nshould not be performed without a proper indication in patients\nwith previous LF, nor should it be used as an ultimate resort when\nother ARTs have failed. In this respect, it is advisable that patients\nthat might bene\ufb01t from a treatment with AOA after previously\nhaving TFF or LF after ICSI, \ufb01rst seek a diagnostic test, such as the\nMOAT, to be able to con\ufb01rm whether a sperm-borne activation de-\n\ufb01ciency is present (Rybouchkin et al., 1996; Araki et al., 2004).\nRecent studies have applied ionophore treatment or electrical stimu-\nlation for infertile patients with no obvious indication, because in\nthese patients the fertilization and pregnancy rates were comparable\nwith or without AOA (Mansour et al., 2008; Borges et al., 2009b).", "mimetype": "text/plain", "start_char_idx": 33287, "end_char_idx": 35122, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e9b3e9e4-408c-4f03-8644-b09f80acea30": {"__data__": {"id_": "e9b3e9e4-408c-4f03-8644-b09f80acea30", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "005be17c-41f3-418e-9823-d272d8fa2301", "node_type": "1", "metadata": {}, "hash": "2625a155b4d2a4c795da66f7ac074553f7ae808f37114c80f9dee280d09c953f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b381b44-201f-475e-b7e9-9a57c2e0ae7e", "node_type": "1", "metadata": {}, "hash": "e0baf5843e3ff8bdb9bfe5a372b952250c69596e6e6e2176ec48bf11bd4a384b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In one study, AOA was even applied in the \ufb01rst cycle ICSI attempt\n(Borges et al., 2009a).\nThe primary objective of this follow-up study was to provide further\ninsight in the necessity of ICSI-AOA in patients in MOAT Group 3 and\nits ef\ufb01ciency with respect to fertilization and pregnancy rates. The low\nsample number and heterogeneity of the study population might inter-\nfere with the predictive value of this study. Nevertheless, we are\ndealing with a very rare but challenging group of patients, for which\nwe hope this study can set guidelines. The proposed diagnostic and\ntherapeutic algorithm based on the outcomes of this study enables\nthe evidence-based counseling of couples suffering from TFF or LF\nafter ICSI. A MOAT, or similar heterologous ICSI test, should\nalways be recommended when the previous ICSI fertilization rate\nwas ,33.3% before ICSI-AOA is considered. This threshold is\nchosen because 33.3% is the 5th percentile of the fertilization rate\nafter ICSI in our centre. Next, if the MOAT shows a normal result,\nany further treatment should depend on the fertility history. If the pre-\nvious fertilization rate was 0%, ICSI-AOA is advisable on all available\nMII oocytes. In contrast, if the previous fertilization rate was\n,33.3%, but not zero, the best strategy is to perform ICSI-AOA on\nhalf of the sibling oocytes to distinguish between a previous coinciden-\ntal LF rate or a real oocyte-related activation de\ufb01ciency. When a\nfuture cycle is necessary, AOA should be performed on all or none\nof the available MII oocytes according to the fertilization results of\nthe split cycle. Finally, if any structural oocyte defect is suspected, non-\ninvasive spindle evaluation on fresh MII oocytes by means of polarized\nlight microscopy or invasive spindle evaluation on spare (MI or unfer-\ntilized) oocytes by means of immunostaining should be considered.\nThus, taking into consideration the history of the couple, a split\nICSI-AOA cycle on sibling oocytes, together with additional diagnostic\napproaches, such as spindle evaluation of the oocytes, is essential to\nselect the proper therapeutic strategy in these cases.", "mimetype": "text/plain", "start_char_idx": 35123, "end_char_idx": 37252, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b381b44-201f-475e-b7e9-9a57c2e0ae7e": {"__data__": {"id_": "9b381b44-201f-475e-b7e9-9a57c2e0ae7e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e9b3e9e4-408c-4f03-8644-b09f80acea30", "node_type": "1", "metadata": {}, "hash": "e528d0e3783b13603cd978ddba179f43d7beacb1b3e5a79263a94a95db57989f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "98eb7538-8674-447b-870d-ae84f61e9a6a", "node_type": "1", "metadata": {}, "hash": "b094efbb8a588b96d2dd9c221f7fde8d8f44d3818ef0aa9af38670fb590833f1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Based on the\nlimited data available, we were able to claim that the fertility history\nof the patients in MOAT Group 3 plays a critical role in choosing the\nappropriate diagnostic and therapeutic approach. Furthermore, it\nwas shown that ICSI-AOA is not bene\ufb01cial for all patients with a sus-\npected oocyte-related activation de\ufb01ciency. As ICSI-AOA is still an\nelaborate and experimental technique, it should only be considered\nin case of a well-diagnosed indication.\nSupplementary data\nSupplementary data are available at http://humrep.oxfordjournals.\norg/.\nAuthors\u2019 roles\nF.V.M. analysed the data, interpreted the results and wrote the manu-\nscript; D.N. contributed to interpreting the results; S.D, V.D. and B.H.\nperformed the assisted oocyte activation; E.V.A and J.G. revised the\nmanuscript; B.H. and P.D.S. designed the study, revised the manu-\nscript and approved the \ufb01nal draft.\nFunding\nF.V.M. is the holder of an aspirant clinical research mandate by the\nFlemish Foundation of Scienti\ufb01c Research (FWO-Vlaanderen). P.D.S.\nis the holder of a fundamental clinical research mandate by the\nsame Flemish foundation of Scienti\ufb01c Research (FWO-Vlaanderen).\nCon\ufb02ict of interest\nNone declared.\nReferences\nAjduk A, Malagocki A, Maleszewski M. Cytoplasmic maturation of\nmammalian oocytes: development of a mechanism responsible for\nsperm-induced Ca2+ oscillations. Reprod Biol 2008;8:3\u201322.\nAraki Y, Yoshizawa M, Abe H, Murase Y, Araki Y. Use of mouse oocytes\nto evaluate the ability of human sperm to activate oocytes after failure of\nactivation\nby\nintracytoplasmic\nsperm\ninjection.\nZygote\n2004;\n12:111\u2013116.\nBorges E Jr, de Almeida Ferreira Braga DP, de Sousa Bonetti TC,\nIaconelli A Jr, Franco JG Jr.", "mimetype": "text/plain", "start_char_idx": 37253, "end_char_idx": 38950, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "98eb7538-8674-447b-870d-ae84f61e9a6a": {"__data__": {"id_": "98eb7538-8674-447b-870d-ae84f61e9a6a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b381b44-201f-475e-b7e9-9a57c2e0ae7e", "node_type": "1", "metadata": {}, "hash": "e0baf5843e3ff8bdb9bfe5a372b952250c69596e6e6e2176ec48bf11bd4a384b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab93033e-461b-4706-b732-b164bf0f5345", "node_type": "1", "metadata": {}, "hash": "1b2fea1af41b265484e49cb71333ddd244a0bc560800f96b881974798fd24a08", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Zygote\n2004;\n12:111\u2013116.\nBorges E Jr, de Almeida Ferreira Braga DP, de Sousa Bonetti TC,\nIaconelli A Jr, Franco JG Jr. Arti\ufb01cial oocyte activation using calcium\nionophore in ICSI cycles with spermatozoa from different sources.\nReprod Biomed Online 2009a;18:45\u201352.\nBorges E Jr, de Almeida Ferreira Braga DP, de Sousa Bonetti TC,\nIaconelli A Jr, Franco JG Jr. Arti\ufb01cial oocyte activation with calcium\nionophore A23187 in intracytoplasmic sperm injection cycles using\nsurgically retrieved spermatozoa. Fertil Steril 2009b;92:131\u2013136.\nBroekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female\nreproductive ageing: current knowledge and future trends. Trends\nEndocrinol Metab 2007;18:58\u201365.\nChi HJ, Koo JJ, Song SJ, Lee JY, Chang SS. Successful fertilization and\npregnancy after intracytoplasmic sperm injection and oocyte activation\nwith calcium ionophore in a normozoospermic patient with extremely\nlow fertilization rates in intracytoplasmic sperm injection cycles. Fertil\nSteril 2004;82:475\u2013477.\nCombelles CM, Morozumi K, Yanagimachi R, Zhu L, Fox JH, Racowsky C.\nDiagnosing cellular defects in an unexplained case of total fertilization\nfailure. Hum Reprod 2010;25:1666\u20131671.\nCox LJ, Larman MG, Saunders CM, Hashimoto K, Swann K, Lai FA. Sperm\nphospholipase Czeta from humans and cynomolgus monkeys triggers\nCa2+ oscillations, activation and development of mouse oocytes.\nReproduction 2002;124:611\u2013623.\nCross NL, Hanks SE. Effects of cryopreservation on human sperm\nacrosomes. Hum Reprod 1991;6:1279\u20131283.", "mimetype": "text/plain", "start_char_idx": 38832, "end_char_idx": 40347, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab93033e-461b-4706-b732-b164bf0f5345": {"__data__": {"id_": "ab93033e-461b-4706-b732-b164bf0f5345", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "98eb7538-8674-447b-870d-ae84f61e9a6a", "node_type": "1", "metadata": {}, "hash": "b094efbb8a588b96d2dd9c221f7fde8d8f44d3818ef0aa9af38670fb590833f1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e3ca5cb-ad5d-423f-8e36-0df355c6cc08", "node_type": "1", "metadata": {}, "hash": "7de7719e1ba87676fd569eaee36173250397f96276c9ba3678aa7718dea50a77", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Reproduction 2002;124:611\u2013623.\nCross NL, Hanks SE. Effects of cryopreservation on human sperm\nacrosomes. Hum Reprod 1991;6:1279\u20131283.\nDam AH, Feenstra I, Westphal JR, Ramos L, van Golde RJ, Kremer JA.\nGlobozoospermia revisited. Hum Reprod Update 2007;13:63\u201375.\nDucibella T, Huneau D, Angelichio E, Xu Z, Schultz RM, Kopf GS,\nFissore R, Madoux S, Ozil JP. Egg-to-embryo transition is driven by\ndifferential responses to Ca(2+) oscillation number. Dev Biol 2002;\n250:280\u2013291.\nIndication for assisted oocyte activation\n1983\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from \nEbner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete\noocyte activation failure after ICSI can be overcome by a modi\ufb01ed\ninjection technique. Hum Reprod 2004;19:1837\u20131841.\nEldar-Geva T, Brooks B, Margalioth EJ, Zylber-Haran E, Gal M, Silber SJ.\nSuccessful pregnancy and delivery after calcium ionophore oocyte\nactivation in a normozoospermic patient with previous repeated failed\nfertilization after intracytoplasmic sperm injection. Fertil Steril 2003;\n79(Suppl. 3):1656\u20131658.\nEsfandiari N, Javed MH, Gotlieb L, Casper RF. Complete failed fertilization\nafter intracytoplasmic sperm injection\u2014analysis of 10 years\u2019 data. Int J\nFertil Womens Med 2005;50:187\u2013192.\nFlaherty SP, Payne D, Swann NJ, Mattews CD. Aetiology of failed and\nabnormal fertilization after intracytoplasmic sperm injection. Hum\nReprod 1995;10:2623\u20132629.\nFlaherty SP, Payne D, Matthews CD.", "mimetype": "text/plain", "start_char_idx": 40214, "end_char_idx": 41701, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e3ca5cb-ad5d-423f-8e36-0df355c6cc08": {"__data__": {"id_": "4e3ca5cb-ad5d-423f-8e36-0df355c6cc08", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab93033e-461b-4706-b732-b164bf0f5345", "node_type": "1", "metadata": {}, "hash": "1b2fea1af41b265484e49cb71333ddd244a0bc560800f96b881974798fd24a08", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "87c0e0f3-ad99-40a6-bdde-5539cad7bc11", "node_type": "1", "metadata": {}, "hash": "283133cf5d138efc13e16c79f43e3a3475b6683486dd51d0b3aa7cb475f0ad43", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Aetiology of failed and\nabnormal fertilization after intracytoplasmic sperm injection. Hum\nReprod 1995;10:2623\u20132629.\nFlaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal\nfertilization after intracytoplasmic sperm injection. Hum Reprod 1998;\n13(Suppl. 1):155\u2013164.\nGoud PT, Goud AP, Van Oostveldt P, Dhont M. Presence and dynamic\nredistribution of type I inositol 1,4,5-trisphosphate receptors in\nhuman oocytes and embryos during in-vitro maturation, fertilization\nand early cleavage divisions. Mol Hum Reprod 1999;5:441\u201351.\nGoud PT, Goud AP, Leybaert L, Van Oostveldt P, Mikoshiba K,\nDiamond MP, Dhont M. Inositol 1,4,5-trisphosphate receptor function\nin human oocytes: calcium responses and oocyte activation-related\nphenomena induced by photolytic release of InsP3 are blocked by a\nspeci\ufb01c antibody to the type I receptor. Mol Hum Reprod 2002;\n8:912\u2013918.\nHeindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option for\nsperm- or oocyte-related fertilization failure: assisted oocyte activation\nfollowing diagnostic heterologous ICSI. Hum Reprod 2005;20:2237\u20132241.\nHeindryckx B, De Gheselle S, Gerris J, Dhont M, De Sutter P. Ef\ufb01ciency of\nassisted oocyte activation as a solution for failed intracytoplasmic sperm\ninjection. Reprod Biomed Online 2008;17:662\u2013668.\nHeytens E, Soleimani R, Lierman S, De Meester S, Gerris J, Dhont M, Van\nder Elst J, De Sutter P. Reprod Biomed Online 2008;17:764\u2013771.", "mimetype": "text/plain", "start_char_idx": 41550, "end_char_idx": 42974, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "87c0e0f3-ad99-40a6-bdde-5539cad7bc11": {"__data__": {"id_": "87c0e0f3-ad99-40a6-bdde-5539cad7bc11", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e3ca5cb-ad5d-423f-8e36-0df355c6cc08", "node_type": "1", "metadata": {}, "hash": "7de7719e1ba87676fd569eaee36173250397f96276c9ba3678aa7718dea50a77", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cf206f45-989f-4f91-b6d8-0df21a1c5c59", "node_type": "1", "metadata": {}, "hash": "29e221d4cbd08fc74bf4f4ae033edc0e48044f8dac3611aad165d304d7c85efd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ito M, Shikano T, Oda S, Horiguchi T, Tanimoto S, Awaji T, Mitani H,\nMiyazaki S. Difference in Ca2+\noscillation-inducing activity and\nnuclear translocation ability of PLCZ1, an egg-activating sperm factor\ncandidate, between mouse, rat, human, and medaka \ufb01sh. Biol Reprod\n2008;78:1081\u20131090.\nKashir J, Heindryckx B, Jones C, De Sutter P, Parrington J, Coward K.\nOocyte activation, phospholipase C zeta and human infertility. Hum\nReprod Update 2010;16:690\u2013703.\nKovacic B, Vlaisavljevic V. Con\ufb01guration of maternal and paternal chromatin\nand pertaining microtubules in human oocytes failing to fertilize after\nintracytoplasmic sperm injection. Mol Reprod Dev 2000;55:197\u2013204.\nKuczyn\u00b4ski W, Dhont M, Grygoruk C, Grochowski D, Wo\u0142czyn\u00b4ski S,\nSzamatowicz M. The outcome of intracytoplasmic injection of fresh\nand\ncryopreserved\nejaculated\nspermatozoa\u2014a\nprospective\nrandomized study. Hum Reprod 2001;16:2109\u20132113.\nLiu J, Nagy Z, Joris H, Tournaye H, Smitz J, Camus M, Devroey P, Van\nSteirteghem A. Analysis of 76 total fertilization failure cycles out of\n2732 intracytoplasmic sperm injection cycles. Hum Reprod 1995;\n10:2630\u20132636.\nMansour R, Fahmy I, Tawab NA, Kamal A, El-Demery Y, Aboulghar M,\nSerour G. Electrical activation of oocytes after intracytoplasmic\nsperm injection: a controlled randomized study. Fertil Steril 2009;\n91:133\u2013139.", "mimetype": "text/plain", "start_char_idx": 42975, "end_char_idx": 44308, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf206f45-989f-4f91-b6d8-0df21a1c5c59": {"__data__": {"id_": "cf206f45-989f-4f91-b6d8-0df21a1c5c59", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "87c0e0f3-ad99-40a6-bdde-5539cad7bc11", "node_type": "1", "metadata": {}, "hash": "283133cf5d138efc13e16c79f43e3a3475b6683486dd51d0b3aa7cb475f0ad43", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2331340-209a-4f5b-adcc-dbdca8245cf2", "node_type": "1", "metadata": {}, "hash": "738949a620bbf2a7eab57b76b81434b4c81b49612bfeffb87ead57acb4e47f15", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertil Steril 2009;\n91:133\u2013139.\nMouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V,\nKupka M, Nygren KG, Nyboe Andersen A. Assisted reproductive\ntechnology\nin\nEurope,\n2006:\nresults\ngenerated\nfrom\nEuropean\nregisters by ESHRE. European IVF-monitoring (EIM) Consortium, for\nthe European Society of Human Reproduction and Embryology\n(ESHRE). Hum Reprod 2010;25:1851\u20131862.\nMurase Y, Araki Y, Mizuno S, Kawaguchi C, Naito M, Yoshizawa M,\nAraki Y. Pregnancy following chemical activation of oocytes in a\ncouple with repeated failure of fertilization using ICSI: case report.\nHum Reprod 2004;19:1604\u20131607.\nNasr-Esfahani MH, Deemeh MR, Tavalaee M. Arti\ufb01cial oocyte activation\nand intracytoplasmic sperm injection. Fertil Steril 2010;94:520\u2013526.\nPalermo GD, Neri QV, Takeuchi T, Rosenwaks Z. ICSI: where we have\nbeen and where we are going. Semin Reprod Med 2009;27:191\u2013201.\nParrington J, Davis LC, Galione A, Wessel G. Flipping the switch: how a\nsperm activates the egg at fertilization. Dev Dyn 2007;236:2027\u20132038.\nRawe VY, Olmedo SB, Nodar FN, Doncel GD, Acosta AA, Vitullo AD.\nCytoskeletal organization defects and abortive activation in human\noocytes after IVF and ICSI failure. Mol Hum Reprod 2000;6:510\u2013516.\nRybouchkin A, Dozortsev D, Pelinck MJ, De Sutter P, Dhont M. Analysis of\nthe oocyte activation capacity and chromosomal complement of\nroundheaded human spermatozoa by their injection into mouse\noocytes. Human Reprod 1996;11:2170\u20132175.", "mimetype": "text/plain", "start_char_idx": 44277, "end_char_idx": 45739, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2331340-209a-4f5b-adcc-dbdca8245cf2": {"__data__": {"id_": "c2331340-209a-4f5b-adcc-dbdca8245cf2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cf206f45-989f-4f91-b6d8-0df21a1c5c59", "node_type": "1", "metadata": {}, "hash": "29e221d4cbd08fc74bf4f4ae033edc0e48044f8dac3611aad165d304d7c85efd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e19dbd15-3045-4302-8ab3-ee2079af1bcc", "node_type": "1", "metadata": {}, "hash": "588086a7fc5f896541f17ef5e4f6d379cb8fa77e546c2d13eda7099a0659180c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Reprod 1996;11:2170\u20132175.\nSaunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM,\nSwann K, Lai FA. PLC zeta: a sperm-speci\ufb01c trigger of Ca(2+)\noscillations in eggs and embryo development. Development 2002;\n129:3533\u20133544.\nShen S, Khabani A, Klein N, Battaglia D. Statistical analysis of factors\naffecting fertilization rates and clinical\noutcome associated with\nintracytoplasmic sperm injection. Fertil Steril 2003;79:355\u2013360.\nSwain JE, Pool TB. ART failure: oocyte contributions to unsuccessful\nfertilization. Hum Reprod Update 2008;14:431\u2013446.\nTesarik J, Mendoza C. In vitro fertilization by intracytoplasmic sperm\ninjection. Bioessays 1999;21:791\u2013801.\nTesarik J, Mendoza C, Greco E. The activity (calcium oscillator?)\nresponsible for human oocyte activation after injection with round\nspermatids is associated with spermatid nuclei. Fertil Steril 2000;\n74:1245\u20131247.\nTesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modi\ufb01ed\nintracytoplasmic sperm injection technique to overcome sperm-borne\nand\noocyte-borne\noocyte\nactivation\nfailures.\nFertil\nSteril\n2002;\n78:619\u2013624.\nVanderheyden V, Wakai T, Bultynck G, De Smedt H, Parys JB, Fissore RA.\nRegulation of inositol 1,4,5-trisphosphate receptor type 1 function\nduring oocyte maturation by MPM-2 phosphorylation. Cell Calcium\n2009;46:56\u201364.\nvan Loendersloot LL, van Wely M, Limpens J, Bossuyt PMM, Repping S,\nvan der Veen F. Predictive factors in in vitro fertilization (IVF): a\nsystematic review and meta-analysis. Human Reprod Update 2010;\n16:577\u2013589.", "mimetype": "text/plain", "start_char_idx": 45708, "end_char_idx": 47236, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e19dbd15-3045-4302-8ab3-ee2079af1bcc": {"__data__": {"id_": "e19dbd15-3045-4302-8ab3-ee2079af1bcc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Vanden Meerschaut (2012).pdf", "node_type": "4", "metadata": {}, "hash": "28d05e35739e26e840a28a454d4558079ae04c007508249414f1528d6074cf71", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2331340-209a-4f5b-adcc-dbdca8245cf2", "node_type": "1", "metadata": {}, "hash": "738949a620bbf2a7eab57b76b81434b4c81b49612bfeffb87ead57acb4e47f15", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Reprod Update 2010;\n16:577\u2013589.\nYanagida K. Complete fertilization failure in ICSI. Hum Cell 2004;\n17:187\u2013193.\nYanagida K, Katayose H, Yazawa H, Kimura Y, Sato A, Yanagimachi H,\nYanagimachi R. Successful fertilization and pregnancy following ICSI\nand electrical oocyte activation. Hum Reprod 1999;14:1307\u20131311.\nYanagida K, Morozumi K, Katayose H, Hayashi S, Sato A. Successful\npregnancy after ICSI with strontium oocyte activation in low rates of\nfertilization. Reprod Biomed Online 2006;13:801\u2013806.\n1984\nMeerschaut et al.\n at University of Lethbridge on November 14, 2015\nhttp://humrep.oxfordjournals.org/\nDownloaded from", "mimetype": "text/plain", "start_char_idx": 47199, "end_char_idx": 47827, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d9d063c-dadd-4e36-942e-071b19931274": {"__data__": {"id_": "5d9d063c-dadd-4e36-942e-071b19931274", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d366835-0c97-4361-beaf-71904242ae16", "node_type": "1", "metadata": {}, "hash": "5ec70508fb28eff91a79a5698ff7b3a32f3dd98059f63e9e82565d7a5fd42ff8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Electrical activation of oocytes after intracytoplasmic\nsperm injection: a controlled randomized study\nRagaa Mansour, M.D., Ph.D., Ibrahim Fahmy, M.D., Nevine A. Tawab, B.Sc., Ahmed Kamal, M.D.,\nYehia El-Demery, B.Sc., Mohamed Aboulghar, M.D., and Gamal Serour, M.D., F.R.C.O.G.\nEgyptian IVF-ET Center, Cairo, Egypt\nObjective: To evaluate the electrical activation of oocytes in patients with previously failed or limited fertilization\nafter intracytoplasmic sperm injection (ICSI) and in patients with possible failure of fertilization.\nDesign: Prospective randomized study.\nSetting: A private IVF center in Egypt.\nPatient(s): Two hundred forty-six patients with severe oligoasthenospermia or nonobstructive azoospermia with\ntotal teratospermia or totally immotile spermatozoa were selected for the study. Patients who previously had total\nfailure or limited fertilization after ICSI also were included.\nIntervention(s): Sibling oocytes were randomly divided after ICSI into two groups: the study group (n \u00bc 1,640)\nwas subjected to electroactivation, and the control group (n \u00bc 1,435), to no electroactivation. Electroactivation was\nperformed by using a double-square direct-current pulse. Embryo transfer was performed with the best available\nembryos.\nMain Outcome Measure(s): Fertilization rate, degeneration rate, and pregnancy outcome.\nResult(s): Two hundred forty-one ICSI cycles were included in the study. The fertilization rate was statistically\nsigni\ufb01cantly higher in the electroactivated group as compared with in the control group (68% vs 60%, odds ratio\n\u00bc 1.397, 95% con\ufb01dence interval \u00bc 1.197 to 1.629). The oocyte degeneration rate was not statistically signi\ufb01cantly\ndifferent between the two groups (5.9% vs 4.9%, odds ratio \u00bc 0.96, 95% con\ufb01dence interval \u00bc 0.73 to 1.26). In\ntotal, 112 clinical pregnancies resulted (pregnancy rate \u00bc 46.5%).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1858, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d366835-0c97-4361-beaf-71904242ae16": {"__data__": {"id_": "6d366835-0c97-4361-beaf-71904242ae16", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d9d063c-dadd-4e36-942e-071b19931274", "node_type": "1", "metadata": {}, "hash": "b966f9421223740bf3804fc66774e646f90baf3a6a747b1062048ef3654b0586", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4dbd1651-884e-41b5-af0a-efa81493cfe7", "node_type": "1", "metadata": {}, "hash": "2502309fced8936398cc2957d7af410080873b07edab48f6e449184359f01dab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\ntotal, 112 clinical pregnancies resulted (pregnancy rate \u00bc 46.5%). Total fertilization failure occurred in 5 cycles in\nthe control group, and none failed in the study group.\nConclusion(s): Oocyte electroactivation after ICSI signi\ufb01cantly improved the fertilization rate in severe oligoas-\nthenoteratospermia and nonobstructive azoospermia. (Fertil Steril\u0002 2009;91:133\u20139. \u00032009 by American Society\nfor Reproductive Medicine.)\nKey Words: ICSI, fertilization, electrical activation, total fertilization failure\nIntracytoplasmic sperm injection (ICSI) has become the most\neffective therapeutic treatment for male-factor infertility (1).\nHowever, total failure of fertilization still occurs in some\ncases, such as globozoospermia (2), teratozoospermia (3),\nimmotile spermatozoa (4), and even unexplained cases (5).\nTotal fertilization failure is a rare event in cases with normal\noocytes and spermatozoa, but it can even occur repeatedly\n(6). It is estimated that failed fertilization occurs in 2%\u20133%\nof ICSI cycles (7, 8).\nIn ICSI, because the spermatozoa is injected inside the\nooplasm, failure of pronuclear formation and division most\nprobably is the result of the failure of oocyte activation.\nMany investigators have tried different techniques for oocyte\nactivation after ICSI to overcome this problem. Ionophore\ntreatment for oocyte activation after ICSI resulted in the birth\nof a healthy baby in a case of previously failed fertilization\ndue to globozoospermia (2). Intracytoplasmic sperm injec-\ntion followed by electrical oocyte activation resulted in the\ndelivery of healthy twins for a couple with previously failed\nfertilization after ICSI (9). Recently, it was demonstrated that\noocyte activation enabled normal fertilization and pregnancy\nin sperm and oocyte\u2013related fertilization failure (8). The aim\nof this study was to estimate the value of the electrical activa-\ntion of oocytes in patients with previously failed or limited\nfertilization after ICSI, as well as in patients with the possi-\nbility of failed fertilization as a result of teratozoospermia.", "mimetype": "text/plain", "start_char_idx": 1789, "end_char_idx": 3861, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4dbd1651-884e-41b5-af0a-efa81493cfe7": {"__data__": {"id_": "4dbd1651-884e-41b5-af0a-efa81493cfe7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d366835-0c97-4361-beaf-71904242ae16", "node_type": "1", "metadata": {}, "hash": "5ec70508fb28eff91a79a5698ff7b3a32f3dd98059f63e9e82565d7a5fd42ff8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2e3adca0-6c18-4e3b-a913-a3e4e1e0b1e6", "node_type": "1", "metadata": {}, "hash": "e9cb70770c995cd9c0185c942458bd14b51c14ecbe0686ec98cce88a180db8bf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MATERIALS AND METHODS\nOn the basis of the experience of other researchers (8, 9), we\ndecided to test electroactivation in a pilot study \ufb01rst. Electro-\nactivation of oocytes after ICSI was performed for 10 patients\nin our center who had had previous total failure of fertiliza-\ntion in 11 ICSI cycles. After the encouraging results of these\n10 cases, approval was obtained from the institutional review\nboard of the Egyptian IVF-ET Center to perform oocyte elec-\ntroactivation in cases with expected poor fertilization in a ran-\ndomized controlled study. The study included 241 ICSI\ncycles for infertile couples with severe oligoasthenoterato-\nspermia (OAT) or azoospermia. Poor fertilization or failure\nof fertilization was expected because of 100% abnormal\nsperm morphology or totally immotile sperms. The patients\nwere counseled and signed consent forms. The female part-\nners were <40 years of age and had normal hormonal pro\ufb01les\nReceived March 24, 2007; revised and accepted August 7, 2007.\nReprint requests: Ragaa Mansour, M.D., Ph.D., The Egyptian IVF-ET Cen-\nter, 3, Street 161, Hadayek El-Maadi, Cairo 11431, Egypt (FAX:\n202-2525-3532; E-mail: ragaa.mansour@gmail.com).\n0015-0282/09/$36.00\nFertility and Sterility\u0004 Vol. 91, No. 1, January 2009\n133\ndoi:10.1016/j.fertnstert.2007.08.017\nCopyright \u00aa2009 American Society for Reproductive Medicine, Published by Elsevier Inc.\nand no pelvic pathology. The oocytes for each patient were\nrandomly divided after ICSI into two groups: the study group\n(electroactivation) and the control group (without electroac-\ntivation). The embryologists who allocated the oocytes and\nthose who followed them afterward were blinded to the ran-\ndomization.\nOvarian Stimulation and Oocyte Pickup\nControlled ovarian stimulation was performed by using the\nlong GnRH-agonist down-regulation protocol.", "mimetype": "text/plain", "start_char_idx": 3862, "end_char_idx": 5693, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2e3adca0-6c18-4e3b-a913-a3e4e1e0b1e6": {"__data__": {"id_": "2e3adca0-6c18-4e3b-a913-a3e4e1e0b1e6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4dbd1651-884e-41b5-af0a-efa81493cfe7", "node_type": "1", "metadata": {}, "hash": "2502309fced8936398cc2957d7af410080873b07edab48f6e449184359f01dab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08293380-7604-46b1-9a55-a24d65a6bbb4", "node_type": "1", "metadata": {}, "hash": "e19f255625b0df8ee1751a9fac02a56af75e03e23edcd04418a782d36d00f7b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ovarian Stimulation and Oocyte Pickup\nControlled ovarian stimulation was performed by using the\nlong GnRH-agonist down-regulation protocol. GnRH agonist\n(Decapeptyl, 0.1 mg SC per d; Ferring Pharmaceuticals, Co-\npenhagen, Denmark) was given starting on day 20 of the cy-\ncle. After 2 to 3 weeks, when the down-regulation had been\ncon\ufb01rmed by E2 levels of <50 pg/mL, hMG was started.\nThe starting dose of hMG was 150\u2013300 mIU/d, according\nto the patient\u2019s age and body weight, as well as the ovarian\nresponse in previous cycles. Monitoring was started on day\n7 of hMG stimulation, with daily E2 measurements and vag-\ninal ultrasonography.\nWhen at least three follicles reached 18 mm in mean diam-\neter, hCG (Pregnyl, 10,000 IU; NV Organon, the Nether-\nlands) was given. Oocyte pickup was scheduled 36 hours\nafter hCG injection.\nSemen Processing Before ICSI\nAfter complete liquefaction, the semen was washed twice\nwith tissue culture media, and the \ufb01nal pellet was resus-\npended in 0.2 mL of medium. Then it was layered carefully\nin the surrounding ring of a Tea tube (10), \ufb01lled with tissue\nculture media, and incubated until the time of injection. In\ncases of azoospermia, testicular tissues were prepared as de-\nscribed elsewhere (11). Testicular biopsy was obtained under\noptical magni\ufb01cation of \u00026.5.\nThe ICSI procedure was performed as described elsewhere\n(12).\nAfter injection, the oocytes for each patient were randomly\ndivided in a 1:1 ratio into two groups: group A (with activa-\ntion) and group B (without activation). After ICSI, one em-\nbryologist randomly allocated the oocytes into two dishes.\nAnother embryologist allocated the dishes for each patient\ninto a control dish and an electroactivation one. The embry-\nologist who checked for signs of fertilization was blinded to\nthe allocation.\nOocyte Electrical Activation\nOocyte electrical activation was performed 30 minutes after\nICSI.", "mimetype": "text/plain", "start_char_idx": 5554, "end_char_idx": 7452, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "08293380-7604-46b1-9a55-a24d65a6bbb4": {"__data__": {"id_": "08293380-7604-46b1-9a55-a24d65a6bbb4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2e3adca0-6c18-4e3b-a913-a3e4e1e0b1e6", "node_type": "1", "metadata": {}, "hash": "e9cb70770c995cd9c0185c942458bd14b51c14ecbe0686ec98cce88a180db8bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "57bba814-fe83-4229-b517-e5e4ecfa1620", "node_type": "1", "metadata": {}, "hash": "b638d8b86a856745a58c04a2a52f15afebbf70da4ccde11fdbe64941b9c41b4f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The embry-\nologist who checked for signs of fertilization was blinded to\nthe allocation.\nOocyte Electrical Activation\nOocyte electrical activation was performed 30 minutes after\nICSI. The time of inducing electrical oocyte activation was\nrecommended to be as soon as possible after ICSI (13), be-\ncause nuclei swelling and chromosome fragmentation was\nobserved in 51% of unfertilized oocytes after ICSI (14).\nThe oocytes were suspended in 0.3 M glucose drops, with\npH at 7.3, and placed between two parallel electrodes (2\nmm apart) in an electric slide chamber (BTX micro slide P/\nN 450, 0.5-mm gap; BTX, San Diego, CA). A double-square\ndirect-current pulse (130V, 50 mc apart) was generated by us-\ning an electro cell manipulator (BTX) to achieve the desired\n\ufb01eld strength of 2.6\u20132.8 kv/cm. The activation setting was ad-\njusted as follows: mode, HV (99 per sec per 3 KV); voltage,\n130\u2013140 V; pulse length, 50 ms; and number of pulses, 2.\nThe electrically stimulated oocytes immediately were\ntransferred back to the tissue culture media to be rinsed,\nthen they were incubated under oil in 5% CO2 in air, at 37\u0003C.\nThe oocytes were checked 16\u201318 hours after injection to\ndetermine the presence of pronuclei. Embryo transfer was\nperformed 48\u201372 hours later, replacing the three best avail-\nable embryos. A b-hCG test was performed 2 weeks after\nthe embryo transfer, and ultrasonography was performed\n3 weeks later for positive cases.\nThe primary outcome measures were de\ufb01ned to be the oo-\ncyte fertilization rate and oocyte degeneration rate. The sec-\nondary outcome measures were the pregnancy rates and\npregnancy outcome.\nStrati\ufb01cation of data was performed to take in account the\ncycle effect. Mantel-Haenszel estimates of both odds ratio\nand c2 statistics were averaged across 241 strata.", "mimetype": "text/plain", "start_char_idx": 7269, "end_char_idx": 9059, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57bba814-fe83-4229-b517-e5e4ecfa1620": {"__data__": {"id_": "57bba814-fe83-4229-b517-e5e4ecfa1620", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08293380-7604-46b1-9a55-a24d65a6bbb4", "node_type": "1", "metadata": {}, "hash": "e19f255625b0df8ee1751a9fac02a56af75e03e23edcd04418a782d36d00f7b4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ce3b3dc-c52b-495d-8f9b-c2b941bf28c1", "node_type": "1", "metadata": {}, "hash": "c6ee2378c944460789c18f1d3844f890886d2a30fa851679856227d38f5c0a14", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Strati\ufb01cation of data was performed to take in account the\ncycle effect. Mantel-Haenszel estimates of both odds ratio\nand c2 statistics were averaged across 241 strata.\nSample-Size Calculation\nIt was assumed that the fertilization rate in dif\ufb01cult ICSI\ncases, with nonobstructive azoospermia and severe OAT\nand with previously failed fertilization, would be around\n50% per metaphase II oocytes. To demonstrate an increase\nof 10% using the electroactivation technique, the sample\nsize needed for a study power of 95% was 660 metaphase\nII oocytes in each group (total \u00bc 1,320). Assuming that\na mean of 12 metaphase II oocytes was retrieved, we needed\n110 patients. Our study included 241 patients.\nRESULTS\nFor the pilot study, 10 patients with previous total failure of\nfertilization in 11 ICSI cycles were subjected to ICSI and\nthen electroactivation. All 10 patients achieved fertilization,\nand 1 had extra fertilized oocytes that were cryopreserved.\nAll 10 patients reached the embryo transfer stage, and 4\nof them achieved pregnancy, resulting in the delivery of\nfour healthy babies. Data from the 10 cycles are shown in\nTable 1.\nThe randomized controlled trial included 241 ICSI cycles\nthat were performed in our center between August 2005 and\nJanuary 2006 (Fig. 1). The mean age of the female partners\nwas 29.41 \u0004 4.79 years. The mean period of infertility was\n8.5 \u0004 4.2 years. Spermatozoa were obtained from ejaculated\nsemen in 190 cycles and from testicular biopsies in 51 cycles.\nThe sperm count ranged from only a few spermatozoa to 25 \u0002\n106/mL, with a mean of 3.75 \u0004 2.51. Motility ranged from\nzero to 30%, and abnormal forms ranged from 90% to\n100%. The fertilization rate was signi\ufb01cantly higher in the\nelectroactivated group, as compared with the case in the con-\ntrol group (68% vs.", "mimetype": "text/plain", "start_char_idx": 8891, "end_char_idx": 10686, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1ce3b3dc-c52b-495d-8f9b-c2b941bf28c1": {"__data__": {"id_": "1ce3b3dc-c52b-495d-8f9b-c2b941bf28c1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "57bba814-fe83-4229-b517-e5e4ecfa1620", "node_type": "1", "metadata": {}, "hash": "b638d8b86a856745a58c04a2a52f15afebbf70da4ccde11fdbe64941b9c41b4f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "570b37d3-6ab5-4f79-976a-222310c1aed3", "node_type": "1", "metadata": {}, "hash": "5de88235bf4bb385f129a5461ef2847690789d7be09c5a89e6caf765083583c4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The fertilization rate was signi\ufb01cantly higher in the\nelectroactivated group, as compared with the case in the con-\ntrol group (68% vs. 60%; odds ratio \u00bc 1.397; 95% con\ufb01dence\ninterval \u00bc 1.197 to 1.629; P<.0001). There was no\n134\nMansour et al.\nElectrical activation of oocytes after ICSI\nVol. 91, No. 1, January 2009\nsigni\ufb01cant difference in the oocyte degeneration rates in both\ngroups (5.9% vs. 4.9%, odds ratio \u00bc 0.96, 95% con\ufb01dence\ninterval \u00bc 0.73 to 1.26; Table 2). Embryo transfer was per-\nformed with the best-quality available embryos (%3 em-\nbryos). In 34 cycles, the embryos used for ET were derived\nfrom the electroactivated group, resulting in 15 pregnancies\n(pregnancy rate \u00bc 44%). Three ended in miscarriage, and\nof the remaining 12, 4 sets of twins and 8 singletons were\ndelivered (9 healthy girls and 7 healthy boys), as shown in\nTable 3. In 69 cycles, the embryos used for ET were derived\nfrom the control group, resulting in 33 pregnancies (preg-\nnancy rate \u00bc 48%). Three ended in miscarriages and one ec-\ntopic pregnancy, and of the remaining 29, 6 sets of twins and\n23 singletons were delivered (1 stillbirth, 20 healthy boys,\nand 14 healthy girls). In the majority of cycles (138), the em-\nbryos used for ETwere derived from both groups, resulting in\n64 pregnancies (pregnancy rate \u00bc 46.4%). Six patients mis-\ncarried, and 58 delivered (1 set of triplets, 10 sets of twins,\nand 47 singletons, for a total of 30 healthy girls and 40\nhealthy boys).", "mimetype": "text/plain", "start_char_idx": 10551, "end_char_idx": 12018, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "570b37d3-6ab5-4f79-976a-222310c1aed3": {"__data__": {"id_": "570b37d3-6ab5-4f79-976a-222310c1aed3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ce3b3dc-c52b-495d-8f9b-c2b941bf28c1", "node_type": "1", "metadata": {}, "hash": "c6ee2378c944460789c18f1d3844f890886d2a30fa851679856227d38f5c0a14", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad9f4738-8fc1-4028-83f2-f71f1e0feca4", "node_type": "1", "metadata": {}, "hash": "e79fb671c3dd454b87c15b271aa9a04a577978f866ce93a4308a0c18de53df0c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Six patients mis-\ncarried, and 58 delivered (1 set of triplets, 10 sets of twins,\nand 47 singletons, for a total of 30 healthy girls and 40\nhealthy boys). In \ufb01ve cycles (2%), there was a total failure\nof fertilization in the control group (without electroactiva-\ntion); consequently, these \ufb01ve patients would have lost their\nchance of embryo transfer and possible pregnancy if no elec-\ntroactivation had been performed. Embryo transfer was\nperformed for these \ufb01ve patients by using the embryos that\nresulted from the electroactivated oocytes. Clinical pregnan-\ncies occurred in 2 patients, and 3 babies were delivered (1 sin-\ngleton and 1 set of twins).\nDISCUSSION\nAlthough ICSI has overcome the most dif\ufb01cult male-factor\ninfertility cases, poor fertilization and a total failure of fertil-\nization still can occur (15) and was estimated to be around\n1%\u20133% (7, 16, 17). In our center, total fertilization failure af-\nter ICSI occurs in about 1.5% to 2% of the cases, and in this\nstudy of 241 cycles, it occurred in 5 cycles (2%) in the control\ngroup oocytes.\nTABLE 1\nResults of oocyte electroactivation in 10 ICSI cycles for patients with previous total failure of\nfertilization.\nCase no.\nOocytes\nretrieved\nMetaphase\nII oocytes\nTwo-pronuclei\noocytes\nNo. of embryos\ntransferred\nNo.", "mimetype": "text/plain", "start_char_idx": 11864, "end_char_idx": 13144, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad9f4738-8fc1-4028-83f2-f71f1e0feca4": {"__data__": {"id_": "ad9f4738-8fc1-4028-83f2-f71f1e0feca4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "570b37d3-6ab5-4f79-976a-222310c1aed3", "node_type": "1", "metadata": {}, "hash": "5de88235bf4bb385f129a5461ef2847690789d7be09c5a89e6caf765083583c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c141dfa2-8669-4a93-8e90-e99c2a158d54", "node_type": "1", "metadata": {}, "hash": "71fbe05beeb9d436af4d17ac70adb0f116a33613db342246db9ca5b1a9867981", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Case no.\nOocytes\nretrieved\nMetaphase\nII oocytes\nTwo-pronuclei\noocytes\nNo. of embryos\ntransferred\nNo. of embryos\ncryopreserved\nPregnancy\nresult\n1\n13\n8\n5\n3\n\u2014\n-ve\n2\n4\n4\n1\n1\n\u2014\n-ve\n3\n18\n10\n2\n2\n\u2014\n-ve\n4\n12\n7\n3\n3\n\u2014\nSingle\n5\n14\n8\n3\n2\n\u2014\n-ve\n6\n12\n6\n2\n1\n\u2014\n-ve\n7\n4\n4\n2\n2\n\u2014\n-ve\n8\n12\n9\n7\n3\n4\nSingle\n9\n6\n5\n2\n2\n\u2014\nSingle\n10\n8\n5\n5\n3\n2\nSingle\nTotal\n103\n66\n31\n22\n6\n4 Healthy babies\nNote: -ve \u00bc negative.\nMansour. Electrical activation of oocytes after ICSI. Fertil Steril 2009.\nTABLE 2\nThe effect of electroactivation on the fertilization and rates of sibling oocytes of 241 ICSI cycles with\nexpected poor or failure of fertilization.\nParameter\nElectroactivated oocytes\nControl oocytes\nNo. (mean \u0004 SD) of metaphase II oocytes\n1,640 (6.8 \u0004 2.48)\n1,435 (5.95 \u0004 29)\nNo. (mean \u0004 SD) of 2-pronuclear oocytes\n1,116 (4.63 \u0004 2.3)\n872 (3.62 \u0004 1.96)\nFertilization rate (%)a\n68\n60\nNo. (mean \u0004 SD) of degenerated oocytes\n98 (1.73 \u0004 1.2)\n70 (1.39 \u0004 0.79)\nDegeneration rate (%)b\n5.9\n4.9\na Odds ratio \u00bc 1.397, 95% con\ufb01dence interval \u00bc 1.198 to 1.63, P<.001.", "mimetype": "text/plain", "start_char_idx": 13044, "end_char_idx": 14065, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c141dfa2-8669-4a93-8e90-e99c2a158d54": {"__data__": {"id_": "c141dfa2-8669-4a93-8e90-e99c2a158d54", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad9f4738-8fc1-4028-83f2-f71f1e0feca4", "node_type": "1", "metadata": {}, "hash": "e79fb671c3dd454b87c15b271aa9a04a577978f866ce93a4308a0c18de53df0c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40f7bf3f-181b-4c8f-819e-192d895ea9a3", "node_type": "1", "metadata": {}, "hash": "7b9028a99851a64b93e83b59ccb235486ce9548f01090057a49a34635fd84d81", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b Odds ratio \u00bc 0.96, 95% con\ufb01dence interval \u00bc 0.73 to 1.26, P\u00bc0.821.\nMansour. Electrical activation of oocytes after ICSI. Fertil Steril 2009.\nFertility and Sterility\u0004\n135\nOocyte activation is manifested by the extrusion of the sec-\nond polar body, decondensation of the haploid set of chromo-\nsomes in the oocyte, and the formation of a nuclear\nmembrane around these chromosomes, forming the female\npronucleus (18). It is not yet fully understood how the sper-\nmatozoa activate the oocytes. It may be attributed to some\nproteins in spermatozoa that initiate activation (19). Oocyte\nactivation after ICSI appears to be induced by non-membra-\nnous factors in the spermatozoon, because ICSI bypasses\ngamete membrane interaction (20). The sperm-borne oocyte\nactivating factors are present in the perinuclear material at\nleast partially (21). Excessive sperm immobilization before\nICSI signi\ufb01cantly improves the fertilization rate (22).\nThe failure of fertilization after ICSI may result from either\nthe lack or de\ufb01ciency of activating factors in spermatozoa or\nmay result from the inability of the oocyte to respond to the\ninjected sperm (9) and from the lack of ooplasmic factors\ntriggering sperm chromatin decondensation (23).\nTotal teratozoospermia is the most common cause of\nfertilization failure after ICSI in our center. Structural abnor-\nmalities may be associated with the de\ufb01ciency of oocyte-ac-\ntivating factors (9). However, it is not yet clear whether sperm\nmorphology has a direct relation to DNA damage (24, 25).\nTotal acrosin activity and acrosome reaction play an impor-\ntant part in fertilization (26, 27). Reduced oocyte activation\nand \ufb01rst-cleavage rate after ICSI was reported in cases of\nchromosomal translocations associated with OAT (28). Ab-\nnormal semen analyses often are associated with abnormal\nchromatin.", "mimetype": "text/plain", "start_char_idx": 14066, "end_char_idx": 15897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40f7bf3f-181b-4c8f-819e-192d895ea9a3": {"__data__": {"id_": "40f7bf3f-181b-4c8f-819e-192d895ea9a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c141dfa2-8669-4a93-8e90-e99c2a158d54", "node_type": "1", "metadata": {}, "hash": "71fbe05beeb9d436af4d17ac70adb0f116a33613db342246db9ca5b1a9867981", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c0bf827b-d55b-4f97-835d-ebf7e2f28b1c", "node_type": "1", "metadata": {}, "hash": "bf60008d6047d4b6e61c4d22646d2758ce93ef46ecc67dc1c1b96ab1d0d03a51", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Reduced oocyte activation\nand \ufb01rst-cleavage rate after ICSI was reported in cases of\nchromosomal translocations associated with OAT (28). Ab-\nnormal semen analyses often are associated with abnormal\nchromatin. However, 8% of men with normal semen analyses\nhave abnormal sperm DNA (29, 30).\nTotal failure or very limited fertilization after ICSI in cases\nof normozoospermia also has been reported (18, 31\u201333). Fi-\nnally, partial or total failure of fertilization also can be a result\nof transient biological reasons or technical imperfections (8).\nCalcium ionophore activation (18, 33) and electrical acti-\nvation (9) were reported to be successful in cases of normo-\nzoospermia with previously failed fertilization after ICSI.\nChemical activation also was shown to induce parthenoge-\nnetic development of oocytes (34). Three successful pregnan-\ncies and deliveries were reported after oocyte activation by\nstrontium chloride in six patients (35).\nOocyte activation also can be induced by many arti\ufb01cial re-\nagents or conditions. The key event of oocyte activation is\na temporal rise in the intracellular Ca2\u00fe concentration (36\u2013\n39). The typical pattern in a Ca2\u00fe rise is repetitive until the\npronuclear stage (38, 39). A single long-lasting Ca2\u00fe rise is\nusually induced by some arti\ufb01cial agents such as ethanol, cal-\ncium ionophore, or a single electric pulse (2, 9, 38, 40\u201344).\nCalcium ionophore treatment has been reported to induce\nsuccessful assisted oocyte activation (2, 18, 33, 40, 42). It has\nbeen used for oocyte activation after ICSI in 17 patients with\npreviously failed fertilization and has proven ef\ufb01cient in nor-\nmalizing the fertilization rate after ICSI and obtaining preg-\nnancies (8). The combination of calcium ionophore with\nTABLE 3\nPregnancy rates and outcomes.\nParameter\nEmbryos for transfer derived\nfrom electroactivated group\nEmbryos for transfer derived\nfrom control group\nEmbryos for transfer derived\nfrom both groups\nNo. of ET procedures\n34\n69\n138\nNo.", "mimetype": "text/plain", "start_char_idx": 15688, "end_char_idx": 17667, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c0bf827b-d55b-4f97-835d-ebf7e2f28b1c": {"__data__": {"id_": "c0bf827b-d55b-4f97-835d-ebf7e2f28b1c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40f7bf3f-181b-4c8f-819e-192d895ea9a3", "node_type": "1", "metadata": {}, "hash": "7b9028a99851a64b93e83b59ccb235486ce9548f01090057a49a34635fd84d81", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fffa90b7-9352-444c-925d-cc1399a044a0", "node_type": "1", "metadata": {}, "hash": "9baf01773415ef019daadf1daa0cbdc82265042a9265e22a376971096e4f80e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "of ET procedures\n34\n69\n138\nNo. (%) of clinical pregnancies\n15 (44)\n33 (48)\n64 (46.4)\nNo. (%) of miscarriages\n3 (20)\n3 (9)\n6 (9.4)\nEctopic pregnancy\n\u2014\n1\n\u2014\nNo. of deliveries\n12 (4 sets of twins, and 8\nsingletons, totaling 16 healthy\nbabies [9\\ \u00fe 7_])\n29 (6 sets of twins and 23\nsingletons, totaling 34 healthy\nbabies [14\\ \u00fe 20_] and 1\nstillbirth)\n58 (1 set of triplets, 10 twins, and\n47 singletons, totaling 70\nhealthy babies [30\\ \u00fe 40_])\nMansour. Electrical activation of oocytes after ICSI. Fertil Steril 2009.\n136\nMansour et al.\nElectrical activation of oocytes after ICSI\nVol. 91, No. 1, January 2009\npuromycin was used to salvage unfertilized oocytes after\nICSI (45). The potential toxic effects of ionophores on oo-\ncytes and embryos have not yet been estimated suf\ufb01ciently\nin clinical ICSI.\nThe modi\ufb01cation of the ICSI technique by performing cy-\ntoplasmic aspiration near the region of the mitochondria with\na high inner mitochondrial membrane potential (46) was\nfound to overcome complete oocyte activation failure (6).\nFIGURE 1\nConsolidated Standards of Reporting Trials statement \ufb02ow diagram. GV \u00bc germinal vesicle; MI \u00bc metaphase I;\nand MII \u00bc metaphase II.", "mimetype": "text/plain", "start_char_idx": 17637, "end_char_idx": 18803, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fffa90b7-9352-444c-925d-cc1399a044a0": {"__data__": {"id_": "fffa90b7-9352-444c-925d-cc1399a044a0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c0bf827b-d55b-4f97-835d-ebf7e2f28b1c", "node_type": "1", "metadata": {}, "hash": "bf60008d6047d4b6e61c4d22646d2758ce93ef46ecc67dc1c1b96ab1d0d03a51", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "66c8321b-d12c-4101-b9aa-0e8c68e6667b", "node_type": "1", "metadata": {}, "hash": "13deadfc99dae5010e54b7a85acf89644a6c76914adac94cb82b40c21c429792", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "FIGURE 1\nConsolidated Standards of Reporting Trials statement \ufb02ow diagram. GV \u00bc germinal vesicle; MI \u00bc metaphase I;\nand MII \u00bc metaphase II.\nAssessed for \neligibility (n=249)\nUnderwent ovum\npick-up (n=241)\nRetrieved oocytes\n(n=3516)\nStarted ovarian\nstimulation (n = 244)\nDropped due to poor\novarian\nresponse (n=3)\nMII oocytes\n(n=3075)\nG.V oocytes (n=290)\nMI oocytes (n=151)\nSelected for the study \n(n=246)\nRefused to participate\n(n=2)\nExcluded (n=3)\nnot meeting \ninclusion criteria\nElectroactivated oocytes\n(n=1640)\nControl oocytes\n(n=1435)\nDegenerated\noocytes\n(n=98) 5.9%\nFertilized\noocytes\n(n=1116) 68%\nDegenerated\noocytes\n(n=70) 4.9%\nFertilized\noocytes\n(n= 872) 60%\nCONSORT statement flow diagram\nMansour. Electrical activation of oocytes after ICSI. Fertil Steril 2009.\nFertility and Sterility\u0004\n137\nArti\ufb01cial activation after ICSI may rescue oocytes that do\nnot produce two pronuclei. It has been reported that about\n70%\u201380% of unfertilized oocytes after ICSI responded to\nelectroactivation and formed two pronuclei (9, 44). Sperma-\ntozoa from three patients who failed to fertilize their female\npartners\u2019 oocytes after ICSI were injected into unfertilized\nmouse oocytes by ICSI (as a test), followed by electrical stim-\nulation (9). Activation was successful in the mouse test for\nthe three patients. Electroactivation then was used for these\nthree patients and resulted in successful fertilization for all\nand in the delivery of healthy twins for one patient. Electro-\nactivation was used after spermatid injection, achieving\na 15% pregnancy rate (35).\nAs was demonstrated elsewhere, electroactivation results\nin a rapid rise in Ca2\u00fe inside the oocyte, which decreases\ngradually to the original level in about 300 seconds (13,\n47).", "mimetype": "text/plain", "start_char_idx": 18664, "end_char_idx": 20400, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "66c8321b-d12c-4101-b9aa-0e8c68e6667b": {"__data__": {"id_": "66c8321b-d12c-4101-b9aa-0e8c68e6667b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fffa90b7-9352-444c-925d-cc1399a044a0", "node_type": "1", "metadata": {}, "hash": "9baf01773415ef019daadf1daa0cbdc82265042a9265e22a376971096e4f80e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "84fd64f4-eeab-4cda-ab4e-c8e7e785eb39", "node_type": "1", "metadata": {}, "hash": "56353a9b68791601f27e7e0d3c03e07af67ea50cf0ee499ee1b1086baefbee21", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As was demonstrated elsewhere, electroactivation results\nin a rapid rise in Ca2\u00fe inside the oocyte, which decreases\ngradually to the original level in about 300 seconds (13,\n47). Comparing this method with the use of ethanol or cal-\ncium ionophore, it has not yet been proven that electrical oo-\ncyte activation is the most ef\ufb01cient and safest method for\noocyte activation in human beings. However, in rats, chemi-\ncal (SrC12) activation was compared with the use of two di-\nrect-current pulses in ICSI with round spermatid injection.\nThese results indicated that direct current was better than\nSrC12 for oocyte activation, in terms of two-cell embryos\ndeveloping to blastocysts and live births (48).\nIn our study, electrical stimulation resulted in a signi\ufb01cant\nimprovement in the fertilization rate after ICSI, in cases with\nprevious total failure of fertilization or limited fertilization.\nEncouraged by the results of electroactivation of other re-\nsearchers, we \ufb01rst experimented with the procedure in 10\nICSI cycles for patients who previously had total failure of\nfertilization (one patient failed twice) with ICSI. In all 10\npatients, fertilization was successful, and pregnancy was\nachieved in 4 patients. These results were the basis for the\ndesign of this randomized controlled trial to evaluate the\nef\ufb01ciency of the procedure in cases of severe OAT and\nazoospermia. The study included a large number of cycles\n(n \u00bc 241) and a large number of oocytes (1,640) that were\nsubjected to electroactivation. The fertilization rate was sig-\nni\ufb01cantly higher in the electroactivated group (68%) as com-\npared with in the control (60%). Most important, a total\nfailure of fertilization occurred in \ufb01ve cases in the control\ngroup; consequently, these patients would have lost their\nchance of embryo transfer and possibility of pregnancy if\nno electroactivation had been performed.", "mimetype": "text/plain", "start_char_idx": 20222, "end_char_idx": 22102, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "84fd64f4-eeab-4cda-ab4e-c8e7e785eb39": {"__data__": {"id_": "84fd64f4-eeab-4cda-ab4e-c8e7e785eb39", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "66c8321b-d12c-4101-b9aa-0e8c68e6667b", "node_type": "1", "metadata": {}, "hash": "13deadfc99dae5010e54b7a85acf89644a6c76914adac94cb82b40c21c429792", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74b7913b-c171-4fdb-bc36-3fb16c035b9d", "node_type": "1", "metadata": {}, "hash": "0587440c6679e99681bb2496b7c1c2e48adc689e91fac4d312399059d236d576", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Most important, a total\nfailure of fertilization occurred in \ufb01ve cases in the control\ngroup; consequently, these patients would have lost their\nchance of embryo transfer and possibility of pregnancy if\nno electroactivation had been performed. Since the com-\nmencement of this randomized controlled trial, we have\nbeen performing routine electroactivation for at least half of\nthe oocytes in cases of severe OAT and azoospermia with\n100% abnormal morphology or rare motile sperms, in which\nwe expect poor or no fertilization. Long-term follow-up stud-\nies are needed to ensure safety. There was a high miscarriage\nrate in the electroactivated group (5 of 15 pregnancies com-\npared with the control [3 of 33]). However, the number of\nthese was too small to draw any conclusions.\nIn conclusion, electroactivation of oocytes after ICSI sig-\nni\ufb01cantly improved fertilization. However, more studies are\nneeded to evaluate the clinical signi\ufb01cance and safety of\nthis technique. It is recommended in cases of previous failure\nof fertilization or limited fertilization, as well as in cases of\nsevere oligoasthenospermia or azoospermia with 100%\nabnormal forms or zero motility.\nREFERENCES\n1. Devroey P, Van Steirteghem A. A review of ten years experience of ICSI.\nHum Reprod Update 2004;10:19\u201328.\n2. Rybouchikin AV, Van der Straetem F, Quatacker J, De Sutter P, Dhont M.\nFertilization and pregnancy after assisted oocyte activation and intracy-\ntoplasmic sperm injection in a case of round-headed sperm associated\nwith de\ufb01cient oocyte activation capacity. Fertil Steril 1997;68:1144\u20137.\n3. Plachot M, Belaisch-Allart J, Mayenga JM, Chouraqui A, Tesquier L,\nSerkine AM. Outcome of conventional IVF and ICSI on sibling oocytes\nin mild male factor infertility. Hum Reprod 2002;17:362\u20139.\n4.", "mimetype": "text/plain", "start_char_idx": 21860, "end_char_idx": 23636, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "74b7913b-c171-4fdb-bc36-3fb16c035b9d": {"__data__": {"id_": "74b7913b-c171-4fdb-bc36-3fb16c035b9d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "84fd64f4-eeab-4cda-ab4e-c8e7e785eb39", "node_type": "1", "metadata": {}, "hash": "56353a9b68791601f27e7e0d3c03e07af67ea50cf0ee499ee1b1086baefbee21", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ba002c1-2745-4f98-be54-d765fc863b3a", "node_type": "1", "metadata": {}, "hash": "a795288217997054166b48683113e99aa5f2c4f9d259241629ffc7a3d8f337b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Outcome of conventional IVF and ICSI on sibling oocytes\nin mild male factor infertility. Hum Reprod 2002;17:362\u20139.\n4. Kihaile PE, Misumi J, Hirotsuru K, Kumasako Y, Kisanga RE,\nUtsunomiya T. Comparison of sibling oocyte outcomes after intracyto-\nplasmic sperm injection and in vitro fertilization in severe teratozoosper-\nmic patients in the \ufb01rst cycle. Int J Androl 2003;26:57\u201362.\n5. Fishel S, Aslam I, Lisi F, Rinaldi L, Timson J, Jacobson M, et al. Should\nICSI be the treatment of choice for all cases of in-vitro conception? Hum\nReprod 2000;15:1278\u201383.\n6. Ebner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete oo-\ncyte activation failure after ICSI can be overcome by a modi\ufb01ed injection\ntechnique. Hum Reprod 2004;19:1837\u201341.\n7. Mahutte NG, Arici A. Failed fertilization: is it predictable? Curr Opin\nObstet Gynecol 2003;15:211\u20138.\n8. Heindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option\nfor sperm- or oocyte-related fertilization failure: assisted oocyte activa-\ntion following diagnostic heterologous ICSI. Hum Reprod 2005;20:\n2237\u201341.\n9. Yanagida K, Katayose H, Yazawa H, Kimura Y, Sato A, Yanagimachi H,\net al. Successful fertilization and pregnancy following ICSI and electrical\noocyte activation. Hum Reprod 1999;14:1307\u201311.\n10. Lucena E, Lucena C, Gomez M, Ortiz JA, Ruiz J, Aango A, et al. Recov-\nery of motile sperm using the migration-sedimentation technique in an in\nvitro fertilization-embryo transfer. Hum Reprod 1989;4:163\u20135.\n11.", "mimetype": "text/plain", "start_char_idx": 23519, "end_char_idx": 24991, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7ba002c1-2745-4f98-be54-d765fc863b3a": {"__data__": {"id_": "7ba002c1-2745-4f98-be54-d765fc863b3a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74b7913b-c171-4fdb-bc36-3fb16c035b9d", "node_type": "1", "metadata": {}, "hash": "0587440c6679e99681bb2496b7c1c2e48adc689e91fac4d312399059d236d576", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "187b57f3-d373-4183-a564-d57f20338df6", "node_type": "1", "metadata": {}, "hash": "7f1fd5aff6002b71876eecd9aa873e168863977ff5fbcf7fd65e750ba2ebbd7c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Recov-\nery of motile sperm using the migration-sedimentation technique in an in\nvitro fertilization-embryo transfer. Hum Reprod 1989;4:163\u20135.\n11. Kamal A, Fahmy I, Mansour RT, Abou-Setta AM, Serour GI,\nAboulghar MA. Selection of individual testicular tubules from biopsied\ntesticular tissue with a stereomicroscope improves sperm retrieval rate. J\nAndrol 2004;25:123\u20137.\n12. Mansour RT, Aboulghar MA, Serour GI, Fahmi I, Ramzy AM, Amin Y.\nIntracytoplasmic sperm injection using microsurgically retrieved epidid-\nymal and testicular sperm. Fertil Steril 1996;65:566\u201372.\n13. Yanagida K. Complete fertilization failure in ICSI. Hum Cell 2004;17:\n187\u201393.\n14. Dozortsev D, De Sutter P, Dhont M. Behaviour of spermatozoa in human\noocytes displaying no or one pronucleus after intracytoplasmic sperm\ninjection. Hum Reprod 1994;9:2139\u201344.\n15. van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intra-\ncytoplasmic sperm injection as a treatment for unexplained total fertil-\nization\nfailure\nor\nlow\nfertilization\nafter\nconventional\nin\nvitro\nfertilization. Fertil Steril 2005;83:612\u20137.\n16. Liu DY, Bourne H, Baker HW. Fertilization and pregnancy with acro-\nsome intact sperm by intracytoplasmic sperm injection in patients with\ndisordered zona pellucida-induced acrosome reaction. Fertil Steril\n1995;64:116\u201321.\n17. Moomjy M, Colombero LT, Veeck LL, Rosenwaks Z, Palermo GD.\nSperm integrity is critical for normal mitotic division and early embry-\nonic development. Mol Hum Reprod 1999;5:836\u201344.\n18.", "mimetype": "text/plain", "start_char_idx": 24846, "end_char_idx": 26345, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "187b57f3-d373-4183-a564-d57f20338df6": {"__data__": {"id_": "187b57f3-d373-4183-a564-d57f20338df6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ba002c1-2745-4f98-be54-d765fc863b3a", "node_type": "1", "metadata": {}, "hash": "a795288217997054166b48683113e99aa5f2c4f9d259241629ffc7a3d8f337b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70e1f38d-4626-4321-849a-2836ecc9d719", "node_type": "1", "metadata": {}, "hash": "d65d75ce1a085b8103f8327d7388144d7ac601683893de52baa3cdf77188ad9a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sperm integrity is critical for normal mitotic division and early embry-\nonic development. Mol Hum Reprod 1999;5:836\u201344.\n18. Murase Y, Araki Y, Mizuno S, Kawaguchi C, Naito M, Yoshizawa M,\net al. Pregnancy following chemical activation of oocytes in a couple\nwith repeated failure of fertilization using ICSI: case report. Hum Reprod\n2004;19:1604\u20137.\n19. Swann K, Lai FA. A novel signalling mechanism for generating Ca2\u00fe\noscillations at fertilization in mammals. Bioessays 1997;19:371\u20138.\n138\nMansour et al.\nElectrical activation of oocytes after ICSI\nVol. 91, No. 1, January 2009\n20. Yanagimachi R. The mammalian oocyte\u2019s response to intracytoplasmic\nsperm injection (ICSI). In: Motta PM, ed. Microscopy of reproduction\nand development: a dynamic approach. Rome, Italy: Antonio Del\ufb01no\nEditore, 1997:187\u201395.\n21. Kimura Y, Yanagimachi R, Kuretake S, Bortkiewicz H, Perry AC,\nYanagimachi H. Analysis of mouse oocyte activation suggests the in-\nvolvement of sperm perinuclear material. Biol Reprod 1998;58:1407\u201315.\n22. Takeuchi T, Neri QV, Katagiri Y, Rosenwaks Z, Palermo GD. Effect of\ntreating induced mitochondrial damage on embryonic development\nand epigenesis. Biol Reprod 2005;72:584\u201392.\n23. Van Blerkom J, Davis PW, Merriam J. Fertilization and early embryol-\nogy: a retrospective analysis of unfertilized and presumed parthenoge-\nnetically activated human oocytes demonstrates a high frequency of\nsperm penetration. Hum Reprod 1994;9:2381\u20138.\n24. Said TM, Agarwal A, Sharma RK, Thomas AJ Jr, Sikka SC.", "mimetype": "text/plain", "start_char_idx": 26221, "end_char_idx": 27724, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70e1f38d-4626-4321-849a-2836ecc9d719": {"__data__": {"id_": "70e1f38d-4626-4321-849a-2836ecc9d719", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "187b57f3-d373-4183-a564-d57f20338df6", "node_type": "1", "metadata": {}, "hash": "7f1fd5aff6002b71876eecd9aa873e168863977ff5fbcf7fd65e750ba2ebbd7c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c3ca4d1-d3e3-4ba8-9dbf-33242f07acc4", "node_type": "1", "metadata": {}, "hash": "3a239bb11d8158c9c4faaac352e57359bbd85550fda9f15301246e77a5b67aac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod 1994;9:2381\u20138.\n24. Said TM, Agarwal A, Sharma RK, Thomas AJ Jr, Sikka SC. Impact of\nsperm morphology on DNA damage caused by oxidative stress induced\nby beta-nicotinamide adenine dinucleotide phosphate. Fertil Steril\n2005;83:95\u2013103.\n25. Payne JF, Raburn DJ, Couchman GM, Price TM, Jamison MG,\nWalmer DK. Rede\ufb01ning the relationship between sperm deoxyribonu-\ncleic acid fragmentation as measured by the sperm chromatin structure\nassay and outcomes of assisted reproductive techniques. Fertil Steril\n2005;84:356\u201364.\n26. Chaudhury K, Das T, Chakravarty B, Bhattacharyya AK. Acrosin activ-\nity as a potential marker for sperm membrane characteristics in unex-\nplained male infertility. Fertil Steril 2005;83:104\u20139.\n27. Mansour RT, Mennatallah GS, Amal MA, Ahmed K, Nevine AT, Mo-\nhamed A, et al. The impact of spermatozoa preincubation time and spon-\ntaneous\nacrosome\nreaction\nin\nintracytoplasmic\nsperm\ninjection:\na controlled randomized study. Fertil Steril. Published online 22 Febru-\nary 2008 [Epub ahead of print].\n28. Baart EB, van der Heijden GW, van der Hoeven FA, Bakker R,\nCooper TG, de Boer P. Reduced oocyte activation and \ufb01rst cleavage\nrate after ICSI with spermatozoa from a sterile mouse chromosome\nmutant. Hum Reprod 2004;19:1140\u20137.\n29. Schlegel PN, Paduch DA. Yet another test of sperm chromatin structure.\nFertil Steril 2005;84:854\u20139.\n30. Zini A, Kamal K, Phang D, Willis J, Jarvi K. Biologic variability of\nsperm DNA denaturation in infertile men. Urology 2001;58:258\u201361.\n31.", "mimetype": "text/plain", "start_char_idx": 27640, "end_char_idx": 29140, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c3ca4d1-d3e3-4ba8-9dbf-33242f07acc4": {"__data__": {"id_": "6c3ca4d1-d3e3-4ba8-9dbf-33242f07acc4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "70e1f38d-4626-4321-849a-2836ecc9d719", "node_type": "1", "metadata": {}, "hash": "d65d75ce1a085b8103f8327d7388144d7ac601683893de52baa3cdf77188ad9a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9af22841-94a2-47ca-ae52-faf0272e41c1", "node_type": "1", "metadata": {}, "hash": "527f649e726d18ba7dd9d7d5f1994d8275e5b0bb33721d72e260973844692b5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Urology 2001;58:258\u201361.\n31. Moomjy M, Sills ES, Rosenwaks Z, Palermo GD. Implications of com-\nplete fertilization failure after intracytoplasmic sperm injection for sub-\nsequent fertilization and reproductive outcome. Hum Reprod 1998;13:\n2212\u20136.\n32. Tesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modi\ufb01ed\nintracytoplasmic sperm injection technique to overcome sperm-borne\noocyte activation failures. Fertil Steril 2002;78:619\u201324.\n33. Chi HJ, Koo JJ, Song SJ, Lee JY, Chang SS. Successful fertilization and\npregnancy after intracytoplasmic sperm injection and oocyte activation\nwith calcium ionophore in a normozoospermic patient with extremely\nlow fertilization rates in intracytoplasmic sperm injection cycles. Fertil\nSteril 2004;82:475\u20137.\n34. Paffoni A, Brevini TA, Somigliana E, Restelli L, Gandol\ufb01F, Ragni G. In\nvitro development of human oocytes after parthenogenetic activation or\nintracytoplasmic sperm injection. Fertil Steril 2007;87:77\u201382.\n35. Kumagai A, Tanaka C, Nishinaka Y, Nakajo H, Uto K. Three successful\npregnancies and deliveries after oocyte activation by stontium chloride\n(SRCL2) in six patients of low fertilization rate. Fertil Steril\n2006;86(S2):S156\u20137.\n36. Cuthbertson KS, Whittingham DG, Cobbold PH. Free Ca2\u00fe increases in\nexponential phases during mouse oocyte activation. Nature 1981;294:\n754\u20137.\n37. Miyazaki S, Igusa Y. Fertilization potential in golden hamster eggs con-\nsists of recurring hyperpolarizations. Nature 1981;290:702\u20134.\n38. Kline D, Kline JT.", "mimetype": "text/plain", "start_char_idx": 29113, "end_char_idx": 30612, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9af22841-94a2-47ca-ae52-faf0272e41c1": {"__data__": {"id_": "9af22841-94a2-47ca-ae52-faf0272e41c1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c3ca4d1-d3e3-4ba8-9dbf-33242f07acc4", "node_type": "1", "metadata": {}, "hash": "3a239bb11d8158c9c4faaac352e57359bbd85550fda9f15301246e77a5b67aac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ce3b33df-8057-483f-a3b2-5b9a90150d20", "node_type": "1", "metadata": {}, "hash": "86c8cdbe453579412303834f3d917363a0d8eee767e2d96bba332aeb07961f15", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Nature 1981;290:702\u20134.\n38. Kline D, Kline JT. Repetitive calcium transients and the role of calcium\nin exocytosis and cell cycle activation in the mouse egg. Dev Biol\n1992;149:80\u20139.\n39. Tesarik J. Calcium in oocyte maturation. How the spermatozoon\nawakens the oocyte: lessons from intracytoplasmic sperm injection.\nHum Reprod 1994;9:977\u20138.\n40. Kim ST, Cha YB, Park JM, Gye MC. Successful pregnancy and delivery\nfrom frozen-thawed embryos after intracytoplasmic sperm injection us-\ning round-headed spermatozoa and assisted oocyte activation in a globo-\nzoospermic patient with mosaic Down syndrome. Fertil Steril 2001;75:\n445\u20137.\n41. Nakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M,\nAono T. Effect of activation with Ca ionophore A23187 and puromycin\non the development of human oocytes that failed to fertilize after intra-\ncytoplasmic sperm injection. Fertil Steril 2001;76:148\u201352.\n42. Eldar-Geva T, Brooks B, Margalioth EJ, Zylber-Haran E, Gal M,\nSilber SJ. Successful pregnancy and delivery after calcium ionophore oo-\ncyte activation in a normozoospermic patient with previous repeated\nfailed fertilization after intracytoplasmic sperm injection. Fertil Steril\n2003;79:1656\u20138.\n43. Battaglia DE, Koehler JK, Klein NA, Tucker MJ. Failure of oocyte acti-\nvation after intracytoplasmic sperm injection using round-headed sperm.\nFertil Steril 1997;68:118\u201322.\n44. Zhang J, Wang CW, Blaszcyzk BA, Grifo JM, Ozil J, Haberman E, et al.\nElectrical activation and in vitro development of human oocytes that fail\nto fertilize after intracytoplasmic sperm injection. Fertil Steril 1999;72:\n509\u201312.\n45.", "mimetype": "text/plain", "start_char_idx": 30567, "end_char_idx": 32168, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ce3b33df-8057-483f-a3b2-5b9a90150d20": {"__data__": {"id_": "ce3b33df-8057-483f-a3b2-5b9a90150d20", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Mansour (2009).pdf", "node_type": "4", "metadata": {}, "hash": "cbd8df58dacd48acb9a4ae7289b1ea4c86bc4c814901cf1a6a9d2c5c168f2c05", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9af22841-94a2-47ca-ae52-faf0272e41c1", "node_type": "1", "metadata": {}, "hash": "527f649e726d18ba7dd9d7d5f1994d8275e5b0bb33721d72e260973844692b5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Electrical activation and in vitro development of human oocytes that fail\nto fertilize after intracytoplasmic sperm injection. Fertil Steril 1999;72:\n509\u201312.\n45. Lu Q, Zhao Y, Gao X, Li Y, Ma S, Mullen S, et al. Combination of cal-\ncium ionophore A23187 with puromycin salvages human unfertilized\noocytes after ICSI. Eur J Obstet Gynecol Reprod Biol 2006;126:72\u20136.\n46. Van Blerkom J, Davis P, Alexander S. Inner mitochondrial membrane po-\ntential (m), cytoplasmic ATP content and free Ca2\u00fe levels in metaphase\nII mouse oocytes. Hum Reprod 2003;18:2429\u201340.\n47. Yanagida K, Katayose H, Hoshi K, Yazawa H, Sato A. Effect of electrical\nstimulation on oocyte activation after intracytoplasmic sperm injection.\nJ Mamm Ova Res 1997;4:132\u20138.\n48. Kato M, Ishikawa A, Hochi S, Hirabayashi M. Effect of activation\nregimens for rat oocytes on full-term development after round spermatid\ninjection. Contemp Top Lab Anim Sci 2004;43:13\u20135.\nFertility and Sterility\u0004\n139", "mimetype": "text/plain", "start_char_idx": 32007, "end_char_idx": 32960, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a4cdaf9a-b225-4456-8edf-280f55d3cd87": {"__data__": {"id_": "a4cdaf9a-b225-4456-8edf-280f55d3cd87", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8ed8c110-e654-40e2-baed-2c215a3340d7", "node_type": "1", "metadata": {}, "hash": "df272f2f5b1168b41fc63a00b7b10fb0c851d6892e42f7a24dd7e90ab31d0118", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Full Terms & Conditions of access and use can be found at\nhttp://www.tandfonline.com/action/journalInformation?journalCode=ihuf20\nDownload by: [Cornell University Library]\nDate: 14 October 2016, At: 11:50\nHuman Fertility\nan international, multidisciplinary journal dedicated to furthering\nresearch and promoting good practice\nISSN: 1464-7273 (Print) 1742-8149 (Online) Journal homepage: http://www.tandfonline.com/loi/ihuf20\nArtificial oocyte activation after intracytoplasmic\nmorphologically selected sperm injection: A\nprospective randomized sibling oocyte study\nBatu Aydinuraz, Enver Kerem Dirican, Safak Olgan, Ozlem Aksunger & Onur\nKadir Erturk\nTo cite this article: Batu Aydinuraz, Enver Kerem Dirican, Safak Olgan, Ozlem Aksunger &\nOnur Kadir Erturk (2016): Artificial oocyte activation after intracytoplasmic morphologically\nselected sperm injection: A prospective randomized sibling oocyte study, Human Fertility, DOI:\n10.1080/14647273.2016.1240374\nTo link to this article:  http://dx.doi.org/10.1080/14647273.2016.1240374\nPublished online: 13 Oct 2016.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1062, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8ed8c110-e654-40e2-baed-2c215a3340d7": {"__data__": {"id_": "8ed8c110-e654-40e2-baed-2c215a3340d7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a4cdaf9a-b225-4456-8edf-280f55d3cd87", "node_type": "1", "metadata": {}, "hash": "f083166a6245050610a251febed7bfdfadde710269fd5948b04f0d4bba9c3d1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a81ce77-0635-4121-b553-b3642bf3fd0d", "node_type": "1", "metadata": {}, "hash": "851031999f57f3564e4969a5a1466d2eec7e7275872fc7388657a3826f78ee3b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Submit your article to this journal \nView related articles \nView Crossmark data\nORIGINAL ARTICLE\nArtificial oocyte activation after intracytoplasmic morphologically selected\nsperm injection: A prospective randomized sibling oocyte study\nBatu Aydinuraza\u0001\n, Enver Kerem Diricanb\u0001\n, Safak Olganb\u0001\n, Ozlem Aksungerc and Onur Kadir Erturkb\naIVF Unit, Private Gelecek Center for Assisted Reproductive Technologies, Antalya, Turkey; bIVF Unit, Department of Obstetrics and\nGynecology, Faculty of Medicine, Akdeniz University, Antalya, Turkey; cIVF Unit, Division of Obstetrics and Gynecology, Memorial\nAntalya Hospital, Antalya, Turkey\nABSTRACT\nThis study aimed to evaluate the effect of artificial oocyte activation (AOA) by calcium ionophore\nafter intracytoplasmic morphologically selected sperm injection (IMSI) on fertilization, cleavage\nrate and embryo quality. A total of 194 oocytes from 21 cycles from women with a history of\nlow fertilization rate accompanying teratozoospermia were enrolled over a 3-month period.\nMature oocytes from each patient were randomly allocated into two groups after IMSI. In the\nstudy group, half of the patients\u2019 oocytes (n \u00bc 97) were exposed to AOA, and in the control\ngroup (n \u00bc 97), AOA was not applied. The mean number of mature oocytes, fertilization and\ncleavage rates were similar between the study and control groups (p > 0.05 for each). However,\nfertilized oocytes of the AOA group were less likely to produce top quality embryos when calcu-\nlated per fertilized oocyte (28/80; 35.0% versus 38/71; 53.5%, respectively; p \u00bc 0.024) and also\nper cycle (13/21; 61.9% versus 20/21; 95.24%, respectively; p \u00bc 0.006). Our study indicates that\nAOA may not improve fertilization rates after IMSI and may even reduce the ability of a success-\nfully fertilized oocyte to develop into a top quality embryo.", "mimetype": "text/plain", "start_char_idx": 1063, "end_char_idx": 2897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9a81ce77-0635-4121-b553-b3642bf3fd0d": {"__data__": {"id_": "9a81ce77-0635-4121-b553-b3642bf3fd0d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8ed8c110-e654-40e2-baed-2c215a3340d7", "node_type": "1", "metadata": {}, "hash": "df272f2f5b1168b41fc63a00b7b10fb0c851d6892e42f7a24dd7e90ab31d0118", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13427dda-901c-4e2e-b099-b8d9775a6756", "node_type": "1", "metadata": {}, "hash": "efd8e82ffc8e15790642d79dc02f05de5adb77205c6a7490414a793efc98ae30", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Our study indicates that\nAOA may not improve fertilization rates after IMSI and may even reduce the ability of a success-\nfully fertilized oocyte to develop into a top quality embryo. AOA should, therefore, be applied to\ncases with a defined oocyte activating deficiency.\nARTICLE HISTORY\nReceived 24 March 2016\nAccepted 20 June 2016\nKEYWORDS\nOocyte; fertilization;\nintracytoplasmic sperm\ninjection (ICSI)\nIntroduction\nSince the introduction of intracytoplasmic sperm injec-\ntion\n(ICSI)\ninto\nassisted\nreproductive\ntechnologies\n(ARTs), there have been numerous studies on the\neffects of the male gamete regarding its morphology,\nquality and capacity to activate the oocyte for success-\nful fertilization (Berkovitz et al., 2006; Moaz, Khattab,\nFoutouh,\n&\nMohsen,\n2006;\nNasr-Esfahani,\nRazavi,\nMardani, Shirazi, & Javanmardi, 2007). Since complete\nfertilization failures and low or moderate fertilization\nrates are still common in ART practice, sperm selection\nand oocyte activation are points of interest for improv-\ning clinical outcomes in male factor infertility (De Vos\net al., 2003; Dozortsev & Nasr-Esfahani, 2012; Ebner\net al., 2012).\nIntracytoplasmic injection of spermatozoa selected\naccording to fine morphology under high magnifica-\ntion (intracytoplasmic morphologically selected sperm\ninjection, IMSI) is used to identify a morphologically\nnormal spermatozoon by precise measurement of\nlength and width of the sperm head and vacuoles.\nThis technique has been used to improve assisted\nreproduction outcomes in cases of male factor infertil-\nity, in terms of improved fertilization rates and ART\noutcome (Antinori et al., 2008; Balaban et al., 2011;\nBerkovitz et al., 2006; De Vos et al., 2013).\nThe oocyte activating ability of the spermatozoon is\na critical factor for fertilization.", "mimetype": "text/plain", "start_char_idx": 2714, "end_char_idx": 4507, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "13427dda-901c-4e2e-b099-b8d9775a6756": {"__data__": {"id_": "13427dda-901c-4e2e-b099-b8d9775a6756", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9a81ce77-0635-4121-b553-b3642bf3fd0d", "node_type": "1", "metadata": {}, "hash": "851031999f57f3564e4969a5a1466d2eec7e7275872fc7388657a3826f78ee3b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "511dffa4-e6ee-4134-8452-e96175da66c0", "node_type": "1", "metadata": {}, "hash": "8e4e26c00c63679da45cb188a07fafb5770fd3ebdc09a7ddfe39b96b174f4597", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The oocyte activating ability of the spermatozoon is\na critical factor for fertilization. During natural fertiliza-\ntion, sperm-oocyte fusion is activated by introducing a\nde-membraned, \u201cnaked\u201d sperm nucleus, which imme-\ndiately becomes accessible to ooplasmic factors, but,\nfollowing ICSI a whole sperm cell with an intact mem-\nbrane is introduced into the ooplasm (Dozortsev &\nNasr-Esfahani, 2012; Tesarik, Sousa, & Testart, 1994).\nFertilization problems after ICSI are, therefore, related\nto the inability of a spermatozoon to release oocyte\nactivation enzymes (Nasr-Esfahani et al., 2007). More\nthan 80% of unfertilized oocytes are thought to con-\ntain\nan\nintact\nspermatozoon\n(Flaherty,\nPayne,\n&\nMatthews, 1998), and artificial oocyte activation (AOA)\nis considered useful in selected cases with deficiencies\nof sperm-associated oocyte activating factors related\nto the acrosome and perinuclear theca (Escalier, 1990).\nCONTACT Enver Kerem Dirican\nekdirican@akdeniz.edu.tr, keremdirican@gmail.com\nAkdeniz University Hospital, Dumlup\u0131nar Bulvar\u0131, 07059 Antalya,\nTurkey\n\u0001These authors contributed equally to this paper as principal investigators.\n\u0001 2016 The British Fertility Society\nHUMAN FERTILITY, 2016\nhttp://dx.doi.org/10.1080/14647273.2016.1240374\nCurrently, AOA by calcium ionophore (A23187) is\nthe most commonly used technique to overcome\nfailed oocyte activation after ICSI (Eldar-Geva et al.,\n2003). AOA is a carboxylic acid ionophore that trans-\nfers\ncalcium\nand\nmagnesium\nfrom\nan\naqueous\nmedium through the cell membrane into a cell (Reed\n& Lardy, 1972).", "mimetype": "text/plain", "start_char_idx": 4418, "end_char_idx": 5985, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "511dffa4-e6ee-4134-8452-e96175da66c0": {"__data__": {"id_": "511dffa4-e6ee-4134-8452-e96175da66c0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13427dda-901c-4e2e-b099-b8d9775a6756", "node_type": "1", "metadata": {}, "hash": "efd8e82ffc8e15790642d79dc02f05de5adb77205c6a7490414a793efc98ae30", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ea5923d-d5ff-44a0-9d68-71b73e7e93c5", "node_type": "1", "metadata": {}, "hash": "c234954c7808d55dc7736373f29b39cf471a611a8af9b4d91d5c5db284db373b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Influx of calcium results in an increase\nin the concentration of calcium in the cytoplasm\nwhich is considered to act as a mitogenic signal to\npromote DNA synthesis and cell division (Luckasen,\nWhite, & Kersey, 1974). Many studies have demon-\nstrated that AOA by calcium ionophore may increase\nfree intracellular calcium and trigger oocyte activation\n(Heindryckx, Van der Elst, De Sutter, & Dhont, 2005)\nand\nit\nis\nconsidered\na\nsafe\napplication\n(Vanden\nMeerschaut et al., 2014).\nIMSI is an emerging assisted fertilization procedure\nwhich has become a preferred choice for the treat-\nment of male factor infertility worldwide. Current lit-\nerature, however, lacks robust evidence on whether\nAOA is effective when IMSI is used for assisted fertiliza-\ntion. We have, therefore, aimed to investigate the\neffects of AOA on embryological parameters, namely\nfertilization, cleavage rates and embryo quality in IMSI\ncycles. This study was designed as a randomized sib-\nling split study, where each patient served as her own\ncontrol, in order to eliminate the possible randomiza-\ntion disadvantages of inter-patient variations.\nMaterials and methods\nPatients\nThis prospective, randomized and single blind study\nwas conducted on infertile couples undergoing treat-\nment at the IVF Clinic, Memorial Hospital, Antalya,\nTurkey, for a 3-month period between December 2013\nand February 2014. The inclusion criteria comprised a\ndiagnosis\nof\nteratozoospermia\n(<4%\naccording\nto\nWHO 2010 reference limits) and a low fertilization rate\n(<50%) in the previous cycle. Complete fertilization\nfailure\nwas\nnot\nobserved\nin\nthe\nprevious\ncycles.\nCouples with a chromosomal abnormality in either\npartner and women with a poor ovarian reserve\naccording to Bologna Criteria, 2011, were excluded\n(Ferraretti et al., 2011). In addition, cycles with <2\nmature oocytes were excluded because splitting was\nnot possible. The selected patients were carefully\ninformed of the objectives and procedures of the\nstudy and signed a consent form. Only mature meta-\nphase II oocytes were injected by IMSI.", "mimetype": "text/plain", "start_char_idx": 5986, "end_char_idx": 8044, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ea5923d-d5ff-44a0-9d68-71b73e7e93c5": {"__data__": {"id_": "6ea5923d-d5ff-44a0-9d68-71b73e7e93c5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "511dffa4-e6ee-4134-8452-e96175da66c0", "node_type": "1", "metadata": {}, "hash": "8e4e26c00c63679da45cb188a07fafb5770fd3ebdc09a7ddfe39b96b174f4597", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "db34c9f5-1b6d-450e-8a00-86a3a61043f6", "node_type": "1", "metadata": {}, "hash": "35654f7d6cbb2ee643afc4f46714c6a7bb230dfe52de5c662ee2797fdb7392c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The selected patients were carefully\ninformed of the objectives and procedures of the\nstudy and signed a consent form. Only mature meta-\nphase II oocytes were injected by IMSI. After injection,\nthe oocytes of each patient were randomized to either\nAOA by calcium ionophore or the control group.\nRandomization was computer-generated, and the allo-\ncation list stored in a locked room by third parties not\notherwise involved in the trial. The clinical and labora-\ntory staff were blind to the intervention throughout\nthe early embryo developmental period. The research\nproject was approved by the regional ethics and\nresearch committee, under approval number 2013007.\nOvarian stimulation and oocyte pick-up\nA GnRH agonist or an antagonist treatment was\nchosen for controlled ovarian stimulation according to\nthe patient characteristics. Recombinant FSH regimens\n(GONAL-f, Merck Serono, Geneva, Switzerland) were\nused\nin\nall\ncases.\nhCG\n(Ovitrelle,\nMerck\nSerono,\nGeneva, Switzerland) was administered subcutaneously\nwhen the dominant follicle had reached a mean diam-\neter of \u000318 mm.\nOocyte\npick-up\nwas\nperformed 36 h\nafter hCG\nadministration, under general anaesthesia, with a 17 G\ndual lumen needle (Wallace, Smiths Medical, Sydney,\nNew\nSouth\nWales,\nAustralia)\nthrough\ntransvaginal\nultrasound guidance.\nRetrieved oocytes were initially placed in a MOPS-\nbuffered\nmedium\n(G-MOPS,\nVitrolife,\nGothenburg,\nSweden)\nunder\noil\n(Ovoil,\nVitrolife,\nGothenburg,\nSweden), supplemented with 5% (w/v) human serum\nalbumin (HSA, Vitrolife, Gothenburg, Sweden) at 37 \u0004C.", "mimetype": "text/plain", "start_char_idx": 7868, "end_char_idx": 9419, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "db34c9f5-1b6d-450e-8a00-86a3a61043f6": {"__data__": {"id_": "db34c9f5-1b6d-450e-8a00-86a3a61043f6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ea5923d-d5ff-44a0-9d68-71b73e7e93c5", "node_type": "1", "metadata": {}, "hash": "c234954c7808d55dc7736373f29b39cf471a611a8af9b4d91d5c5db284db373b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "05f91917-a900-4f3e-8374-df0e76ac9787", "node_type": "1", "metadata": {}, "hash": "293269f0991b27e4a59feb80de50721333355c2b5cd51f68ef200c6ce4ad7662", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After reduction of the excess cumulus oophorus with\nthe help of two fine needles, oocytes were transferred\nto fertilization medium (G-IVF, Vitrolife, Gothenburg,\nSweden)\nunder\noil\n(Ovoil,\nVitrolife,\nGothenburg,\nSweden) supplemented with 10% (w/v) human serum\nalbumin (HSA) and placed in a CO2\u2013O2 incubator\n(HERAcell, Thermo Scientific, Waltham, MA) for 2 h\nuntil hyaluronidase treatment. All consequent incuba-\ntion steps were handled in a CO2\u2013O2 incubator under\noil (Ovoil, Vitrolife, Gothenburg, Sweden).\nSperm evaluation and preparation\nSemen samples were freshly collected on the day of\noocyte retrieval. After allowing liquefaction at 37 \u0004C, an\ninitial evaluation was performed. Sperm concentration,\nmotility, progression and morphology were evaluated\naccording to the World Health Organization 2010\nguidelines. Samples were prepared for IMSI by swim\nup from a washed pellet (Sperm Rinse, Vitrolife,\nGothenburg, Sweden) technique.\nA second evaluation after preparation was per-\nformed and recorded. Final sperm suspensions were\ndiluted to 0.1 \u0005 106 progressive motile spermatozoa\nper ml, and placed into micro droplets on Petri dishes\n2\nB. AYDINURAZ ET AL.\nprepared\nfor\nIMSI\n(WillCo-Dish,\nWillCo\nWells,\nAmsterdam, Netherlands).\nIMSI procedure\nAll laboratory procedures were carried out on Nunc\nIVF\nProduct\nLine\n(Roskilde,\nDenmark)\nplastic-ware\nexcept IMSI (WillCo-Dish, Amsterdam, Netherlands).\nOocyte denudation was performed in HEPES-buffered\nmedium (G-Gamete, Vitrolife, Gothenburg, Sweden) 2 h\nafter oocyte retrieval by using 40 IU enzymatic diges-\ntion by hyaluronic acid (HYASE, Vitrolife, Gothenburg,\nSweden), followed by gentle pipetting.\nIMSI was performed in HEPES-buffered medium\n(G-Gamete, Vitrolife, Gothenburg, Sweden).", "mimetype": "text/plain", "start_char_idx": 9420, "end_char_idx": 11158, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "05f91917-a900-4f3e-8374-df0e76ac9787": {"__data__": {"id_": "05f91917-a900-4f3e-8374-df0e76ac9787", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "db34c9f5-1b6d-450e-8a00-86a3a61043f6", "node_type": "1", "metadata": {}, "hash": "35654f7d6cbb2ee643afc4f46714c6a7bb230dfe52de5c662ee2797fdb7392c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b24e6465-fdd4-4936-a5d5-ff08956a189b", "node_type": "1", "metadata": {}, "hash": "a80d3221af84afe239e256f2b2a05c966e490618c732e41d3242aaeb202ee332", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "IMSI was performed in HEPES-buffered medium\n(G-Gamete, Vitrolife, Gothenburg, Sweden). PVP was\nused for sperm selection and immobilization (ICSI,\nVitrolife, Gothenburg, Sweden). For all oocytes, a single,\nmotile spermatozoon exhibiting normal morphology\naccording to the oval shape of the nucleus, length and\nwidth of the head and nuclear vacuoles was identified\nand selected in a glass bottom Petri dish (WillCo-Dish,\nAmsterdam, Netherlands), under an inverted micro-\nscope at 600 \u0005 original and 6000 \u0005 enhanced digital\nmagnification (DMI3000 B, Leica, Wetzlar, Germany),\nequipped with an Integra TI micromanipulation set\n(Research Instruments, Cornwall, UK) and IMSI digital\noptics (Research Instruments, Cornwall, UK). Sperm\ninjection was performed after aggressive sperm immo-\nbilization as previously described (Palermo et al., 1996).\nOocyte activation by calcium ionophore\nHalf of the injected oocytes from each patient were\nincubated for 15 min in the 30 ll of pre-equilibrated\ndrops of medium containing Ca2\u00fe-ionophore (GM508\nCult-Active, Gynemed, Lensahn, Germany), immediately\nafter IMSI according to the instruction manual. After a\nseries of rinsing steps, oocytes were transferred to the\nmicro droplets of fresh fertilization medium (G-IVF),\nsupplemented with 5% (w/v) human serum albumin\n(HSA). The remaining half of the oocytes of a given\npatient\nwere\ndirectly\ntransferred\nto\nfertilization\nmedium (G-IVF), supplemented with 5% (w/v) human\nserum albumin (HSA) to serve as control.\nEmbryo culture and evaluation\nAll embryos were cultured to the cleavage stage (3 d)\nin a 37 \u0004C incubator (HERAcell, Thermo Scientific,\nWaltham, MA) with 6% CO2, 5% O2, 89% N2 and\nhumidified atmosphere. Sibling oocytes of the same\npatient were cultured in the same compartment of the\nincubator.", "mimetype": "text/plain", "start_char_idx": 11072, "end_char_idx": 12859, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b24e6465-fdd4-4936-a5d5-ff08956a189b": {"__data__": {"id_": "b24e6465-fdd4-4936-a5d5-ff08956a189b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05f91917-a900-4f3e-8374-df0e76ac9787", "node_type": "1", "metadata": {}, "hash": "293269f0991b27e4a59feb80de50721333355c2b5cd51f68ef200c6ce4ad7662", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc60321a-a95c-4874-9566-624cc6e617da", "node_type": "1", "metadata": {}, "hash": "28ab0b2e9d3b4a48c5541a8ce8281be7bc6ac0f26413c92ca67bf8724032010e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sibling oocytes of the same\npatient were cultured in the same compartment of the\nincubator.\nFertilization was evaluated blindly by two embryolo-\ngists 16\u201318 h after IMSI. Two clearly visible pronuclei\nwere\nconsidered\nevidence\nof\nnormal\nfertilization.\nFertilization rates were calculated as the number of\nnormally fertilized oocytes/the number of metaphase II\noocytes injected \u0005100. Fertilized oocytes were trans-\nferred to the pre-equilibrated micro droplets of fresh\ncleavage medium (G1) supplemented with 5% (w/v)\nhuman serum albumin (HSA) under oil and placed in a\nCO2\u2013O2 incubator for embryo culture.\nOn day 3, a second evaluation was performed by\nthe same embryologists to assess embryo quality.\nCleavage rates were calculated as the number of\ncleaved embryos on day 3/the number of normally fer-\ntilized oocytes \u0005100. Embryo grading was classified\naccording to the ASEBIR consensus scheme (ASEBIR,\n2008). Embryos with less than 10% fragmentation and\nconsisting of 7\u20138 even-sized blastomeres on day 3\nwithout any vacuolization, granulation and multinu-\ncleation were considered grade A (top quality). The\npercentage of top quality embryos on day 3 was cal-\nculated as the number of top quality embryos on day\n3/the number of normally fertilized oocytes \u0005100, and\nthe number of cases with at least one top quality\nembryo was calculated as the percentage of cases\nholding at least one top quality embryo on day 3.\nStatistical analysis\nWe calculated that an appropriate sample size for stat-\nistical analysis would be 42 patients, with 21 patients\nin each group, with the type I probability of error\nbeing fixed at 5% and the type II error 20%. This sam-\nple size was able to detect if AOA could change fertil-\nization rates, assuming an expected 10% difference\nbetween the groups.\nAll data were extracted from the patients\u2019 electronic\nmedical records. The statistical analysis was done with\nSPSS\n22.0\nsoftware\nfor\nwindows\n(IBM\nSoftware,\nNew\nYork,\nNY).", "mimetype": "text/plain", "start_char_idx": 12768, "end_char_idx": 14722, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cc60321a-a95c-4874-9566-624cc6e617da": {"__data__": {"id_": "cc60321a-a95c-4874-9566-624cc6e617da", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b24e6465-fdd4-4936-a5d5-ff08956a189b", "node_type": "1", "metadata": {}, "hash": "a80d3221af84afe239e256f2b2a05c966e490618c732e41d3242aaeb202ee332", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f80ea38-2872-4c09-a77e-26ee9404f77a", "node_type": "1", "metadata": {}, "hash": "08c55cd0bd33eae03ac361f5c5b75d66963087ad4f8f67bb63337a5c08cb6cfb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All data were extracted from the patients\u2019 electronic\nmedical records. The statistical analysis was done with\nSPSS\n22.0\nsoftware\nfor\nwindows\n(IBM\nSoftware,\nNew\nYork,\nNY).\nFor\nindependent\nsamples,\nthe\nMann\u2013Whitney U test was used for analyses involving\ncontinuous variables, including difference in fertiliza-\ntion rates, the number of Grade A (top quality)\nembryos on day 3. The v2 (or Fisher exact test where\nappropriate) was used for analyses involving categor-\nical variables. A p value <0.05 was selected as the level\nof statistical significance.\nResults\nDuring the study period, 21 couples meeting the inclu-\nsion criteria underwent 21 IMSI cycles. The mean age\nat treatment was 30.2 years (range 23\u201335). All the\nHUMAN FERTILITY\n3\npatients\nhad\na\nhistory\nof\npreviously\nunsuccessful\nIVF-ET attempts (mean 1.47 \u00b1 0.68). The numbers of\noocytes retrieved and MII oocytes were 13.0 \u00b1 6.4 and\n9.2 \u00b1 4.7, respectively.\nNinety-seven oocytes were injected in both groups\nand the mean number of AOA-treated and non-treated\nmetaphase\nII\noocytes\nwas\n4.6 \u00b1 2.4\nand\n4.6 \u00b1 2.3,\nrespectively. The number of oocytes fertilized was\ncomparable between the groups (p > 0.05). The total\nnumber of cleaved embryos on day 3 was similar\nbetween the AOA-treated and non-treated groups\n(p > 0.05) (Table 1).\nThe number of top quality embryos produced on\nday 3 was 28 (38.4%) in the AOA-treated group and\n38 (58.5%) in the non-treated group. The difference\nwas statistically significant (p \u00bc 0.024). Consequently, in\nthe AOA-treated oocyte cohort, the number of cases\nwith at least one top quality embryo was statistically\nsignificantly lower than that in the control group (13/\n21; 61.9% versus 20/21; 95.24%, respectively; p \u00bc 0.006)\n(Table 1).", "mimetype": "text/plain", "start_char_idx": 14552, "end_char_idx": 16275, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0f80ea38-2872-4c09-a77e-26ee9404f77a": {"__data__": {"id_": "0f80ea38-2872-4c09-a77e-26ee9404f77a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc60321a-a95c-4874-9566-624cc6e617da", "node_type": "1", "metadata": {}, "hash": "28ab0b2e9d3b4a48c5541a8ce8281be7bc6ac0f26413c92ca67bf8724032010e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "097992a6-44e4-435e-a4ed-b09e227516c3", "node_type": "1", "metadata": {}, "hash": "803f37639f84151949d35b2a922e808ef9d58c5421f02a514be82c5808e96523", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There were no significant differences in pregnancy,\nongoing pregnancy and implantation rates between\nstudy and control groups, when single-embryo transfer\ncycles were compared (p > 0.05 for all). The outcomes\nof double-embryo transfer (DET) cycles were not calcu-\nlated because tracing the implanted embryo back to\nstudy or control groups was not possible.\nDiscussion\nNumerous studies have been performed to evaluate\nthe\nefficacy\nof\nAOA\nafter\nstandard\nICSI\n(Borges,\nde\nAlmeida\nFerreira\nBraga,\nde\nSousa\nBonetti,\nIaconelli, & Franco, 2009; De Vos et al., 2003; Hsu\net al., 1999; Moaz et al., 2006; Nasr-Esfahani, Razavi,\nJavdan, & Tavalaee, 2008) but the effects of AOA on\nfertilization rates have not been studied following\nIMSI in a sibling oocyte design within the same\ncycle.\nThe\npresent\nfindings\ndo\nnot\nreveal\nan\nimproved\neffect\nof\nAOA\non\nfertilization\nrates.\nSimilarly,\ncleavage\nrates\nand\nnumber\nof\ncleaved\nembryos were found to be comparable between the\ngroups. Our results are in contrast with a previous\nstudy demonstrating improved fertilization rates by\nAOA compared with IMSI alone (Yoon et al., 2014),\nbut the former study compared two different cycles\nof the same couple. Our study was designed to\ninclude sibling oocyte by splitting into study and\ncontrol groups, in order to eliminate the possible\nrandomization\nproblems\nof\ninter-cycle\nvariations.\nOther studies have reported that the use of AOA\nwith calcium ionophore in patients with a history of\nfertilization failure is a safe and reliable tool in cryp-\ntozoospermic cases (Ebner et al., 2012; Nasr-Esfahani,\nDeemeh, & Tavalaee, 2010). However, these studies\nalso compared different cycles and thus the possible\ndisadvantage\nof\ninter-cycle\nvariations\nwithin\nthe\npatient.", "mimetype": "text/plain", "start_char_idx": 16276, "end_char_idx": 18014, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "097992a6-44e4-435e-a4ed-b09e227516c3": {"__data__": {"id_": "097992a6-44e4-435e-a4ed-b09e227516c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f80ea38-2872-4c09-a77e-26ee9404f77a", "node_type": "1", "metadata": {}, "hash": "08c55cd0bd33eae03ac361f5c5b75d66963087ad4f8f67bb63337a5c08cb6cfb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d97eca6a-e5f6-4282-9aac-62ec73791ede", "node_type": "1", "metadata": {}, "hash": "414726d18ea473f5161aa9bd5a21e95f56814015acd855d5d8e6870e9dc99bf9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, these studies\nalso compared different cycles and thus the possible\ndisadvantage\nof\ninter-cycle\nvariations\nwithin\nthe\npatient.\nIMSI was introduced as a valuable tool to identify\nand select a spermatozoon with a high fertilizing abil-\nity (Yoon et al., 2014). AOA is considered to be useful\nin selected patients who have low fertilization poten-\ntial (Sermondade et al., 2011; Taylor et al., 2010) and a\nbeneficial effect of AOA was implied for patients with\na compromised fertilization due to globozoospermia\nTable 1. Comparison of IMSI treatment outcomes between AOA and control groups.", "mimetype": "text/plain", "start_char_idx": 17880, "end_char_idx": 18475, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d97eca6a-e5f6-4282-9aac-62ec73791ede": {"__data__": {"id_": "d97eca6a-e5f6-4282-9aac-62ec73791ede", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "097992a6-44e4-435e-a4ed-b09e227516c3", "node_type": "1", "metadata": {}, "hash": "803f37639f84151949d35b2a922e808ef9d58c5421f02a514be82c5808e96523", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "122081d6-cfc6-4c96-a229-a2e69c93da33", "node_type": "1", "metadata": {}, "hash": "de6c7dbb12d2844c49d320b1bfc11d4b1c7464cef00baa7bfa09493da1166b5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Comparison of IMSI treatment outcomes between AOA and control groups.\nAOA group\nControl group\np Value\nTotal number of MII oocytes\n97\n97\nMII oocytes per patient\n4.6 \u00b1 2.4\n4.6 \u00b1 2.3\n0.929\nTotal number of fertilized oocytes\n80/97 (82.5)\n71/97 (73.2)\n0.125\nFertilized oocytes per patient\n3.8 \u00b1 2.5\n3.4 \u00b1 1.8\n0.817\nTotal number of cleaved embryos\n73/80 (91.3)\n65/71 (91.5)\n0.999\nEmbryos per patient\n3.5 \u00b1 2.4\n3.1 \u00b1 1.6\n0.938\nTotal number of top quality embryos\n28/80 (35.0)\n38/71 (53.5)\n0.024\nTop quality embryos per patient\n1.3 \u00b1 1.5\n1.8 \u00b1 1.2\n0.112\nNumber of cases with \u00031 top quality embryo\n13/21 (61.9)\n20/21 (95.2)\n0.006\nNumber of transferred embryos\nin DET\n4\n6\nSET\n6\n10\n0.170\nPregnancy outcomea\nImplantation\n2 (33.3)\n4 (40.0)\n0.608\nBiochemical pregnancy\n0 (0.0)\n0 (0.0)\n\u2013\nClinical pregnancy\n2 (33.3)\n4 (40.0)\n0.608\nSpontaneous abortion\n0 (0.0)\n1 (10.0)\n0.625\nOngoing pregnancyb\n2 (33.3)\n3 (30.0)\n0.654\nIMSI: intracytoplasmic morphologically selected sperm injection; AOA: artificial oocyte activation; MII: metaphase 2; SET: sin-\ngle embryo transfer; DET: double embryo transfer. Mann\u2013Whitney U test or Pearson Chi-squared test was used for the ana-\nlysis. Data are mean \u00b1 SD or n (%) unless otherwise specified. Boldface data indicates statistical significance (p < 0.05).\naData for pregnancy outcomes are expressed per embryo transfer and only for SET.\nbDefined as progression beyond 12 weeks of gestation.", "mimetype": "text/plain", "start_char_idx": 18406, "end_char_idx": 19815, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "122081d6-cfc6-4c96-a229-a2e69c93da33": {"__data__": {"id_": "122081d6-cfc6-4c96-a229-a2e69c93da33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d97eca6a-e5f6-4282-9aac-62ec73791ede", "node_type": "1", "metadata": {}, "hash": "414726d18ea473f5161aa9bd5a21e95f56814015acd855d5d8e6870e9dc99bf9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ca93689-131f-4173-8c35-2a8cd7d1f61d", "node_type": "1", "metadata": {}, "hash": "b5e08b909ccd23ae96c24bb112d4ec5ada6f49c9c8fcfe07937952c70e785a65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Boldface data indicates statistical significance (p < 0.05).\naData for pregnancy outcomes are expressed per embryo transfer and only for SET.\nbDefined as progression beyond 12 weeks of gestation.\n4\nB. AYDINURAZ ET AL.\n(Dirican, Isik, Vicdan, Sozen, & Suludere, 2008; Ebner\net al., 2012; Montag, K\u20acoster, van der Ven, Bohlen, &\nvan\nder\nVen,\n2012;\nNasr-Esfahani\net\nal.,\n2010).\nConsistently, high fertilization rates were obtained in\nour study with IMSI in both AOA-treated and non-\ntreated oocytes, and AOA did not seem to confer any\nbeneficial effect on improving fertilization rates.\nNo adverse effects of calcium ionophore on in vitro\nor in vivo embryo development have previously been\nnoted (Ebner & Montag, 2016; Heytens et al., 2008;\nKyono,\nTakisawa,\nNakajo,\nDoshida,\n&\nToya,\n2012;\nVanden Meerschaut et al., 2012). However, the safety\nand efficacy of AOA has recently been questioned. It is\nconsidered to affect cell homeostasis by mediating\nexport of potassium through the plasma membrane\nwhich results in consecutive acidification of the cytosol\n(Manag\u0002o et al., 2015) and may have long-term effects\non\ngene\nexpression\nand\nepigenetic\nmodifications\n(Santella & Dale, 2015). In addition, the artificial cal-\ncium oscillations created by AOA are suspected of hav-\ning undesirable downstream consequences, such as\neffects on mitochondrial metabolism or other develop-\nmentally critical pathways (van Blerkom, Cohen, &\nJohnson, 2015).\nIn our study, the total number of top quality\nembryos was significantly reduced in the AOA-treated\ngroup. This is clinically important because selection\nand transfer of top-quality embryos is an essential\nelement of success in assisted reproduction.", "mimetype": "text/plain", "start_char_idx": 19620, "end_char_idx": 21305, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ca93689-131f-4173-8c35-2a8cd7d1f61d": {"__data__": {"id_": "6ca93689-131f-4173-8c35-2a8cd7d1f61d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "122081d6-cfc6-4c96-a229-a2e69c93da33", "node_type": "1", "metadata": {}, "hash": "de6c7dbb12d2844c49d320b1bfc11d4b1c7464cef00baa7bfa09493da1166b5b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7dd94584-3d5c-4971-890d-7380e58afb79", "node_type": "1", "metadata": {}, "hash": "05d95b8e1859f82cb9ef88bbadd3665236fce1052578ecabade0dc972e871187", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This is clinically important because selection\nand transfer of top-quality embryos is an essential\nelement of success in assisted reproduction. These\nfindings might be related either to effects of calcium\nionophore on oocyte homeostasis or mitochondrial\nmetabolism (Santella & Dale, 2015; van Blerkom et al.,\n2015), or through disturbance in the embryo culture\ndue to the addition of an extra oocyte culture and\nmanipulation step.\nAs a ready-to-use calcium ionophore solution (Cult-\nActive) was used in our study, it was not possible to\ncontrol for any solvent effect. In addition, the present\nstudy did not evaluate the effects of the calcium iono-\nphore in a dose-dependent manner, where there\nmight be non-specific effects due to additional rinsing\nand transferring steps. These are the main limitations\nof the study.\nThe primary outcomes were fertilization rates and\nembryo quality, but not pregnancy. Consequently, due\nto low sample size of our study, we were unable to\ncompare the differences in implantation, clinical and\nongoing pregnancy rates.\nOur study reveals that AOA after IMSI does not\nimprove the fertilization rates and may reduce the\nability of successfully fertilized oocytes to develop into\ntop-quality embryos. Further studies including ongoing\npregnancy and livebirth outcomes with larger sample\nsizes are required.\nDisclosure statement\nAll authors declare that they do not have any conflict of\ninterest. All authors state that this study follows the princi-\nples of the Declaration of Helsinki.\nORCiD\nBatu Aydinuraz\nhttp://orcid.org/0000-0002-9681-2526\nEnver\nKerem\nDirican\nhttp://orcid.org/0000-0001-6230-\n1229\nSafak Olgan\nhttp://orcid.org/0000-0002-1934-7106\nReferences\nAntinori, M., Licata, E., Dani, G., Cerusico, F., Versaci, C.,\nD\u2019angelo, D., & Antorini, S. (2008). Intracytoplasmic mor-\nphologically\nselected\nsperm\ninjection:\nA\nprospective\nrandomized\ntrial.\nReproductive\nBiomedicine\nOnline,\n16,\n835\u2013841.", "mimetype": "text/plain", "start_char_idx": 21162, "end_char_idx": 23094, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7dd94584-3d5c-4971-890d-7380e58afb79": {"__data__": {"id_": "7dd94584-3d5c-4971-890d-7380e58afb79", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ca93689-131f-4173-8c35-2a8cd7d1f61d", "node_type": "1", "metadata": {}, "hash": "b5e08b909ccd23ae96c24bb112d4ec5ada6f49c9c8fcfe07937952c70e785a65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c05d35a-3965-4c10-954a-74a414a0b0b0", "node_type": "1", "metadata": {}, "hash": "b96fd289191295c1e894643c41795542bf7e60087d113b2cf47456b9ddd3b1b2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Intracytoplasmic mor-\nphologically\nselected\nsperm\ninjection:\nA\nprospective\nrandomized\ntrial.\nReproductive\nBiomedicine\nOnline,\n16,\n835\u2013841. doi: 10.1016/S1472-6483(10)60150-2.\nASEBIR. (2008). Criterios de valoraci\u0003on morfol\u0003ogicos de ooci-\ntos, embriones tempranos y blastocistos humanos. II\nCuaderno\nde\nEmbriolog\u0003\u0131a\nCl\u0003\u0131nica.\n(www.asebir.com/\n\u2026 /cuadernos \u2026 /ii-cuadernos-de-embriolog\u0003\u0131a-cl\u0003\u0131nica).\nBalaban, B., Yakin, K., Alatas, C., Oktem, O., Isiklar, A., &\nUrman, B. (2011). Clinical outcome of intracytoplasmic\ninjection of spermatozoa morphologically selected under\nhigh\nmagnification:\nA\nprospective\nrandomized\nstudy.\nReproductive Biomedicine Online, 22, 472\u2013476.\ndoi: http://\ndx.doi.org/10.1016/j.rbmo.2010.11.003.\nBerkovitz, A., Eltes, F., Lederman, H., Peer, S., Ellenbogen, A.,\nFeldberg, B., & Bartoov, B. (2006). How to improve IVF-ICSI\noutcome by sperm selection. Reproductive Biomedicine\nOnline, 12, 634\u2013638.\ndoi: http://dx.doi.org/10.1016/S1472-\n6483(10)61191-1.\nBorges, E., Jr., de Almeida Ferreira Braga, D.P., de Sousa\nBonetti, T.C., Iaconelli, A., Jr., & Franco, J.G., Jr. (2009).\nArtificial oocyte activation with calcium ionophore A23187\nin intracytoplasmic sperm injection cycles using surgically\nretrieved spermatozoa. Fertility and Sterility, 92, 131\u2013136.\ndoi: http://dx.doi.org/10.1016/j.fertnstert.2008.04.046.", "mimetype": "text/plain", "start_char_idx": 22956, "end_char_idx": 24291, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c05d35a-3965-4c10-954a-74a414a0b0b0": {"__data__": {"id_": "6c05d35a-3965-4c10-954a-74a414a0b0b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7dd94584-3d5c-4971-890d-7380e58afb79", "node_type": "1", "metadata": {}, "hash": "05d95b8e1859f82cb9ef88bbadd3665236fce1052578ecabade0dc972e871187", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cdb10ca3-018a-47b5-8628-a73550becd2b", "node_type": "1", "metadata": {}, "hash": "11344f1f291ef7c45f5501b3992f7099a8d8c6acce35de73f3a894baf2ba6a3f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertility and Sterility, 92, 131\u2013136.\ndoi: http://dx.doi.org/10.1016/j.fertnstert.2008.04.046.\nDe Vos, A., Van de Velde, H., Bocken, G., Eylenbosch, G.,\nFranceus, N., Meersdom, G., \u2026 Verheyen, G. (2013). Does\nintracytoplasmic morphologically selected sperm injection\nimprove embryo development? A randomized sibling-\noocyte study. Human Reproduction, 28, 617\u2013626.\ndoi: 10.\n1093/humrep/des435.\nDe Vos, A., Van De Velde, H., Joris, H., Verheyen, G., Devroey,\nP., & Van Steirteghem, A. (2003). Influence of individual\nsperm morphology on fertilization, embryo morphology\nand pregnancy outcome of intracytoplasmic sperm injec-\ntion. Fertility and Sterility, 79, 42\u201348. doi: http://dx.doi.org/\n10.1016/S0015-0282(02)04571-5.\nDirican, E.K., Isik, A., Vicdan, K., Sozen, E., & Suludere, Z.\n(2008). Clinical pregnancies and livebirths achieved by\nintracytoplasmic injection of round headed acrosomeless\nHUMAN FERTILITY\n5\nspermatozoa with and without oocyte activation in famil-\nial\nglobozoospermia:\nCase\nreport.\nAsian\nJournal\nof\nAndrology, 10, 332\u2013336.\ndoi: 10.1111/j.1745-7262.2008.\n00248.x.\nDozortsev, D., & Nasr-Esfahani, M.H. (2012). Mechanism of\nhuman oocyte activation during ICSI and methodology for\novercoming low or failed fertilization. In Z.P. Nagy, A.\nVarghese & A. Agarwal (Eds.), Practical manual of in vitro\nfertilization: Advanced methods and novel devices (pp.\n321\u2013326). New York: Springer.", "mimetype": "text/plain", "start_char_idx": 24197, "end_char_idx": 25596, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cdb10ca3-018a-47b5-8628-a73550becd2b": {"__data__": {"id_": "cdb10ca3-018a-47b5-8628-a73550becd2b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c05d35a-3965-4c10-954a-74a414a0b0b0", "node_type": "1", "metadata": {}, "hash": "b96fd289191295c1e894643c41795542bf7e60087d113b2cf47456b9ddd3b1b2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7e9ab3e5-6a63-4d83-aa97-95948be1b0b7", "node_type": "1", "metadata": {}, "hash": "2deda1cf7652f653a3462e4db633e0076b0812954a9427b5687909abf6498db7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Nagy, A.\nVarghese & A. Agarwal (Eds.), Practical manual of in vitro\nfertilization: Advanced methods and novel devices (pp.\n321\u2013326). New York: Springer.\nEbner, T., K\u20acoster, M., Shebl, O., Moser, M., Van der Ven, H.,\nTews, G., & Montag, M. (2012). Application of a ready-to-\nuse calcium ionophore increases rates of fertilization and\npregnancy in severe male factor infertility. Fertility and\nSterility, 98, 1432\u20131437.\ndoi: http://dx.doi.org/10.1016/j.\nfertnstert.2012.07.1134.\nEbner, T., & Montag, M. (2016). Artificial oocyte activation:\nEvidence for clinical readiness. Reproductive Biomedicine\nOnline, 32, 271\u2013273. doi:10.1016/j.rbmo.2015.12.004..\nEbner, T., Montag, M., The Oocyte Activation Study Group,\nMontag, M., Van der Ven, K., Van der Ven, H., \u2026 Etien, C.\n(2015). Live birth after artificial oocyte activation using a\nready-to-use ionophore: A prospective multicenter study.\nReproductive Biomedicine Online, 30, 359\u2013365.\ndoi: http://\ndx.doi.org/10.1016/j.rbmo.2014.11.012.\nEldar-Geva, T., Brooks, B., Margalioth, E.J., Zylber-Haran, E.,\nGal, M., & Silber, S.J. (2003). Successful pregnancy and\ndelivery after calcium ionophore oocyte-activation in a\nnormozoospermic patient with previous repeated failed\nfertilization after intracytoplasmic sperm injection. Fertility\nand Sterility, 79(Suppl 3), 1656\u20131658.\ndoi: 10.1016/S0015-\n0282(03)00369-8.\nEscalier,\nD.\n(1990).", "mimetype": "text/plain", "start_char_idx": 25444, "end_char_idx": 26819, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e9ab3e5-6a63-4d83-aa97-95948be1b0b7": {"__data__": {"id_": "7e9ab3e5-6a63-4d83-aa97-95948be1b0b7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cdb10ca3-018a-47b5-8628-a73550becd2b", "node_type": "1", "metadata": {}, "hash": "11344f1f291ef7c45f5501b3992f7099a8d8c6acce35de73f3a894baf2ba6a3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "760d7fcc-b4c4-47ac-b0d0-56682dbe5540", "node_type": "1", "metadata": {}, "hash": "1aa462ddfd9b12c08247daaabda5cd0301cc7ca2cf6067bfbd8f04a95ef11d4c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "doi: 10.1016/S0015-\n0282(03)00369-8.\nEscalier,\nD.\n(1990).\nFailure\nof\ndifferentiation\nof\nthe\nnuclear\u2013perinuclear\nskeletal\ncomplex\nin\nthe\nround-\nheaded\nhuman\nspermatozoa.\nInternational\nJournal\nof\nDevelopmental\nBiology,\n34,\n287\u2013297.\nretrieved\nfrom:\nhttp://www.ijdb.ehu.es/web/paper/2201396/failure-of-dif-\nferentiation-of-the-nuclear-perinuclear-skeletal-complex-in-\nthe-round-headed-human-spermatozoa.\nFerraretti,\nA.P.,\nLa\nMarca,\nA.,\nFauser,\nB.C.,\nTarlatzis,\nB.,\nNargund, G., & Gianaroli, L. ESHRE Working Group on Poor\nOvarian Response Definition. (2011). ESHRE consensus on\nthe definition of \u2018poor response\u2019 to ovarian stimulation for\nin\nvitro\nfertilization:\nThe\nBologna\ncriteria.\nHuman\nReproduction, 26, 1616\u20131624. doi:10.1093/humrep/der092.\nFlaherty, S.P., Payne, D., & Matthews, C.D. (1998). Fertilization\nfailures and abnormal fertilization after intracytoplasmic\nsperm\ninjection.\nHuman\nReproduction,\n13(Suppl\n1),\n155\u2013164. doi:10.1093/humrep/13.suppl_1.155.\nHeindryckx, B., Van der Elst, J., De Sutter, P., & Dhont, M.\n(2005). Treatment option for sperm-or oocyte-related fer-\ntilization failure: Assisted oocyte activation following diag-\nnostic\nheterologous\nICSI.\nHuman\nReproduction,\n20,\n2237\u20132241. doi:10.1093/humrep/dei029.\nHeytens, E., Soleimani, R., Lierman, S., De Meester, S., Gerris,\nJ., Dhont, M., \u2026 De Sutter, P. (2008). Effect of ionomycin\non oocyte activation and embryo development in mouse.", "mimetype": "text/plain", "start_char_idx": 26762, "end_char_idx": 28171, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "760d7fcc-b4c4-47ac-b0d0-56682dbe5540": {"__data__": {"id_": "760d7fcc-b4c4-47ac-b0d0-56682dbe5540", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7e9ab3e5-6a63-4d83-aa97-95948be1b0b7", "node_type": "1", "metadata": {}, "hash": "2deda1cf7652f653a3462e4db633e0076b0812954a9427b5687909abf6498db7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "57c7d7ab-6658-43f1-a935-4e4765d59736", "node_type": "1", "metadata": {}, "hash": "027f36be1c95b1412d9a8ded0a3faaf8ddd52c89f8e3c4e01a30f353c0b8dd3f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(2008). Effect of ionomycin\non oocyte activation and embryo development in mouse.\nReproductive Biomedicine Online, 17, 764\u2013771.\ndoi: http://\ndx.doi.org/10.1016/S1472-6483(10)60403-8.\nHsu, M.I., Mayer, J., Aronshon, M., Lanzendorf, S., Muasher, S.,\nKolm, P., & Oehninger, S. (1999). Embryo implantation in\nin vitro fertilization and intracytoplasmic sperm injection:\nImpact of cleavage status, morphology grade, and number\nof embryos transferred. Fertility and Sterility, 72, 679\u2013685.\nDOI: http://dx.doi.org/10.1016/S0015-0282(99)00320-9.\nKyono, K., Takisawa, T., Nakajo, Y., Doshida, M., & Toya, M.\n(2012). Birth and follow-up of babies born following ICSI\nwith oocyte activation using strontium chloride or calcium\nionophore A23187. Journal of Mammalian Ova Research,\n29, 35\u201340. doi: http://doi.org/10.1274/jmor.29.35.\nLuckasen, J.R., White, J.G., & Kersey, J.H. (1974). Mitogenic\nproperties of a calcium ionophore, A23187. Proceedings of\nthe National Academy of Sciences of the United States of\nAmerica, 71, 5088\u20135090.\ndoi:http://www.ncbi.nlm.nih.gov/\npmc/articles/PMC434045/.\nManag\u0002o, A., Leanza, L., Carraretto, L., Sassi, N., Grancara, S.,\nQuintana-Cabrera, R., \u2026 Szab\u0002o, I. (2015). Early effects of\nthe antineoplastic agent salinomycin on mitochondrial\nfunction. Cell Death & Disease, 6, e1930. doi:10.1038/cddis.\n2015.263.\nMoaz, M.N., Khattab, S., Foutouh, I.A., & Mohsen, E.A. (2006).", "mimetype": "text/plain", "start_char_idx": 28090, "end_char_idx": 29482, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57c7d7ab-6658-43f1-a935-4e4765d59736": {"__data__": {"id_": "57c7d7ab-6658-43f1-a935-4e4765d59736", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "760d7fcc-b4c4-47ac-b0d0-56682dbe5540", "node_type": "1", "metadata": {}, "hash": "1aa462ddfd9b12c08247daaabda5cd0301cc7ca2cf6067bfbd8f04a95ef11d4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b88dc522-2fa4-4515-a233-a5b5f68245bf", "node_type": "1", "metadata": {}, "hash": "2f84eea14ae2a3181eb7885d59ad7bfa945c22b6db4d608b45e4b2c18f40bc22", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "doi:10.1038/cddis.\n2015.263.\nMoaz, M.N., Khattab, S., Foutouh, I.A., & Mohsen, E.A. (2006).\nChemical activation of oocytes in different types of sperm\nabnormalities in cases of low or failed fertilization after\nICSI: A prospective pilot study. Reproductive Biomedicine\nOnline, 13, 791\u2013794.\ndoi: http://dx.doi.org/10.1016/S1472-\n6483(10)61025-5.\nMontag, M., K\u20acoster, M., van der Ven, K., Bohlen, U., & van der\nVen, H. (2012). The benefit of oocyte activation is depend-\nent on the fertilization rate in a previous treatment cycle.\nReproductive Biomedicine Online, 24, 521\u2013526.\ndoi: http://\ndx.doi.org/10.1016/j.rbmo.2012.02.002.\nNasr-Esfahani, M.H., Deemeh, M.R., & Tavalaee, M. (2010).\nArtificial oocyte activation and intracytoplasmic sperm\ninjection. Fertility and Sterility, 94, 520\u2013526. doi: http://dx.\ndoi.org/10.1016/j.fertnstert.2009.03.061.\nNasr-Esfahani, M.H., Razavi, S., Javdan, Z., & Tavalaee, M.\n(2008). Artificial oocyte activation in severe teratozoosper-\nmia undergoing intracytoplasmic sperm injection. Fertility\nand Sterility, 90, 2231\u20132237.\ndoi: http://dx.doi.org/10.\n1016/j.fertnstert.2007.10.047.\nNasr-Esfahani, M.H., Razavi, S., Mardani, M., Shirazi, R., &\nJavanmardi, S. (2007). Effects of failed oocyte activation\nand sperm protamine deficiency on fertilization post-ICSI.\nReproductive Biomedicine Online, 14, 422\u2013429.", "mimetype": "text/plain", "start_char_idx": 29391, "end_char_idx": 30733, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b88dc522-2fa4-4515-a233-a5b5f68245bf": {"__data__": {"id_": "b88dc522-2fa4-4515-a233-a5b5f68245bf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "57c7d7ab-6658-43f1-a935-4e4765d59736", "node_type": "1", "metadata": {}, "hash": "027f36be1c95b1412d9a8ded0a3faaf8ddd52c89f8e3c4e01a30f353c0b8dd3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa0d4463-c02c-4410-9e89-ba1ab63832ce", "node_type": "1", "metadata": {}, "hash": "77c39aabe11d6914358645cf62ef813d466aecf480f5e4a142fd2b90fd09345e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(2007). Effects of failed oocyte activation\nand sperm protamine deficiency on fertilization post-ICSI.\nReproductive Biomedicine Online, 14, 422\u2013429.\ndoi: http://\ndx.doi.org/10.1016/S1472-6483(10)60888-7.\nPalermo, G.D., Schlegel, P.N., Colombero, L.T., Zaninovic, N.,\nMoy, F., & Rosenwaks, Z. (1996). Aggressive sperm immo-\nbilization prior to intracytoplasmic sperm injection with\nimmature spermatozoa improves fertilization and preg-\nnancy\nrates.\nHuman\nReproduction,\n11,\n1023\u20131029.\nRetrieved from: http://humrep.oxfordjournals.org/content/\n11/5/1023.abstract.\nReed, P.W., & Lardy, H.A. (1972). A23187: A divalent cation\nionophore.\nThe\nJournal\nof\nBiological\nChemistry,\n247,\n6970\u20136977.\nRetrieved from: http://www.jbc.org/content/\n247/21/6970.full.pdf\u00fehtml.\nSantella, L., & Dale, B. (2015). Assisted yes, but where\ndo\nwe\ndraw\nthe\nline?\nReproductive\nBiomedicine\nOnline, 31, 476\u2013478.\ndoi: http://dx.doi.org/10.1016/j.rbmo.\n2015.06.013.\nSermondade,\nN.,\nHafhouf,\nE.,\nDupont,\nC.,\nBechoua,\nS.,\nPalacios, C., Eustache, F., \u2026 Sifer, C. (2011). Successful\nchildbirth after intracytoplasmic morphologically selected\nsperm injection without assisted oocyte activation in a\n6\nB. AYDINURAZ ET AL.\npatient with globozoospermia. Human Reproduction, 26,\n2944\u20132949. doi:10.1093/humrep/der258.\nTaylor,\nS.L.,\nYoon,\nS.Y.,\nMorshedi,\nM.S.,\nLacey,\nD.R.,\nJellerette,\nT.,\nFissore,\nR.A.,\n&\nOehninger,\nS.\n(2010).", "mimetype": "text/plain", "start_char_idx": 30585, "end_char_idx": 31968, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa0d4463-c02c-4410-9e89-ba1ab63832ce": {"__data__": {"id_": "aa0d4463-c02c-4410-9e89-ba1ab63832ce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b88dc522-2fa4-4515-a233-a5b5f68245bf", "node_type": "1", "metadata": {}, "hash": "2f84eea14ae2a3181eb7885d59ad7bfa945c22b6db4d608b45e4b2c18f40bc22", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "24c1e624-b5f5-4aae-9efd-120d8a6b3386", "node_type": "1", "metadata": {}, "hash": "5f997f0ab8749bd3ace50bc046829462afdd79f15f1469259ac210623768b97c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Taylor,\nS.L.,\nYoon,\nS.Y.,\nMorshedi,\nM.S.,\nLacey,\nD.R.,\nJellerette,\nT.,\nFissore,\nR.A.,\n&\nOehninger,\nS.\n(2010).\nComplete globozoospermia associated with PLCf defi-\nciency\ntreated\nwith\ncalcium\nionophore\nand\nICSI\nresults in pregnancy. Reproductive Biomedicine Online,\n20, 559\u2013564.\ndoi: http://dx.doi.org/10.1016/j.rbmo.2009.\n12.024.\nTesarik, J., Sousa, M., & Testart, J. (1994). Human oocyte acti-\nvation\nafter\nintracytoplasmic\nsperm\ninjection.\nHuman\nReproduction, 9, 511\u2013518.\nRetrieved from: http://humrep.\noxfordjournals.org/content/9/3/511.abstract.\nvan Blerkom, J., Cohen, J., & Johnson, M. (2015). A plea for\ncaution and more research in the 'experimental' use of\nionophores\nin\nICSI.\nReproductive\nBiomedicine\nOnline, 30, 323\u2013324.\ndoi: http://dx.doi.org/10.1016/j.rbmo.\n2015.02.002.\nVanden\nMeerschaut,\nF.,\nD\u2019haeseleer,\nE.,\nGysels,\nH.,\nThienpont,\nY.,\nDewitte,\nG.,\nHeindryckx,\nB.,\n\u2026\nDe\nSutter,\nP.\n(2014).\nNeonatal\nand\nneurodevelopmental\noutcome of children aged 3\u201310 years born following\nassisted\noocyte\nactivation.\nReproductive\nBiomedicine\nOnline, 28, 54\u201363.\ndoi: http://dx.doi.org/10.1016/j.rbmo.\n2013.07.013.\nVanden\nMeerschaut,\nF.,\nNikiforaki,\nD.,\nDe\nGheselle,\nS.,\nDullaerts, V., Van den Abbeel, E., Gerris, J., \u2026 De Sutter,\nP. (2012). Assisted oocyte activation is not beneficial for\nall patients with a suspected oocyte-related activation\ndeficiency.", "mimetype": "text/plain", "start_char_idx": 31859, "end_char_idx": 33212, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "24c1e624-b5f5-4aae-9efd-120d8a6b3386": {"__data__": {"id_": "24c1e624-b5f5-4aae-9efd-120d8a6b3386", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Aydinuraz (2016).pdf", "node_type": "4", "metadata": {}, "hash": "ed2098cc4d8e001579a7c4ca3673cf0e06b6a7dee13b129784d5a732bbe69ed8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa0d4463-c02c-4410-9e89-ba1ab63832ce", "node_type": "1", "metadata": {}, "hash": "77c39aabe11d6914358645cf62ef813d466aecf480f5e4a142fd2b90fd09345e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(2012). Assisted oocyte activation is not beneficial for\nall patients with a suspected oocyte-related activation\ndeficiency. Human Reproduction, 27, 1977\u20131984.\ndoi:10.\n1093/humrep/des097.\nYoon, H.Y., Kim, H.J., Bae, I.H., Chae, S.J., Yoon, S.H., Lee,\nW.D., & Lim, J.H. (2014). An effective method for improv-\ning\noutcomes in patients with a\nfertilization defect.\nClinical\nand\nExperimental\nReproductive\nMedicine,\n41,\n137\u2013139. doi: 10.5653/cerm.2014.41.3.137.\nHUMAN FERTILITY\n7", "mimetype": "text/plain", "start_char_idx": 33088, "end_char_idx": 33563, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "98560698-244d-405d-a578-aa4e48279c41": {"__data__": {"id_": "98560698-244d-405d-a578-aa4e48279c41", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d45f7025-aa09-4dbb-b6bd-d58a513f39ac", "node_type": "1", "metadata": {}, "hash": "413a9c70028591230ca0112405c37763f4741684b5d44d1b8b9ab40b8e4e0161", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Arti\ufb01cial oocyte activation in severe teratozoospermia\nundergoing intracytoplasmic sperm injection\nMohammad H. Nasr-Esfahani, Ph.D,a,b Shahnaz Razavi, Ph.D.,c Zeinab Javdan, M.D.,c\nand Marzeyeh Tavalaee, M.Sc.a\na Department of Embryology and Andrology, Royan Institute, Tehran, Iran; b Isfahan Fertility and Infertility Center, Isfahan, Iran;\nand c Department of Anatomy, Isfahan Medical University, Isfahan, Iran\nObjective: To evaluate ef\ufb01ciency of Ionomycin on fertilization and cleavage rates, embryo development, and preg-\nnancy rate after intracytoplasmic sperm injection (ICSI) in teratozoospermic patients.\nDesign: Laboratory study.\nSetting: Isfahan fertility and infertility Center, and Royan institute, Tehran, Iran.\nPatient(s): Eighty-seven couples with male factor etiology (severe teratozoospermia) undergoing ICSI.\nIntervention(s): Ionomycin for arti\ufb01cial oocyte activation.\nMain Outcome Measure(s): After oocyte collection, the oocytes were randomly divided into two groups: control\nand arti\ufb01cial oocyte activation (AOA). The injected oocytes in the control group were cultured in G1. The remain-\ning oocytes were chemically activated by exposure to 10 mM Ionomycin for 10 minutes. Around 16 to 18 hours\nafter ICSI, fertilization was assessed by the presence of pronuclei. The percentage of cleavage and high-quality\nembryos were calculated 48 and 72 hours after ICSI. Clinical pregnancy also was determined based on ultrasound\nobservation of a fetal heart beat.\nResult(S): There are signi\ufb01cant differences in the mean of fertilization and cleavage rates 72 hours after ICSI be-\ntween AOA and control groups. In patients who had no fertilization in the control group and all the embryos for\ntransfer derived from the AOA group, two pregnancies were recorded.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1772, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d45f7025-aa09-4dbb-b6bd-d58a513f39ac": {"__data__": {"id_": "d45f7025-aa09-4dbb-b6bd-d58a513f39ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "98560698-244d-405d-a578-aa4e48279c41", "node_type": "1", "metadata": {}, "hash": "8ec3b422975d734cf8b123989d32b567ae3ebc207732967fbd00dcd063a87f41", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32c9bc69-c52e-4098-8ec4-d71ad4e017ff", "node_type": "1", "metadata": {}, "hash": "6e9370decd690030932b2cd834e66f05b589262ade8d01733168a0aef6d0a72e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In patients who had no fertilization in the control group and all the embryos for\ntransfer derived from the AOA group, two pregnancies were recorded. In the patients who had poor fertilization rate\n(1%\u201333%) in the control group (14.30%), there was a signi\ufb01cant increase in mean fertilization rate (58.31%) be-\ncause of AOA. The results of the present study also reveal that the samples had motile sperm, whereas in the chem-\nically activated group this difference was not signi\ufb01cant.\nConclusion (s): It can be concluded that in cases with severe teratozoospermia AOA may improve fertilization and\ncleavage rates, which in turn, affect the implantation and pregnancy rate. (Fertil Steril\u0002 2008;90:2231\u20137. \u00032008 by\nAmerican Society for Reproductive Medicine.)\nKey Words: Ionomycin, teratozoospermia, failed fertilization, oocyte activation, ICSI\nIntracytoplasmic sperm injection (ICSI) in human reproduc-\ntion provides possibilities for achieving fertilization even\nin cases of oligoasthenoteratozoospermia. Even though sev-\neral critical steps in normal fertilization are bypassed in\nICSI, fertilization rate remains within 60% to 70% (1, 2).\nAlthough, >80% of these oocytes contain spermatozoon\n(1), failed fertilization in these oocytes has been attributed\nto the inability of the sperm to activate the oocyte, or an in-\nability of the oocyte to decondense the sperm (3\u20135). Many\nstudies have suggested that failure of oocyte activation after\naneuploidy is the principal cause of failed fertilization after\nICSI (5\u20138).\nDuring failed fertilization, meiosis-to-mitosis transition is\nimpaired, and thus the fertilization failure is de\ufb01ned as failure\nof the M\u2013G1 transition in metaphase II (MII) oocytes.", "mimetype": "text/plain", "start_char_idx": 1623, "end_char_idx": 3323, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32c9bc69-c52e-4098-8ec4-d71ad4e017ff": {"__data__": {"id_": "32c9bc69-c52e-4098-8ec4-d71ad4e017ff", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d45f7025-aa09-4dbb-b6bd-d58a513f39ac", "node_type": "1", "metadata": {}, "hash": "413a9c70028591230ca0112405c37763f4741684b5d44d1b8b9ab40b8e4e0161", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a900225e-8ac4-4158-9735-961ac8ae897c", "node_type": "1", "metadata": {}, "hash": "cb4d37a0babd57b9d9e3244c9f2ee4fff972e10219fead50d253dd2218025ad0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During failed fertilization, meiosis-to-mitosis transition is\nimpaired, and thus the fertilization failure is de\ufb01ned as failure\nof the M\u2013G1 transition in metaphase II (MII) oocytes. The\nprocess of M\u2013G1 transition in MII oocytes is called \u2018\u2018oocyte\nactivation.\u2019\u2019\nActivation of the oocyte results in a cascade of events in-\ncluding extrusion of the second polar body, decondensation\nof a haploid set of chromosomes, formation of a nuclear\nmembrane around the chromosomes, and initiation of embry-\nonic development (9, 10). Oocyte activation is also character-\nized by two main molecular events including an increase in\nintracellular Ca2\u00fe concentrations followed by meiotic pro-\nmoting factor inactivation for M\u2013G1 transition (11).\nBoth sperm and oocyte factors are believed to be involved\nin failed oocyte activation after ICSI (12). Therefore, in failed\nfertilized oocytes sperm may have a different status including\nintact, condensed head, partially to completely decondensed,\nand premature chromosomal condensation to metaphase ar-\nrest (5, 13, 14). Sperm nuclear chromatin decondensation\nfailure has been related to sperm quality, a high rate of\nDNA fragmentation, and perhaps because of inadequate cal-\ncium activation (15, 16). Lopes et al. (2) observed a correla-\ntion between the rate of DNA fragmentation and loss of\noscilin activity. In addition, failed fertilization has also\nbeen attributed to acrosomal defects (17\u201319). Indeed,\nround-head spermatozoa (globozoospermia) lacking the ac-\nrosomal membrane and acrosin contents (20) not only fails\nto penetrate oocytes but also if injected into an oocyte fails\nReceived June 21, 2007; revised and accepted October 22, 2007.\nSupported by the Royal Institute.\nReprint requests: Nasr-Esfahani, Ph.D., Royan Institute, P.O. Box\n19395-4644, Tehran, Iran (FAX: 98-311-2605525; E-mail: mh_nasr@\nmed.mui.ac.ir).\n0015-0282/08/$34.00\nFertility and Sterility\u0004 Vol.", "mimetype": "text/plain", "start_char_idx": 3142, "end_char_idx": 5050, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a900225e-8ac4-4158-9735-961ac8ae897c": {"__data__": {"id_": "a900225e-8ac4-4158-9735-961ac8ae897c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32c9bc69-c52e-4098-8ec4-d71ad4e017ff", "node_type": "1", "metadata": {}, "hash": "6e9370decd690030932b2cd834e66f05b589262ade8d01733168a0aef6d0a72e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a0b9ec3f-9c3d-4006-9ec1-5e2a6a043fe0", "node_type": "1", "metadata": {}, "hash": "e7fe6d263efdc7e1dd7e34cbc872dfa0acc7f6a3fda51829a1aa5d08f36b09d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0015-0282/08/$34.00\nFertility and Sterility\u0004 Vol. 90, No. 6, December 2008\n2231\ndoi:10.1016/j.fertnstert.2007.10.047\nCopyright \u00aa2008 American Society for Reproductive Medicine, Published by Elsevier Inc.\nto initiate oocyte activation because of de\ufb01ciency of sperm-\nassociated oocyte-activating factor related with acrosome\nand perinuclear theca (21\u201323).\nTo overcome failed oocyte activation after ICSI or to in-\nduce parthenogenetic activation, different measures have\nbeen taken including electrical activation (24), chemical ac-\ntivation (25, 26), or modi\ufb01ed ICSI (12, 27). Among these pro-\ncedures, chemical activation is the most commonly used.\nLiterature studies reveal that these activators are used mainly\nin case reports or used to activate failed fertilized oocytes\naround 24 hours after ICSI (26, 28, 29). Thus, the aim of\nthis study was to evaluate the ef\ufb01ciency of Ionomycin on fer-\ntilization and cleavage rates, embryo development, and preg-\nnancy rate after ICSI in teratozoospermic patients.\nMATERIALS AND METHODS\nSperm Preparation and Patient Selection\nEighty-seven couples with male factor etiology (severe tera-\ntozoospermia) were initially consulted and selected based on\nsperm morphology of their previous semen analysis among\npatients referring to the Isfahan Fertility and Infertilirty Cen-\nter. This study was initially approved in the ethical and scien-\nti\ufb01c committee of the Isfahan Fertility and Infertility Center\nand Royan Institute, and there is no con\ufb02ict of interest in this\nstudy.\nThe semen samples were collected by masturbation after\n3\u20134 days of abstinence on the day of oocyte recovery. In\nsome cases sperm were obtained from testicular sperm ex-\ntraction (TESE) or by \ufb01ne needle aspiration (FNA). In semen\nsamples, sperm count was assessed by a Makler chamber,\nsperm motility was estimated by light microscopy according\nto the World Health Organization criteria (30), and sperm\nmorphology was assessed by wet preparation during routine\nsemen assessment.", "mimetype": "text/plain", "start_char_idx": 5001, "end_char_idx": 6991, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a0b9ec3f-9c3d-4006-9ec1-5e2a6a043fe0": {"__data__": {"id_": "a0b9ec3f-9c3d-4006-9ec1-5e2a6a043fe0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a900225e-8ac4-4158-9735-961ac8ae897c", "node_type": "1", "metadata": {}, "hash": "cb4d37a0babd57b9d9e3244c9f2ee4fff972e10219fead50d253dd2218025ad0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d9911a0-9a4e-4ad6-ba79-cb4c11abcb65", "node_type": "1", "metadata": {}, "hash": "efc4b05bcf95d09317b34c7f70762a7ae252824819817930185061c60b7ce709", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During the ICSI procedure, in some cases,\nsemen samples were prepared for routine ICSI using discon-\ntinuous PureSperm gradients (80:40) (Nidacon, Gothenburg,\nSweden), and in others, because of low sperm motility and\ndensity, semen samples were washed three times with G-rinse\n(Vitolife, Gothenburg, Sweden). In FNA, TESE, and cases\nwith very low sperm count, we were not able to carry out mor-\nphologic assessment using Diff Quick staining. Therefore,\nthe result of morphologic assessment using Diff Quick stain-\ning was not available for all the cases, so only the results of\nsperm morphology during the ICSI procedure at 400\u0002 mag-\nni\ufb01cation were presented, and patient selection was based on\nmorphologic assessment at 400\u0002 under an inverted micro-\nscope during the ICSI. Cases were included for AOA that\nhad over 98% abnormal sperm and their partners had at least\nfour mature oocytes.\nSperm Morphology Assessment\nSperm were assessed according to Kruger\u2019s strict criteria,\nwithin limits of 400\u0002 magni\ufb01cation of the inverted micro-\nscope (31). Sperm were considered normal when the head\nwas normal in size, shape, and acrosome, and lacking mid-\npiece or tail defects.\nIntracytoplasmic Sperm Injection\nAll of the media were purchased from Vitrolife, Gothenburg,\nSweden, G3 series plus, unless otherwise stated. After oocyte\ncollection, the oocytes were treated in hyaluronidase (Hyase)\nin G-MOPS medium. Oocytes were then washed in fresh G-\nMOPS and transferred to G-oocyte under oil in a Falcon 1006\ndish prepared for ICSI. When possible, a PureSperm pro-\ncessed semen sample was introduced into ICSI-100 (a vis-\ncous sperm handling solution) in the same dish, or other\nwise washed semen samples or washed FNA or TESE sam-\nples were introduced into G-oocyte. In each case, sperm\nwere selected according to the best sperm present based on\nmorphology and motility. Eppendorf micromanipulator\nmounted on a Nikon inverted microscope was used to per-\nform ICSI.", "mimetype": "text/plain", "start_char_idx": 6992, "end_char_idx": 8949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d9911a0-9a4e-4ad6-ba79-cb4c11abcb65": {"__data__": {"id_": "6d9911a0-9a4e-4ad6-ba79-cb4c11abcb65", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a0b9ec3f-9c3d-4006-9ec1-5e2a6a043fe0", "node_type": "1", "metadata": {}, "hash": "e7fe6d263efdc7e1dd7e34cbc872dfa0acc7f6a3fda51829a1aa5d08f36b09d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "433d41ab-90d1-445e-9645-52fc2e75e240", "node_type": "1", "metadata": {}, "hash": "9c3b20c61b7a7358abf112bad3567dd0b8139a27788012da1374c10fee18d503", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In each case, sperm\nwere selected according to the best sperm present based on\nmorphology and motility. Eppendorf micromanipulator\nmounted on a Nikon inverted microscope was used to per-\nform ICSI. The injected oocytes were then washed in G-\nMOPS and were randomly divided to control and AOA\ngroups. The injected oocytes in the control group were cul-\ntured in G1. The remaining oocytes were arti\ufb01cially activated\nby exposure to 10 mM Ionomycin for 10 minutes (5). Follow-\ning oocyte activation, the oocytes were thoroughly washed in\nG1 and cultured in the same medium. Around 16 to 18 hours\nafter ICSI fertilization was assessed by the presence of pronu-\nclei. Oocytes with single, three, or higher pronuclei were very\nfew and excluded from the data. Percentage offertilization was\ncalculated by multiplying the ratio of fertilized oocytes to the\ntotal number of survived injected metaphase II (MII) oocytes\nmultiplied by 100 in two groups. To reduce the oocyte factor,\nany patients with fewer than four matured MII oocytes that\nhad survived the ICSI procedure were excluded from the\npresent study. Furthermore, immature, deformed, and post-\nmature oocytes, or any oocyte with certain types of abnormal-\nity, were also excluded from this study.\nNumeric numbers were used to label dishes in each group.\nAssessment of fertilization and embryo scoring were per-\nformed by experience embryologists who were unaware of\nthe labeling system.\nCleavage Rate and Embryo Quality\nForty-eight and 72 hours after ICSI, embryos were assessed\nfor their cleavage and quality. Embryos with even-sized blas-\ntomeres, and <10% fragmentations were given a score of A.\nEmbryos with even-sized blastomeres and between 10% and\n50% fragmentations were given a score of B. Embryos with\nuneven-sized blastomeres and /or with >50% fragmentations\nwere given a score of C (5). Grade A and B embryos were\nconsidered high-quality embryos, and their percentage was\ncalculated.", "mimetype": "text/plain", "start_char_idx": 8752, "end_char_idx": 10696, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "433d41ab-90d1-445e-9645-52fc2e75e240": {"__data__": {"id_": "433d41ab-90d1-445e-9645-52fc2e75e240", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d9911a0-9a4e-4ad6-ba79-cb4c11abcb65", "node_type": "1", "metadata": {}, "hash": "efc4b05bcf95d09317b34c7f70762a7ae252824819817930185061c60b7ce709", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "12ebc7e7-beea-4c7f-8b26-de66e9bfbda9", "node_type": "1", "metadata": {}, "hash": "8458ddc385c08c0e01aaef59c602a48f027ff81acbb95a912cc42709ed633cc5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Grade A and B embryos were\nconsidered high-quality embryos, and their percentage was\ncalculated. The percentage of cleavage for 48 hours post-\nICSI was calculated as follows: sum of cleaved embryos/total\nnumber of zygotes \u0002 100. The percentage of cleavage for 72\nhours after ICSI was calculated as the number of embryos\nwith greater than six cells over the total number of embryo\npresent 48 hours after ICSI.\n2232\nNasr-Esfahani et al.\nOocyte activation and teratozoospermia\nVol. 90, No. 6, December 2008\nEmbryo Transfer, Pregnancy Rate, and Patient Follow-up\nDuring the present study a maximum of four embryos were\ntransferred to each patient on day 3. The number of embryos\ntransferred to each patient was according to age, number of\nprevious failed cycles, and quality of embryos present at\nthe time of embryo transfer. Embryos selection for transfer\nwas based on embryo quality, irrespective of whether em-\nbryo(s) were from the control or AOA group. Following pos-\nitive b-hCG, clinical pregnancy was determined based on\nultrasound and observation of a fetal heart beat. Children\u2019s\nhealth was followed up by questionnaire through calling\nthe patients.\nStatistical Analysis\nA Student\u2019s t test was performed to compare mean difference\nfor each parameter between AOA and control groups, using\nthe Statistical Package for the Social Studies (SPSS 11.5;\nSPS Inc., Chicago, IL) software.\nRESULTS\nTable 1 provides descriptive information regarding semen\nparameters and oocyte distribution in the control and oocyte\nactivated groups. Table 2 shows the mean number of oo-\ncytes, fertilization rate, percentage of cleavage, and high-\nquality embryos 48 and 72 hours after ICSI. The statistical\nanalysis of the data reveals that there is no signi\ufb01cant differ-\nence in mean number of oocytes in the control and AOA\ngroups, while fertilization rate and cleavage rate at 72 hours\npost-ICSI were signi\ufb01cantly different between the two\ngroups. Furthermore, there was no signi\ufb01cant difference,\nin cleavage rate 48 hours after ICSI and the percentage of\nhigh-quality embryo 48 and 72 hours after ICSI between\nthe two groups.", "mimetype": "text/plain", "start_char_idx": 10600, "end_char_idx": 12710, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "12ebc7e7-beea-4c7f-8b26-de66e9bfbda9": {"__data__": {"id_": "12ebc7e7-beea-4c7f-8b26-de66e9bfbda9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "433d41ab-90d1-445e-9645-52fc2e75e240", "node_type": "1", "metadata": {}, "hash": "9c3b20c61b7a7358abf112bad3567dd0b8139a27788012da1374c10fee18d503", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b1bb3dd0-959f-4eed-963f-14d10908ac4d", "node_type": "1", "metadata": {}, "hash": "c912b98022a4e998844909b7393d53bc4580828d81a5be6f3bd2d92d4ddf575d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Furthermore, there was no signi\ufb01cant difference,\nin cleavage rate 48 hours after ICSI and the percentage of\nhigh-quality embryo 48 and 72 hours after ICSI between\nthe two groups.\nTo evaluate the bene\ufb01cial effect of AOA in different pa-\ntients, patients were further divided according to fertilization\nrate in the control group. The results of Figure 1 show that in\n10 patients no fertilization was achieved in the control group,\nwhereas the AOA group resulted in a mean fertilization rate\nof 57.78%. In the patients who had poor fertilization rate\n(1%\u201333%) in the control group (14.30%), there was a signif-\nicant increase in mean fertilization rate (58.31%) because of\narti\ufb01cial activation, whereas in the patients who had a moder-\nate fertilization rate (34%\u201365%) in the control group (47%),\nthere was a signi\ufb01cant increase in mean fertilization rate\n(63.4%) because of chemical activation. But unlike the latter\ngroups, there was insigni\ufb01cant reduction in the mean fertil-\nization rate between the patients with good fertilization rate\n(66%\u2013100%) in the control group (85.83%) compared with\nthe AOA group (77.9%).\nBecause of sociogeographic status of some couples, data\non chemical and clinical pregnancy could only be obtained\nfor 54 out of 87 patients. Twenty-\ufb01ve of 54 were pregnant\nin this study, resulting in overall pregnancy rate of 37.04%.\nIn the patient who had no fertilization in the control group\nand all the embryos were transferred from the chemically ac-\ntivated group, two pregnancies were reported, whereas 4, 11,\nand 8 pregnancies were reported out of 9, 19, and 20 couples,\nresulting in 44%, 58%, and 40% pregnancy rate in poor, mod-\nerate, and good fertilization groups, respectively. Two multi-\nple pregnancies were reported from the latter group.\nRegarding the health of children born through this procedure,\nTABLE 1\nDescriptive information on semen parameters and oocyte distribution in the control and AOA groups.", "mimetype": "text/plain", "start_char_idx": 12532, "end_char_idx": 14472, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b1bb3dd0-959f-4eed-963f-14d10908ac4d": {"__data__": {"id_": "b1bb3dd0-959f-4eed-963f-14d10908ac4d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "12ebc7e7-beea-4c7f-8b26-de66e9bfbda9", "node_type": "1", "metadata": {}, "hash": "8458ddc385c08c0e01aaef59c602a48f027ff81acbb95a912cc42709ed633cc5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "34e9fc3f-7bf3-4ea5-9b92-88fd30fa2118", "node_type": "1", "metadata": {}, "hash": "2656f8462d186011d0ab34647c7db20d136d3226b7c14d9f99778d783720288e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Two multi-\nple pregnancies were reported from the latter group.\nRegarding the health of children born through this procedure,\nTABLE 1\nDescriptive information on semen parameters and oocyte distribution in the control and AOA groups.\nMean \u00b1 SD\nMaximum\nMinimum\nParameters\n15.09 \u0003 18.37\n80.00\n0.1\nConcentration (\u0002106/mL)\n56.43 \u0003 87.53\n400.00\n0.1\nTotal density\n19.56 \u0003 16.70\n80.00\n0.00\n% Sperm motility\n96.02 \u0003 3.28\n100.00\n90.00\n% Abnormal sperm morphologya\n30.04 \u0003 4.39\n45.00\n19.00\nMale age\n26.10 \u0003 4.27\n40.00\n18.00\nFemale age\n15.94 \u0003 7.01\n35.00\n4.00\nTotal oocyte MII No.\n7.61 \u0003 2.77\n17.00\n2.00\nOocyte in control group No.\n7.73 \u0003 3.74\n18.00\n2.00\nOocyte in AOA group No.\n1.22 \u0003 2.36\n14.00\n0.00\nGV oocyte No.\n0.75 \u0003 1.37\n7.00\n0.00\nNo. degenerate oocyte\n0.24 \u0003 1.00\n6.00\n0.00\nNo. degenerate oocyte 18 hours after ICSI\nin control group\n0.34 \u0003 0.64\n3.00\n0.00\nNo. degenerate oocyte 18 hours after ICSI\nin AOA group\nNote: ICSI \u00bc intracytoplasmic sperm injection; AOA \u00bc arti\ufb01cial oocyte activation.\na Assessed during semen preparation.\nNasr-Esfahani. Oocyte activation and teratozoospermia. Fertil Steril 2008.\nFertility and Sterility\u0004\n2233\nin the couples who could be contacted, no particular congen-\nital anomalies were reported.\nDuring this study patients were also divided according to\nmotility status of their semen samples.", "mimetype": "text/plain", "start_char_idx": 14240, "end_char_idx": 15558, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34e9fc3f-7bf3-4ea5-9b92-88fd30fa2118": {"__data__": {"id_": "34e9fc3f-7bf3-4ea5-9b92-88fd30fa2118", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b1bb3dd0-959f-4eed-963f-14d10908ac4d", "node_type": "1", "metadata": {}, "hash": "c912b98022a4e998844909b7393d53bc4580828d81a5be6f3bd2d92d4ddf575d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb128918-799a-4925-b6c1-9abd76867000", "node_type": "1", "metadata": {}, "hash": "a0c156eb6fe886db37f1b6c241a414079ecb7e94e36d5300c524abcf712934f7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertility and Sterility\u0004\n2233\nin the couples who could be contacted, no particular congen-\nital anomalies were reported.\nDuring this study patients were also divided according to\nmotility status of their semen samples. Fertilization rate\nwas compared between samples with immotile sperm and\nsamples with motile sperm in the control and chemically ac-\ntivated groups. Figure 2 reveals that the sample with the im-\nmotile sperm have lower, but insigni\ufb01cant (P\u00bc.088),\nfertilization rate in the control group compared with the sam-\nples with motile sperm, whereas in the AOA group this differ-\nence was not signi\ufb01cant.\nDISCUSSION\nLow fertilization rate in some of the ICSI cases has been at-\ntributed to total or partial de\ufb01ciency in the sperm capacity to\nactivate oocytes or to the inability of the oocytes to decon-\ndense the sperm (3, 4). Capacity of sperm to induce oocyte\nactivation has been related to sperm-associated oocyte acti-\nvating factor, which is present in the perinuclear theca, in\nclose association with acrosome (7, 26, 32, 33). Sperm with\nabnormal acrosome or morphology has been shown to have\nlower fertilization potential in comparison to sperm with nor-\nmal morphology (17, 34, 35). Previous studies suggest that\nsperm with abnormal morphology or small acrosome have\nlower capacity to induce oocyte activation (32, 33, 36).\nTo overcome failed oocyte activation different protocols\nhave been used for arti\ufb01cial activation or for production of\nparthenogenic embryos. These protocols include electrical\nand chemical arti\ufb01cial oocyte activation (8, 25, 26, 37, 38).\nClinical applications of these methods to human oocytes\nare very limited. They are mainly presented as case report\nstudies regarding human oocyte activation in an assisted re-\nproductive technique setting (26, 28, 34). Therefore, during\nthis study the effect of Ionomycin on human oocyte activation\nwas evaluated in ICSI cases with severe teratozoospermia.", "mimetype": "text/plain", "start_char_idx": 15340, "end_char_idx": 17277, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cb128918-799a-4925-b6c1-9abd76867000": {"__data__": {"id_": "cb128918-799a-4925-b6c1-9abd76867000", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "34e9fc3f-7bf3-4ea5-9b92-88fd30fa2118", "node_type": "1", "metadata": {}, "hash": "2656f8462d186011d0ab34647c7db20d136d3226b7c14d9f99778d783720288e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3d8d8555-dc03-4fb6-87f0-1c3b390f4b04", "node_type": "1", "metadata": {}, "hash": "b81db9932728422759af20d0ab4933ad7f0d4d1687147a06f37eabbcfe8c3693", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Therefore, during\nthis study the effect of Ionomycin on human oocyte activation\nwas evaluated in ICSI cases with severe teratozoospermia.\nFIGURE 1\nShows percentage of fertilization in control group,\nsubdivided according to fertilization rate and their\ncorresponding AOA group and their related\npregnancy rate.\n0\n10\n20\n30\n40\n50\n60\n70\n80\n90\n100\nZero\nLow\nModrate\nHigh\nFertilization Rate\nControl Group\nAOA Group\nPregnancy\nNasr-Esfahani. Oocyte activation and teratozoospermia. Fertil Steril 2008.\nFIGURE 2\nComparison of fertilization rate in the control and\nchemically activated groups containing immotile and\nmotile sperm.\n0\n10\n20\n30\n40\n50\n60\n70\n80\n90\n100\nImmotile sperm\nMotile sperm\nFertilization Rate\nAOA Group\nControl Group\nNasr-Esfahani. Oocyte activation and teratozoospermia. Fertil Steril 2008.\nTABLE 2\nComparison of mean number of oocytes, fertilization rate, cleavage, and embryo quality score 24 and\n48 hours after ICSI between AOA and control groups in 87 patients.\nP-value\nAOA group Mean \u00b1 SD\nControl group Mean \u00b1 SD\nVariables\n.251\n7.24 \u0003 3.04\n7.73 \u0003 3.74\nNo.", "mimetype": "text/plain", "start_char_idx": 17140, "end_char_idx": 18208, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3d8d8555-dc03-4fb6-87f0-1c3b390f4b04": {"__data__": {"id_": "3d8d8555-dc03-4fb6-87f0-1c3b390f4b04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cb128918-799a-4925-b6c1-9abd76867000", "node_type": "1", "metadata": {}, "hash": "a0c156eb6fe886db37f1b6c241a414079ecb7e94e36d5300c524abcf712934f7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad881b08-387d-44c1-b119-b264d87effc9", "node_type": "1", "metadata": {}, "hash": "fa8ef110f56d2f9ae9f40fcfff77daa5b82f0a22b640d30a1cc1cab073d905b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "P-value\nAOA group Mean \u00b1 SD\nControl group Mean \u00b1 SD\nVariables\n.251\n7.24 \u0003 3.04\n7.73 \u0003 3.74\nNo. oocytes\n.001\n66.79 \u0003 23.57\n52.73 \u0003 31.71\nFertilization rate\n.15\n95.73 \u0003 36.16\n88.45 \u0003 30.87\nCleavage rate (48 hours after ICSI)\n.001\n74.77 \u0003 36.22\n49.95 \u0003 38.58\nCleavage rate (72 hours after ICSI)\n.309\n75.12 \u0003 39.89\n69.49 \u0003 39.94\n% High-quality embryo (48 hours\nafter ICSI)\n.85\n67.99 \u0003 36.24\n67.16 \u0003 38.43\n% High-quality embryo (72 hours\nafter ICSI)\nNote: ICSI \u00bc intracytoplasmic sperm injection; AOA \u00bc arti\ufb01cial oocyte activation.\nNasr-Esfahani. Oocyte activation and teratozoospermia. Fertil Steril 2008.\n2234\nNasr-Esfahani et al.\nOocyte activation and teratozoospermia\nVol. 90, No. 6, December 2008\nThe results of this study reveal that fertilization rate has sig-\nni\ufb01cantly increased in the AOA group compared with the\ncontrol group. Even though the fertilization rate has signi\ufb01-\ncantly increased from 52.73 \u0003 31.71 to 66.79 \u0003 23.57, this\nmay reveal that this difference may not be valuable at the\nclinical level. However, when patients were grouped accord-\ning to the fertilization rate in the control group to zero, low,\nmoderate, and high fertilization rates, the results show that\nin 10 patients in whom there was no fertilization, AOA re-\nsulted in 57.78% fertilization rate and two pregnancies. Fur-\nthermore, this treatment prevented cancellation of the ICSI\ncycle in these 10 patients.", "mimetype": "text/plain", "start_char_idx": 18114, "end_char_idx": 19507, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad881b08-387d-44c1-b119-b264d87effc9": {"__data__": {"id_": "ad881b08-387d-44c1-b119-b264d87effc9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3d8d8555-dc03-4fb6-87f0-1c3b390f4b04", "node_type": "1", "metadata": {}, "hash": "b81db9932728422759af20d0ab4933ad7f0d4d1687147a06f37eabbcfe8c3693", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c75e8929-eaba-4d5f-b7b0-854f726311cc", "node_type": "1", "metadata": {}, "hash": "1347a85f73b0781605c8e019a0e989a970ad6b8cac57dcf8d5ad13b52f1ca75e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fur-\nthermore, this treatment prevented cancellation of the ICSI\ncycle in these 10 patients. Although the overall pregnancy\nrate in this study was 37.04%, to evaluate the effect of\nAOA on ICSI pregnancy outcome further study with a higher\nnumber of patients is required. In addition, arti\ufb01cial oocyte\nactivation increases the number of embryos or embryos\nwith a higher cell number available for transfer (Table 2).\nThe fertilization rate obtained with AOA was higher than\nthe activation rate reported in other studies using calcium ion-\nophore A23187 (41%\u201342%) on fresh oocytes (39, 40). Te-\nsarik and Sousa (23) also showed that 88% of the oocytes\nthat did not fertilize spontaneously 24 hours after ICSI devel-\noped 2PN after treatment with calcium ionophore, and 82%\nof treated oocytes reached the two-cell stage. The result of\nour previous study on the failed fertilized oocytes using Ion-\nomycin is consistent with the aforementioned report (5).\nFurthermore, with AOA, fertilization rate substantially and\nmoderately, but signi\ufb01cantly, increased in the low and mod-\nerate fertilization groups, respectively (Fig. 1). However,\nthe fertilization rate in the high fertilization group was not\nsigni\ufb01cantly different compared with the AOA group. Even\nthough all the patients in this study were selected according\nto severity of abnormal morphology, the results of Figure 1\nreveals that not all the patients may bene\ufb01t from this arti\ufb01cial\nactivation protocol. Therefore, diagnostic tests, like the\nmouse oocyte activation test, may be useful to evaluate acti-\nvation potentials of a semen sample before assisted arti\ufb01cial\noocyte activation in clinical settings (41, 42). However, usage\nof the mouse oocyte activation test may be inconvenient in\nclinical settings, so other tests such as acrosome-related tests,\nlike the gelationlysis test, may become useful or informative\nto assess integrity of acrosome, which may be related to\nsperm oocyte activation capacity (43, 44).", "mimetype": "text/plain", "start_char_idx": 19415, "end_char_idx": 21386, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c75e8929-eaba-4d5f-b7b0-854f726311cc": {"__data__": {"id_": "c75e8929-eaba-4d5f-b7b0-854f726311cc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad881b08-387d-44c1-b119-b264d87effc9", "node_type": "1", "metadata": {}, "hash": "fa8ef110f56d2f9ae9f40fcfff77daa5b82f0a22b640d30a1cc1cab073d905b5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e79e415-4e4a-43ac-b442-01f445634ee5", "node_type": "1", "metadata": {}, "hash": "9deb5ae1e7bbd73b842a81546e9af489c6ec0e51b01f2471e1c8e3ae0499d8e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The results of Table 2 reveal that not only the fertilization\nrate has been improved by arti\ufb01cial oocyte activation, but in\naddition, cleavage rate 72 hours post-ICSI. Therefore, it can\nbe concluded that in cases with severe teratozoospermia ar-\nti\ufb01cial oocyte activation may improve fertilization and cleav-\nage rate 72 hours after ICSI. These results are consistent with\nthe results obtained using different arti\ufb01cial activation proto-\ncol for bovine oocytes, which suggests that different activa-\ntion protocols affect the developmental competence or\nblastocyst rate (45). Furthermore, addition of protein kinase\ninhibitor, like 6-DAMP, to activation protocol in bovine\noocytes, signi\ufb01cantly improves the blastocyst rate (45, 46).\nThus, proper activation of oocytes may help the developmen-\ntal competence of the oocytes and explain the increased\ncleavage and embryo quality rate observed in the AOA\ngroup.\nThe results of this study also reveal that in the control\ngroup, as expected, the fertilization rate is slightly, but insig-\nni\ufb01cantly (P\u00bc.088) higher in the semen sample when motile\nsperm are available for ICSI, compared with cases where mo-\ntile sperm are not available for ICSI. However, in the arti\ufb01-\ncially activated oocyte subgroup with immotile sperm the\nfertilization rate improves and is not signi\ufb01cantly different\nfrom the arti\ufb01cial oocyte activated subgroup with motile\nsperm, thus concluding that arti\ufb01cial activation has a greater\neffect on fertilization rate in the semen samples with immo-\ntile sperm compared with those with the motile sperm. Naka-\ngawa et al. (25) found that 84.9% of failed fertilized oocytes\nafter ICSI-exposed calcium ionophore A23187 and puromy-\ncin were activated, and about 64% were cleaved. They further\nreported that oocyte activation improves fertilization rate of\nsemen samples with the immotile sperm, which is inconsis-\ntent with our results.\nIn the present study, sperm abnormality was not catego-\nrized; however, a recent study by Moaz et al.", "mimetype": "text/plain", "start_char_idx": 21387, "end_char_idx": 23387, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e79e415-4e4a-43ac-b442-01f445634ee5": {"__data__": {"id_": "0e79e415-4e4a-43ac-b442-01f445634ee5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c75e8929-eaba-4d5f-b7b0-854f726311cc", "node_type": "1", "metadata": {}, "hash": "1347a85f73b0781605c8e019a0e989a970ad6b8cac57dcf8d5ad13b52f1ca75e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "675b6243-3f2f-4fe7-ac8f-8a9f6d99c4d3", "node_type": "1", "metadata": {}, "hash": "3c4fdccf4f1664b5eab7d13c7bb22955cb142e10693cea83481c338d5c2c8978", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the present study, sperm abnormality was not catego-\nrized; however, a recent study by Moaz et al. (47) subgrouped\nthe sperm abnormality to the amorphous head, tapered head,\nand bent neck, and used a similar chemical activation proto-\ncol to this study; their results suggest that fertilization rate\npostchemical activation increased in the sperm with amor-\nphous and tapered head and not in the subgroup with the\nbent neck.\nPrevious studies suggest that sperm morphology and nor-\nmalcy of nucleus may effect fertilization and it subsequent\ndevelopment (35, 48). Failed fertilization in these cases\nmay be related to failed oocyte activation. In addition, failed\nfertilization has also been reported in normospermic cases\n(29). The results of the present study and other studies sug-\ngest that failed fertilization can be overcome by arti\ufb01cial oo-\ncyte activation, even in failed fertilized oocytes after ICSI,\ntermed \u2018\u2018rescued ICSI.\u2019\u2019 In rescued ICSI, the time of oocyte\nactivation may be considered as an important factor on fertil-\nization rate and subsequent development (38).\nThe results of the present study and other studies also sug-\ngest that arti\ufb01cial oocyte activation results in a high cleavage\nrate, and does not imposed inhibitory effect on subsequent\nembryo development (26, 28, 37, 38). In addition, this is\nthe \ufb01rst study using Ionomycin on a large number of patients\nfor AOA. The only concern regarding the AOA is the possible\nadverse affect on the health of babies born through this pro-\ncedure. The results of the present study and other studies so\nfar reveal that oocyte activation does not adversely affect\nthe health of babies born through this procedure (28, 37,\n38, 49). In addition, chromosomal analysis using FISH\nhave shown that embryos derived through arti\ufb01cial oocyte ac-\ntivation have a normal chromosomal number (38).\nHowever, we propose that further studies to evaluate the\nteratogenic and mutagenic effects should be studied in the an-\nimal model. Further, more group studies evaluating the health\nFertility and Sterility\u0004\n2235\nof these babies might provide additional information to the\nfuture of arti\ufb01cial oocyte activation technology.", "mimetype": "text/plain", "start_char_idx": 23286, "end_char_idx": 25460, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "675b6243-3f2f-4fe7-ac8f-8a9f6d99c4d3": {"__data__": {"id_": "675b6243-3f2f-4fe7-ac8f-8a9f6d99c4d3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e79e415-4e4a-43ac-b442-01f445634ee5", "node_type": "1", "metadata": {}, "hash": "9deb5ae1e7bbd73b842a81546e9af489c6ec0e51b01f2471e1c8e3ae0499d8e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3efffaa-0611-481b-a447-da839eb98abc", "node_type": "1", "metadata": {}, "hash": "3ee30d1ff0dc46e223b0c9dfea38716b43c5ec66cf39bf0fde1d476396446557", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Further, more group studies evaluating the health\nFertility and Sterility\u0004\n2235\nof these babies might provide additional information to the\nfuture of arti\ufb01cial oocyte activation technology.\nAcknowledgments: The authors express their gratitude to the staff of the Is-\nfahan Fertility and Infertility Center and Isfahan School of Medical Sciences\nfor their kind collaboration.\nREFERENCES\n1. Flaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal\nfertilization after intracytoplasmic sperm injection. Hum Reprod\n1998;11:155\u201364.\n2. Lopes S, Jurisicova A, Casper RF. Gamete-speci\ufb01c DNA fragmentation\nin unfertilized human oocytes after intracytoplasmic sperm injection.\nHum Reprod 1998;13:703\u20138.\n3. Sakkas D, Urner F, Bianchi PG, Bizzaro D, Wagner I, Jaquenoud N, et al.\nSperm chromatin anomalies can in\ufb02uence decondensation after intracy-\ntoplasmic sperm injection. Hum Reprod 1996;11:837\u201343.\n4. Schmiady H, Tandler-Schneider A, Kentenich H. Premature chromo-\nsome condensation of the sperm nucleus after intracytoplasmic sperm in-\njection. Hum Reprod 1996;11:2239\u201345.\n5. Nasr-Esfahani MH, Razavi S, Mardani M, Shirazi R, Javanmardi S. The\neffects of failed oocyte activation and sperm protamine de\ufb01ciency on fer-\ntilization post ICSI. Reprod Biomed Online 2007;14:422\u20139.\n6. Sousa M, Tesarik J. Ultrastructural analysis of fertilization failure after\nintracytoplasmic sperm injection. Hum Reprod 1994;9:2374\u201380.\n7. Dozortsev D, De Sutter P, Dhont M. Behaviour of spermatozoa in human\noocytes displaying no or one pronucleus after intracytoplasmic sperm in-\njection. Hum Reprod 1994;9:2139\u201344.\n8.", "mimetype": "text/plain", "start_char_idx": 25271, "end_char_idx": 26878, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3efffaa-0611-481b-a447-da839eb98abc": {"__data__": {"id_": "b3efffaa-0611-481b-a447-da839eb98abc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "675b6243-3f2f-4fe7-ac8f-8a9f6d99c4d3", "node_type": "1", "metadata": {}, "hash": "3c4fdccf4f1664b5eab7d13c7bb22955cb142e10693cea83481c338d5c2c8978", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9660842f-f2c2-4ef8-945b-9c0b16ab640a", "node_type": "1", "metadata": {}, "hash": "ecacdbea8b266af230a7f59954231ddeb121d335902c43288d052a1aaa9497be", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod 1994;9:2139\u201344.\n8. Tesarik J, Sousa M, Testart J. Human oocyte activation after intracyto-\nplasmic sperm injection. Hum Reprod 1994;9:511\u20138.\n9. Swann K, Lai FA. A novel signalling mechanism for generating Ca2\u00fe\noscillations at fertilization in mammals. Bioessays 1997;19:371\u20138.\n10. Schultz RM, Kopf GS. Molecular basis of mammalian egg activation.\nCurr Top Dev Biol 1995;30:21\u201362.\n11. Tesarik J, Mendoza C, Greco E. The activity (calcium oscillator?)\nresponsible for human oocyte activation after injection with round\nspermatids is associated with spermatid nuclei. Fertil Steril 2000;74:\n1245\u20137.\n12. Tesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modi\ufb01ed in-\ntracytoplasmic sperm injection technique to overcome sperm-borne and\noocyte-borne oocyte activation failures. Fertil Steril 2002;78:619\u201324.\n13. Nasr-Esfahani MH, Razavi S, Mozdarani H, Mardani M, Azvagi H. Re-\nlationship between protamine de\ufb01ciency with fertilization rate and inci-\ndence of sperm premature chromosomal condensation post-ICSI.\nAndrologia 2004;36:95\u2013100.\n14. Nasr-Esfahani MH, Naghshizadian N, Imani H, Razavi S, Mardani M,\nKazemi S, et al. Can sperm protamine de\ufb01ciency induce sperm prema-\nture chromosomal condensation? Andrologia 2006;38:92\u20138.\n15. Rawe VY, Olmedo SB, Nodar FN, Doncel GD, Acosta AA, Vitullo AD.\nCytoskeletal organization defects and abortive activation in human oo-\ncytes after IVF and ICSI failure. Mol Hum Reprod 2000;6:510\u20136.\n16.", "mimetype": "text/plain", "start_char_idx": 26849, "end_char_idx": 28300, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9660842f-f2c2-4ef8-945b-9c0b16ab640a": {"__data__": {"id_": "9660842f-f2c2-4ef8-945b-9c0b16ab640a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3efffaa-0611-481b-a447-da839eb98abc", "node_type": "1", "metadata": {}, "hash": "3ee30d1ff0dc46e223b0c9dfea38716b43c5ec66cf39bf0fde1d476396446557", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c49a36f1-40e8-4e3d-9b1e-7627eb67aff6", "node_type": "1", "metadata": {}, "hash": "ce5f9db5960bdad2c19cb025f943d93f049283f57d0c6901f7fe941100a8c9a9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cytoskeletal organization defects and abortive activation in human oo-\ncytes after IVF and ICSI failure. Mol Hum Reprod 2000;6:510\u20136.\n16. Collas P, Fissore R, Robl JM, Sullivan EJ, Barnes FL. Electrically in-\nduced calcium elevation, activation, and parthenogenetic development\nof bovine oocytes. Mol Reprod Dev 1993;34:212\u201323.\n17. Cummins JM, Pember SM, Jequier AM, Yovich JL, Hartmann PE. A test\nof the human sperm acrosome reaction following ionophore challenge:\nrelationship to fertility and other seminal parameters. J Androl\n1991;12:98\u2013103.\n18. Fenichel P, Donzeau M, Farahifar D, Basteris B, Ayraud N, Hsi BL. Dy-\nnamics of human sperm acrosome reaction: relation with in vitro fertil-\nization. Fertil Steril 1991;55:994\u20139.\n19. Mahutte NG, Arici A. Failed fertilization: is it predictable? Curr Opin\nObstet Gynecol 2003;15:211\u20138.\n20. Florke-Gerloff S, Topfer-Petersen E, Muller-Esterl W, Mansouri A,\nSchatz R, Schirren C, et al. Biochemical and genetic investigation of\nround-headed spermatozoa in infertile men including two brothers and\ntheir father. Andrologia 1984;16:187\u2013202.\n21. Escalier D. Failure of differentiation of the nuclear-perinuclear skeletal\ncomplex in the round-headed human spermatozoa. Int J Dev Biol\n1990;34:287\u201397.\n22. Courtot AM. Presence and localization of the 60 kD calicin in human\nspermatozoa presenting postacrosomal sheath defects: preliminary re-\nsults. Mol Reprod Dev 1991;28:272\u20139.\n23.", "mimetype": "text/plain", "start_char_idx": 28163, "end_char_idx": 29589, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c49a36f1-40e8-4e3d-9b1e-7627eb67aff6": {"__data__": {"id_": "c49a36f1-40e8-4e3d-9b1e-7627eb67aff6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9660842f-f2c2-4ef8-945b-9c0b16ab640a", "node_type": "1", "metadata": {}, "hash": "ecacdbea8b266af230a7f59954231ddeb121d335902c43288d052a1aaa9497be", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "579c0bf3-c572-4b86-addc-f1d85cb49d6f", "node_type": "1", "metadata": {}, "hash": "db35b7fc2f0a1ea5259cdcc0bf25ddc297beb8a8e107a79c1e9054a83082dd7b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mol Reprod Dev 1991;28:272\u20139.\n23. Tesarik J, Sousa M. More than 90% fertilization rates after intracytoplas-\nmic sperm injection and arti\ufb01cial induction of oocyte activation with\ncalcium ionophore. Fertil Steril 1995;63:343\u20139.\n24. Yanagida K, Katayose H, Yazawa H. Successful fertilization and preg-\nnancy following ICSI and electrical oocyte activation. Hum Reprod\n1999;14:1307\u201311.\n25. Nakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M,\nAono T. Effect of activation with Ca ionophore A23187 and puromycin\non the development of human oocytes that failed to fertilize after intra-\ncytoplasmic sperm injection. Fertil Steril 2001;76:148\u201352.\n26. Eldar-Geva T, Brooks B, Margalioth EJ, Zylber-Haran E, Gal M,\nSilber SJ. Successful pregnancy and delivery after calcium ionophore oo-\ncyte activation in a normozoospermic patient with previous repeated\nfailed fertilization after intracytoplasmic sperm injection. Fertil Steril\n2003;79:138\u201340.\n27. Ebner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete oo-\ncyte activation failure after ICSI can be overcome by a modi\ufb01ed injection\ntechnique. Hum Reprod 2004;19:1837\u201341.\n28. Murase Y, Araki Y, Mizuno S, Kawaguchi C, Naito M, Yoshizawa M,\net al. Pregnancy following chemical activation of oocytes in a couple\nwith repeated failure of fertilization using ICSI: case report. Hum Reprod\n2004;19:1604\u20137.\n29. Chi HJ, Koo JJ, Song SJ, Lee JY, Chang SS.", "mimetype": "text/plain", "start_char_idx": 29556, "end_char_idx": 30959, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "579c0bf3-c572-4b86-addc-f1d85cb49d6f": {"__data__": {"id_": "579c0bf3-c572-4b86-addc-f1d85cb49d6f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c49a36f1-40e8-4e3d-9b1e-7627eb67aff6", "node_type": "1", "metadata": {}, "hash": "ce5f9db5960bdad2c19cb025f943d93f049283f57d0c6901f7fe941100a8c9a9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "73bd7ce1-4760-4efb-ab70-61cb406ef000", "node_type": "1", "metadata": {}, "hash": "fb5459c9e613a1afcfaf0cbaffda7e4ed98a8ef3dc0ef195c5063d8f21f8b73c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod\n2004;19:1604\u20137.\n29. Chi HJ, Koo JJ, Song SJ, Lee JY, Chang SS. Successful fertilization and\npregnancy after intracytoplasmic sperm injection and oocyte activation\nwith calcium ionophore in a normozoospermic patient with extremely\nlow fertilization rates in intracytoplasmic sperm injection cycles. Fertil\nSteril 2004;82:475\u20137.\n30. World Health Organization. WHO laboratory manual for the examina-\ntion of human semen and semen\u2013cervical mucus interaction. Cambridge:\nCambridge University Press, 1999.\n31. Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van der Merwe JP,\nvan Zyl JA, et al. Sperm morphologic features as a prognostic factor in\nin vitro fertilization. Fertil Steril 1986;46:1118\u201323.\n32. Parrington J, Swann K, Shevchenko VI, Sesay AK, Lai FA. Calcium os-\ncillations in mammalian eggs triggered by a soluble sperm protein. Na-\nture 1996;25:364\u20138.\n33. Kimura Y, Yanagimachi R, Kuretake S, Bortkiewicz H, Perry AC,\nYanagimachiH.Analysisofmouseoocyteactivationsuggeststheinvolve-\nment of sperm perinuclear material. Biol Reprod 1998;58:1407\u201315.\n34. Rybouchkin AV, Sutter PD, Straeten FV, Dhont M, Quatacker J. Fertiliza-\ntion and pregnancy after assisted oocyte activation and intracytoplasmic\nsperm injection in a case of round-headed sperm associated with de\ufb01-\ncient oocyte activation capacity. Fertil Steril 1997;68:1144\u20138.\n35. Bartoov B, Berkovitz A, Eltes F, Kogosowski A, Menezo Y, Barak Y.\nReal-time \ufb01ne morphology of motile human sperm cell is associated\nwith IVF-ICSI outcome. J Androl 2002;23:1\u20138.\n36.", "mimetype": "text/plain", "start_char_idx": 30886, "end_char_idx": 32417, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73bd7ce1-4760-4efb-ab70-61cb406ef000": {"__data__": {"id_": "73bd7ce1-4760-4efb-ab70-61cb406ef000", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "579c0bf3-c572-4b86-addc-f1d85cb49d6f", "node_type": "1", "metadata": {}, "hash": "db35b7fc2f0a1ea5259cdcc0bf25ddc297beb8a8e107a79c1e9054a83082dd7b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10935ce3-303d-411c-b447-ac80e0e2b509", "node_type": "1", "metadata": {}, "hash": "6c17efcdcbde72ad06ae801a5e0725c5551c0844f9feac6e7e65209b93c521d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Androl 2002;23:1\u20138.\n36. Battaglia DE, Koehler JK, Klein NA, Tucker MJ. Failure of oocyte acti-\nvation after intracytoplasmic sperm injection using round-headed sperm.\nFertil Steril 1997;68:118\u201322.\n37. Kim ST, Cha YB, Park JM, Gye MC. Successful pregnancy and delivery\nfrom frozen\u2013thawed embryos after intracytoplasmic sperm injection us-\ning round-headed spermatozoa and assisted oocyte activation in a globo-\nzoospermic patient with mosaic Down syndrome. Fertil Steril 2001;79:\n445\u20137.\n38. Lu Q, Zhao Y, Gao X, Li Y, Ma S, Mullen S, et al. Combination of cal-\ncium ionophore A23187 with puromycin salvages human unfertilized\noocytes after ICSI. Eur J Obstet Gynecol Reprod Biol 2006;126:72\u20136.\n39. Winston N, Johnson M, Pickering S, Braude P. Parthenogenetic activa-\ntion and development of fresh and aged human oocytes. Fertil Steril\n1991;56:904\u201312.\n40. Taylor DM, Ray PF, Ao A, Winston RM, Handyside AH. Paternal tran-\nscripts\nfor\nglucose-6-phosphate\ndehydrogenase\nand\nadenosine\n2236\nNasr-Esfahani et al.\nOocyte activation and teratozoospermia\nVol. 90, No. 6, December 2008\ndeaminase are \ufb01rst detectable in the human preimplantation embryo at\nthe three- to four-cell stage. Mol Reprod Dev 1997;48:442\u20138.\n41. Araki Y, Yoshizawa M, Abe H, Murase Y, Araki Y. Use of mouse oocytes\nto evaluate the ability of human sperm to activate oocytes after failure of\nactivation by intracytoplasmic sperm injection. Zygote 2004;12:\n111\u20136.\n42.", "mimetype": "text/plain", "start_char_idx": 32392, "end_char_idx": 33822, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "10935ce3-303d-411c-b447-ac80e0e2b509": {"__data__": {"id_": "10935ce3-303d-411c-b447-ac80e0e2b509", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "73bd7ce1-4760-4efb-ab70-61cb406ef000", "node_type": "1", "metadata": {}, "hash": "fb5459c9e613a1afcfaf0cbaffda7e4ed98a8ef3dc0ef195c5063d8f21f8b73c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2240faf3-9f26-4f02-a03f-c87a29cf3586", "node_type": "1", "metadata": {}, "hash": "9417451965d7c00152ae7b59fa3662bbe87f0f31e4df31939626f5959a02be53", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Zygote 2004;12:\n111\u20136.\n42. Heindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option for\nsperm- or oocyte-related fertilization failure: assisted oocyte activation\nfollowing diagnostic heterologous ICSI. Hum Reprod 2005;20:2237\u201341.\n43. Henkel R, Muller C, Miska W, Schill WB, Kleinstein J, Gips H. Acrosin\nactivity of human spermatozoa by means of a simple gelatinolytic tech-\nnique: a method useful for IVF. J Androl 1995;16:272\u20137.\n44. Nasr-Esfahani MH, Razavi S, Tavalaee M. Failed fertilization post ICSI\nand spermiogenic defects. Fertil Steril. In press.\n45. Oikawa T, Takada N, Kikuchi T, Numabe T, Takenaka M, Horiuchi T.\nEvaluation of activation treatments for blastocyst production and birth\nof viable calves following bovine intracytoplasmic sperm injection.\nAnim Reprod Sci 2005;86:87\u201394.\n46. Chian RC, Tan SL, Sirard MA. Protein phosphorylation is essential for\nformation of male pronucleus in bovine oocytes. Mol Reprod Dev\n1999;52:43\u20139.\n47. Moaz MN, Khattab S, Foutouh IA, Mohsen EA. Chemical activation of\noocytes in different types of sperm abnormalities in cases of low or failed\nfertilization after ICSI: a prospective pilot study. Reprod Biomed Online\n2006;13:791\u20134.\n48. Berkovitz A, Eltes F, Yaari S, Katz N, Barr I, Fishman A, et al. The mor-\nphological normalcy of the sperm nucleus and pregnancy rate of intracy-\ntoplasmic injection with morphologically selected sperm. Hum Reprod\n2005;20:185\u201390.\n49. Yuzpe AA, Liu Z, Fluker MR.", "mimetype": "text/plain", "start_char_idx": 33796, "end_char_idx": 35257, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2240faf3-9f26-4f02-a03f-c87a29cf3586": {"__data__": {"id_": "2240faf3-9f26-4f02-a03f-c87a29cf3586", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nasr\u2010Esfahani (2008).pdf", "node_type": "4", "metadata": {}, "hash": "19359ed1e1346e6c1a1b8c02b20bdbb8aa520aec3ae99babb74c79a89521e543", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10935ce3-303d-411c-b447-ac80e0e2b509", "node_type": "1", "metadata": {}, "hash": "6c17efcdcbde72ad06ae801a5e0725c5551c0844f9feac6e7e65209b93c521d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod\n2005;20:185\u201390.\n49. Yuzpe AA, Liu Z, Fluker MR. Rescue intracytoplasmic sperm injection\n(ICSI)-salvaging in vitro fertilization (IVF) cycles after total or near-total\nfertilization failure. Fertil Steril 2000;73:1115\u20139.\nFertility and Sterility\u0004\n2237", "mimetype": "text/plain", "start_char_idx": 35199, "end_char_idx": 35459, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b45649c-df98-48a6-b7ac-1269fa75e562": {"__data__": {"id_": "9b45649c-df98-48a6-b7ac-1269fa75e562", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b1bd25c9-b5a4-4e75-9b96-2cec78d4fc23", "node_type": "1", "metadata": {}, "hash": "35fc42b7f48ac0e3d5e3f279228eb4202b29fe084b7256b10000454885179981", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Original Article \nJ Reprod Infertil. 2019;20(1):3-9 \nEffect of Artificial Oocyte Activation on Intra-Cytoplasmic Sperm Injection  \nOutcomes in Patients with Lower Percentage of Sperm Containing  \nPhospholipase C\u03b6: A Randomized Clinical Trial  \n \nHamid Nazarian 1, Nahid Azad 1, 2, Leila Nazari 3, Abbas Piryaei 1,4, Mohammad Hassan Heidari 1, Reza Masteri-\nFarahani 1, Maryam Karimi 5, Marefat Ghaffari-Novin 5\uf02a \n \n1- Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, \nIran \n2- Department of Reproductive Biology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran \n3- Department of Obstetrics and Gynecology, Preventative Gynecology Research Center, Shahid Beheshti University of Medical \nSciences, Tehran, Iran  \n4- Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran \n5- Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran \n \n \n \nAbstract \nBackground: Artificial oocyte activation (AOA) is a specialized method in assisted \nreproductive technique (ART). According to increasing concern about using AOA, it \nis necessary to evaluate sperm-borne oocyte activating factors (SOAFs) including \nphospholipase C zeta (PLC\u03b6). In this study, PLC\u03b6 before AOA was evaluated first \nand then the impact of AOA on pre-implantation embryo development was investi-\ngated.  \nMethods: This prospective clinical trial enrolled couples subjected to ICSI. By eval-\nuating PLC\u03b6, semen samples were categorized into two groups; I (Control) and II \n(PLC\u03b6 deficient). Retrieved oocytes from partners were put into three categories: \ncontrol group (Injected with sperm from group I, n=113), group without AOA (In-\njected with sperm from group II and no exposure to AOA, n=106), and group AOA \n(Injected with sperm from group II and exposure to AOA, n=114).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1936, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b1bd25c9-b5a4-4e75-9b96-2cec78d4fc23": {"__data__": {"id_": "b1bd25c9-b5a4-4e75-9b96-2cec78d4fc23", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b45649c-df98-48a6-b7ac-1269fa75e562", "node_type": "1", "metadata": {}, "hash": "ebd1e900e9e292eceaede56148d8f1acfd1033e9e9fe164f2b56d88963cb252a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4de88f85-cec6-478a-9b51-360978159647", "node_type": "1", "metadata": {}, "hash": "b25cf7685c1f514a75f6ca2a8483810b06a6243ea3a48a2421b90ca7065a51ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Finally, fertiliza-\ntion results were compared via Kruskal-Wallis followed by Dunn\u2019s multiple compar-\nison test. The p<0.05 was considered statistically significant. \nResults: Fertilization rate was significantly lower in the group without AOA com-\npared to control group (41.9\u00b16.3 vs. 78.1\u00b14.7, p<0.001). AOA improved fertilization \nrate in group AOA compared to the group without AOA (69.5\u00b13.9 vs. 41.9\u00b16.3, p< \n0.01); however, cleavage (91.7\u00b12.8, 90.9\u00b14.6, and 95.2\u00b13.4, respectively) and em-\nbryo quality (2.5\u00b10.1, 2.3\u00b10.2, and 2.4\u00b10.2, respectively) scores were not substan-\ntially different between groups of control, with and without AOA.  \nConclusion: We showed that PLC\u03b6 can be considered as a good biomarker in evalu-\nation of oocyte activation capability. Further studies are required to establish the best \nuse of PLC\u03b6 as a biomarker in clinics. \n \nKeywords: Artificial oocyte activation, Biomarker, Intra-cytoplasmic sperm injection, Phos-\npholipase C zeta, Sperm. \nTo cite this article: Nazarian H, Azad N, Nazari L, Piryaei A, Heidari MH, Masteri-Farahani \nR, et al. Effect of Artificial Oocyte Activation on Intra-Cytoplasmic Sperm Injection Out-\ncomes in Patients with Lower Percentage of Sperm Containing Phospholipase C\u03b6: A Ran-\ndomized Clinical Trial. J Reprod Infertil. 2019;20(1):3-9. \n \n \nIntroduction \nocyte activation is an imperative stage in the \ninitiation of embryo development during the \nfertilization.", "mimetype": "text/plain", "start_char_idx": 1937, "end_char_idx": 3370, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4de88f85-cec6-478a-9b51-360978159647": {"__data__": {"id_": "4de88f85-cec6-478a-9b51-360978159647", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b1bd25c9-b5a4-4e75-9b96-2cec78d4fc23", "node_type": "1", "metadata": {}, "hash": "35fc42b7f48ac0e3d5e3f279228eb4202b29fe084b7256b10000454885179981", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "39ddf46d-77be-4c2a-9f49-8c02d81c55c4", "node_type": "1", "metadata": {}, "hash": "011eec39df0c58b39d4f31bb323e0bcc297931944ca4b6d2bc4b3971fb3d8e1c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Reprod Infertil. 2019;20(1):3-9. \n \n \nIntroduction \nocyte activation is an imperative stage in the \ninitiation of embryo development during the \nfertilization. Indeed, the entrance of sperm  \n \n \n \n \ninto the oocyte causes sequences of calcium oscil-\nlations in its cytoplasm, regulating a series of mo-\nlecular events such as exocytosis of cortical gran-\n* Corresponding Author:  \nMarefat Ghaffari Novin, \nInfertility and Reproductive \nHealth Research Center, \nShahid Beheshti University \nof Medical Sciences,  \nTehran, Iran \nE-mail:  \nmghaffarin@yahoo.com, \nmghaffarin@sbmu.ac.ir \n \nReceived: Sept. 18, 2018 \nAccepted: Nov. 24, 2018 \n \n \n \n4 \nJ Reprod Infertil, Vol 20, No 1, Jan-Mar 2019 \nAOA in Patients with PLC\u03b6 Deficiency \nJRI\n \nules, recruitment of maternal mRNA, pronuclear \nformation, and polyspermy prevention. These \nevents are collectively known as oocyte activation \n(1). \nBased on the best available evidence in the liter-\nature, phospholipase C zeta (PLC\u03b6) has been pro-\nposed to be the main factor involved in oocyte \nactivation; however, this remains to be established \ndefinitively (2, 3). It has been suggested that \nPLC\u03b6 can start the calcium oscillations by hydrol-\nysis of PIP2 into inositol-1,4,5-triphosphate (IP3) \nand diacylglycerol (DAG) after its entrance into \nthe oocyte (4). Afterward, via the IP3 receptor \n(IP3R) on the surface of the endoplasmic reticu-\nlum produces calcium oscillations in oocytes (4, 5). \nAbnormal localization patterns, reduced amount of \nPLC\u03b6, and total deficiency of protein in sperm fail \nto induce calcium oscillations (6-8), which can be \nrescued by microinjection of PLC\u03b6 mRNA as well \nas recombinant PLC\u03b6 protein into the oocyte (6, 7, \n9).  \nOocyte activation can be artificially induced by \ncalcium ionophores.", "mimetype": "text/plain", "start_char_idx": 3209, "end_char_idx": 4985, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39ddf46d-77be-4c2a-9f49-8c02d81c55c4": {"__data__": {"id_": "39ddf46d-77be-4c2a-9f49-8c02d81c55c4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4de88f85-cec6-478a-9b51-360978159647", "node_type": "1", "metadata": {}, "hash": "b25cf7685c1f514a75f6ca2a8483810b06a6243ea3a48a2421b90ca7065a51ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3ffcf484-5737-4b51-8e63-f349c48397a9", "node_type": "1", "metadata": {}, "hash": "d69c5b57322b9b4893f13aa22a8edc9bb807d8ed01a5c4d90bc3509b6fc6a9b7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Oocyte activation can be artificially induced by \ncalcium ionophores. This method is known as ar-\ntificial oocyte activation (AOA) and is believed to \nbe useful in the case of fertilization failure that \noccurs in 1\u20135% of intra-cytoplasmic sperm injec-\ntion (ICSI) cycles (5, 10, 11). However, AOA is \nnot helpful for all cases of fertilization failure \nwith a suspected oocyte-related activation defi-\nciency (12). Although neonatal, developmental, \nand behavioral assessments of children born fol-\nlowing ICSI- AOA revealed no serious adverse \neffects in a small sample size (13), AOA does not \nmimic accurately the physiological fertilization \nprocess which may have harmful effects on oo-\ncytes and embryos (14-16). Considering the in-\ncreased awareness and extensive caution in the \nuse of AOA (14, 17), it should only be used when \nit is defensible by supplementary data such as pro-\nven PLC\u03b6 deficiency (17).  \nAlthough PLC\u03b6 is suggested as a diagnostic bi-\nomarker for oocyte activation capability in prior \nstudies (2, 5, 18-20), there is an ongoing need to \nestablish reference ranges for its applying in infer-\ntility clinics. In this study, PLC\u03b6 was evaluated \nbefore AOA and then the impact of AOA on pre-\nimplantation embryo development was investigat-\ned later. \n \nMethods \nPatient selection and ethics: The study was re-\nviewed and approved by the ethical committee of \nShahid Beheshti University of Medical Sciences \nand appropriate regulatory bodies within the infer-\ntility center (Registration no. IR.SBMU.MSP. REC. \n1395.93). The trial was registered at Iranian Regis-\ntry of Clinical Trials (irct), number IRCT 2016 \n0722029027N4. Informed written consents for \nenrollment in the study were taken from all partic-\nipants. Sperm samples were prepared from cou-\nples who had been referred to the infertility center \nand subjected to ICSI. After PLC\u03b6 evaluation, in-\ndividuals who showed our inclusion criteria were \nenrolled in the study. The percentage of PLC\u03b6 \npositive sperm more than 85% (pos.", "mimetype": "text/plain", "start_char_idx": 4916, "end_char_idx": 6933, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3ffcf484-5737-4b51-8e63-f349c48397a9": {"__data__": {"id_": "3ffcf484-5737-4b51-8e63-f349c48397a9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "39ddf46d-77be-4c2a-9f49-8c02d81c55c4", "node_type": "1", "metadata": {}, "hash": "011eec39df0c58b39d4f31bb323e0bcc297931944ca4b6d2bc4b3971fb3d8e1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "502055fc-5e5a-438a-8cbc-226d90982deb", "node_type": "1", "metadata": {}, "hash": "ed00f61091e357292fb8991c410fd99d66ab1dfb435ece6f6a502999097a8674", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After PLC\u03b6 evaluation, in-\ndividuals who showed our inclusion criteria were \nenrolled in the study. The percentage of PLC\u03b6 \npositive sperm more than 85% (pos. PLC\u03b6 >85%) \nand the percentage of PLC\u03b6 positive sperm less \nthan 60% (pos. PLC\u03b6 <60%) were the inclusion \ncriteria for group I (Control) and group II (PLC\u03b6 \ndeficient), respectively (8, 21). The exclusion cri-\nteria were any history of trauma and surgery of \nthe testis, age >40 years, and having the percent-\nage of PLC\u03b6 positive sperm between 85%-60% in \nmen, and also any female factors of infertility, and \nage >35 years in women. The study was perform-\ned in two parts: \n \nPart I- Semen analysis and processing: Semen \nsamples were collected by masturbation after 2-5 \ndays of abstinence. After the liquefaction of the \nsemen, the sample was processed by swim-up \ntechnique (22). Briefly, after centrifuging the se-\nmen and washing, sperm plaque was overlayered \nby Ham\u2019s F-10 medium (Sigma-Aldrich, Germa-\nny). After 30-45 min, sperm cells in the upper part \nof the medium were taken and used for ICSI.  \nConventional sperm parameters including sperm \nconcentration (\u00d7106/ml), total motility (Non-pro-\ngressive+progressive spermatozoa) (%), and sperm \nmorphology (%) were determined according to \nWorld Health Organization criteria and Kruger \nstrict criteria (22, 23). \n \nPLC\u03b6 immunofluorescence staining in sperm: As \npreviously described (6, 24), PLC\u03b6 was identified \nusing immunofluorescence staining with some al-\nterations. First, sperm cells were fixed with fresh-\nly-prepared PBS/paraformaldehyde 4% for 10 min \nand permeabilized with 0.2% Triton x-100-PBS \nfor 10 min on ice. After washing the sample with \n0.1% Tween 20-PBS (PBST), blocking was per-\nformed with 5% normal goat serum (Sigma-Al-\ndrich, Germany).", "mimetype": "text/plain", "start_char_idx": 6775, "end_char_idx": 8560, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "502055fc-5e5a-438a-8cbc-226d90982deb": {"__data__": {"id_": "502055fc-5e5a-438a-8cbc-226d90982deb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3ffcf484-5737-4b51-8e63-f349c48397a9", "node_type": "1", "metadata": {}, "hash": "d69c5b57322b9b4893f13aa22a8edc9bb807d8ed01a5c4d90bc3509b6fc6a9b7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "424c2355-74b1-4a22-9baf-aeaac67bad4b", "node_type": "1", "metadata": {}, "hash": "f8489b54997fdc1f267d4c79b44b860c09bdfacedd2bce3cbfa1857237ed3483", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After washing the sample with \n0.1% Tween 20-PBS (PBST), blocking was per-\nformed with 5% normal goat serum (Sigma-Al-\ndrich, Germany). Then, the sperm were incubated \nin primary antibody (A PLC\u03b6 Rabbit Polyclonal \nAntibody, LifeSpan BioSciences, USA) overnight \nat 4\u00b0C. After washing, the sperm were incubated \nwith secondary antibody (Goat Anti-Rabbit IgG \nH&L, Abcam Company, UK) in the dark room. \n \n \nJ Reprod Infertil, Vol 20, No 1, Jan-Mar 2019 \n    5 \n                                                      Nazarian H, et al. JRI\n \nFinally, the cells were counterstained with DAPI \n(10 \u00b5g/ml) and mounted. \nFluorescence images were captured with a Nikon \nmicroscope (TS100, Japan) equipped with a Ni-\nkon camera (DS-Fi1c, Japan) (Figure 1). After-\nward, the percentage of sperm exhibiting PLC\u03b6 \nimmunofluorescence was evaluated (n=200). \nThe mean percentage of PLC\u03b6 positive sperm \nless than 60% (pos. PLC\u03b6 <60%) was the inclu-\nsion criterion for PLC\u03b6 deficient group. For the \ncontrol group, the percentage of PLC\u03b6 positive \nsperm more than 85% (pos. PLC\u03b6 >85%) was \nconsidered as the inclusion criterion (8, 21). \n \nPart II- Ovarian stimulation, ovum pickup, and IC-\nSI: Recombinant FSH (Gonal-F, Merck Inc, Ger-\nmany) was administered on menstrual cycle day \n2-3 at an initial dose of 150 IU/day. During stimu-\nlation, transvaginal ultrasound was done. The go-\nnadotropin dose was adjusted according to serial \nultrasound monitoring. The GnRH antagonist (Ce-\ntritide, Merck, Germany) 0.25 mg/day was admin-\nistered when the prominent follicle reached 14-15 \nmm in maximum diameter. When a minimum of \ntwo follicles reached a mean diameter of 18 mm, \n10,000 IU of hCG (Choriomon, IBSA, Switzer-\nland) was administered.", "mimetype": "text/plain", "start_char_idx": 8425, "end_char_idx": 10152, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "424c2355-74b1-4a22-9baf-aeaac67bad4b": {"__data__": {"id_": "424c2355-74b1-4a22-9baf-aeaac67bad4b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "502055fc-5e5a-438a-8cbc-226d90982deb", "node_type": "1", "metadata": {}, "hash": "ed00f61091e357292fb8991c410fd99d66ab1dfb435ece6f6a502999097a8674", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f326ec05-a2d0-44fa-83e5-d977a41f816f", "node_type": "1", "metadata": {}, "hash": "176e726c1f01e1298906628dde09461f8e7eff3d0db80d65be49abd25692fd60", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When a minimum of \ntwo follicles reached a mean diameter of 18 mm, \n10,000 IU of hCG (Choriomon, IBSA, Switzer-\nland) was administered. Transvaginal oocyte re-\ntrieval was performed 36 hr after hCG administra-\ntion. After retrieval, oocytes (n=359) were washed \nwith HTF medium and put in CO2 incubator for 4 \nhr. Cumulus cells were removed mechanically \nand enzymatically by a 30-second exposure to \nhyaluronidase (Vitrolife, Sweden). Denuded oo-\ncytes were then evaluated for nuclear maturity. \nOocytes with the first polar body were selected \nfor ICSI. Eppendorf micromanipulator mounted \non a Nikon inverted microscope was used to per-\nform ICSI. Afterward, the injected oocytes were \ncultured in global medium (lifeGlobal, USA).  \nFor each partner in group II (PLC\u03b6 deficient), a \nsplit ICSI-AOA cycle using sibling oocytes was \nperformed. Next, the oocytes retrieved from each \npartner in group II were divided into two parts \nrandomly (Groups AOA and without AOA). Col-\nlectively, oocytes were categorized into three \ngroups: 1- group control (Injected with sperm \nfrom group I, n=113), 2- group without AOA (In-\njected with sperm from group II and no exposure \nto AOA, n=106), and 3- group AOA (Injected \nwith sperm from group II and exposure to AOA, \nn=114). \nAOA: Oocyte activation was performed as de-\nscribed by Montag et al. (25). Briefly, immediate-\nly after ICSI, oocytes were incubated in 10 \u03bcmol/l \ncalcium ionophore A23187 for 15 min (Sigma-\nAldrich, Germany) (Dissolved in DMSO) in cul-\nture medium covered by mineral oil. After wash-\ning with culture medium, injected oocytes were \ncultured in an incubator at 37\u00b0C under 6% CO2.", "mimetype": "text/plain", "start_char_idx": 10017, "end_char_idx": 11665, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f326ec05-a2d0-44fa-83e5-d977a41f816f": {"__data__": {"id_": "f326ec05-a2d0-44fa-83e5-d977a41f816f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "424c2355-74b1-4a22-9baf-aeaac67bad4b", "node_type": "1", "metadata": {}, "hash": "f8489b54997fdc1f267d4c79b44b860c09bdfacedd2bce3cbfa1857237ed3483", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0d69da79-e85a-4c5a-905e-fe594ae0199e", "node_type": "1", "metadata": {}, "hash": "5133b43ae4c6ffeb2d80ae10c0759a110caa9a37e59c5cbecdd57275db138438", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After wash-\ning with culture medium, injected oocytes were \ncultured in an incubator at 37\u00b0C under 6% CO2. \n \nEvaluation of fertilization rate (%), cleavage rate \n(%), and embryo quality score for each patient: After \n16-18 hr of post-injection, oocytes were observed \nfor pronuclei observation. Oocytes failing to show \n2 pronuclei after 25 hr were considered unferti-\nlized. Fertilized oocytes were cultured in the in-\ncubator and their cleavage and quality was rec-\norded on day 3 after oocyte retrieval. Blastomere \nnumber, size, and the percentage of fragmentation \nwere assessed for embryo morphology (A, B, C). \nGrade A (Score 3) used for embryos with equal \nsize of blastomeres and no fragmentation or less \nthan 10%. Grade B (Score 2) was used for embry-\nos with the even size of blastomeres and moderate \nfragmentation (Between 10-45%). Lastly, grade C \n(Score 3) was used for embryos with unequal size \nof blastomeres and severe fragmentation more \nthan 45%. Embryo quality score of each patient \nwas calculated as the sum of quality of scores for \nembryos/total number of cleaved embryos (26). \nThe cleavage score was calculated as described by \nSheikhi et al. (27). The cleavage score for each \npatient was calculated as the sum of cleaved em-\nbryos/total number of fertilized embryos (%). \n \nStatistical analysis: All data were analyzed by \nPrism 6/Graph-Pad. Fertilization rates, embryo \nquality score, and cleavage scores were analyzed \nby Kruskal-Wallis test followed by Dunn\u2019s multi-\nple comparison test. Data were shown as a mean\u00b1 \nstandard error of the mean (SEM) in the text, fig-\nures, and tables. The p<0.05 was considered sta-\ntistically significant.  \n \nFigure 1. PLC\u03b6 immunofluorescence staining. The sperm \nnuclei are counterstained with DAPI. A: Merged DAPI and \nbright field images. B: Anti- PLC\u03b6 immunofluorescence.", "mimetype": "text/plain", "start_char_idx": 11559, "end_char_idx": 13404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0d69da79-e85a-4c5a-905e-fe594ae0199e": {"__data__": {"id_": "0d69da79-e85a-4c5a-905e-fe594ae0199e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f326ec05-a2d0-44fa-83e5-d977a41f816f", "node_type": "1", "metadata": {}, "hash": "176e726c1f01e1298906628dde09461f8e7eff3d0db80d65be49abd25692fd60", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "27c8f3f4-d006-4ad1-a2c5-c1fff2108b5e", "node_type": "1", "metadata": {}, "hash": "eaf9d2c116aea85096e45d9156dee4406fec8f320033f0c45d6acb7fb0df491d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The sperm \nnuclei are counterstained with DAPI. A: Merged DAPI and \nbright field images. B: Anti- PLC\u03b6 immunofluorescence. C: \nMerged DAPI and PLC\u03b6 stains. Bar=10 \u00b5m \n \n \n6 \nJ Reprod Infertil, Vol 20, No 1, Jan-Mar 2019 \nAOA in Patients with PLC\u03b6 Deficiency \nJRI\n \nResults \nPLC\u03b6 deficiency: The mean percentage of sperm \nexhibiting PLC\u03b6 immunofluorescence, and sperm \nparameters in the patients are presented in table 1. \nThere was no significant difference in sperm con-\ncentration (\u00d7106), total motility (%), and normal \nmorphology (%) between groups. Eleven men \nshowing the mean percentage of PLC\u03b6 positive \nsperm more than 85% entered group I (89\u00b10.8) \nand 15 men showing the mean percentage of \nPLC\u03b6 positive sperm less than 60% entered group \nII (45.6\u00b15.1). Among all individuals in group II, 6 \nmen had at least one ICSI cycle with previous \nfertilization failure.  \n \nICSI outcomes: The rate of fertilization, embryo \nquality, and cleavage scores were calculated on \nday 3 after ICSI. As shown in figure 2, signifi-\ncantly lower rate of fertilization was observed in \ngroup without AOA compared to control group \n(41.9\u00b16.3 vs. 78.1\u00b14.7, p<0.001), while incubation \nof oocytes in calcium ionophore in group AOA \nelicited a significant increase in fertilization rates \ncompared to group without AOA (69.5\u00b13.9 vs. \n41.9\u00b16.3, p<0.01). No significant difference in \nfertilization rate was observed between control \nand AOA groups (78.1\u00b1 4.7 vs. 69.5\u00b13.9, p>0.05).", "mimetype": "text/plain", "start_char_idx": 13282, "end_char_idx": 14749, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "27c8f3f4-d006-4ad1-a2c5-c1fff2108b5e": {"__data__": {"id_": "27c8f3f4-d006-4ad1-a2c5-c1fff2108b5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0d69da79-e85a-4c5a-905e-fe594ae0199e", "node_type": "1", "metadata": {}, "hash": "5133b43ae4c6ffeb2d80ae10c0759a110caa9a37e59c5cbecdd57275db138438", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c63544bc-16a3-4dc9-873c-0752b9dbffcc", "node_type": "1", "metadata": {}, "hash": "48e5f368f92d3621eaf1b8b1065d9e75aa08d9613fd00457c9c537d9e1031798", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "No significant difference in \nfertilization rate was observed between control \nand AOA groups (78.1\u00b1 4.7 vs. 69.5\u00b13.9, p>0.05). \nIn addition, cleavage (91.7\u00b12.8, 90.9\u00b14.6, and \n95.2\u00b13.4, respectively) and embryo quality (2.5\u00b1 \n0.1, 2.3\u00b10.2, and 2.4\u00b1 0.2, respectively) scores \nwere not substantially different between groups of \ncontrol, without AOA and AOA.  \n \nDiscussion \nOur study showed that a lower percentage of \nsperm-containing PLC\u03b6 compared to control group \ncauses a significantly lower rate of fertilization \nfollowing ICSI, while the use of AOA can signifi-\ncantly improve that in these patients. It was also \nshown that embryo quality and cleavage scores \nbetween all groups (Control, without AOA, and \nAOA) did not differ significantly.   \nAfter fertilization, oocyte activation which is re-\nquired for the development of the embryo occurs \nby a series of intracellular calcium oscillations \n(28). Calcium oscillations are believed to be trig-\ngered by PLC\u03b6 expression (18), affecting different \naspects of oocyte activation and embryo devel-\nopment (29). Although PLC\u03b6 is reported to be a \nTable 1.", "mimetype": "text/plain", "start_char_idx": 14622, "end_char_idx": 15736, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c63544bc-16a3-4dc9-873c-0752b9dbffcc": {"__data__": {"id_": "c63544bc-16a3-4dc9-873c-0752b9dbffcc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "27c8f3f4-d006-4ad1-a2c5-c1fff2108b5e", "node_type": "1", "metadata": {}, "hash": "eaf9d2c116aea85096e45d9156dee4406fec8f320033f0c45d6acb7fb0df491d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e6ef68a-6f6f-4c1b-937d-bac3106b2bee", "node_type": "1", "metadata": {}, "hash": "719e1d1d742be56fe981fe11ae36300e13ef6e1446a62c5eb5ee984e5ce84d99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although PLC\u03b6 is reported to be a \nTable 1. Basic and demographic characteristics of couples studied \n \nParameters \nGroup I (Control) \n(n=11) \nGroup II (PLC\u03b6 deficient) \n(n=15) \np-value \nFemale age (years) \n30.3\u00b11.3 \n31.26\u00b10.92 \n- \nMale age (years) \n32.1\u00b11.2 \n33.06 \u00b10.98 \n- \nSperm concentration (\u00d7106/ml) \n53.6\u00b19.6 \n31.2\u00b18.06 \n0.06 \nTotal motility (Progressive + non-progressive) (%) \n53.2\u00b17.5 \n37.6\u00b16.5 \n0.1 \nSperm morphology (%) \n3.8\u00b10.6 \n2.9\u00b10.6 \n0.3 \nThe mean percentage of sperm containing PLC\u03b6 \n89\u00b10.8 \n45.6\u00b15.1 \n<0.0001 \n \nAll data are shown as Mean\u00b1SEM \n \nFigure 2. Comparison of fertilization rate, cleavage score, \nand embryo quality score between control, without AOA, and \nAOA groups. *** p<0.001 and **** p<0.0001, significant \ndifferences \n \n \nJ Reprod Infertil, Vol 20, No 1, Jan-Mar 2019 \n    7 \n                                                      Nazarian H, et al. JRI\n \ndiagnostic biomarker for oocyte activation capaci-\nty (5, 18), further clinical studies are necessary to \ndetermine a reference range for the percentage of \nsperm-containing PLC\u03b6 affecting fertilization rates \nfollowing ICSI. In this regard, Kashir et al. re-\nvealed a lower percentage of sperm-containing \nPLC\u03b6 in patients suffering from oocyte activation \ndeficiency (OAD) compared to control group \n(27.4% in OAD group vs. 82.6% in control group) \n(8). It was also reported that patients with a histo-\nry of fertilization failure show significantly lower \npercentages of PLC\u03b6 positive sperm (58.4\u00b125) \ncompared to the control group (87.6\u00b19.8) (Mean\u00b1 \nSD) (21).", "mimetype": "text/plain", "start_char_idx": 15693, "end_char_idx": 17248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3e6ef68a-6f6f-4c1b-937d-bac3106b2bee": {"__data__": {"id_": "3e6ef68a-6f6f-4c1b-937d-bac3106b2bee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c63544bc-16a3-4dc9-873c-0752b9dbffcc", "node_type": "1", "metadata": {}, "hash": "48e5f368f92d3621eaf1b8b1065d9e75aa08d9613fd00457c9c537d9e1031798", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "887d3d28-96fe-41ea-94cd-28f393d6cff5", "node_type": "1", "metadata": {}, "hash": "5d1411cfd36296fbb8b4259827336cae4fb09bd38a5298834ae37edfefd7d419", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "With considering these clinical experi-\nments, individuals with the percentages of PLC\u03b6 \npositive sperm >85% as a control group (Group I) \nand also the percentages of PLC\u03b6 positive sperm \n<60% as PLC\u03b6 deficient group were included \n(Group II). \nAs shown in previous studies, PLC\u03b6 localization \npatterns, protein levels, and PLC\u03b6 positive sperm \ncorrelated with fertilization rates following ICSI \n(19, 20). In agreement with those studies, it was \nshown that fertilization rate was significantly low-\ner in the group without AOA compared to control \ngroup. However, another study conducted by Fer-\nrer-Vaquer et al. showed the opposite results, in-\ndicating no correlation between ICSI fertilization \nrates and PLC\u03b6 (30).  \nSeveral studies have been conducted on the ap-\nplication of AOA after conventional ICSI such as \nin patients with fertilization failure (12, 31), glo-\nbozoospermia (32, 33), teratozoospermia (34, 35), \nand azoospermia or cryptozoospermia (36). How-\never, to the best our knowledge, a few studies \nhave been carried out on the use of AOA after \nPLC\u03b6 diagnostic tests in ICSI cycles in humans. \nAccordingly, Taylor et al. showed a lack of PLC\u03b6 \nin sperm from a globozoospermic patient using \nimmunofluorescence and western blotting tech-\nniques. They found that ICSI followed by AOA \nresulted in high rates of fertilization and pregnan-\ncy in this patient (33). In another case-report \nstudy, PLC\u03b6 deficiency resulted in the failure of \nfertilization and impaired calcium oscillations dur-\ning ICSI. AOA procedure following ICSI enhanc-\ned fertilization and development of the embryo in \nthis patient (37).", "mimetype": "text/plain", "start_char_idx": 17249, "end_char_idx": 18877, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "887d3d28-96fe-41ea-94cd-28f393d6cff5": {"__data__": {"id_": "887d3d28-96fe-41ea-94cd-28f393d6cff5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e6ef68a-6f6f-4c1b-937d-bac3106b2bee", "node_type": "1", "metadata": {}, "hash": "719e1d1d742be56fe981fe11ae36300e13ef6e1446a62c5eb5ee984e5ce84d99", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "00a26eac-43ff-4374-8daf-60b6c9eeb79f", "node_type": "1", "metadata": {}, "hash": "1c165d45d130818c579c6a472cb68052c14d7617eb99dd467f446cff62896811", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "AOA procedure following ICSI enhanc-\ned fertilization and development of the embryo in \nthis patient (37). In a recent study, Tavalaee and \nNasr-Esfahani indicated the lower expression of \nPLC\u03b6 and two other candidates for sperm born ac-\ntivating factors (SOAFs) [including postacroso-\nmal sheath WW domain-binding protein (PAWP) \nand TR-KIT] in 12 globozoospermic men and \nobserved an improvement in fertilization rate fol-\nlowing ICSI-AOA in the majority of the patients \n(32). In accordance with these clinical studies, it \nwas demonstrated that AOA significantly im-\nproved the rate of fertilization in patients with a \nlower percentage of sperm-containing PLC\u03b6 (Fig-\nure 2). \nOur finding is similar to some animal studies \nwhich were performed in wobbler mice (A useful \nmodel for globozoospermia with abnormalities in \nlocalization, but not in PLC\u03b6 expression). Accord-\ningly, microinjection of sperm from wobbler mice \ninto oocytes led to lower fertilization rates, lower \ncleavage rate, and no blastocyst formation. The \nuse of AOA in these oocytes recovered their ferti-\nlization ability, cleavage rate, and embryo devel-\nopment to blastocyst (38). In another study, Van-\nden Meerschaut et al. found that the percentage of \noocytes injected with wobbler sperm showed less \nsignificant rises in calcium, lower fertilization \nrate, and lower development to the blastocyst stage \ncompared with the wild type. Following AOA ap-\nplication, all of the mentioned parameters have \nbeen improved (39). However, these studies show-\ning the effect of abnormal localization patterns \nand AOA on embryo cleavage and quality in wob-\nbler mice manifested no considerable difference \nin terms of embryo quality and cleavage scores \nbetween our three groups. This result agreed with \na recent study which showed no correlation be-\ntween the percentage of PLC\u03b6 positive sperm and \nembryo quality (20). It seems that frequency and \namplitude of calcium signals have no effect in \nearly embryo cleavage of activated oocytes.", "mimetype": "text/plain", "start_char_idx": 18771, "end_char_idx": 20784, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "00a26eac-43ff-4374-8daf-60b6c9eeb79f": {"__data__": {"id_": "00a26eac-43ff-4374-8daf-60b6c9eeb79f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "887d3d28-96fe-41ea-94cd-28f393d6cff5", "node_type": "1", "metadata": {}, "hash": "5d1411cfd36296fbb8b4259827336cae4fb09bd38a5298834ae37edfefd7d419", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3438acf-34a2-43df-91e8-4c656042cc04", "node_type": "1", "metadata": {}, "hash": "ca1f8d1a0e91d1ba2e763c6ed718a6de3e9f3007dbe98beed742a493c3e5d93f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It seems that frequency and \namplitude of calcium signals have no effect in \nearly embryo cleavage of activated oocytes. How-\never, the developmental capacity and morphology \nof post-implantation rabbit embryos were affected \nby abnormal calcium signals, suggesting the pos-\nsibility of epigenetic events and long-term devel-\nopmental effects (40). Similarly, Ozil et al. stated \nthat the enhancement or reduction of calcium sig-\nnaling following fertilization has no effect on the \npre-implantation development of the embryo to \nblastocyst. Nevertheless, they confirmed long-term \neffects on both gene expression and development \nto term (29). These reports are in a good agree-\nment with our results, showing similar embryo \nquality and cleavage in control, without AOA, and \nAOA groups although post-implantation devel-\nopment in our participants was not followed.  \n \nConclusion \nIn conclusion, our study confirmed previous \nstudies reporting PLC\u03b6 as an oocyte activation \n \n \n8 \nJ Reprod Infertil, Vol 20, No 1, Jan-Mar 2019 \nAOA in Patients with PLC\u03b6 Deficiency \nJRI\n \nfactor that its deficiency can be amended by \nAOA. However, further studies with larger series \nare required to establish a reference value for the \nbest clinical use of PLC\u03b6 and other SOAF(s) can-\ndidates in clinics as diagnostic biomarkers of oo-\ncyte activation.  \n \nAcknowledgement \nWe would like to express our appreciation to \nSousan Sajadpour for her technical assistance in \nthis study. This article has been extracted from the \nthesis written by Mrs. Nahid Azad in School of \nMedicine, Shahid Beheshti University of Medical \nSciences (Registration No: 218.). The study was \nfinancially supported by Shahid Beheshti Univer-\nsity of Medical Sciences, Tehran, Iran. \n \nConflict of Interest \nAuthors declare no conflict of interest. \n \nReferences \n1. Tosti E, Menezo Y. Gamete activation: basic know-\nledge and clinical applications. Hum Reprod Update. \n2016;22(4):420-39. \n \n2. Amdani SN, Yeste M, Jones C, Coward K. Sperm \nfactors and oocyte activation: current controversies \nand considerations.", "mimetype": "text/plain", "start_char_idx": 20664, "end_char_idx": 22742, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f3438acf-34a2-43df-91e8-4c656042cc04": {"__data__": {"id_": "f3438acf-34a2-43df-91e8-4c656042cc04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00a26eac-43ff-4374-8daf-60b6c9eeb79f", "node_type": "1", "metadata": {}, "hash": "1c165d45d130818c579c6a472cb68052c14d7617eb99dd467f446cff62896811", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3b8818e-a77f-418c-a315-157aa1989e31", "node_type": "1", "metadata": {}, "hash": "b6de62273fb2546e1477f10e6c6e3be981941b75a1d3bc9645cf421deabf11e1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2016;22(4):420-39. \n \n2. Amdani SN, Yeste M, Jones C, Coward K. Sperm \nfactors and oocyte activation: current controversies \nand considerations. Biol Reprod. 2015;93(2):50. \n \n3. Vadnais ML, Gerton GL. From PAWP to \"Pop\": \nopening up new pathways to fatherhood. Asian J \nAndrol. 2015;17(3):443-4. \n \n4. Swann K, Lai FA. PLCzeta and the initiation of \nCa(2+) oscillations in fertilizing mammalian eggs. \nCell Calcium. 2013;53(1):55-62. \n \n5. Ramadan WM, Kashir J, Jones C, Coward K. Oo-\ncyte activation and phospholipase C zeta (PLCzeta): \ndiagnostic and therapeutic implications for assisted \nreproductive technology. Cell Commun Signal. 2012; \n10(1):12. \n \n6. Yoon SY, Jellerette T, Salicioni AM, Lee HC, Yoo \nMS, Coward K, et al. Human sperm devoid of PLC, \nzeta 1 fail to induce Ca(2+) release and are unable to \ninitiate the first step of embryo development. J Clin \nInvest. 2008;118(11):3671-81. \n \n7. Heytens E, Parrington J, Coward K, Young C, Lam-\nbrecht S, Yoon SY, et al. Reduced amounts and ab-\nnormal forms of phospholipase C zeta (PLCzeta) in \nspermatozoa from infertile men. Hum Reprod. 2009; \n24(10):2417-28. \n \n8. Kashir J, Jones C, Mounce G, Ramadan WM, Lem-\nmon B, Heindryckx B, et al. Variance in total levels \nof phospholipase C zeta (PLC-zeta) in human sperm \nmay limit the applicability of quantitative immuno-\nfluorescent analysis as a diagnostic indicator of oo-\ncyte activation capability. Fertil Steril. 2013;99(1): \n107-17.", "mimetype": "text/plain", "start_char_idx": 22598, "end_char_idx": 24048, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3b8818e-a77f-418c-a315-157aa1989e31": {"__data__": {"id_": "c3b8818e-a77f-418c-a315-157aa1989e31", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3438acf-34a2-43df-91e8-4c656042cc04", "node_type": "1", "metadata": {}, "hash": "ca1f8d1a0e91d1ba2e763c6ed718a6de3e9f3007dbe98beed742a493c3e5d93f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c149f51-8202-4839-b399-df40b0ebe323", "node_type": "1", "metadata": {}, "hash": "b169c7a251dc1d76df56e82ad2bcce8a6020e275bef483dbe23ef43cd83b4d49", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertil Steril. 2013;99(1): \n107-17. \n \n9. Nomikos M, Yu Y, Elgmati K, Theodoridou M, \nCampbell K, Vassilakopoulou V, et al. Phospholi-\npase C\u03b6 rescues failed oocyte activation in a pro-\ntotype of male factor infertility. Fertil Steril. 2013; \n99(1):76-85. \n \n10. Vanden Meerschaut F, Nikiforaki D, Heindryckx \nB, De Sutter P. Assisted oocyte activation follow-\ning ICSI fertilization failure. Reprod Biomed \nOnline. 2014;28(5):560-71. \n \n11. Vanden Meerschaut F, Leybaert L, Nikiforaki D, \nQian C, Heindryckx B, De Sutter P. Diagnostic and \nprognostic value of calcium oscillatory pattern an-\nalysis for patients with ICSI fertilization failure. \nHum Reprod. 2013;28(1):87-98. \n \n12. Vanden Meerschaut F, Nikiforaki D, De Gheselle \nS, Dullaerts V, Van den Abbeel E, Gerris J, et al. \nAssisted oocyte activation is not beneficial for all \npatients with a suspected oocyte-related activation \ndeficiency. Hum Reprod. 2012;27(7):1977-84. \n \n13. Vanden Meerschaut F, D\u2019Haeseleer E, Gysels H, \nThienpont Y, Dewitte G, Heindryckx B, et al. Neo-\nnatal and neurodevelopmental outcome of children \naged 3-5 years born following assisted oocyte \nactivation. Reprod Biomed Online. 28(1):54-63. \n \n14. Santella L, Dale B. Assisted yes, but where do we \ndraw the line? Reprod Biomed Online. 2015;31(4): \n476-8. \n \n15.", "mimetype": "text/plain", "start_char_idx": 24013, "end_char_idx": 25317, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5c149f51-8202-4839-b399-df40b0ebe323": {"__data__": {"id_": "5c149f51-8202-4839-b399-df40b0ebe323", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3b8818e-a77f-418c-a315-157aa1989e31", "node_type": "1", "metadata": {}, "hash": "b6de62273fb2546e1477f10e6c6e3be981941b75a1d3bc9645cf421deabf11e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9889ecd1-3dd1-4a1a-bb44-17fdf99d938b", "node_type": "1", "metadata": {}, "hash": "0d4d01ca77218d1aac941db25039bf942a354505d77365beec98c64967f369cd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "14. Santella L, Dale B. Assisted yes, but where do we \ndraw the line? Reprod Biomed Online. 2015;31(4): \n476-8. \n \n15. Nasr-Esfahani MH, Deemeh MR, Tavalaee M. Ar-\ntificial oocyte activation and intracytoplasmic sperm \ninjection. Fertil Steril. 2010;94(2):520-6. \n \n16. Amdani SN, Jones C, Coward K. Phospholipase C \nzeta (PL C\u03b6): oocyte activation and clinical links to \nmale factor infertility. Adv Biol Regul. 2013;53(3): \n292-308. \n \n17. van Blerkom J, Cohen J, Johnson M. A plea for \ncaution and more research in the 'experimental' use \nof ionophores in ICSI. Reprod Biomed Online. \n2015;30(4):323-4. \n \n18. Kashir J, Heindryckx B, Jones C, De Sutter P, \nParrington J, Coward K. Oocyte activation, phos-\npholipase C zeta and human infertility. Hum Re-\nprod Update. 2010;16(6):690-703. \n \n19. Yelumalai S, Yeste M, Jones C, Amdani SN, Ka-\nshir J, Mounce G, et al. Total levels, localization \npatterns, and proportions of sperm exhibiting phos-\npholipase C zeta are significantly correlated with \nfertilization rates after intracytoplasmic sperm in-\njection. Fertil Steril. 2015;104(3):561-8.4. \n \n20. Tavalaee M, Kiani-Esfahani A, Nasr-Esfahani MH. \nRelationship between potential sperm factors in-\nvolved in oocyte activation and sperm DNA frag-\n \n \nJ Reprod Infertil, Vol 20, No 1, Jan-Mar 2019 \n    9 \n                                                      Nazarian H, et al. JRI\n \nmentation with intra-cytoplasmic sperm injection \nclinical outcomes. Cell J. 2017;18(4):588-96. \n \n21.", "mimetype": "text/plain", "start_char_idx": 25199, "end_char_idx": 26689, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9889ecd1-3dd1-4a1a-bb44-17fdf99d938b": {"__data__": {"id_": "9889ecd1-3dd1-4a1a-bb44-17fdf99d938b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c149f51-8202-4839-b399-df40b0ebe323", "node_type": "1", "metadata": {}, "hash": "b169c7a251dc1d76df56e82ad2bcce8a6020e275bef483dbe23ef43cd83b4d49", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0842cf97-fb33-4f6d-8457-41a929f3c5af", "node_type": "1", "metadata": {}, "hash": "23f8971b09309bbbde07d4c1947b2d050d522c1f95c00ad9155247518ac086a2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "JRI\n \nmentation with intra-cytoplasmic sperm injection \nclinical outcomes. Cell J. 2017;18(4):588-96. \n \n21. Azad N, Nazarian H, Nazari L, Ghaffari Novin M, \nPiryaei A, Heidari MH, et al. Evaluation of PAWP \nand PLC? expression in infertile men with previous \nICSI fertilization failure. Urol J. 2018;15(3):116-\n21. \n \n22. World Health Organisation. WHO laboratory man-\nual for the examination and processing of human \nsemen. 5th ed. Geneva: World Health Organization \nPress; 2010. 307 p. \n \n23. Kruger TF, Menkveld R, Stander FS, Lombard CJ, \nVan der Merwe JP, van Zyl JA, et al. Sperm \nmorphologic features as a prognostic factor in in \nvitro fertilization. Fertil Steril. 1986;46(6):1118-\n23. \n \n24. Grasa P, Coward K, Young C, Parrington J. The \npattern of localization of the putative oocyte activ-\nation factor, phospholipase Czeta, in uncapacitated, \ncapacitated, and ionophore-treated human sperma-\ntozoa. Hum Reprod. 2008;23(11):2513-22. \n \n25. Montag M, Koster M, van der Ven K, Bohlen U, \nvan der Ven H. The benefit of artificial oocyte \nactivation is dependent on the fertilization rate in a \nprevious treatment cycle. Reprod Biomed Online. \n2012;24(5):521-6. \n \n26. Nasr-Esfahani MH, Salehi M, Razavi S, Mardani \nM, Bahramian H, Steger K, et al. Effect of pro-\ntamine-2 deficiency on ICSI outcome. Reprod Bio-\nmed Online. 2004;9(6):652-8. \n \n27.", "mimetype": "text/plain", "start_char_idx": 26581, "end_char_idx": 27939, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0842cf97-fb33-4f6d-8457-41a929f3c5af": {"__data__": {"id_": "0842cf97-fb33-4f6d-8457-41a929f3c5af", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9889ecd1-3dd1-4a1a-bb44-17fdf99d938b", "node_type": "1", "metadata": {}, "hash": "0d4d01ca77218d1aac941db25039bf942a354505d77365beec98c64967f369cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1e34a1d-e107-4a11-83a5-722ccaa2c0b5", "node_type": "1", "metadata": {}, "hash": "3521a35ae5782fc6a845e7b48344784ee8e05aef7ed33b1092b7509ec54f4f58", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Effect of pro-\ntamine-2 deficiency on ICSI outcome. Reprod Bio-\nmed Online. 2004;9(6):652-8. \n \n27. Sheikhi A, Jalali M, Gholamian M, Jafarzadeh A, \nJannati S, Mousavifar N. Elimination of apoptotic \nspermatozoa by magnetic-activated cell sorting im-\nproves the fertilization rate of couples treated with \nICSI procedure. Andrology. 2013;1(6):845-9. \n \n28. Saunders CM, Larman MG, Parrington J, Cox LJ, \nRoyse J, Blayney LM, et al. PLC zeta: a sperm-\nspecific trigger of Ca(2+) oscillations in eggs and \nembryo development. Development. 2002;129(15): \n3533-44. \n \n29. Ozil JP, Banrezes B, Toth S, Pan H, Schultz RM. \nCa2+ oscillatory pattern in fertilized mouse eggs \naffects gene expression and development to term. \nDev Biol. 2006;300(2):534-44. \n \n30. Ferrer-Vaquer A, Barragan M, Freour T, Vernaeve \nV, Vassena R. PLC\u03b6 sequence, protein levels, and \ndistribution in human sperm do not correlate with \nsemen characteristics and fertilization rates after \nICSI. J Assist Reprod Genet. 2016;33(6):747-56. \n \n31. Heindryckx B, De Gheselle S, Gerris J, Dhont M, \nDe Sutter P. Efficiency of assisted oocyte activ- \n \n \nation as a solution for failed intracytoplasmic \nsperm injection. Reprod Biomed Online. 2008;17 \n(5):662-8. \n \n32. Tavalaee M, Nasr-Esfahani MH. Expression pro-\nfile of PLC\u03b6, PAWP, and TR-KIT in association \nwith fertilization potential, embryo development, \nand pregnancy outcomes in globozoospermic can-\ndidates for intra-cytoplasmic sperm injection and \nartificial oocyte activation. Andrology.", "mimetype": "text/plain", "start_char_idx": 27840, "end_char_idx": 29354, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d1e34a1d-e107-4a11-83a5-722ccaa2c0b5": {"__data__": {"id_": "d1e34a1d-e107-4a11-83a5-722ccaa2c0b5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0842cf97-fb33-4f6d-8457-41a929f3c5af", "node_type": "1", "metadata": {}, "hash": "23f8971b09309bbbde07d4c1947b2d050d522c1f95c00ad9155247518ac086a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2a2c6d77-22cf-4858-87d9-ab17d2427306", "node_type": "1", "metadata": {}, "hash": "6a0338da7e5bc2a65cc89361bfc5a950286af249f1342d38f70f7999a41e2d27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Andrology. 2016;4(5): \n850-6. \n \n33. Taylor SL, Yoon SY, Morshedi MS, Lacey DR, \nJellerette T, Fissore RA, et al. Complete globozoo-\nspermia associated with PLCzeta deficiency treated \nwith calcium ionophore and ICSI results in preg-\nnancy. Reprod Biomed Online. 2010;20(4):559-64. \n \n34. Eftekhar M, Janati S, Rahsepar M, Aflatoonian A. \nEffect of oocyte activation with calcium ionophore \non ICSI outcomes in teratospermia: a randomized \nclinical trial. Iran J Reprod Med. 2013;11(11):875-\n82. \n \n35. Nasr-Esfahani MH, Razavi S, Javdan Z, Tavalaee \nM. Artificial oocyte activation in severe teratozoo-\nspermia undergoing intracytoplasmic sperm injec-\ntion. Fertil Steril. 2008;90(6):2231-7. \n \n36. Ebner T, Koster M, Shebl O, Moser M, Van der \nVen H, Tews G, et al. Application of a ready-to-\nuse calcium ionophore increases rates of fertiliz-\nation and pregnancy in severe male factor inferti-\nlity. Fertil Steril. 2012;98(6):1432-7. \n \n37. Chithiwala ZH, Lee HC, Hill DL, Jellerette-Nolan \nT, Fissore R, Grow D, et al. Phospholipase C-zeta \ndeficiency as a cause for repetitive oocyte fertiliz-\nation failure during ovarian stimulation for in vitro \nfertilization with ICSI: a case report. J Assisted \nReprod Genet. 2015;32(9):1415-9. \n \n38. Heytens E, Schmitt-John T, Moser JM, Jensen \nNM, Soleimani R, Young C, et al. Reduced fer-\ntilization after ICSI and abnormal phospholipase C \nzeta presence in spermatozoa from the wobbler \nmouse. Reprod Biomed Online.", "mimetype": "text/plain", "start_char_idx": 29344, "end_char_idx": 30808, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a2c6d77-22cf-4858-87d9-ab17d2427306": {"__data__": {"id_": "2a2c6d77-22cf-4858-87d9-ab17d2427306", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Nazarian (2018).pdf", "node_type": "4", "metadata": {}, "hash": "715000e797275e33acf3599e67dba9475cd92b200f7a5ac77dd3212cca871270", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1e34a1d-e107-4a11-83a5-722ccaa2c0b5", "node_type": "1", "metadata": {}, "hash": "3521a35ae5782fc6a845e7b48344784ee8e05aef7ed33b1092b7509ec54f4f58", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Reduced fer-\ntilization after ICSI and abnormal phospholipase C \nzeta presence in spermatozoa from the wobbler \nmouse. Reprod Biomed Online. 2010;21(6):742-9. \n \n39. Vanden Meerschaut F, Nikiforaki D, De Roo C, \nLierman S, Qian C, Schmitt-John T, et al. Com-\nparison of pre- and post-implantation development \nfollowing the application of three artificial activ-\nating stimuli in a mouse model with round-headed \nsperm cells deficient for oocyte activation. Hum \nReprod. 2013;28(5):1190-8. \n \n40. Ozil JP, Huneau D. Activation of rabbit oocytes: \nthe impact of the Ca2+ signal regime on develop-\nment. Development. 2001;128(6):917-28.", "mimetype": "text/plain", "start_char_idx": 30668, "end_char_idx": 31302, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5e463115-2b22-4110-b039-caf0eec60127": {"__data__": {"id_": "5e463115-2b22-4110-b039-caf0eec60127", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c7b65309-6163-4163-b7f5-22ad8f5bc740", "node_type": "1", "metadata": {}, "hash": "ff7d97117bdacc358621521099c86e8e57851aad05823523f2433458ec0c5371", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "O-6 Monday, October 14, 2019 12:00 PM\nPHASE 3 TRIAL RESULTS: EFFICACYAND SAFETYOF\nELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE\nFIBROIDS AND ADENOMYOSIS.\nOzgul Muneyyirci-De-\nlale, MD,a David F. Archer, MD,b Jin Hee Jeannie Kim, MD,c\nRan Liu, PhD,d\nCharlotte D. Owens, MD,d\nElizabeth E. Puscheck, MD,\nMS, MBAe aState University of New York, Brooklyn, NY; bEastern Virginia\nMedical School, Norfolk, VA; cColumbia University, New York, NY; dAbbVie,\nInc., North Chicago, IL; eWayne State Uinversity, Detroit, MI.\nOBJECTIVE: Adenomyosis is a benign lesion within the myometrium\nassociated with heavy menstrual bleeding (HMB) and dysmenorrhea, and\ncommonly co-exists with uterine \ufb01broids (UF). Adenomyosis is also present\nin 15-57% of hysterectomy specimens with leiomyoma (Genc M, et al, 2015;\nTaran FA, et al, 2010). This analysis evaluated the ef\ufb01cacy and safety of ela-\ngolix, an oral, gonadotropin-releasing hormone receptor antagonist, with\nadd-back therapy in a subset of women with UF, HMB and co-existing ad-\nenomyosis.\nDESIGN: Data were pooled from two 6-month, randomized, double-blind,\nplacebo-controlled phase 3 studies, Elaris UF-1 and UF-2. Premenopausal\nwomen (18-51 years) with ultrasound-con\ufb01rmed diagnosis of UF and\nHMB (>80mL menstrual blood loss [MBL]/cycle) were randomized 1:1:2\nto placebo, elagolix 300mg twice daily (BID), or elagolix 300mg BID with\n1mg estradiol/0.5mg norethindrone acetate (E2/NETA) once daily.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1430, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7b65309-6163-4163-b7f5-22ad8f5bc740": {"__data__": {"id_": "c7b65309-6163-4163-b7f5-22ad8f5bc740", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5e463115-2b22-4110-b039-caf0eec60127", "node_type": "1", "metadata": {}, "hash": "401557d82aeede2be1ed085d0509e434fb96c28f8a744e6781b8f1fb980c6c7f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "34b050d2-36e3-4344-8cae-229cc065a8ff", "node_type": "1", "metadata": {}, "hash": "425508e607503dbb69d1d19666dc9f090af8990fc3b8b5aa24cf4c82c13fb098", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MATERIALS AND METHODS: This subset analysis was conducted in\nwomen with HMB associated with UF and co-existing adenomyosis diag-\nnosed by ultrasound and/or MRI at baseline (BL). The primary endpoint\nwas the proportion of women with <80mL MBL during the \ufb01nal month\nand R50% reduction in MBL from BL to the \ufb01nal month. MBL and the diag-\nnosis of HMB was assessed with the alkaline hematin method. Adverse\nevents (AEs) were monitored.\nRESULTS: Of 790 women treated, 16% had ultrasound and/or MRI diag-\nnosed adenomyosis at BL. Pooled data demonstrated that the proportion of\nresponders for the primary endpoint was signi\ufb01cantly greater (P<0.001)\nfor elagolix+E2/NETA [76.8% (95% CI, 65.84, 87.82)] compared to placebo\n[12.1% (95% CI, 0.97, 23.150)]. AEs reported in the adenomyosis subset\nincluded hot \ufb02ushes, night sweats, headache, and nausea.\nCONCLUSIONS: In women with HMB associated with UF and co-exist-\ning adenomyosis at BL, elagolix +E2/NETA signi\ufb01cantly reduced MBL\nversus placebo similar to the all-subject group. AEs reported in this group\nwere similar to the all subject group. These data suggest that further studies\ninvestigating the effect of elagolix in women with HMB associated with UF\nand adenomyosis may be warranted.\nReferences: 1. Genc, M., et al., Adenomyosis and accompanying gyneco-\nlogical pathologies. Arch Gynecol Obstet. 2015. 291(4): p. 877-881.\n2. Taran, F.A., et al., Characteristics indicating adenomyosis coexisting\nwith leiomyomas: a case-control study. Human reproduction (Oxford, En-\ngland). 2010. 25(5): p. 1177-1182.\nSUPPORT: This work was funded by AbbVie Inc.", "mimetype": "text/plain", "start_char_idx": 1431, "end_char_idx": 3029, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34b050d2-36e3-4344-8cae-229cc065a8ff": {"__data__": {"id_": "34b050d2-36e3-4344-8cae-229cc065a8ff", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c7b65309-6163-4163-b7f5-22ad8f5bc740", "node_type": "1", "metadata": {}, "hash": "ff7d97117bdacc358621521099c86e8e57851aad05823523f2433458ec0c5371", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "65d31939-9391-4a0c-aea8-d28b804ebab4", "node_type": "1", "metadata": {}, "hash": "6346541dedc884111cb6970982b5a17dc031493beac089a4aef7d1bfed58418f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human reproduction (Oxford, En-\ngland). 2010. 25(5): p. 1177-1182.\nSUPPORT: This work was funded by AbbVie Inc. AbbVie participated in\nthe study design, research, data collection, analysis and interpretation of data,\nwriting, reviewing, and approving the publication.\nART LAB: BASIC\nO-7 Monday, October 14, 2019 10:45 AM\nIMPLEMENTATION\nOF\nAN\nELECTRONIC\nWHITEBOARD\nFOR\nQUALITY\nMANAGEMENT\nIN\nTHE\nIN\nVITRO\nFERTILIZATION\nLABORATORY.\nPhillip\nA.\nRomanski,\nMD,a\nAnn M. Thomas, PhD,b\nJay Patel, MS,c\nDan Zhang, MD, PhD,a\nCatherine Racowsky, PhDb aBrigham & Women\u2019s Hospital and Harvard\nMedical School, Boston, MA; bBrigham & Women\u2019s Hospital, Boston,\nMA; cBrigham and Womens Hospital, Boston, MA.\nOBJECTIVE: In 2014, we implemented an electronic whiteboard as a\nquality management tool to assist our embryologists to ensure their adher-\nence to established standards for performing time-sensitive procedures (1).\nWe aimed to test the hypothesis that use of an electronic whiteboard in the\nIVF laboratory increases the likelihood that critical evaluation procedures\nare performed within optimum pre-set time ranges.\nDESIGN: Retrospective cohort study.\nMATERIALS AND METHODS: Retrievals in our IVF clinic between 6/1/\n12 and 5/31/18 were included. The pre-electronic whiteboard time-period\nwas 6/1/12 to 4/5/14, during which embryologists strived to adhere to the\nset optimum evaluation times but without a formal guide. The post-electronic\nwhiteboard time-period was 3/1/15 to 5/31/18. The 13 months after the elec-\ntronic whiteboard was introduced (4/6/14-2/28/15) were de\ufb01ned as a transi-\ntion period and were excluded.", "mimetype": "text/plain", "start_char_idx": 2918, "end_char_idx": 4530, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "65d31939-9391-4a0c-aea8-d28b804ebab4": {"__data__": {"id_": "65d31939-9391-4a0c-aea8-d28b804ebab4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "34b050d2-36e3-4344-8cae-229cc065a8ff", "node_type": "1", "metadata": {}, "hash": "425508e607503dbb69d1d19666dc9f090af8990fc3b8b5aa24cf4c82c13fb098", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26e01579-6891-488c-ba07-508bee9ade1f", "node_type": "1", "metadata": {}, "hash": "3439f271d472f4bf1912fdc22711e78ad17c5bfad08ecd816f71baf32e6cd53a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The 13 months after the elec-\ntronic whiteboard was introduced (4/6/14-2/28/15) were de\ufb01ned as a transi-\ntion period and were excluded. Optimum pre-set time ranges were 16-18\nhours post-insemination or ICSI (HPI) for the pronuclei (PN) check, 65-67\nHPI for day 3 evaluations and 114-117 HPI for day 5 evaluations. Log bino-\nmial models estimated the risk ratio (RR, 95% con\ufb01dence interval [CI]) of\nevaluations occurring within the optimum time ranges. Models were adjusted\na priori for ICSI.\nRESULTS: A total of 44,957 oocytes from 6,302 retrievals met inclusion\ncriteria, of which 44.4% underwent ICSI. There were 16,434 oocytes from\n2,703 retrievals pre-electronic whiteboard and 28,523 oocytes from 3,599 re-\ntrievals post-electronic whiteboard. The proportion of oocytes evaluated at\nthe PN check within the optimum time range was statistically signi\ufb01cantly\nincreased after implementation of the electronic whiteboard (89.2% vs\n80.8%, RR 1.11 [95% CI 1.10 \u2013 1.12]). The proportion of day 3 and day 5\nchecks that occurred within the optimum time ranges were also statistically\nsigni\ufb01cantly increased after implementation of the electronic whiteboard\n(day 3: 73.3% vs 57.2%, RR 1.75 [95% CI 1.54 \u2013 1.99]) and (day 5:\n74.1% vs 58.8%, RR 1.26 [95% CI 1.24 \u2013 1.29]).\nCONCLUSIONS: Our \ufb01ndings indicate that use of an electronic white-\nboard that posts optimum time ranges for performing critical IVF laboratory\nprocedures tightens the actual evaluation times towards these ranges. Such\nimproved standardization may lead to positive downstream effects on quality\nassurance analyses and embryo transfer and embryo cryopreservation man-\nagement decisions. Future studies will investigate whether use of an elec-\ntronic whiteboard in the IVF laboratory improves overall clinical care.\nReference: 1.", "mimetype": "text/plain", "start_char_idx": 4395, "end_char_idx": 6187, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "26e01579-6891-488c-ba07-508bee9ade1f": {"__data__": {"id_": "26e01579-6891-488c-ba07-508bee9ade1f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "65d31939-9391-4a0c-aea8-d28b804ebab4", "node_type": "1", "metadata": {}, "hash": "6346541dedc884111cb6970982b5a17dc031493beac089a4aef7d1bfed58418f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bf72e3ca-1814-421b-a0d1-86da4cee2a5e", "node_type": "1", "metadata": {}, "hash": "3e9610b29f1662276375b3b511c9cd79e66221f882d49aa7d99edf0b492c0958", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Future studies will investigate whether use of an elec-\ntronic whiteboard in the IVF laboratory improves overall clinical care.\nReference: 1. Olofsson JI, Banker MR, Sjoblom LP. Quality management\nsystems for your in vitro fertilization clinic\u2019s laboratory: Why bother? Jour-\nnal of Human Reproductive Sciences. 2013;6:3.\nSUPPORT: None.\nO-8 Monday, October 14, 2019 11:00 AM\nTHE CLINICAL RESULTS OF PIEZO-ICSI COMPARED\nTO\nCONVENTIONAL-ICSI:\nA\nSIBLING-OOCYTE\nSTUDY.\nNoriyuki Okuyama, M.Sc.,a\nRyuichiro Obata,\nPh.D.,a\nNao\nOka,\nM.Sc.,a\nNobuya\nAono,\nPh.D.,b\nTomoko Hashimoto, M.D., Ph.D.,a Koichi Kyono, M.D., Ph.D.a aKyono ART\nClinic Takanawa, Tokyo, Japan; b3-13-1, takanawa, Minato-ku, Tokyo, Japan.\nOBJECTIVE: Clinically, conventional ICSI (CI) is a common, widely-\nused method, while there are few reports with respect to Piezo ICSI (PI).\nPI is effective in degeneration rate and fertilization rate (Kimura, Y & Yana-\ngimachi, R, 1995). It is known that the survival rates of mice oocytes are low\nafter CI; however, degeneration rate improved markedly using PI. PI is an\neffective technique for cases with fragile oocytes. It has been reported that\nthe survival rate is similarly improved in human oocytes (Hiraoka, K & Ki-\ntamura, S, 2015). However, most of the studies reporting on PI are retrospec-\ntive studies. Here, we prospectively compared the degeneration rates,\nfertilization rates and embryo development of PI and CI in a sibling study.\nDESIGN: This is a prospective randomized controlled single-center study,\nusing sibling oocytes, conducted from August 2018 to March 2019. Written\ninformed consent was obtained from all patients involved in this study.\nMATERIALS AND METHODS: This sibling oocyte study comprised 26\ncycles in 26 cases.", "mimetype": "text/plain", "start_char_idx": 6046, "end_char_idx": 7794, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf72e3ca-1814-421b-a0d1-86da4cee2a5e": {"__data__": {"id_": "bf72e3ca-1814-421b-a0d1-86da4cee2a5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26e01579-6891-488c-ba07-508bee9ade1f", "node_type": "1", "metadata": {}, "hash": "3439f271d472f4bf1912fdc22711e78ad17c5bfad08ecd816f71baf32e6cd53a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8fe5dc88-e38e-441c-a398-fe068c827d06", "node_type": "1", "metadata": {}, "hash": "0b673fc8e93b9b47c164855c1059c52881ef1347b62ccac8e26591a35af0abab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Written\ninformed consent was obtained from all patients involved in this study.\nMATERIALS AND METHODS: This sibling oocyte study comprised 26\ncycles in 26 cases. CI was performed in 149 mature oocytes. CI consists of\nmechanical penetration of the zona pellucida, breaking the oocyte membrane\nby aspiration of cytoplasm. PI was performed in 162 mature oocytes. PI con-\nsists of breaking the oocyte membrane and zona pellucida by Piezo pulse. P-\nvalue\nof\n0.05\nor\nless\nwas\nconsidered\nto\nbe\nstatistically\nsigni\ufb01-\ncant.~aVVLimitation: The clinical results using vitri\ufb01ed oocytes, arti\ufb01cial\noocyte activation, cryptozoospermia, azoospermia cases, and females aged\nover 40 years old were not included in this study. The pregnancy outcome\nhas not been con\ufb01rmed in our study.\nRESULTS: There were no statistically signi\ufb01cant differences in the fertil-\nization rates, degeneration rates, cleavage rates, blastocyst formation rates or\ngood quality blastocyst rates (according to the Gardner criteria) between CI\nand PI (75.8% vs. 78.4% (P\u00bc0.592), 7.4% vs. 3.7% (P\u00bc0.146), 100% vs.\n96.8% (P\u00bc0.160), 61.9% vs. 64.0% (P\u00bc0.743) and 41.6% vs. 36.8%\n(P\u00bc0.450), respectively).\nCONCLUSIONS: In conclusion, the present study has demonstrated there\nwas no signi\ufb01cant difference in the clinical results of piezo-ICSI and conven-\ntional-ICSI. However, this may be attributable to the limited number of cases\nwith fragile oocytes, etc. In our experience, PI is safer and easier to learn and\ne4\nASRM Abstracts\nVol. 112, No. 3, Supplement, September 2019\nperform in clinical work in a shorter period, especially for beginners. Further\nstudies are necessary.", "mimetype": "text/plain", "start_char_idx": 7633, "end_char_idx": 9263, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8fe5dc88-e38e-441c-a398-fe068c827d06": {"__data__": {"id_": "8fe5dc88-e38e-441c-a398-fe068c827d06", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf72e3ca-1814-421b-a0d1-86da4cee2a5e", "node_type": "1", "metadata": {}, "hash": "3e9610b29f1662276375b3b511c9cd79e66221f882d49aa7d99edf0b492c0958", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5370834e-f927-4713-b100-00b9527155ac", "node_type": "1", "metadata": {}, "hash": "c79451d79e22328e41616cd02056c142a285eaff555f35c3079be53a0b9c29c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "112, No. 3, Supplement, September 2019\nperform in clinical work in a shorter period, especially for beginners. Further\nstudies are necessary.\nO-9 Monday, October 14, 2019 11:15 AM\nWOULD AN AUTOMATED SYSTEM DETECTING EM-\nBRYO DEVELOPMENTAL EVENTS SELECT THE\nSAME EMBRYO AS AN EMBRYOLOGIST USING A\nMORPHOKINETIC ALGORITHM?.\nRaquel Del Gal-\nlego, PhD,a Lorena Bori Arnal, PhD,a Lucia Alegre, PhD,a Teija Peura,\nPhD,b Manuel Ugidos, PhD,c Marcos Meseguer, PhDd aIVIRMA Global,\nValencia, Spain; bGenea Biomedx, Sydney, NSW, Australia; cInstituto de\nBiomedicina de Valencia, Valencia, Spain; dIVIRMA Global, Valencia,\nSpain, Tel Aviv, Israel.\nOBJECTIVE: The objective of this study is to compare embryo grading\nand clinical result prediction obtained with a morphokinetic algorithm using\nan automated system for embryo developmental events annotations vs.\nmanual annotations performed by an embryologist team.\nDESIGN: Retrospective study including morphokinetic manual and auto-\nmated data from 1,370 embryos (284 patients) at IVIRMA Valencia clinic.\nAll embryos were normally fertilized embryos cultured up to day 5/6. All\nwere included regardless of their treatment (egg donation or autologous),\noocyte origin (fresh or frozen) or patient age (range: 27-44 years).\nMATERIALS AND METHODS: All embryos were annotated manually\nby a busy embryologist team in the routine clinical practice using Geri\nAssess\u0001 1.3 software (IVI). The same videos were retrospectively assessed\nby the stand-alone Geri Assess\u0001 2.0 software (GA2), including \ufb01ltration of\nevents falling outside the pre-de\ufb01ned time-ranges, as is done in the full Geri\nsystem. Both morphokinetic manual and automated annotations went\nthrough an embryo selection algorithm developed by Basile et al. (2015)\nconsidering the morphokinetic parameters t3, cc2 (t3-t2) and t5.", "mimetype": "text/plain", "start_char_idx": 9122, "end_char_idx": 10943, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5370834e-f927-4713-b100-00b9527155ac": {"__data__": {"id_": "5370834e-f927-4713-b100-00b9527155ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8fe5dc88-e38e-441c-a398-fe068c827d06", "node_type": "1", "metadata": {}, "hash": "0b673fc8e93b9b47c164855c1059c52881ef1347b62ccac8e26591a35af0abab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f48423e0-9804-488f-be81-e4f9b4d3487d", "node_type": "1", "metadata": {}, "hash": "e086db4c2177564cc67fc2e1bd0847c8b4e3eccd908f93f93b1dd0821a8a8d59", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Both morphokinetic manual and automated annotations went\nthrough an embryo selection algorithm developed by Basile et al. (2015)\nconsidering the morphokinetic parameters t3, cc2 (t3-t2) and t5. Embryos\nwere graded and the accuracy in the prediction was assessed between both\ngroups in terms of embryo outcome, bHCG test, and fetal heartbeat. Data\nwas statistically analyzed with chi-squared and binomial proportion tests.\nRESULTS: High accordance was found between IVI and GA2 embryo\ngrading through Basile\u2019s algorithm. Out of the 1,370 embryos, 1,045 were\nutilized as transferred or vitri\ufb01ed, showing no statistically signi\ufb01cant differ-\nences between both groups in all grades: A+, A, B+, B, C+, C, D+ and D;\nexcept for No Grade (p < 0.05). More ungraded embryos were found in\nthe automated group, as Geri Assess\u0001 2.0 is designed to eliminate events\nfalling outside of pre-de\ufb01ned time-ranges, these annotations being consid-\nered anomalous. t3 was the most unavailable parameter in the GA2 data.\nRegarding only the 391 KID transferred embryos, bHCG test and fetal heart-\nbeat data also did not show statistically signi\ufb01cant results between IVI and\nGA2. Previous studies in our group have proven a high GA2 detection rate\nin the great majority of the events, especially in early cleavage divisions,\nwhich explains its good performance with the algorithm parameters: t3,\ncc2 and t5.\nCONCLUSIONS: The results of the study support the use of automated\nsystems for embryo morphokinetic annotations. This non-invasive and objec-\ntive tool standardizes the annotating process avoiding inter- and intra-grader\nvariability, in addition to facilitating the routine clinical practice. The estab-\nlishment of automation would need a gradual transition controlled by lab pro-\nfessionals, as yet chaotic embryos or artifacts in the well hinders its\nperformance.", "mimetype": "text/plain", "start_char_idx": 10750, "end_char_idx": 12598, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f48423e0-9804-488f-be81-e4f9b4d3487d": {"__data__": {"id_": "f48423e0-9804-488f-be81-e4f9b4d3487d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5370834e-f927-4713-b100-00b9527155ac", "node_type": "1", "metadata": {}, "hash": "c79451d79e22328e41616cd02056c142a285eaff555f35c3079be53a0b9c29c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ee91883c-f070-413c-8d84-447440864936", "node_type": "1", "metadata": {}, "hash": "f78817666253abd4f93db294d6388b8f9a99b5294ee3291132f740da0831ae93", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The estab-\nlishment of automation would need a gradual transition controlled by lab pro-\nfessionals, as yet chaotic embryos or artifacts in the well hinders its\nperformance.\nReferences: Basile N, Vime P, Florensa M, Aparicio Ruiz B, Garc\u0002\u0131a Ve-\nlasco JA, Remoh\u0002\u0131 J, Meseguer M. The use of morphokinetics as a predictor\nof implantation: A multicentric study to de\ufb01ne and validate an algorithm for\nembryo selection. Hum Reprod 2015; 30:276\u2013283.\nSUPPORT: Predoctoral Generalitat Valenciana and European Social Fund.\nO-10 Monday, October 14, 2019 11:30 AM\nPROPORTION OF PATIENTS DETECTED WITH SUB-\nCLINICAL HYPOTHYROIDISM IS INDEPENDENT OF\nTIME OF BLOOD DRAW.\nChristine Briton-Jones, PhD,\nHCLD,a\nJenna Friedenthal, MD,b\nSydney Chang, MD,b\nTaraneh Gharib Nazem, MD,b\nDmitry Gounko, MA,a\nJoseph A. Lee,\nBA,a\nAlan B. Copperman, MDb aReproductive Medicine Associates of\nNew York, New York, NY; bIcahn School of Medicine at Mount Sinai,\nNew York, NY.\nOBJECTIVE: There are differences in clinical opinion regarding the\nbene\ufb01t of treating subclinical hypothyroidism in infertile patients. However,\nfor patients with a thyroid stimulating hormone (TSH) serum level >\n2.5mIU/L it is recommended to continue monitoring or administer levothyr-\noxine to reduce TSH serum levels <2.5mIU/L (ASRM guideline document\n2015). TSH levels in adults, have a predictable circadian rhythm, with the\nhighest levels produced between 2am and 4am; while the lowest levels occur\nbetween 4pm and 8pm. Whether there is a misdiagnosis of subclinical hypo-\nthyroidism and underlying normal circadian rhythm due to testing afternoon\nblood draw is a current clinical concern. Only one study has showed the po-\ntential for this misdiagnosis, albeit the study included a small sample size.", "mimetype": "text/plain", "start_char_idx": 12425, "end_char_idx": 14174, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee91883c-f070-413c-8d84-447440864936": {"__data__": {"id_": "ee91883c-f070-413c-8d84-447440864936", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f48423e0-9804-488f-be81-e4f9b4d3487d", "node_type": "1", "metadata": {}, "hash": "e086db4c2177564cc67fc2e1bd0847c8b4e3eccd908f93f93b1dd0821a8a8d59", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b687125c-07dd-4940-887a-400f034f89e4", "node_type": "1", "metadata": {}, "hash": "7fd0a175a975646beb74ef5f6ab8cade4ac8f9b13b9caea26920cda60c07bd13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Only one study has showed the po-\ntential for this misdiagnosis, albeit the study included a small sample size. [1]\nThe objective of this study was to identify any differences in the mean TSH\nlevels obtained from morning compared to afternoon blood draws in patients\nseeking infertility treatment.\nDESIGN: Retrospective cohort analysis\nMATERIALS AND METHODS: This study examined patients having\nroutine TSH levels tested for either cycle day 3 evaluations or as part of a\nnew patient consultation from January 2018 and March 2019. Serum TSH\nconcentrations were obtained via electrochemiluminescence immunoassay\nElecsys for use on Cobas e601(Roche) Detection range of 0.005 \u2013 100\nmIU/L. Chi Square analysis was used to determine statistical signi\ufb01cance\nwith p<0.05 considered signi\ufb01cant.\nRESULTS: Of the 8345 patients who had routine TSH testing performed,\n5028 were drawn in the morning and 3281were drawn in the afternoon. There\nwas no signi\ufb01cant difference in the mean (\u0002 SD) TSH levels, 2.10408 (4.30)\nfor am blood draws and 2.10426 (4.31) for pm blood draws. There was also\nno differences in the in the percentage of TSH results showing >2.5mIU/L in\nmorning 25% compared to afternoon blood draw groups 26%.\nCONCLUSIONS: This study showed no shift in the mean or in percentage\nof patients with elevated TSH levels in the morning compared to afternoon\nblood draw group. This data shows that afternoon blood draws are just as\nlikely to detect elevated TSH levels as blood samples drawn in the morning.\nThe strength of this study is its ability to de\ufb01ne risks of misdiagnosis of sub-\nclinical hypothyroidism due to potential underlying changes in TSH levels\nfor the different times of blood draw using binomial sorting of patient data\nin a diverse population of patients seeking ART treatment. This study high-\nlights how TSH \ufb02uctuations that may occur throughout the day are clinically\ninsigni\ufb01cant and even with ultra-sensitive immunoassays not, detectable in a\npopulation of patients undergoing reproductive treatment.", "mimetype": "text/plain", "start_char_idx": 14063, "end_char_idx": 16084, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b687125c-07dd-4940-887a-400f034f89e4": {"__data__": {"id_": "b687125c-07dd-4940-887a-400f034f89e4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ee91883c-f070-413c-8d84-447440864936", "node_type": "1", "metadata": {}, "hash": "f78817666253abd4f93db294d6388b8f9a99b5294ee3291132f740da0831ae93", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f51a1a32-ce47-4b4e-882f-3461e5377732", "node_type": "1", "metadata": {}, "hash": "09edbbbb0708cc74585495e23f0e301f0264a4f6dcbdd04803e14816eea146e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Reference: Roelfsema F. and Veldhuis JD. Thyrotropin secretion patterns\nin health and disease. Endocrinology Reviews. 2013 34(5): 619-57.\nSUPPORT: None.\nO-11 Monday, October 14, 2019 11:45 AM\nPRELIMINARY\nRESULTS\nFROM\nTHE\nFIRST\nREGISTERED\nPILOT\nTRIAL\nWITH\nMATERNAL\nSPINDLE\nTRANSFER\nTO\nOVERCOME\nINFERTILITY.\nNuno Costa-Borges, PhD,a\nEros Nikitos,\nMSc,b Katharina Spath, PhD,c Dagan Wells, PhD,c Klaus Rink, PhD,a\nYannis\nVasilopoulos,\nMD,d\nIoannis\nZervomanolakis,\nMD,b\nDimitropoulos\nKonstantinos,\nMD,b\nPolyzos\nPanagiotis,\nMD,b\nStylianos\nGrigorakis,\nMD,\nFRCOG,b\nGeorge\nKontopoulos,\nMD,b\nKonstantinos\nKostaras,\nMD,\nPhD,d\nPanagiotis\nS.\nPsathas,\nMD,d\nGloria Calder\u0002on, PhDa aEmbryotools, Barcelona, Spain; bInstitute of Life,\nAthens, Greece; cIVI RMA, Oxford, United Kingdom; dInstitute of Life,\nAtherns, Greece.\nGroup\nConventional ICSI Piezo ICSI\nP\nPatients (N)\n26\n-\nNo. of ICSI cycles\n26\n-\nFemale age, years (mean \u0002 SD) 34.8 \u0002 4.2\n-\nMale age, years (mean \u0002 SD)\n36.9 \u0002 5.4\n-\nNo.", "mimetype": "text/plain", "start_char_idx": 16085, "end_char_idx": 17057, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f51a1a32-ce47-4b4e-882f-3461e5377732": {"__data__": {"id_": "f51a1a32-ce47-4b4e-882f-3461e5377732", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Okuyama (2019).pdf", "node_type": "4", "metadata": {}, "hash": "646e199eac5c24549f92c7049d633c15809ceb1a22436ab131fa1e7aea274875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b687125c-07dd-4940-887a-400f034f89e4", "node_type": "1", "metadata": {}, "hash": "7fd0a175a975646beb74ef5f6ab8cade4ac8f9b13b9caea26920cda60c07bd13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "of oocytes\n149\n162\n-\nN(%) of zygotes (2PN)\n113 (75.8)\n127 (78.4) 0.592\nN(%) of degenerated oocytes\n11 (7.4)\n6 (3.7)\n0.146\nN(%) of cleaved oocytes\n113 (100)\n122 (96.8) 0.167\nN(%) of blastocysts\n70 (61.9)\n80 (64.0) 0.477\nN(%) of good quality blastocysts\n47 (41.6)\n46 (36.8) 0.498\nFERTILITY & STERILITY\u0001\ne5", "mimetype": "text/plain", "start_char_idx": 17058, "end_char_idx": 17361, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dcfaddf2-45b7-45a4-8d27-f2ef202217fd": {"__data__": {"id_": "dcfaddf2-45b7-45a4-8d27-f2ef202217fd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7941db33-a293-4bf8-8019-94787b226219", "node_type": "1", "metadata": {}, "hash": "b8b134b5ddc8a560d699c9755450303b6fe112c1ec886ead6558469d9c4b5292", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Reproduction, Vol.33, No.9 pp. 1636\u20131644, 2018\nAdvanced Access publication on August 7, 2018\ndoi:10.1093/humrep/dey258\nORIGINAL ARTICLE Embryology\nArti\ufb01cial oocyte activation with SrCl2\nor calcimycin after ICSI improves\nclinical and embryological outcomes\ncompared with ICSI alone: results of\na randomized clinical trial\nMohamed Fawzy1,*, Mai Emad1, Ali Mahran2, Mohamed Sabry3,\nAhmed N. Fetih4, Hazem Abdelghafar3, and Salah Rasheed3\n1IbnSina IVF Centre, IbnSina Hospital, Sohag 15322, Egypt 2Department of Dermatology, Venereology and Andrology, Faculty of Medicine,\nAssiut University, AG 71515, Egypt 3Department of Obstetrics and Gynecology, Sohag University, Sohag 82524, Egypt 4Department of\nObstetrics and Gynecology, Faculty of Medicine, Assiut University, AG 71515, Egypt\n*Correspondence address. IVF Laboratory Director (IbnSina and Banoon IVF Centres), IbnSina Hospital, 146El Aref Square, Sohag, Egypt.\nTel: +20-101-112-2286; E-mail: drfawzy001@me.com\nSubmitted on February 28, 2018; resubmitted on June 30, 2018; accepted on July 9, 2018\nSTUDY QUESTION: Are pregnancy and birth rates affected by arti\ufb01cial oocyte activation (AOA) with SrCl2 or calcimycin after ICSI for\ncouples with male-factor infertility linked to abnormal sperm morphology or for couples with previous ICSI cycles of unexplained low fertiliza-\ntion or inadequate fertilization associated with impaired oocyte morphology?\nSUMMARY ANSWER: AOA with either SrCl2 or calcimycin can improve the rates of clinical pregnancy, ongoing pregnancy and live birth\ncompared with ICSI alone, and the two agents have diverse effects for different subgroups of patients.\nWHAT IS KNOWN ALREADY: ICSI is a successful treatment for infertility, but not in all individuals.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1741, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7941db33-a293-4bf8-8019-94787b226219": {"__data__": {"id_": "7941db33-a293-4bf8-8019-94787b226219", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dcfaddf2-45b7-45a4-8d27-f2ef202217fd", "node_type": "1", "metadata": {}, "hash": "f8c9c5265f8122576140d9202894b61e386b93cda27e6fb08068077ad3f80783", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd9043ab-a3a3-4b4f-ac90-50dfc0084e23", "node_type": "1", "metadata": {}, "hash": "a25778cf58a8f108a03a86ee0ad72745904df8f075b7a66b970859047be1eb9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "WHAT IS KNOWN ALREADY: ICSI is a successful treatment for infertility, but not in all individuals. AOA has potential to overcome\ninadequate fertilization in ICSI. Calcimycin and SrCl2 are candidate agents for AOA, but their effectiveness remains to be compared.\nSTUDY DESIGN, SIZE, DURATION: This study was a randomized, open-label, three-arm, parallel-group, double-centre, superiority\ntrial conducted between April 2015 and January 2016. The study evaluated the effects of AOA with calcimycin or SrCl2 for clinical pregnancy\nrates after ICSI and included 343 couples divided into three groups.\nPARTICIPANTS/MATERIALS, SETTING, METHODS: Couples were included if they had two previous ICSI cycles of no or low fertil-\nization (0\u201330%) with unknown causes or impaired oocyte morphology. Male-factor infertility cycles (frozen\u2013thawed sperm, surgically\nretrieved sperm or ejaculates contained <10 millions spermatozoa/ml) undergoing their \ufb01rst ICSI attempt were also included if they had\n100% abnormal sperm morphology (including globozoospermia and tapered-head). Couples were randomized to undergo ICSI with SrCl2\nAOA, ICSI with calcimycin AOA or ICSI alone, with clinical pregnancy as the primary endpoint. Effect sizes were summarized as absolute rate\ndifferences (ARDs) and odds ratios (ORs), with precision evaluated by 95% CIs.\nMAIN RESULTS AND THE ROLE OF CHANCE: Both SrCl2 and calcimycin AOA improved clinical pregnancy rates compared to ICSI\nalone (49, 42 and 27%; ARD 22, 95% CI: 9\u201333; P = 0.0007 and ARD 16, 95% CI: 3\u201327; P = 0.014). SrCl2 and calcimycin AOA were also\nsuperior to ICSI alone on the rates of ongoing pregnancy (42, 36 and 23%; P = 0.0019 and P = 0.023) and live birth (40, 33 and 18%;\nP = 0.0002 and P = 0.012).", "mimetype": "text/plain", "start_char_idx": 1643, "end_char_idx": 3379, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd9043ab-a3a3-4b4f-ac90-50dfc0084e23": {"__data__": {"id_": "dd9043ab-a3a3-4b4f-ac90-50dfc0084e23", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7941db33-a293-4bf8-8019-94787b226219", "node_type": "1", "metadata": {}, "hash": "b8b134b5ddc8a560d699c9755450303b6fe112c1ec886ead6558469d9c4b5292", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "78410b94-8da7-494d-881d-f354469491a6", "node_type": "1", "metadata": {}, "hash": "ccb7f8a16ac3c742faa28bdbf41570c7713da79f4215df1d0f17be0abe507e27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among couples with previous ICSI cycles of low fertilization, AOA with SrCl2 (but not with calcimycin) was super-\nior to ICSI alone for rates of clinical pregnancy (ARD 35 percentage points (pp), P = 0.0007), ongoing pregnancy (ARD 27 pp, P = 0.009) and\nlive birth (ARD 37 pp, P = 0.002). Among couples affected by male-factor infertility, AOA with calcimycin (but not with SrCl2) was superior\nto ICSI alone for rates of clinical pregnancy (ARD 22 pp, P = 0.006), ongoing pregnancy (ARD 19 pp, P = 0.013) and live birth (ARD 17 pp,\nP = 0.02).\n\u00a9 The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.\nFor Permissions, please e-mail: journals.permissions@oup.com\nLIMITATIONS, REASONS FOR CAUTION: This study was an open-label trial, and this design might have introduced bias, although ran-\ndomization methods were used. The study did not include a longitudinal follow-up, so further evidence is required to demonstrate the safety\nof AOA.\nWIDER IMPLICATIONS OF THE FINDINGS: The decision to use SrCl2 or calcimycin for AOA after ICSI may depend on whether the\nactivation failure originates in the oocyte or the sperm.\nSTUDY FUNDING/COMPETING INTEREST(S): The study received no funding and the authors have no con\ufb02icts of interest to\ndeclare.\nTRIAL REGISTRATION NUMBER: NCT02424214.\nTRIAL REGISTRATION DATE: 22 April 2015.\nDATE OF FIRST PATIENT\u2019S ENROLMENT: 27 April 2015.\nKey words: oocyte activation / calcium ionophore / calcium oscillation / failed fertilization / male factor infertility\nIntroduction\nIVF and ICSI are effective treatments for infertility (Palermo et al.,\n1992; Steptoe and Edwards, 1992; Kissin et al., 2014). Successful fertil-\nization requires oocyte activation, which depends on a proper inter-\naction between the gametes (Yeste et al., 2016).", "mimetype": "text/plain", "start_char_idx": 3380, "end_char_idx": 5240, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "78410b94-8da7-494d-881d-f354469491a6": {"__data__": {"id_": "78410b94-8da7-494d-881d-f354469491a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd9043ab-a3a3-4b4f-ac90-50dfc0084e23", "node_type": "1", "metadata": {}, "hash": "a25778cf58a8f108a03a86ee0ad72745904df8f075b7a66b970859047be1eb9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff9b4900-ff68-4df1-a32f-842f539fae3c", "node_type": "1", "metadata": {}, "hash": "a7bb26fe4fcf13868896a8c72979575f86df7d6507804e1cfb1d89c5bf23e207", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Successful fertil-\nization requires oocyte activation, which depends on a proper inter-\naction between the gametes (Yeste et al., 2016). Activation failure\nresults in poor fertilization rates (Flaherty et al., 1998; Cheng et al.,\n2011; Clift and Schuh, 2013).\nOocyte activation triggers a cascade of events including Ca2+ oscilla-\ntion, leading to fertilization and embryo development (Yeste et al.,\n2016). In animal models, the duration, amplitude and frequency of Ca2+\noscillation affect the normal oocyte activation and embryo development\n(Sfontouris et al., 2015). The precise mechanisms underlying oocyte\nactivation remain elusive. A likely mechanism is that the phospholipase\nC zeta (PLC\u03b6) of a fertilizing spermatozoon produces inositol-1,4,5-\ntrisphosphate within the oocyte which interacts with receptors in the\nendoplasmic reticulum, causing Ca2+ oscillation (Ridgway et al., 1977;\nSteinhardt et al., 1977; Miyazaki et al., 1992, 1993; Wassarman et al.,\n2001; Ducibella et al., 2002; Saunders et al., 2002; Horner and Wolfner,\n2008; Kashir et al., 2010; Amdani et al., 2013; Nomikos et al., 2013;\nEscof\ufb01er et al., 2014). Reports suggest that abnormal sperm morphology\nreduces the rates of fertilization and implantation (De Vos et al., 2003;\nLu et al., 2012; Greco et al., 2013). The oocyte also contributes to the\nactivation events via identi\ufb01ed and unidenti\ufb01ed factors (Tesarik et al.,\n2002; Eldar-Geva et al., 2003; Heindryckx et al., 2005, 2008; Combelles\net al., 2010; Yelumalai et al., 2015).\nArti\ufb01cial oocyte activation (AOA) can repair a defective activation\n(Yeste et al., 2016), improving ICSI outcomes (Montag et al., 2012).", "mimetype": "text/plain", "start_char_idx": 5104, "end_char_idx": 6749, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff9b4900-ff68-4df1-a32f-842f539fae3c": {"__data__": {"id_": "ff9b4900-ff68-4df1-a32f-842f539fae3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "78410b94-8da7-494d-881d-f354469491a6", "node_type": "1", "metadata": {}, "hash": "ccb7f8a16ac3c742faa28bdbf41570c7713da79f4215df1d0f17be0abe507e27", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f00be8b-452b-46c5-9597-4b90469385f5", "node_type": "1", "metadata": {}, "hash": "d7a41bae187ebdb19d79ae6d5a27fc8ec06de81f0d58094d4e75f73ff4a5b4d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Arti\ufb01cial oocyte activation (AOA) can repair a defective activation\n(Yeste et al., 2016), improving ICSI outcomes (Montag et al., 2012).\nMechanical, electrical and chemical activation serve as AOA methods\n(Vanden Meerschaut et al., 2012; 2014). Chemical AOA is the prominent,\nand it induces either a single, prolonged wave or pulsatile waves of intracy-\ntoplasmic Ca2+ (Yeste et al., 2016; Murugesu et al., 2017). Calcimycin,\nionomycin, puromycin and 6-dimethylaminopurine increase membrane\npermeability to extracellular Ca2+, inducing a single, prolonged Ca2+ wave\n(Rybouchkin et al., 1997; Ebner et al., 2015; Yeste et al., 2016). Strontium\nchloride (SrCl2), phorbol esters or anhydrous alcohol release the Ca2+\nfrom the endoplasmic reticulum in pulsatile waves (Kline and Kline, 1992;\nKishikawa et al., 1999; Kim et al., 2014; Yeste et al., 2016).\nAOA with calcimycin or SrCl2 can improve outcomes for ICSI cycles\nof impaired fertilization (Yanagida et al., 2006; Chen et al., 2010; Kim\net al., 2014; Murugesu et al., 2017). Variable studies including retro-\nspective designed analyses, historical comparisons or relatively under-\npowered studies have synthesized this evidence. Most of the studies\nhave only examined calcimycin AOA, although SrCl2 has shown poten-\ntial for AOA (Kim et al., 2014; Yeste et al., 2016). Recently, Lu et al.\n(2018) showed that SrCl2 AOA cannot provoke calcium oscillation or\nparthenogenic division for human oocytes. However, Lu et al. used\nin vitro matured oocytes or oocytes characterized by smooth endo-\nplasmic reticulum. In addition, there has been no comparative rando-\nmized clinical trial (RCT) to evaluate the relative effectiveness of\ncalcimycin and SrCl2.", "mimetype": "text/plain", "start_char_idx": 6613, "end_char_idx": 8313, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0f00be8b-452b-46c5-9597-4b90469385f5": {"__data__": {"id_": "0f00be8b-452b-46c5-9597-4b90469385f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff9b4900-ff68-4df1-a32f-842f539fae3c", "node_type": "1", "metadata": {}, "hash": "a7bb26fe4fcf13868896a8c72979575f86df7d6507804e1cfb1d89c5bf23e207", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae5cdbe6-c6c7-4d4b-8bac-109a089e67fe", "node_type": "1", "metadata": {}, "hash": "18b4f26f868177e6af49cc0721393a3bcedb88a48929483d3fc0b0e0976e4a3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In addition, there has been no comparative rando-\nmized clinical trial (RCT) to evaluate the relative effectiveness of\ncalcimycin and SrCl2. Whether the sperm or the oocyte is most\nresponsible for the activation defects remains unidenti\ufb01able from a\nclinical perspective (Murugesu et al., 2017).\nTo address these questions, we compared SrCl2 and calcimycin\nAOA with each other and with ICSI alone in this prospective RCT,\nidentifying the rate of clinical pregnancy as a primary endpoint. To\ndetermine whether the sperm or the oocyte is most responsible, infer-\ntile couples included were those undergoing ICSI cycles for previous\nlow fertilization (<30%) but normal semen parameters or \ufb01rst ICSI\ncycles for male-factor infertility with abnormal sperm morphology.\nMaterials and Methods\nTrial design\nThe study adopted a randomized, open-label, three-arm, parallel-group,\ndouble-centre, superiority trial design (NCT02424214, registered at www.\nClinicalTrials.gov). Two private IVF facilities in Egypt (Ibnsina IVF Centre,\nSuhag and Banoon IVF Centre, Asyut) conducted the trial. The trial included a\nscreening period of 18 months (from the time of getting the consent to the\nstart of assignment of participants). Research instructors disclosed the details\nto eligible couples. From January to April 2015, research instructors recalled\nparticipants for randomization and enrolment. The \ufb01rst couple was recruited\non 30 April 2015, and the last oocyte retrieval was performed on 17 January\n2016. Participants provided written informed consent. The ethics committees\nof the centres approved the study (Number 09; 02/2013). Independent\nexperts and safety committees oversaw this study.\nParticipants\nWomen were 18\u201340 years of age with a BMI of <31 kg/m2. Inclusion cri-\nteria were deliberately broad to include couples with two previous ICSI\ncycles of no or low fertilization (0\u201330%) or with male-factor infertility\n1637\nSrCl2 and calcimycin regulate oocyte activation\nundergoing their \ufb01rst ICSI cycle.", "mimetype": "text/plain", "start_char_idx": 8173, "end_char_idx": 10166, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ae5cdbe6-c6c7-4d4b-8bac-109a089e67fe": {"__data__": {"id_": "ae5cdbe6-c6c7-4d4b-8bac-109a089e67fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f00be8b-452b-46c5-9597-4b90469385f5", "node_type": "1", "metadata": {}, "hash": "d7a41bae187ebdb19d79ae6d5a27fc8ec06de81f0d58094d4e75f73ff4a5b4d2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e1e4a91b-eba7-4532-8dd3-52be9c907e41", "node_type": "1", "metadata": {}, "hash": "57844f9fc4bd890f31f85e35b890e8474cc783ec866362424aabcd649aa8d022", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We classi\ufb01ed previous cycles of low fertiliza-\ntion as \u2018unexplained low fertilization\u2019 or as \u2018low fertilization associated with\nimpaired oocyte morphology\u2019, but within normal sperm limits. Impaired\nmorphology of oocytes, according to the Istanbul Consensus, was non-\nconformity with the following de\ufb01nition: a spherical structure in a uniform\nzona pellucida with a uniform translucent cytoplasm free of inclusions and\nwith a size-proper polar body (Alpha Scientists in Reproductive Medicine\nand ESHRE Special Interest Group of Embryology, 2011). The male-factor\ninfertility cycles (frozen\u2013thawed sperm, surgically retrieved sperm or ejacu-\nlates containing <10 million spermatozoa/ml) undergoing their \ufb01rst ICSI\nattempt had 100% abnormal sperm morphology (including globozoospermia\nand tapered-head). Couples had primary infertility with no previous com-\npleted pregnancy or abortion. Exclusion criteria were couples with endo-\nmetriosis, thin endometrial lining or pinhead sperm defects.\nRandomization and masking\nUsing an online randomization tool (http://www.openepi.com/Random/\nRandom.htm), independent data managers assigned participants to SrCl2\nAOA, calcimycin AOA or ICSI alone with a 1:1:1 allocation ratio. Block\nrandomization was performed to ensure equal representation of couples\nin the study groups. Each allocation was sealed in a sequentially numbered,\nopaque envelope. On 27 April 2015, independent instructors recorded\neach envelope number in each woman\u2019s case-record \ufb01le. On Day 21 of\nthe cycle preceding ICSI, research instructors opened the envelope and\nassigned the participant to the relevant group. Immediately, the instructors\ntransferred the allocation result to the laboratory team, keeping gynaecol-\nogists and participants unaware of the result until the embryo transfer.\nStimulation protocol, embryo transfer and\nluteal-phase support\nPituitary\ndownregulation\nwas\nattainable\nby\nsubcutaneous\nGnRH-a\n(Decapeptyl 0.1 mg, Ferring, Saint-Prex, Switzerland) from Day 21 of the\ncycle preceding ICSI.", "mimetype": "text/plain", "start_char_idx": 10167, "end_char_idx": 12188, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e1e4a91b-eba7-4532-8dd3-52be9c907e41": {"__data__": {"id_": "e1e4a91b-eba7-4532-8dd3-52be9c907e41", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae5cdbe6-c6c7-4d4b-8bac-109a089e67fe", "node_type": "1", "metadata": {}, "hash": "18b4f26f868177e6af49cc0721393a3bcedb88a48929483d3fc0b0e0976e4a3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c5ae8542-e65c-4448-ade8-8062fc4be831", "node_type": "1", "metadata": {}, "hash": "c07f903e2d4d8463224bb8e8e55a565ba1865e9786a8c8805ce91228f207cec3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "On Day 2 of the ICSI cycle, women received\n225\u2013300 IU of rFSH (Gonal-F, Merck Serono) and hMG injections\n(Menogon, Ferring) with a 2:1 ratio, with the dose adjusted according to\nthe response. When three follicles measured 18 mm diameter, \ufb01nal matur-\nation was induced by 10 000 IU human chorionic gonadotropin (hCG,\nChoriomon, IBSA, Lugano, Switzerland). Oocytes were collected 37 h\nlater and the metaphase II (MII) were inseminated by ICSI (Palermo et al.,\n1992). On Day 5, speci\ufb01ed clinicians followed a standard protocol, trans-\nferring one to two blastocysts for each woman. For luteal phase support,\nwomen began intramuscular progesterone (100-mg, Prontogest, IBSA)\nfrom the day after oocyte retrieval to the 12th week of gestation, unless\nthe biochemical pregnancy test was negative.\nSperm preparation, oocyte retrieval,\ndenudation and ICSI\nFresh, frozen\u2013thawed and surgically retrieved sperm were prepared at\nroom\ntemperature\nby\ndensity-gradient\ncentrifugation\n(PureSperm,\nNidacon, M\u00f6lndal, Sweden) (Bj\u00f6rndahl et al., 2010). Samples were then\nwashed and incubated in AllGrade Wash medium (LifeGlobal, Guilford,\nCT, USA). Follicles were aspirated into, and handled in, Global HEPES\nmedium (LifeGlobal) at 37\u00b0C, using a tube warmer. With chemical and\nmechanical tools (80 IU hyaluronidase, LifeGlobal; Denudation Pipette,\nVitrolife, G\u00f6teborg, Sweden), oocytes were denuded at 39 h after hCG.\nImmediately, ICSI was performed at 37\u00b0C, in Global HEPES (LifeGlobal).", "mimetype": "text/plain", "start_char_idx": 12189, "end_char_idx": 13656, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c5ae8542-e65c-4448-ade8-8062fc4be831": {"__data__": {"id_": "c5ae8542-e65c-4448-ade8-8062fc4be831", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e1e4a91b-eba7-4532-8dd3-52be9c907e41", "node_type": "1", "metadata": {}, "hash": "57844f9fc4bd890f31f85e35b890e8474cc783ec866362424aabcd649aa8d022", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0ac23d77-5341-4cac-9702-70b39483f26d", "node_type": "1", "metadata": {}, "hash": "158a57f78671b3b386222546011fd07779b561cdad5104ed9d0a6eea04344f7c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Immediately, ICSI was performed at 37\u00b0C, in Global HEPES (LifeGlobal).\nCulture protocol and embryo scoring\nIn the two centres and across the study, laboratory variables were con-\ntrolled using: only Minc-1000 incubators (Cook, USA); Global Total medium\n(LifeGlobal); 37 \u00b1 0.1\u00b0C culture temperature veri\ufb01ed by a thermocouple\n(Chino, Tokyo, Japan); 7.25 \u00b1 0.02 pH validated weekly by a blood gas ana-\nlyser (Epocal, Ottawa, Canada); group culture of three oocytes; 15 \u03bcl\nmedium droplet in micro-droplet dish (Vitrolife) overlaid by 5 ml oil (NidOil,\nNidacon); continuous culture from Day 0 through Day 5/6, without medium\nrenewal; premixed gas (7.5% CO2, 5% O2 and 87.5% N2); and the same\nbatches of disposables. Fertilization check and embryo grading were\nperformed on Days 1, 3 and 5 of culture (Alpha Scientists in Reproductive\nMedicine and ESHRE Special Interest Group of Embryology, 2011).\nInterventions\nImmediately after ICSI, AOA was performed and comprised incubation for\n1 h in 10 mM SrCl2 (Sigma, St Louis, MO, USA) diluted in Global Total\nmedium or incubation for 20 min in a commercial calcimycin (Cult-active\nCa-Ionophore; Gynemed, Lensahn, Germany). AOA droplets were 200 \u03bcl\neach in 60-mm dishes (353652, BD Falcon, USA) overlaid with 10 ml oil\n(NidOil) and were equilibrated overnight at 37\u00b0C and in an atmosphere of\n7.5% CO2, 5% O2, and 87.5% N2 (pH 7.25 \u00b1 0.02).\nStudy outcomes\nThe primary endpoint was clinical pregnancy rate (positive heartbeat on\nultrasonography at \u22654 weeks after ET).", "mimetype": "text/plain", "start_char_idx": 13586, "end_char_idx": 15089, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0ac23d77-5341-4cac-9702-70b39483f26d": {"__data__": {"id_": "0ac23d77-5341-4cac-9702-70b39483f26d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c5ae8542-e65c-4448-ade8-8062fc4be831", "node_type": "1", "metadata": {}, "hash": "c07f903e2d4d8463224bb8e8e55a565ba1865e9786a8c8805ce91228f207cec3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7861ad15-19aa-4e5a-8ea5-4165a8b88c66", "node_type": "1", "metadata": {}, "hash": "f918afa12bf5e9b9812d391e6b949b5554111276c95d13a7103f83911d50786f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Study outcomes\nThe primary endpoint was clinical pregnancy rate (positive heartbeat on\nultrasonography at \u22654 weeks after ET). Secondary endpoints included the\nrates of (i) fertilization (fertilized oocytes with two pronuclei per MII\noocyte injected); (ii) high-quality embryos on Day 3 (seven or eight blasto-\nmeres of equal-size and <10% fragmentation by volume); (iii) formed\nblastocyst on Day 5/6 from fertilized oocytes; (iv) high-quality blastocysts\n(blastocysts \u22653.1.1 grade, per fertilized oocyte); (v) biochemical pregnancy\n(positive b-hCG at \u226514 days following ET); (vi) ongoing pregnancy (preg-\nnancy following week 12 of gestation); (vii) multiple pregnancy (\u2265two\nfoetuses with a heartbeat); (viii) implantation (sacs with a heartbeat);\n(ix) miscarriage (pregnancy loss before gestational week 12); and (x) live birth\n(viable neonate at \u226530 weeks of gestation).\nStatistical analysis\nPrevious cycles of low fertilization for women younger than 40 years of age\nshowed a 16% clinical pregnancy rate (Murugesu et al., 2017). This trial was\npowered to detect a 14% rise in pregnancy rate (16\u201330%) with 80% power\nat 5% signi\ufb01cance level, requiring 342 participants (114 per arm) to undergo\nSrCl2 AOA, calcimycin AOA or ICSI alone and reach the primary endpoint.\nAn alternative was to enrol up to 450 women, to allow for any signi\ufb01cant\ndropout. The independent data and safety committees performed an\ninterim analysis at 343 participants, advising that no more enrolment is\nneeded. Data were analysed using binomial logistic regression with log link,\none-way ANOVA, Fisher\u2019s exact and Chi-square tests where appropriate.\nBetween-clinician and between-embryologist differences were controlled by\nFleiss\u2019 Kappa analysis (McHugh, 2012). Results are reported as an intention-\nto-treat and per indication analyses and are presented as an absolute rate\ndifference (ARD), odds ratio (OR) with 95% CI) or means with SD where\nappropriate.", "mimetype": "text/plain", "start_char_idx": 14964, "end_char_idx": 16897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7861ad15-19aa-4e5a-8ea5-4165a8b88c66": {"__data__": {"id_": "7861ad15-19aa-4e5a-8ea5-4165a8b88c66", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ac23d77-5341-4cac-9702-70b39483f26d", "node_type": "1", "metadata": {}, "hash": "158a57f78671b3b386222546011fd07779b561cdad5104ed9d0a6eea04344f7c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b3f4512-26b0-424b-ae07-d3c1ff4155af", "node_type": "1", "metadata": {}, "hash": "680d577072bfc88d612dd7290f238e65c69d7ee3b42ef4ecbc4fe043946af835", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results are reported as an intention-\nto-treat and per indication analyses and are presented as an absolute rate\ndifference (ARD), odds ratio (OR) with 95% CI) or means with SD where\nappropriate. P < 0.05 was regarded as statistically signi\ufb01cant. All analyses\nwere performed using SPSS (version 22, IBM. Armonk, NY, USA).\nResults\nBetween 27 April 2015 and 17 January 2016, we recruited 343 partici-\npants (SrCl2 AOA = 115, calcimycin AOA = 113 and ICSI alone = 115)\n1638\nFawzy et al.\nafter excluding 49 (Fig. 1). Patient and cycle characteristics were similar\nin the three groups (Table I).\nOverall (Table II), the clinical pregnancy rate was signi\ufb01cantly higher\nwith SrCl2 and calcimycin AOA than with ICSI alone (49, 42 and 27%;\nARD 22, 95% CI: 9\u201333 and ARD 16, 95% CI: 3\u201327). SrCl2 and calci-\nmycin AOA also signi\ufb01cantly increased the biochemical pregnancy rate\ncompared with ICSI alone. The ongoing pregnancy rate was consider-\nably higher with SrCl2 and calcimycin AOA than with ICSI alone (42,\n36 and 23%; ARD 19, 95% CI: 7\u201330 and ARD 14, 95% CI: 2\u201325). The\nimplantation rate was signi\ufb01cantly also higher with SrCl2 and calcimycin\nAOA than with ICSI alone (32, 28 and 18%; ARD 14, 95% CI: 5\u201323\nand ARD 10, 95% CI: 2\u201319). These results culminated in signi\ufb01cantly\nhigher rates of live birth for SrCl2 and calcimycin AOA than for ICSI\nalone (40, 33 and 18%; ARD 22, 95% CI: 10\u201333 for SrCl2 and ARD\n14, 95% CI: 3\u201325).", "mimetype": "text/plain", "start_char_idx": 16702, "end_char_idx": 18121, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b3f4512-26b0-424b-ae07-d3c1ff4155af": {"__data__": {"id_": "9b3f4512-26b0-424b-ae07-d3c1ff4155af", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7861ad15-19aa-4e5a-8ea5-4165a8b88c66", "node_type": "1", "metadata": {}, "hash": "f918afa12bf5e9b9812d391e6b949b5554111276c95d13a7103f83911d50786f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74382c08-8a9d-49b1-8fda-3f0973f6236a", "node_type": "1", "metadata": {}, "hash": "69387985a201c2e06c4353a0a2cef6228913f754147ea1f9725054263ef1725f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The rates of cancelled transfer, chemical preg-\nnancy, miscarriage and multiple pregnancy were similar between the\ngroups. Both SrCl2 and calcimycin AOA resulted in similar rates of\nongoing pregnancy, implantation and live birth (Supplementary\nTable SV).\nAmong couples with previous low fertilization, SrCl2 AOA signi\ufb01cantly\nimproved the clinical pregnancy rate compared with ICSI alone (ARD\n35, 95% CI: 15\u201352; Supplementary Table SI) or calcimycin AOA (ARD\n30, 95% CI: 10\u201347; Supplementary Table SV), whereas calcimycin AOA\nand ICSI alone were comparable (ARD 5, 95% CI:\u221214 to 24;\nSupplementary Table SI). SrCl2 AOA was superior to ICSI alone regard-\ning the rates of biochemical pregnancy, ongoing pregnancy and implant-\nation, resulting in a higher live birth rate (ARD 37, 95% CI: 16\u201353;\nSupplementary Table SI). SrCl2 AOA was also superior to calcimycin\nAOA, resulting in higher rates of ongoing pregnancy and live birth (ARD\n22, 95% CI: 2\u201340 and ARD 26, 95% CI: 6\u201344; Supplementary\nTable SV). Only the implantation rate was signi\ufb01cantly higher with calci-\nmycin AOA than with ICSI alone (Supplementary Table SI).\nAmong couples of male-factor infertility with abnormal sperm, calci-\nmycin AOA signi\ufb01cantly improved the clinical pregnancy rate com-\npared with ICSI alone (ARD 22, 95% CI: 6\u201336; Supplementary\nTable SII), whereas SrCl2 AOA and ICSI alone were comparable\n(ARD 12, 95% CI:\u22123 to 26). Calcimycin AOA was superior to ICSI\nalone regarding the rates of biochemical pregnancy, clinical pregnancy\n115 women who produced 1180 \nMII oocytes were assigned to \nthe control group (no chemical \nactivation post-ICSI).\n115 women who produced\n1377 MII oocytes were \nassigned to intervention \ngroup I (oocyte activation \n-\nfor 60 min post\n2\nSrCl\nusing \nICSI).", "mimetype": "text/plain", "start_char_idx": 18122, "end_char_idx": 19881, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "74382c08-8a9d-49b1-8fda-3f0973f6236a": {"__data__": {"id_": "74382c08-8a9d-49b1-8fda-3f0973f6236a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b3f4512-26b0-424b-ae07-d3c1ff4155af", "node_type": "1", "metadata": {}, "hash": "680d577072bfc88d612dd7290f238e65c69d7ee3b42ef4ecbc4fe043946af835", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "005e3249-f08a-44d9-acc4-03097c443d0e", "node_type": "1", "metadata": {}, "hash": "b2d4539b3e08cf1767a03ac13c4ca96ef7b51996289b36b788360a85073ddfed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "115 women who produced\n1377 MII oocytes were \nassigned to intervention \ngroup I (oocyte activation \n-\nfor 60 min post\n2\nSrCl\nusing \nICSI).\n392 women were \nassessed for eligibility \n360 women were eligible, of whom 17 decided to freeze all embryos before \nrecruitment.\nTherefore, 343 were assigned to three groups and produced 3867 MII oocytes \n32 women were excluded\n- 18 declined to participate \n- 4 had diabetes \n- 6 had endometriosis\n- 4 had poor endometrium\n115 women were included \nin the analysis, of whom \n108 reached Day 5 transfer.\n- 4 women had poor \nembryo development \nand did not reach \ntransfer  \n- 1 woman developed \nOHSS and had her\nembryos frozen\n- 2 women were lost to \nfollow-up \n- 9 women had poor \nembryo development \nand did not reach \ntransfer  \n- 2 women developed \nOHSS and had their\nembryos frozen\n- 1 woman was lost to \nfollow-up \n115 women were included \nin the analysis, of whom \n103 reached Day 5 transfer.\n113 women who produced 1310 \nMII oocytes were assigned to \nintervention group II (oocyte \nactivation using calcimycin for \n20 min post-ICSI).\n- 10 women had poor \nembryo development \nand did not reach \ntransfer  \n- 1 woman developed \nOHSS and had her\nembryos frozen\n- 3 women were lost to \nfollow-up \n113 women were included \nin the analysis, of whom 99\nreached Day 5 transfer.\nFigure 1 Study \ufb02ow diagram.\n1639\nSrCl2 and calcimycin regulate oocyte activation\nand ongoing pregnancy, implantation, live birth and live-birth implant-\nation, whereas SrCl2 AOA and ICSI alone were comparable, as were\nSrCl2\nand\ncalcimycin\nAOA\nwere\ncomparable\n(Supplementary\nTables SII and SV).\nSrCl2 AOA resulted in signi\ufb01cantly greater rates of fertilization, top-\nquality embryo and compaction on Day 3, blastocyst development,\nhigh-quality blastocysts and cryopreservation compared with ICSI\nalone (all P < 0.0001; Table III).", "mimetype": "text/plain", "start_char_idx": 19743, "end_char_idx": 21587, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "005e3249-f08a-44d9-acc4-03097c443d0e": {"__data__": {"id_": "005e3249-f08a-44d9-acc4-03097c443d0e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74382c08-8a9d-49b1-8fda-3f0973f6236a", "node_type": "1", "metadata": {}, "hash": "69387985a201c2e06c4353a0a2cef6228913f754147ea1f9725054263ef1725f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c43adef-6e44-46f8-a632-d0d2c08038de", "node_type": "1", "metadata": {}, "hash": "3988073230a48c09d79efb4348a8cd2ff7f091f7428a4da98d4702bd0a96b73f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Calcimycin AOA also resulted in sig-\nni\ufb01cantly higher rates of fertilization, blastocyst formation and cryo-\npreservation compared with ICSI alone (P = 0.003, P = 0.026 and\nP < 0.0001; Table III). The embryological outcomes for the subgroup\nanalyses are shown in Supplementary Tables SIII and SIV.\nDiscussion\nTo our knowledge, this RCT is the \ufb01rst to compare SrCl2 and calcimy-\ncin AOA after ICSI to ICSI alone for cycles of previous low fertilization\nor male-factor infertility. Overall, this trial demonstrated signi\ufb01cantly\nhigher rates of clinical pregnancy and live birth for either SrCl2 or calci-\nmycin AOA after ICSI compared with ICSI alone, whereas SrCl2 and\ncalcimycin AOA were comparable. Our \ufb01ndings concur with a recent\nmeta-analysis (Murugesu et al., 2017).\nAmong couples with previous ICSI cycles of low fertilization, SrCl2\nAOA was more effective than ICSI alone, whereas calcimycin AOA\nwas comparable to ICSI alone. In this subgroup, neither sperm entry\nnor ICSI appears suf\ufb01cient to initiate the oocyte activation. This is likely\nto relate the activation defects to the oocyte (Miyara et al., 2003;\nEbner et al., 2006; Xing et al., 2011; Kilani and Chapman, 2014).\nReports suggest that ICSI with SrCl2 AOA appears to stimulate pulsa-\ntile waves of Ca2+ oscillation from the endoplasmic reticulum during\nfertilization and further development (Kline and Kline, 1992; Kishikawa\net al., 1999; Kim et al., 2014; Yeste et al., 2016). Although SrCl2 AOA\ndid not show signs of Ca2+ oscillation or parthenogenetic division for\nin-vitro matured oocytes (Lu et al., 2018), this situation may differ from\nthe MII oocytes undergoing ICSI with AOA.", "mimetype": "text/plain", "start_char_idx": 21588, "end_char_idx": 23240, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5c43adef-6e44-46f8-a632-d0d2c08038de": {"__data__": {"id_": "5c43adef-6e44-46f8-a632-d0d2c08038de", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "005e3249-f08a-44d9-acc4-03097c443d0e", "node_type": "1", "metadata": {}, "hash": "b2d4539b3e08cf1767a03ac13c4ca96ef7b51996289b36b788360a85073ddfed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f821a1d9-6560-41f8-9cbd-209ee42143d0", "node_type": "1", "metadata": {}, "hash": "729877181817ee206b5ff2a16205dbf831634f058879e4fa7054daed9558d2ba", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Therefore, given its\npotential to improve ICSI outcomes, further studies are required to\nidentify whether SrCl2 AOA activates the oocyte by Ca2+ oscillation\nor other mechanisms.\nFor calcimycin AOA and previous ICSI cycles of low fertilization, our\n\ufb01ndings showed that calcimycin AOA and ICSI alone were compar-\nable. Our results can be explained as calcimycin might be less effective\nthan SrCl2 because it induces a single Ca2+ wave that is not converted\ninto oscillation. Although our observations contradict a recent meta-\nanalysis (Murugesu et al., 2017) yet concur with an earlier one\n(Sfontouris et al., 2015), the conclusions from the meta-analyses seem\nto be not substantial due to the heterogenous designs of their studies.\nTherefore, calcimycin AOA appears to be not bene\ufb01cial for ICSI cycles\nwith previous impaired fertilization, but normal sperm parameters.\nAmong couples with male-factor infertility, calcimycin AOA was\nsuperior to SrCl2 AOA or ICSI alone. It is likely that when the problem\nresults from male-factor infertility, Ca2+ oscillation is functional in the\noocyte, but it has insuf\ufb01cient stimulation by the ICSI alone with\naffected sperm (Vanden Meerschaut et al., 2013; Ferrer-Buitrago et al.,\n2018). Calcimycin AOA provides additional Ca2+ in\ufb02ux from the\n...................................................................................\n...............\n.......................\n..........................\n.............................................................................................................................................................................................\nTable I Baseline characteristics by trial group.\nArti\ufb01cial oocyte activation (AOA) groups\nSrCl2 AOA\nCalcimycin AOA\nControl (no AOA)\n(n = 115)\n(n = 113)\n(n = 115)\nAge (years): mean \u00b1 SD\n31 \u00b1 5.1\n32.4 \u00b1 5.2\n32 \u00b1 5.2\nBMI (kg/m2): mean \u00b1 SD\n28.4 \u00b1 2.7\n28.4 \u00b1 2.7\n28.3 \u00b1 2.7\nDuration of infertility (years): mean \u00b1 SD\n6 \u00b1 2.7\n6 \u00b1 2.5\n6 \u00b1 2.", "mimetype": "text/plain", "start_char_idx": 23241, "end_char_idx": 25197, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f821a1d9-6560-41f8-9cbd-209ee42143d0": {"__data__": {"id_": "f821a1d9-6560-41f8-9cbd-209ee42143d0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c43adef-6e44-46f8-a632-d0d2c08038de", "node_type": "1", "metadata": {}, "hash": "3988073230a48c09d79efb4348a8cd2ff7f091f7428a4da98d4702bd0a96b73f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0b421b3c-492c-4566-8d97-ea6eb9673d1f", "node_type": "1", "metadata": {}, "hash": "0a6be7eadadd013b16a3348a513b1e4e9daea3c4cd414790f9c9736a58b61bff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7\n28.4 \u00b1 2.7\n28.3 \u00b1 2.7\nDuration of infertility (years): mean \u00b1 SD\n6 \u00b1 2.7\n6 \u00b1 2.5\n6 \u00b1 2.2\nBasal FSH (IU/L): mean \u00b1 SD\n6 \u00b1 1.2\n6 \u00b1 1.3\n6 \u00b1 2\nAntral follicle count: mean \u00b1 SD\n15.0 \u00b1 2.2\n14.0 \u00b1 2.1\n14.3 \u00b1 2.3\nTotal FSH/hMG: mean \u00b1 SD\n2245 \u00b1 244\n2294 \u00b1 195\n2264 \u00b1 227\nImpaired-fertilization cycles:\nPrevious fertilization failure: n (%)\n7 (6)\n5 (4)\n7 (6)\nPrevious low fertilization (<30%) with average oocyte quality: n (%)\n14 (12)\n13 (12)\n12 (11)\nPrevious low fertilization (<30%) associated with impaired oocyte quality: n (%)\n26 (23)\n27 (23)\n24 (21)\nMale-factor infertility cycles:\nFrozen\u2013thawed sperm of affected-morphology samples: n (%)\n22 (19)\n24 (21)\n23 (20)\nSurgically retrieved sperm of affected-morphology samples: n (%)\n19 (17)\n21 (19)\n22 (19)\nGlobozoospermia: n (%)\n4 (3)\n3 (3)\n5 (4)\n100% tapered-head sperm: n (%)\n23 (20)\n20 (18)\n22 (19)\nNumber of oocytes collected: mean \u00b1 SD\n14 \u00b1 9.4\n13 \u00b1 9.1\n12 \u00b1 8.0\nNumber of mature oocytes: mean \u00b1 SD\n13 \u00b1 6.5\n12 \u00b1 8.0\n11 \u00b1 6.2\nNumber of embryos transferred: mean \u00b1 SD\n1.7 \u00b1 0.5\n1.6 \u00b1 0.5\n1.6 \u00b1 0.5\nComparison of the differences between the three groups was performed by one-way ANOVA and the chi-square test where appropriate.\n1640\nFawzy et al.\nsurrounding medium, boosting the initiation of Ca2+ oscillation (Yeste\net al., 2016).", "mimetype": "text/plain", "start_char_idx": 25108, "end_char_idx": 26389, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0b421b3c-492c-4566-8d97-ea6eb9673d1f": {"__data__": {"id_": "0b421b3c-492c-4566-8d97-ea6eb9673d1f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f821a1d9-6560-41f8-9cbd-209ee42143d0", "node_type": "1", "metadata": {}, "hash": "729877181817ee206b5ff2a16205dbf831634f058879e4fa7054daed9558d2ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "191647a6-0b01-4147-a00d-55e78411dd2a", "node_type": "1", "metadata": {}, "hash": "7191b0caab0f55cfa74e5f5436861ea4f3dd85b13629d1fb2c0747f4ac519f0e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1640\nFawzy et al.\nsurrounding medium, boosting the initiation of Ca2+ oscillation (Yeste\net al., 2016). In this situation, SrCl2 may have less effect because the\ndefect is not with the Ca2+ oscillation machinery itself, just the initi-\nation of oscillation. Our observations concur with a recent meta-\nanalysis (Murugesu et al., 2017) as it also included cycles with affected\nsperm function. Therefore, calcimycin AOA appears promising for\nICSI cycles with abnormal sperm morphology.\nRegarding embryo development, AOA with SrCl2 or calcimycin gave\nsigni\ufb01cantly better results than conventional ICSI in the overall and\nsubgroup analyses. The effect sizes for SrCl2 were larger than for calci-\nmycin. Both AOA protocols were superior to ICSI alone for the\nblastocyst cryopreservation rate, suggesting that, besides the clinical\nimprovements observed, AOA might improve the cumulative preg-\nnancy rate. The improvements in embryo development could have\nresulted from restoration of Ca2+ oscillation to physiological or supra-\nphysiological status. However, the mechanisms by which this restor-\nation might have occurred are beyond this study, and whether\npossible supraphysiological Ca2+ oscillation might have epigenetic\neffects remains a subject for further investigation.\nPrevious studies (Murugesu et al., 2017) have shown that the clinical\npregnancy rate is 16% for ICSI cycles with previous low fertilization.\nThis rate appears relatively lower than that we observed in our facil-\nities and we reported for this group. In our study, the rigorous control\nfor the laboratory and clinical confounders, the relatively young age of\nwomen included (~32), and the short time of conduct seemed to be\nre\ufb02ected in the observed outcomes in the three groups.\nTo limit the sample size required, the margin of superiority was set\nat 14%, which is a relatively high. This margin was considered because\nalthough calcimycin and SrCl2 appear safe, this safety has not been\nproved unequivocally (Yeste et al., 2016).\nOur study has several strengths.", "mimetype": "text/plain", "start_char_idx": 26286, "end_char_idx": 28319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "191647a6-0b01-4147-a00d-55e78411dd2a": {"__data__": {"id_": "191647a6-0b01-4147-a00d-55e78411dd2a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0b421b3c-492c-4566-8d97-ea6eb9673d1f", "node_type": "1", "metadata": {}, "hash": "0a6be7eadadd013b16a3348a513b1e4e9daea3c4cd414790f9c9736a58b61bff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "97161929-0471-494b-b339-c1b80b59b21a", "node_type": "1", "metadata": {}, "hash": "81abb5aaac263fac654817a291feea8d3e6d0dc756cf3ad375f6125f07450343", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This margin was considered because\nalthough calcimycin and SrCl2 appear safe, this safety has not been\nproved unequivocally (Yeste et al., 2016).\nOur study has several strengths. It represents, to our knowledge,\nthe \ufb01rst RCT with an appropriate sample size to compare SrCl2 to cal-\ncimycin for AOA. Although clinical pregnancy was the primary out-\ncome, ongoing pregnancy and live birth rates were also assessed. Our\n...........................................................\n........................................\n........................................\n..............................................................................................................................................................................................\nTable II Clinical Outcomes in the trial groups by intention-to-treat analysis.\nArti\ufb01cial oocyte activation (AOA)\ngroups (%)\nAbsolute rate difference,\npercentage points (95% CI)\nOdds ratio (95% CI)\nSrCl2\nAOA\n(n = 115)\nCalcimycin\nAOA\n(n = 113)\nControl\n(no AOA)\n(n = 115)\nSrCl2 to\ncontrol\nCalcimycin\nto control\nSrCl2 to\ncontrol\nCalcimycin\nto control\nCancelled transfer rate\n7/115\n(6)\n14/113\n(12)\n12/115\n(10)\n\u22124.3\n(\u221212 to 3)\n2\n(\u22126.5 to 11)\n0.56\n(0.21\u20131.47)\nP = 0.23\n1.21\n(0.54\u20132.75)\nP = 0.64\nBiochemical pregnancy rate\n62/115\n(54)\n61/113\n(54)\n39/115\n(34)\n20\n(7\u201332)\n20\n(7\u201332)\n2.28\n(1.34\u20133.88)\nP = 0.002\n2.29\n(1.34\u20133.90)\nP = 0.002\nClinical pregnancy rate\n56/115\n(49)\n48/113\n(42)\n31/115\n(27)\n22\n(9\u201333)\n16\n(3\u201327)\n2.57\n(1.48\u20134.46)\nP = 0.0007\n2.0\n(1.15\u20133.49)\nP = 0.014\nChemical pregnancy rate\n6/115\n(5)\n13/113\n(11)\n8/115\n(7)\n\u22121.", "mimetype": "text/plain", "start_char_idx": 28141, "end_char_idx": 29709, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "97161929-0471-494b-b339-c1b80b59b21a": {"__data__": {"id_": "97161929-0471-494b-b339-c1b80b59b21a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "191647a6-0b01-4147-a00d-55e78411dd2a", "node_type": "1", "metadata": {}, "hash": "7191b0caab0f55cfa74e5f5436861ea4f3dd85b13629d1fb2c0747f4ac519f0e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "05826b2d-9b29-4b70-b8be-47668cf5bf3c", "node_type": "1", "metadata": {}, "hash": "4eef9566d374bc84a6f6b5a24ef72af96953326447c703df81f3c6888a3beeb6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0\n(1.15\u20133.49)\nP = 0.014\nChemical pregnancy rate\n6/115\n(5)\n13/113\n(11)\n8/115\n(7)\n\u22121.7\n(\u22128 to 5)\n5\n(\u22123 to 13)\n0.74\n(0.25\u20132.19)\nP = 0.58\n1.74\n(0.69\u20134.37)\nP = 0.24\nOngoing pregnancy rate\n48/115\n(42)\n41/113\n(36)\n26/115\n(23)\n19 (7\u201330)\n14 (2\u201325)\n2.45\n(1.38\u20134.35)\nP = 0.0019\n1.95\n(1.10\u20133.49)\nP = 0.023\nMiscarriage rate\n14/115\n(12)\n20/113\n(18)\n13/115\n(11)\n0.9\n(\u22128 to 9.4)\n6.4\n(\u22122.9 to 15.7)\n1.09\n(0.49\u20132.43)\nP = 0.84\n1.69\n(0.79\u20133.58)\nP = 0.17\nMultiple pregnancy rate\n5/115\n(4)\n4/113\n(4)\n2/115\n(2)\n2.6\n(\u22122.4 to 8.2)\n1.8\n(\u22123.1 to 7.2)\n2.57\n(0.49\u201313.5)\nP = 0.45\n2.07\n(0.37\u201311.6)\nP = 0.44\nImplantation rate\n61/190\n(32)\n52/184\n(28)\n33/182\n(18)\n14\n(5\u201323)\n10\n(2\u201319)\n2.14\n(1.31\u20133.47)\nP = 0.0019\n1.78\n(1.08\u20132.92)\nP = 0.022\nLive birth rate\n46/115\n(40)\n37/113\n(33)\n21/115\n(18)\n22\n(10\u201333)\n14\n(3\u201325)\n2.98\n(1.63\u20135.45)\nP = 0.", "mimetype": "text/plain", "start_char_idx": 29626, "end_char_idx": 30427, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "05826b2d-9b29-4b70-b8be-47668cf5bf3c": {"__data__": {"id_": "05826b2d-9b29-4b70-b8be-47668cf5bf3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "97161929-0471-494b-b339-c1b80b59b21a", "node_type": "1", "metadata": {}, "hash": "81abb5aaac263fac654817a291feea8d3e6d0dc756cf3ad375f6125f07450343", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f20a94ab-395d-4887-bab6-2c27c5ccf15e", "node_type": "1", "metadata": {}, "hash": "f21238277c6d53100e2fade0ca413dcbdd6b713bb0dffd6d75a80e30dfa94719", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "98\n(1.63\u20135.45)\nP = 0.0002\n2.18\n(1.18\u20134.03)\nP = 0.012\nLive-birth-implantation rate\n46/190\n(24)\n37/184\n(20)\n21/182\n(12)\n13\n(5\u201320)\n9\n(1\u201316)\n2.45\n(1.39\u20134.30)\nP = 0.0015\n1.93\n(1.08\u20133.45)\nP = 0.025\nThe logistic regression analysis veri\ufb01ed that there was no association between the primary outcome and the confounding variables including each centre\u2019s cycle characteristics, except\nfor SrCl2 AOA and Calcimycin AOA. Chemical pregnancy indicates a positive pregnancy test with no gestational sac identi\ufb01ed 15 days after the test.\n1641\nSrCl2 and calcimycin regulate oocyte activation\n...............................................................\n.................................................\n.................................................\n..........................................................................................................................................................................................................................................................\nTable III Embryological outcomes in the trial groups.\nArti\ufb01cial oocyte activation (AOA)\ngroups (%)\nAbsolute rate difference,\npercentage points (95% CI)\nOdds ratio (95% CI)\nSrCl2\nAOA (n\n= 115)\nCalcimycin\nAOA\n(n = 113)\nControl (no\nAOA)\n(n = 115)\nSrCl2 to control\nCalcimycin to\ncontrol\nSrCl2 to control\nCalcimycin to\ncontrol\nMaturation rate: MII oocytes/collected oocytes\n1377/\n1581\n(87)\n1310/1483\n(88)\n1180/1329\n(89)\n\u22121.7\n(\u22124.1 to 0.7)\n\u22120.45\n(\u22122.8 to 1.9)\n0.85\n(0.68\u20131.07)\nP = 0.16\n0.96\n(0.76\u20131.21)\nP = 0.71\nFertilization rate: 2PN oocytes/injected MII oocytes\n1168/\n1377\n(85)\n874/1310\n(67)\n720/1180\n(61)\n24\n(20\u201327)\n5.7\n(1.9\u20139.5)\n3.", "mimetype": "text/plain", "start_char_idx": 30406, "end_char_idx": 32026, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f20a94ab-395d-4887-bab6-2c27c5ccf15e": {"__data__": {"id_": "f20a94ab-395d-4887-bab6-2c27c5ccf15e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05826b2d-9b29-4b70-b8be-47668cf5bf3c", "node_type": "1", "metadata": {}, "hash": "4eef9566d374bc84a6f6b5a24ef72af96953326447c703df81f3c6888a3beeb6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0cc4b88c-f74b-4dd0-8290-a4095af61cad", "node_type": "1", "metadata": {}, "hash": "3cd2b54abd402e9c60f3c4c0520ed2f7315a8b5e822609e73694b1d2b640eb8c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7\n(1.9\u20139.5)\n3.57\n(2.96\u20134.31)\nP < 0.0001\n1.28\n(1.09\u20131.51)\nP = 0.003\nCleavage rate: cleaved embryos/fertilized oocytes\n1134/\n1168\n(97)\n854/874\n(98)\n702/720\n(98)\n\u22120.4\n(\u22121.9 to 1.2)\n0.2\n(\u22121.3 to 1.8)\n0.86\n(0.48\u20131.53)\nP = 0.597\n1.09\n(0.5\u201372.09)\nP = 0.78\nTop-quality Day 3 embryos/fertilized oocytes\n1021/\n1168\n(87)\n513/874\n(59)\n413/720\n(57)\n30\n(26\u201334)\n1.3\n(3.5\u20136.0)\n5.16\n(4.11\u20136.48)\nP < 0.0001\n1.06\n(0.87\u20131.29)\nP = 0.59\nCompaction rate: compacted Day 3 embryos/fertilized\noocytes\n518/1168\n(44)\n212/874\n(24)\n189/720\n(26)\n18\n(14\u201322)\n\u22122\n(\u22126.3 to 2.3)\n2.24\n(1.83\u20132.74)\nP < 0.0001\n0.89\n(0.72\u20131.13)\nP = 0.36\nBlastocyst formation rate: blastocysts/fertilized oocytes\n722/1168\n(62)\n447/874\n(51)\n328/720\n(46)\n17\n(12\u201321)\n5.6\n(0.7\u201310.5)\n1.93\n(1.60\u20132.34)\nP < 0.0001\n1.25\n(1.03\u20131.52)\nP = 0.026\nHigh-quality blastocysts/fertilized oocytes\n475/1168\n(41)\n232/874\n(27)\n195/720\n(27)\n14\n(9\u201318)\n\u22120.5\n(\u22120.5 to 0.", "mimetype": "text/plain", "start_char_idx": 32012, "end_char_idx": 32898, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0cc4b88c-f74b-4dd0-8290-a4095af61cad": {"__data__": {"id_": "0cc4b88c-f74b-4dd0-8290-a4095af61cad", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f20a94ab-395d-4887-bab6-2c27c5ccf15e", "node_type": "1", "metadata": {}, "hash": "f21238277c6d53100e2fade0ca413dcbdd6b713bb0dffd6d75a80e30dfa94719", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89468b73-294a-43ca-90c0-47117aac2e45", "node_type": "1", "metadata": {}, "hash": "2f6639bab6e476c83cdb87059caf5c5e0be15eef29a8e1afb04f5cb9a18d9ea9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5\n(\u22120.5 to 0.4)\n1.85\n(1.51\u20132.26)\nP < 0.0001\n0.97\n(0.78\u20131.22)\nP = 0.806\nCryopreservation rate: vitri\ufb01ed blastocysts/fertilized oocytes\n518/1168\n(44)\n251/874\n(29)\n133/720\n(18)\n26\n(22\u201330)\n6.1\n(6\u201314)\n3.52\n(2.82\u20134.39)\nP < 0.0001\n1.7\n(1.40\u20132.26)\nP < 0.0001\n2PN, two pronuclei; MII, metaphase II.\n1642\nFawzy et al.\n\ufb01ndings provide insight into the relative suitability of SrCl2 and calcimy-\ncin for AOA for particular causes of infertility, which can improve the\noutcomes for subgroups of patients who experience poor outcomes\nof ICSI.\nOur study also has several limitations. The open-label trial design\nmight have introduced bias, although randomization, at least partly,\naddressed this possibility. The study did not include a longitudinal\nfollow-up period, so further evidence regarding the safety of AOA is\nstill required. The study included couples with different indications for\nICSI, rather than focusing on a single subgroup, but post hoc analyses\nwere performed to determine the particular effects of AOA in these\nsubgroups.\nIn conclusion, in our study population, ICSI followed by AOA with\nSrCl2 or calcimycin was associated with signi\ufb01cantly better embryo-\nlogical and clinical outcomes than ICSI alone. Calcimycin AOA appears\neffective in overcoming defects related to abnormal sperm morph-\nology, whereas SrCl2 AOA appears to improve outcomes for ICSI\ncycles characterized by previous impaired fertilization. In consideration\nof the current lack of knowledge regarding the long-term safety and\ntransgenerational effects of AOA, we do not recommend this treat-\nment for the general ICSI population. Instead, we recommend that\nmore studies are performed, to further elucidate the mechanisms that\nunderlie our \ufb01ndings, in particular those related to SrCl2 AOA.", "mimetype": "text/plain", "start_char_idx": 32885, "end_char_idx": 34648, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89468b73-294a-43ca-90c0-47117aac2e45": {"__data__": {"id_": "89468b73-294a-43ca-90c0-47117aac2e45", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0cc4b88c-f74b-4dd0-8290-a4095af61cad", "node_type": "1", "metadata": {}, "hash": "3cd2b54abd402e9c60f3c4c0520ed2f7315a8b5e822609e73694b1d2b640eb8c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1cacdca8-7f0c-4c68-915c-338c09bd9b1f", "node_type": "1", "metadata": {}, "hash": "f11714c577c7434b4064cc7707734df28ca4c9a8a30d9b8b15840aaf503867f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Instead, we recommend that\nmore studies are performed, to further elucidate the mechanisms that\nunderlie our \ufb01ndings, in particular those related to SrCl2 AOA. We\nalso recommend that a multicentre trial is conducted to identify the\ncumulative live birth rate and to assess the health of the offspring as\nprimary outcomes. Until these studies have been conducted, we rec-\nommend that AOA should be used cautiously, and the advantages and\ndisadvantages regarding its use should be weighed in each case.\nSupplementary data\nSupplementary data are available at Human Reproduction online.\nAcknowledgements\nThe authors thank the IbnSina IVF laboratory team for their dedicated\nefforts during the study, especially Dr Ahmed AlAboudy and Dr\nMostafa Ail.\nAuthors\u2019 roles\nM.F. created the concept and design of the study, was the primary\ninvestigator and wrote the article. M.E. participated in the investigation\nas well as the collection, analysis and interpretation of the data. All\nother authors participated in critically reviewing the concept upon\nwhich the study was conducted and participated in the investigation.\nAll authors critically revised the manuscript and gave their \ufb01nal\napproval of the version for publication.\nFunding\nThe research was not funded by any agency.\nCon\ufb02ict of interest\nThe authors have no con\ufb02icts of interest to declare.\nREFERENCES\nAlpha Scientists in Reproductive Medicine and ESHRE Special Interest\nGroup of Embryology. Alpha Scientists in Reproductive Medicine and\nESHRE Special Interest Group of Embryology. The Istanbul consensus\nworkshop on embryo assessment: proceedings of an expert meeting.\nHum Reprod 2011;26:1270\u20131283.\nAmdani SN, Jones C, Coward K. Phospholipase C zeta (PLC\u03b6): oocyte\nactivation and clinical links to male factor infertility. Adv Biol Regul 2013;\n53:292\u2013308.\nBj\u00f6rndahl L, Mortimer D, Barratt CLR, Castilla JA, Menkveld R, Kvist U,\nAlvarez JG, Haugen TB. A Practical Guide to Basic Laboratory Andrology.\nCambridge, UK: Cambridge University Press, 2010.", "mimetype": "text/plain", "start_char_idx": 34489, "end_char_idx": 36488, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1cacdca8-7f0c-4c68-915c-338c09bd9b1f": {"__data__": {"id_": "1cacdca8-7f0c-4c68-915c-338c09bd9b1f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89468b73-294a-43ca-90c0-47117aac2e45", "node_type": "1", "metadata": {}, "hash": "2f6639bab6e476c83cdb87059caf5c5e0be15eef29a8e1afb04f5cb9a18d9ea9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "deeea9ab-855c-481d-bf4e-d5d543700ef1", "node_type": "1", "metadata": {}, "hash": "fc5c0321ee113960ba245e2b97e5add833e59e31f51254c798cfb80eeb5bc51e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A Practical Guide to Basic Laboratory Andrology.\nCambridge, UK: Cambridge University Press, 2010.\nChen J, Qian Y, Tan Y, Mima H. Successful pregnancy following\noocyte activation by strontium in normozoospermic patients of\nunexplained infertility with fertilisation failures during previous\nintracytoplasmic sperm injection treatment. Reprod Fertil Dev 2010;\n22:852\u2013855.\nCheng D, Li J, Guo C-C, Xiong C-L. [Failed fertilization after ICSI: causes\nand countermeasures]. Zhonghua Nan Ke Xue 2011;17:1131\u20131134.\nClift D, Schuh M. Restarting life: fertilization and the transition from meiosis\nto mitosis. Nat Rev Mol Cell Biol 2013;14:549\u2013562.\nCombelles CMH, Morozumi K, Yanagimachi R, Zhu L, Fox JH, Racowsky\nC. Diagnosing cellular defects in an unexplained case of total fertilization\nfailure. Hum Reprod 2010;25:1666\u20131671.\nDe Vos A, Van De Velde H, Joris H, Verheyen G, Devroey P, Van\nSteirteghem A. In\ufb02uence of individual sperm morphology on fertilization,\nembryo morphology, and pregnancy outcome of intracytoplasmic sperm\ninjection. Fertil Steril 2003;79:42\u201348.\nDucibella T, Huneau D, Angelichio E, Xu Z, Schultz RM, Kopf GS, Fissore\nR, Madoux S, Ozil JP. Egg-to-embryo transition is driven by differential\nresponses to Ca2+ oscillation number. Dev Biol 2002;250:280\u2013291.\nEbner T, Montag M, Montag M, Van Der Ven K, Van Der Ven H, Ebner T,\nShebl O, Oppelt P, Hirchenhain J, Kr\u00fcssel J et al. Live birth after arti\ufb01cial\noocyte activation using a ready-to-use ionophore: a prospective multi-\ncentre study. Reprod Biomed Online 2015;30:359\u2013365.", "mimetype": "text/plain", "start_char_idx": 36391, "end_char_idx": 37932, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "deeea9ab-855c-481d-bf4e-d5d543700ef1": {"__data__": {"id_": "deeea9ab-855c-481d-bf4e-d5d543700ef1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1cacdca8-7f0c-4c68-915c-338c09bd9b1f", "node_type": "1", "metadata": {}, "hash": "f11714c577c7434b4064cc7707734df28ca4c9a8a30d9b8b15840aaf503867f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8b94a20-68ba-4654-9466-862e59c1467f", "node_type": "1", "metadata": {}, "hash": "3c846f4d1254783a2f0f6cb9c7d74e8acd1771b018a17edda5d6d021e7476d1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Live birth after arti\ufb01cial\noocyte activation using a ready-to-use ionophore: a prospective multi-\ncentre study. Reprod Biomed Online 2015;30:359\u2013365.\nEbner T, Moser M, Tews G. Is oocyte morphology prognostic of embryo\ndevelopmental potential after ICSI? Reprod Biomed Online 2006;12:\n507\u2013512.\nEldar-Geva T, Brooks B, Margalioth EJ, Zylber-Haran E, Gal M, Silber SJ.\nSuccessful pregnancy and delivery after calcium ionophore oocyte acti-\nvation in a normozoospermic patient with previous repeated failed fertil-\nization after intracytoplasmic sperm injection. Fertil Steril 2003;79:\n1656\u20131658.\nEscof\ufb01er J, Yassine S, Lee HC, Martinez G, Delaroche J, Coutton C,\nKaraouz\u00e9ne T, Zouari R, Metzler-Guillemain C, Pernet-Gallay K et al.\nSubcellular localization of phospholipase Cz in human sperm and its\nabsence in DPY19L2-de\ufb01cient sperm are consistent with its role in\noocyte activation. Mol Hum Reprod 2014;21:157\u2013168.\nFerrer-Buitrago M, Dhaenens L, Lu Y, Bonte D, Meerschaut F Vanden,\nSutter P De, Leybaert L, Heindryckx B. Human oocyte calcium ana-\nlysis predicts the response to assisted oocyte activation in patients\nexperiencing fertilization failure after ICSI. Hum Reprod 2018;33:\n416\u2013425.\nFlaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal fer-\ntilization after intracytoplasmic sperm injection. Hum Reprod 1998;13:\n155\u2013164.", "mimetype": "text/plain", "start_char_idx": 37783, "end_char_idx": 39130, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8b94a20-68ba-4654-9466-862e59c1467f": {"__data__": {"id_": "b8b94a20-68ba-4654-9466-862e59c1467f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "deeea9ab-855c-481d-bf4e-d5d543700ef1", "node_type": "1", "metadata": {}, "hash": "fc5c0321ee113960ba245e2b97e5add833e59e31f51254c798cfb80eeb5bc51e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45d7ce31-3546-4430-be49-3fbc8a79fa51", "node_type": "1", "metadata": {}, "hash": "68c403f284cadbc4f5b6a3ed59f74b58b45a90d103ba4a9ef6bf265485e4d8e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Flaherty SP, Payne D, Matthews CD. Fertilization failures and abnormal fer-\ntilization after intracytoplasmic sperm injection. Hum Reprod 1998;13:\n155\u2013164.\nGreco E, Scarselli F, Fabozzi G, Colasante A, Zavaglia D, Alviggi E, Litwicka\nK, Varricchio MT, Minasi MG, Tesarik J. Sperm vacuoles negatively affect\noutcomes in intracytoplasmic morphologically selected sperm injection\nin terms of pregnancy, implantation, and live-birth rates. Fertil Steril\n2013;100:379\u2013385.\n1643\nSrCl2 and calcimycin regulate oocyte activation\nHeindryckx B, De Gheselle S, Gerris J, Dhont M, De Sutter P. Ef\ufb01ciency of\nassisted oocyte activation as a solution for failed intracytoplasmic sperm\ninjection. Reprod Biomed Online 2008;17:662\u2013668.\nHeindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option for\nsperm- or oocyte-related fertilization failure: assisted oocyte activation\nfollowing\ndiagnostic\nheterologous\nICSI.\nHum\nReprod\n2005;20:\n2237\u20132241.\nHorner VL, Wolfner MF. Transitioning from egg to embryo: triggers and\nmechanisms of egg activation. Dev Dyn 2008;237:527\u2013544.\nKashir J, Heindryckx B, Jones C, De Sutter P, Parrington J, Coward K.\nOocyte activation, phospholipase C zeta and human infertility. Hum\nReprod Update 2010;16:690\u2013703.\nKilani S, Chapman MG. Meiotic spindle normality predicts live birth in patients\nwith recurrent in vitro fertilization failure. Fertil Steril 2014;101:403\u20136.\nKim JW, Kim SD, Yang SH, Yoon SH, Jung JH, Lim JH. Successful pregnancy\nafter SrCl2 oocyte activation in couples with repeated low fertilization\nrates following calcium ionophore treatment. Syst Biol Reprod Med 2014;\n60:177\u2013182.", "mimetype": "text/plain", "start_char_idx": 38975, "end_char_idx": 40592, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45d7ce31-3546-4430-be49-3fbc8a79fa51": {"__data__": {"id_": "45d7ce31-3546-4430-be49-3fbc8a79fa51", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8b94a20-68ba-4654-9466-862e59c1467f", "node_type": "1", "metadata": {}, "hash": "3c846f4d1254783a2f0f6cb9c7d74e8acd1771b018a17edda5d6d021e7476d1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4218994-bd60-49e3-852a-c3bf55dc3356", "node_type": "1", "metadata": {}, "hash": "c066fb1ab19d20c3bd7407e2a47522cd0b25d647de245c2a088c1e56ea865528", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Successful pregnancy\nafter SrCl2 oocyte activation in couples with repeated low fertilization\nrates following calcium ionophore treatment. Syst Biol Reprod Med 2014;\n60:177\u2013182.\nKishikawa H, Wakayama T, Yanagimachi R. Comparison of oocyte-\nactivating agents for mouse cloning. Cloning 1999;1:153\u2013159.\nKissin DM, Jamieson DJ, Bar\ufb01eld WD. Monitoring health outcomes of\nassisted reproductive technology. N Engl J Med 2014;371:91\u201393.\nKline D, Kline JT. Repetitive calcium transients and the role of calcium in\nexocytosis and cell cycle activation in the mouse egg. Dev Biol 1992;149:\n80\u201389.\nLu Y, Gao H, Li B, Zheng Y, Ye Y, Qian Y, Xu C, Huang H, Jin F. Different\nsperm sources and parameters can in\ufb02uence intracytoplasmic sperm\ninjection outcomes before embryo implantation. J Zhejiang Univ Sci B\n2012;13:1\u201310.\nLuYReddyRBuitragoMFVander Jeught MNeupaneJDe VosWHVan Den\nAbbeelELiermanSDe SutterPHeindryckxB2018Strontium fails to induce\nCa2+ release and activation in human oocytes despite the presence of\nfunctional TRPV3 channelsHum Reprod Open31\u201311\nMcHugh ML. Interrater reliability: the kappa statistic. Biochem Med 2012;\n22:276\u2013282.\nMiyara F, Aubriot FX, Glissant A, Nathan C, Douard S, Stanovici A, Herve\nF, Dumont-Hassan M, LeMeur A, Cohen-Bacrie P et al. Multiparameter\nanalysis of human oocytes at metaphase II stage after IVF failure in non-\nmale infertility. Hum Reprod 2003;18:1494\u20131503.\nMiyazaki S, Shirakawa H, Nakada K, Honda Y. Essential role of the inositol\n1,4,5-trisphosphate receptor/Ca2+ release channel in Ca2+ waves and Ca2\n+ oscillations at fertilization of mammalian eggs.", "mimetype": "text/plain", "start_char_idx": 40415, "end_char_idx": 42008, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d4218994-bd60-49e3-852a-c3bf55dc3356": {"__data__": {"id_": "d4218994-bd60-49e3-852a-c3bf55dc3356", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45d7ce31-3546-4430-be49-3fbc8a79fa51", "node_type": "1", "metadata": {}, "hash": "68c403f284cadbc4f5b6a3ed59f74b58b45a90d103ba4a9ef6bf265485e4d8e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8809a3e-d4f3-4c9b-9582-0f2e909f293f", "node_type": "1", "metadata": {}, "hash": "8f15ed3bc99623d3c321d4fe10951580ce15f7a91c287ff5439b20b81069eb2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dev Biol 1993;158:62\u201378.\nMiyazaki S, Yuzaki M, Nakada K, Shirakawa H, Nakanishi S, Nakade S,\nMikoshiba K. Block of Ca2+ wave and Ca2+ oscillation by antibody to\nthe inositol 1,4,5-trisphosphate receptor in fertilized hamster eggs.\nScience 1992;257:251\u2013255.\nMontag M, K\u00f6ster M, van der Ven K, Bohlen U, van der Ven H. The bene\ufb01t\nof arti\ufb01cial oocyte activation is dependent on the fertilization rate in a\nprevious treatment cycle. Reprod Biomed Online 2012;24:521\u2013526.\nMurugesu S, Saso S, Jones BP, Bracewell-Milnes T, Athanasiou T, Mania A,\nSerhal P, Ben-Nagi J. Does the use of calcium ionophore during arti\ufb01cial\noocyte activation demonstrate an effect on pregnancy rate? A meta-\nanalysis. Fertil Steril 2017;108:468\u2013482.e3.\nNomikos M, Kashir J, Swann K, Lai FA. Sperm PLC\u03b6: from structure to\nCa2+ oscillations, egg activation and therapeutic potential. FEBS Lett\n2013;587:3609\u20133616.\nPalermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after\nintracytoplasmic injection of single spermatozoon into an oocyte. Lancet\n1992;340:17\u201318.\nRidgway EB, Gilkey JC, Jaffe LF. Free calcium increases explosively in acti-\nvating medaka eggs. Proc Natl Acad Sci USA 1977;74:623\u2013627.\nRybouchkin AV, De Sutter P, Van Der Straeten F, Dhont M, Quatacker J.\nFertilization and pregnancy after assisted oocyte activation and intracyto-\nplasmic sperm injection in a case of round-headed sperm associated with\nde\ufb01cient oocyte activation capacity. Fertil Steril 1997;68:1144\u20131147.", "mimetype": "text/plain", "start_char_idx": 42009, "end_char_idx": 43475, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e8809a3e-d4f3-4c9b-9582-0f2e909f293f": {"__data__": {"id_": "e8809a3e-d4f3-4c9b-9582-0f2e909f293f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4218994-bd60-49e3-852a-c3bf55dc3356", "node_type": "1", "metadata": {}, "hash": "c066fb1ab19d20c3bd7407e2a47522cd0b25d647de245c2a088c1e56ea865528", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f524e131-1259-448b-85ba-6407783fcc76", "node_type": "1", "metadata": {}, "hash": "3d13fcc8a0b3ffb029ca6c493101909e134676a7efbc3bc1eb6f80592248cf4b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertil Steril 1997;68:1144\u20131147.\nSaunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM,\nSwann K, Lai FA. PLC zeta: a sperm-speci\ufb01c trigger of Ca(2+) oscilla-\ntions in eggs and embryo development. Development 2002;129:3533\u2013\n3544.\nSfontouris IA, Nastri CO, Lima MLS, Tahmasbpourmarzouni E, Raine-Fenning\nN, Martins WP. Arti\ufb01cial oocyte activation to improve reproductive out-\ncomes in women with previous fertilization failure: a systematic review and\nmeta-analysis of RCTs. Hum Reprod 2015;30:1831\u20131841.\nSteinhardt R, Zucker R, Schatten G. Intracellular calcium release at fertiliza-\ntion in the sea urchin egg. Dev Biol 1977;58:185\u2013196.\nSteptoe PC, Edwards RG. Birth after the reimplantation of a human\nembryo. Arch Pathol Lab Med 1992;116:321.\nTesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modi\ufb01ed intra-\ncytoplasmic sperm injection technique to overcome sperm-borne and\noocyte-borne oocyte activation failures. Fertil Steril 2002;78:619\u2013624.\nVanden Meerschaut F, Leybaert L, Nikiforaki D, Qian C, Heindryckx B, De\nSutter P. Diagnostic and prognostic value of calcium oscillatory pattern ana-\nlysis for patients with ICSI fertilization failure. Hum Reprod 2013;28:87\u201398.\nVanden Meerschaut F, Nikiforaki D, De Gheselle S, Dullaerts V, Van Den\nAbbeel E, Gerris J, Heindryckx B, De Sutter P. Assisted oocyte activa-\ntion is not bene\ufb01cial for all patients with a suspected oocyte-related acti-\nvation de\ufb01ciency. Hum Reprod 2012;27:1977\u20131984.", "mimetype": "text/plain", "start_char_idx": 43443, "end_char_idx": 44907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f524e131-1259-448b-85ba-6407783fcc76": {"__data__": {"id_": "f524e131-1259-448b-85ba-6407783fcc76", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Fawzy (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0e334e6c3a057f97f593b956c9b9428cd22a700e19531100e4ce0b03a692e7a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e8809a3e-d4f3-4c9b-9582-0f2e909f293f", "node_type": "1", "metadata": {}, "hash": "8f15ed3bc99623d3c321d4fe10951580ce15f7a91c287ff5439b20b81069eb2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod 2012;27:1977\u20131984.\nVanden Meerschaut F, Nikiforaki D, Heindryckx B, De Sutter P. Assisted\noocyte activation following ICSI fertilization failure. Reprod Biomed Online\n2014;28:560\u2013571.\nWassarman PM, Jovine L, Litscher ES. A pro\ufb01le of fertilization in mammals.\nNat Cell Biol 2001;3:E59\u2013E64.\nXing X, Zhao H, Li M, Sun M, Li Y, Chen ZJ. Morphologically abnormal\noocytes not capable of fertilization despite repeated strategies. Fertil\nSteril 2011;95:2435.e5\u20137.\nYanagida K, Morozumi K, Katayose H, Hayashi S, Sato A. Successful preg-\nnancy after ICSI with strontium oocyte activation in low rates of fertiliza-\ntion. Reprod Biomed Online 2006;13:801\u2013806.\nYelumalai S, Yeste M, Jones C, Amdani SN, Kashir J, Mounce G, Silva SJM\nDa, Barratt CL, McVeigh E, Coward K. Total levels, localization patterns,\nand proportions of sperm exhibiting phospholipase C zeta are signi\ufb01-\ncantly correlated with fertilization rates after intracytoplasmic sperm\ninjection. Fertil Steril 2015;104:561\u2013568.e4.\nYeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activation de\ufb01-\nciency: a role for an oocyte contribution? Hum Reprod Update 2016;22:\n23\u201347.\n1644\nFawzy et al.", "mimetype": "text/plain", "start_char_idx": 44878, "end_char_idx": 46037, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fa948224-a4b2-4f78-b7f5-42ae3633b934": {"__data__": {"id_": "fa948224-a4b2-4f78-b7f5-42ae3633b934", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Takahashi (2015).pdf", "node_type": "4", "metadata": {}, "hash": "f39c2aaee0e4d5fe4912f0af711794451820d9a30edc2220657b35833bcfd080", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fd55de99-473e-484c-a651-afb3f541aba0", "node_type": "1", "metadata": {}, "hash": "916f4242e139acaaf00d983c483b45e80f8320e3c30ef576178a2573544a1819", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "and 3 x Zand-air 100C units were used as air \ufb01ltration. Chi square and stu-\ndent\u2019s t-tests were used as appropriate. There were no lab protocol changes\nduring the study period, besides the in-duct air system.\nRESULTS: 289 ART cycles were analyzed, 163 cycles pre and 126 cycles\npost in-duct air \ufb01ltration installation. There were no differences between the\ntwo groups in the mean age of the patient, the number of oocytes retrieved,\npercentage of mature oocytes per patient, number of fertilized oocytes, or\nnumber of embryos transferred. However, signi\ufb01cant increases were seen in\nthe number of positive pregnancies, ongoing pregnancy rate, and viable blas-\ntocyst development rates. Air quality VOC testing demonstrated improved air\nquality after the installation of the in-duct air system (0.0 ppm) as compared\nwith previous VOC readings prior to installation (0.3 ppm).\nFreestanding air\n\ufb01ltration units\nalone\nIn-duct air\n\ufb01ltration\nunits\np value\nMean age of patient (years)\n30.5\n30.5\nNumber of patients (n)\n163\n126\nMean no. eggs retrieved\n12.6\n13.3\np\u00bc0.3231\nMean no. mature eggs\n8.77\n9.77\np\u00bc0.0583\nMean no. fertilized eggs\n7.28\n7.67\np\u00bc0.4128\nMean no. embryos\ntransferred\n1.88\n1.79\np\u00bc0.0749\nMean no. viable blastocysts\n1.75\n3.50\np\u00bc0.0001\nFirst bhCG (%)\n47.2%\n63.5%\np\u00bc0.0059\nClinical pregnancy rate\n(%)(gestational sac)\n45.4%\n55.6%\np\u00bc0.0868\nOngoing pregnancy rate (%)\n(fetal heart tones)\n34.5%\n55.6%\np\u00bc0.0003\nCONCLUSIONS: Air quality in the IVF laboratory has been shown to have\nan impact on embryo development and resultant pregnancy outcomes. In an\nurban, multi-of\ufb01ce, multiple story building, air quality is often dif\ufb01cult to\ncontrol.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1638, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fd55de99-473e-484c-a651-afb3f541aba0": {"__data__": {"id_": "fd55de99-473e-484c-a651-afb3f541aba0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Takahashi (2015).pdf", "node_type": "4", "metadata": {}, "hash": "f39c2aaee0e4d5fe4912f0af711794451820d9a30edc2220657b35833bcfd080", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fa948224-a4b2-4f78-b7f5-42ae3633b934", "node_type": "1", "metadata": {}, "hash": "b116840525a1d196a28f2c52b22abd401a2e07957931566639a214c2375a2b5a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a241af33-0aa0-4474-86a1-ce94c3ab99a7", "node_type": "1", "metadata": {}, "hash": "c3c1ccf4f60d37918076408309adf8bd1cfba22967655ef257f04fde01100c00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In an\nurban, multi-of\ufb01ce, multiple story building, air quality is often dif\ufb01cult to\ncontrol. The results of this study show that even multiple types and numbers\nof freestanding air \ufb01ltration units may not be enough to create an ideal air\nquality environment within the IVF laboratory. The observations seen in\nthis study suggest that the installation of an in-duct, positive pressure air \ufb01ltra-\ntion system does increase viable blastocyst development and pregnancy rates.\nP-616 Wednesday, October 21, 2015\nPREDICTING BLASTOCYST FORMATION RATE: AN AUTO-\nMATIC CELL TRACKING SYSTEM AIDS IN THE SELECTION\nAMONG\nGOOD\nMORPHOLOGY\nEMBRYOS.\nN.\nBasile,a\nI. Cabanes,a\nM. Testillano,a\nD. Cernuda,a\nJ. A. Garcia-Velasco,a\nM. Meseguer.b aIVI, Madrid, Spain; bClinical Embryology, Valencia, Spain.\nOBJECTIVE: To quantify, by multivariable analysis, the blastocyst forma-\ntion rate according to the three predictive categories provided by Eeva (Early\nEmbryo Viability Assessment).\nDESIGN: Retrospective cohort study.\nMATERIALS AND METHODS: Patients undergoing IVF cycles using\ntheir own or donated oocytes. Embryos were cultured in standard incubators\nincluding multiple Eeva systems. The Eeva test utilizes an automatic cell\ntracking software to classify embryos into three categories (HIGH-ME-\nDIUM-LOW) according to their probability of becoming a blastocyst. For\nthat aim the system relies on an algorithm based on the variables P2 \u00bc t3-\nt2 (time to 3 cell - time to 2 cell) and P3 \u00bc t4-t3 (time to 4 cell - time to 3\ncell). In order to quantify the blastocyst formation rate according to the\nEeva categories, a logistic regression analysis was performed taking in\nconsideration possible confounding factors: embryo morphology according\nto ASEBIR (Spanish Association of Biologists; A-B-C-D), source of oocytes\n(own or donated), and number of oocytes.\nRESULTS: A total of 494 patients generated 3596 embryos.", "mimetype": "text/plain", "start_char_idx": 1546, "end_char_idx": 3443, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a241af33-0aa0-4474-86a1-ce94c3ab99a7": {"__data__": {"id_": "a241af33-0aa0-4474-86a1-ce94c3ab99a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Takahashi (2015).pdf", "node_type": "4", "metadata": {}, "hash": "f39c2aaee0e4d5fe4912f0af711794451820d9a30edc2220657b35833bcfd080", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fd55de99-473e-484c-a651-afb3f541aba0", "node_type": "1", "metadata": {}, "hash": "916f4242e139acaaf00d983c483b45e80f8320e3c30ef576178a2573544a1819", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "71c02030-ced9-4e75-a916-086926ae1850", "node_type": "1", "metadata": {}, "hash": "7339202c07b1d7ec78c953614c0368af2d5872dfad0d0ee90dc6bd7ab6452ce5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RESULTS: A total of 494 patients generated 3596 embryos. The overall\nblastocyst formation ratewas 59.3 % (1347/2269). When categorizing accord-\ning to Eeva, we found signi\ufb01cant differences in the overall blastocyst forma-\ntion rate between LOW vs. MEDIUM (p< 0.001, OR\u00bc 1.964 CI95% 1.550-\n2.489) and LOW vs. HIGH (p< 0.001, OR\u00bc 3.743 CI95% 2.724-5.143).\nDevelopment to \u2018\u2018optimal\u2019\u2019 blastocyst was also analyzed with signi\ufb01cant dif-\nferences between LOW vs. MEDIUM (p< 0.001, OR\u00bc 1.634 CI95% 1.248-\n2.140) and LOW vs. HIGH (p< 0.001, OR\u00bc 3.053 CI95% 2.295-4.061). The\nonly confounding factor presenting a signi\ufb01cant effect was embryo\nmorphology according to ASEBIR. The correlation between Eeva categories\nand blastocyst formation rate differs between good quality embryos (A-B) and\npoor quality embryos (C-D). Taking this in consideration, we still found sig-\nni\ufb01cant differences between LOW vs. MEDIUM (p\u00bc 0.001, OR\u00bc 1.554\nCI95% 1.207-1.999) and LOW vs. HIGH (p< 0.001, OR\u00bc 2.505 CI95%\n1.792-3.502) for the overall blastocyst formation rate but correlation was\nreduced in 21% and 33% respectively. For \u2018\u2018optimal\u2019\u2019 blastocyst formation\nrate, no signi\ufb01cant differences were observed between LOW vs. MEDIUM\n(p\u00bc 0.110, OR\u00bc 1.263 CI95% 0.948-1.682) but we did observe signi\ufb01cant\ndifferences between LOW vs. HIGH (p< 0.001, OR\u00bc 1.950 CI95% 1.437-\n2.647). Once again correlation was reduced in 23% and 36% respectively.", "mimetype": "text/plain", "start_char_idx": 3387, "end_char_idx": 4799, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "71c02030-ced9-4e75-a916-086926ae1850": {"__data__": {"id_": "71c02030-ced9-4e75-a916-086926ae1850", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Takahashi (2015).pdf", "node_type": "4", "metadata": {}, "hash": "f39c2aaee0e4d5fe4912f0af711794451820d9a30edc2220657b35833bcfd080", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a241af33-0aa0-4474-86a1-ce94c3ab99a7", "node_type": "1", "metadata": {}, "hash": "c3c1ccf4f60d37918076408309adf8bd1cfba22967655ef257f04fde01100c00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d3f004d9-158b-4a7f-adc1-93271e83d62f", "node_type": "1", "metadata": {}, "hash": "9031ed14643553b62c3656bc8121375ce4d0d366630a639236a61b9dbd7cf60a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "HIGH (p< 0.001, OR\u00bc 1.950 CI95% 1.437-\n2.647). Once again correlation was reduced in 23% and 36% respectively.\nCONCLUSIONS: Eeva categories are strongly correlated with blastocyst\nformation rates and the prediction is signi\ufb01cantly affected by day 3 embryo\nmorphology. Therefore the best strategy, among good quality embryos, is the\ncombination of both: morphology and morphokinetics.\nP-617 Wednesday, October 21, 2015\nEFFECT OFARTIFICIAL OOCYTE ACTIVATION IN INTRACYTO-\nPLASMIC SPERM INJECTION USING TESTICULAR SPERMATO-\nZOA ON SIBLING OOCYTES.\nC. Takahashi, S. Mizuta, R. Nishiyama,\nK. Yamaguchi, K. Kitaya, H. Matsubayashi, T. Ishikawa. Reproduction\nClinic Osaka, Osaka, Japan.\nOBJECTIVE: Arti\ufb01cial oocyte activation (AOA) has been proposed as a\nsuitable means to overcome the problem of failed or impaired fertilization af-\nter intracytoplasmic sperm injection (ICSI). To analyze with calcium iono-\nphore after ICSI using testicular spermatozoa improves fertilization,\nembryonic development and pregnancy outcome in patients with obstructive\nazoospermia (OA) or non-obstructive azoospermia (NOA).\nDESIGN: Prospective clinical analysis on sibling oocytes.\nMATERIALS AND METHODS: This prospective study was performed\nbetween October 2013 and April 2015. All patients involved gave written\nconsent, and institutional review board approval was granted. This study in-\ncludes 22 OA and 47 NOA couples. We excluded the couples using only\nimmotile spermatozoa for ICSI. Retrieved oocytes were incubated in culture\nmedium (Universal IVF Medium: UIM) for 2 hours at 37C and 6% CO\u2082 and\nwere underwent ICSI with motile testicular spermatozoa. When eight or more\nmetaphase M (MII) oocytes were available, AOA was performed on half of\nthe sibling MII oocytes.", "mimetype": "text/plain", "start_char_idx": 4689, "end_char_idx": 6438, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d3f004d9-158b-4a7f-adc1-93271e83d62f": {"__data__": {"id_": "d3f004d9-158b-4a7f-adc1-93271e83d62f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Takahashi (2015).pdf", "node_type": "4", "metadata": {}, "hash": "f39c2aaee0e4d5fe4912f0af711794451820d9a30edc2220657b35833bcfd080", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "71c02030-ced9-4e75-a916-086926ae1850", "node_type": "1", "metadata": {}, "hash": "7339202c07b1d7ec78c953614c0368af2d5872dfad0d0ee90dc6bd7ab6452ce5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9ef54e7b-7006-4dcc-9b81-cf18576b516f", "node_type": "1", "metadata": {}, "hash": "cac2ff1dd1bb269e800de804783bd8f72fe51d896f078eb47e48700c99e61de8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When eight or more\nmetaphase M (MII) oocytes were available, AOA was performed on half of\nthe sibling MII oocytes. After ICSI, oocytes were incubated in UIM for 30\nminutes, and exposed to 10mM of calcium ionophore A23187 for 15 minutes.\nThe oocytes were then washed and placed in UIM. Two pronuclei (2PN) oo-\ncytes, blastocysts development, good-quality blastocysts, biochemical preg-\nnancies, and clinical pregnancies rates were compared between two groups.\nRESULTS: In terms of OA couples, there were no signi\ufb01cant difference in\n2PN oocytes, blastocysts development, and good-quality blastocysts rates\n(73.0%, 56.1%, and 47.8% with AOA and 66.0%, 41.2%, and 45.7% without\nAOA, respectively). For NOA couples, 2PN oocytes with AOA (74.0%) was\nsigni\ufb01cantly higher than those without AOA (61.2%). Blastocysts develop-\nment, and good-quality blastocysts rates for NOA couples were 53.8% and\n38.4% with AOA and 56.7% and 40.5% without AOA, respectively (no sig-\nni\ufb01cant differences).\nCONCLUSIONS: AOA with calcium ionophore showed favorable effect\non fertilization rate in patients with NOA but OA. The sperm source was\nstrongly affect the fertility potential or clinical outcomes. Severe male factor\ninfertility, especially NOA, could be an indication for application of AOA.\nP-618 Wednesday, October 21, 2015\nAN EVALUATION OF CONTINUOUS HUMAN EMBRYO CULTURE\nUSING THE WOW DISH.\nH. Watanabe, N. Fukunaga, K. Nakayama,\nM. Shimomura,\nH. Tsuji,\nH. Kitasaka,\nF. Tamura,\nY. Konuma,\nM. Kojima, Y. Asada. Asada Ladies Clinic Medical Corporation, Nagoya,\nJapan.", "mimetype": "text/plain", "start_char_idx": 6324, "end_char_idx": 7875, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9ef54e7b-7006-4dcc-9b81-cf18576b516f": {"__data__": {"id_": "9ef54e7b-7006-4dcc-9b81-cf18576b516f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Takahashi (2015).pdf", "node_type": "4", "metadata": {}, "hash": "f39c2aaee0e4d5fe4912f0af711794451820d9a30edc2220657b35833bcfd080", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3f004d9-158b-4a7f-adc1-93271e83d62f", "node_type": "1", "metadata": {}, "hash": "9031ed14643553b62c3656bc8121375ce4d0d366630a639236a61b9dbd7cf60a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Asada Ladies Clinic Medical Corporation, Nagoya,\nJapan.\nOBJECTIVE: The WOW dish (LinKIDTMculture dish,DNP) 25 micro-\nwells that allows group culture under a single drop of medium. Through its\ndesign it is possible to manage embryos separately whilst in group culture.\nThere are several reports (SUGIMURA et al, 2013) suggesting that the\nWOW dish improved bovine embryo culture results. Therefore, we investi-\ngated whether the WOW dish is suitable for continuous human embryo cul-\nture without exchange of culture medium.\nDESIGN: Retrospective study.\nMATERIALS AND METHODS: The study consisted of three experi-\nmental groups. \u2018\u201815ul drop culture\u2019\u2019 group (control) was the standard embryo\nculture method with exchange from single medium to single medium at Day3\nFERTILITY & STERILITY\u0001\ne317", "mimetype": "text/plain", "start_char_idx": 7820, "end_char_idx": 8608, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d34908ed-3a24-450d-962e-3eb6c346fa78": {"__data__": {"id_": "d34908ed-3a24-450d-962e-3eb6c346fa78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "253ccfd6-43a9-4fbb-bf49-d69d1633373d", "node_type": "1", "metadata": {}, "hash": "3b30f6be57eee83118b7e06884345b8266df0f2720fc6dac6dc09ea1ab4b86ac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "P-215 Tuesday, October 18, 2016\nDYNAMICANALYSIS OFHUMAN PARTHENOGENETIC ZYGOTES\nINDUCED BY ARTIFICIAL OOCYTE ACTIVATION.\nA. Tanaka,\nK. Yumoto, K. Iwata, C. Mizoguchi, M. Tsuneto, Y. Mio. Reproductive\nCentre, Mio Fertility Clinic, Yonago, Japan.\nOBJECTIVE: The origin of the pronucleus (PN) in a single PN zygote\n(1PN), and whether its genome is normal still remains controversial. We\nrecently established a novel method of discriminating between maternally-\nand paternally-derived PN using immuno\ufb02uorescence staining and demon-\nstrated the possibility that both the male and female genome could be packed\nin 1PN in some cases. However, currently analyzing karyotypes is an invasive\ntechnique, limiting its clinical application. Therefore, we tried to distinguish\nbetween normally-fertilized zygotes and 1PN zygotes by their morphology\nor developmental behavior. In this study, we used a microscope with time-\nlapse system to analyze the developmental time course and morphology of\nhuman 1PN zygotes, especially parthenogenetic zygotes induced by arti\ufb01cial\noocyte activation.\nDESIGN: Research study.\nMATERIALS AND METHODS: This study used 32 MII oocytes donated\nbetween October 2014 and August 2015 by patients who gave informed con-\nsent for this study. Fresh or freeze-thawed MII oocytes were activated elec-\ntronically and the oocytes were observed by EmbryoScope\u0001. We compared\nthe developmental time course and morphology between parthenogenetic zy-\ngotes and normal 2PN zygotes fertilized by assisted reproductive technology.\nRESULTS: There was no difference in the diameter of the PN in partheno-\ngenetic zygotes compared to the female PN in normal fertilized zygotes (28.9\n\u0001 2.2 vs 26.4 \u0001 2.0 m m, respectively).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1718, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "253ccfd6-43a9-4fbb-bf49-d69d1633373d": {"__data__": {"id_": "253ccfd6-43a9-4fbb-bf49-d69d1633373d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d34908ed-3a24-450d-962e-3eb6c346fa78", "node_type": "1", "metadata": {}, "hash": "9e39e082be19507b0a2bf635cd66c878e38d4fe2f70e4a429c1bc798623a1b93", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eae26353-8dfe-40db-bd02-b560358048d4", "node_type": "1", "metadata": {}, "hash": "fd107509c09517a57ac86f03f812435cc6abcc418d153245917d4e6fd902d6d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There were signi\ufb01cant differences be-\ntween normal 2PN and parthenogenetic zygotes for the time from intracyto-\nplasmic sperm injection or electronic activation to the 2nd polar body (PB)\nextrusion (3.0 \u0001 1.7 vs 2.3 \u0001 0.5 h, respectively), from 2nd PB extrusion\nto syngamy (20.8 \u0001 4.1 vs 18.7 \u0001 2.9 h, respectively), from syngamy to\n1st cleavage (3.0 \u0001 2.3 vs 3.9 \u0001 1.1 h, respectively), and from 1st cleavage\nto 2nd cleavage (9.8 \u0001 4.8 vs 13.6 \u0001 5.2 h, respectively). In addition, some\nparthenogenetic zygotes (6 of 21) developed to blastocysts.\nCONCLUSIONS: The time required from electronic activation to 2nd PB\nextrusion and from 2nd PB extrusion to syngamy in parthenogenetic zygotes\nwas signi\ufb01cantly shorter than in normal zygotes. This may be because oocyte\nactivation or decondensation of the sperm nucleus is not required in partheno-\ngenetic zygotes. In addition, the time required from syngamy to 1st cleavage,\nand from 1st cleavage to 2nd cleavage in parthenogenetic zygotes was signif-\nicantly longer than in normal embryos. Thus, differences in the time course of\nembryonic development in activated zygotes could be used to identify the\ncharacteristics of parthenogenetic zygotes, even though further studies are\nneeded. Furthermore, although some parthenogenetic zygotes develop to\nblastocysts, the clinical use of zygotes with 1PN should be questioned.\nP-216 Tuesday, October 18, 2016\nEFFECT OF OOCYTE ACTIVATION WITH CALCIUM IONO-\nPHORE ON ICSI OUTCOMES IN PATIENTS WITH PREVIOUS\nFERTILIZATION FAILURE.", "mimetype": "text/plain", "start_char_idx": 1719, "end_char_idx": 3238, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eae26353-8dfe-40db-bd02-b560358048d4": {"__data__": {"id_": "eae26353-8dfe-40db-bd02-b560358048d4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "253ccfd6-43a9-4fbb-bf49-d69d1633373d", "node_type": "1", "metadata": {}, "hash": "3b30f6be57eee83118b7e06884345b8266df0f2720fc6dac6dc09ea1ab4b86ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1f208597-d38a-4650-92ca-958a4e3b8d56", "node_type": "1", "metadata": {}, "hash": "483b2a4b713b44df448498f235a64e1b47f57384b0ae016cef26efaa22dd6e8e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "S. A. Hebisha,a\nB. A. Aboelazm,a\nH. M. Adel,a A. A. Aboali,a A. I. Ahmed.b aGynecology, Alexandria Uni-\nversity - Faculty of Medicine, Alexandria, Egypt; bObstetrics and Gynecol-\nogy, MFM Division, Department of Medical Genetics, Perinatology\nResearch Branch, Wayne State University, Detroit, MI.\nOBJECTIVE: To evaluate the ef\ufb01ciency of chemical oocyte activation\nwith calcium ionophore on fertilization and pregnancy outcomes after intra-\ncytoplasmic sperm injection (ICSI) in patients with previous fertilization\nfailure.\nDESIGN: Prospective controlled study.\nMATERIALS AND METHODS: One hundred and eight patients with his-\ntory of previous fertilization failure undergoing ICSI treatment with long\nagonist protocol were randomly divided into two groups: group A (n\u00bc54)\nand group B (n\u00bc54).\nA total of 756 metaphase II (MII) oocytes were retrieved . In the oocytes of\ngroup A(n\u00bc350 oocyte), routine ICSI was applied; while oocytes in group B\n(n\u00bc406 oocyte) were entered in culture medium supplemented with 5 mM\ncalcium ionophore (A23187) for 10 minutes and then washed at least \ufb01ve\ntimes with MOPS solution immediately after ICSI.\nIn both groups, the fertilization was evaluated after 16-18 hours.\nRESULTS: The number of fertilized oocytes and embryos obtained were\nsigni\ufb01cantly different between two groups (p\u00bc<0.001*).\nFertilization rate was signi\ufb01cantly higher in group B -where calcium iono-\nphore was applied-compared to group A-control group-(32.2% vs. 9.1%,\nrespectively, p\u00bc0.01*).\nCleavage rate also was signi\ufb01cantly higher in group B compared to group\nA (26.7% vs 6.25% respectively, p\u00bc0.028*). Implantation rate was signi\ufb01-\ncantly higher in group B than in group A (17.64% vs.", "mimetype": "text/plain", "start_char_idx": 3239, "end_char_idx": 4926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1f208597-d38a-4650-92ca-958a4e3b8d56": {"__data__": {"id_": "1f208597-d38a-4650-92ca-958a4e3b8d56", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eae26353-8dfe-40db-bd02-b560358048d4", "node_type": "1", "metadata": {}, "hash": "fd107509c09517a57ac86f03f812435cc6abcc418d153245917d4e6fd902d6d0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1849771f-6a25-4962-8a4b-c135165cff6f", "node_type": "1", "metadata": {}, "hash": "e313b7eb1c33e84c48dcdb7558532c2359cc925294bc9a40256fc4554fe99d54", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Implantation rate was signi\ufb01-\ncantly higher in group B than in group A (17.64% vs. 2.41% respectively,\np\u00bc0.035*).Pregnancy rate also was signi\ufb01cantly higher in group B than in\ngroup A (21% vs. 3.7% respectively, p\u00bc0.042*).\nCONCLUSIONS: Chemical oocyte activation with calcium ionophore re-\nsulted in a signi\ufb01cant improvement in fertilization, cleavage, implantation\nand pregnancy rates after ICSI in infertile patients with previous fertilization\nfailure.\nReferences:\n1. Heindryckx, B., Van der Elst, J., De Sutter, et al.Treatment option for\nsperm- or oocyte-related fertilization failure: assisted oocyte activa-\ntion\nfollowing\ndiagnostic\nheterologous\nICSI.\nHum.\nReprod.\n2005;20:2237-41.\n2. Lu, Q., Zhao, Y., Gao, X., Li, Y., Ma, S., et al.Combination of calcium\nionophore A23187 with puromycin salvages human unfertilized oo-\ncytes after ICSI. Eur. J. Obstet. Gynecol. Reprod. Biol. 2006;126:72-76.\n3. Manipalviratn, S., Ahnonkitpanit, V., Numchaisrika, P.,et al.Results of\ndirect current electrical activation of failed-to-fertilize oocytes after\nintracytoplasmic sperm injection. J. Reprod. Med. 2006;51:493-9.\n4. Ahmady, A. and Michael .Successful pregnancy and delivery\nfollowing intracytoplasmic injection of frozenthawed nonviable\ntesticular sperm and oocyte activation with calcium ionophore. J. An-\ndrol. 2007;28:13-4.\n5. Nasr-Esfahani, M.H., Razavi, S., Javdan, et al.Arti\ufb01cial oocyte activa-\ntion in severe teratozoospermia undergoing intracytoplasmic sperm\ninjection. Fertil.", "mimetype": "text/plain", "start_char_idx": 4844, "end_char_idx": 6333, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1849771f-6a25-4962-8a4b-c135165cff6f": {"__data__": {"id_": "1849771f-6a25-4962-8a4b-c135165cff6f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1f208597-d38a-4650-92ca-958a4e3b8d56", "node_type": "1", "metadata": {}, "hash": "483b2a4b713b44df448498f235a64e1b47f57384b0ae016cef26efaa22dd6e8e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2396ab86-198f-41d8-b54d-de70f32e060a", "node_type": "1", "metadata": {}, "hash": "e41c39a476911f39567dfa775b7e26771a83674c6d12a25b7ab94675a827ba96", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fertil. Steril., 2008;90:2231-7.\n6. Kyono, K., Kumagai, S., Nishinaka, C., et al.Birth and follow-up of\nbabies born following ICSI using SrC12 oocyte activation. Reprod.\nBiomed. Online, 2008;17:53-8.\n7. Heindryckx, B., De Gheselle, S., Gerris, J.,et al. Ef\ufb01ciency of assisted\noocyte activation as a solution for failed intracytoplasmic sperm injec-\ntion. Reprod. Biomed. Online, 2008;17:662-8.\n8. Braga, D.P., de Sousa Bonetti, T.C., Iaconelli, et al. Arti\ufb01cial oocyte\nactivation with calcium ionophore A23187 in intracytoplasmic sperm\ninjection cycles using surgically retrieved spermatozoa. Fertil. Steril.,\n2009;92:131-6.\nDemographic Characteristics and Laboratory Data\n0%\n0%\n<20%\n<20%\n>70%\n>70%\nConventional (n\u00bc17)\nICSI (n\u00bc13)\nConventional (n\u00bc23)\nICSI (n\u00bc15)\nConventional (n\u00bc237)\nICSI (n\u00bc104)\nAge\n40.9\u00013.9\n41.8\u00011.9\n38.3\u00016.4\n40.3\u00015.5\n37.1\u00016.6\n38.5\u00015.7\nBMI\n25.6\u00016.5\n24.8\u00015.1\n25.6\u00016.1\n23.3\u00014.0\n25.8\u00015.1\n25.9\u00015.7\nDay 3 FSH\n9.2\u00015.6\n8.6\u00014.4\n8.3\u00013.7\n9.1\u00015.4\n6.8\u00013.7\n7.0\u00013.4\nOocytes Retrieved\n4.5\u00014.8\n3.8\u00012.3\n12.9\u00017.3\n9.3\u00014.7\n12.3\u00017.9\n12.0\u00018.", "mimetype": "text/plain", "start_char_idx": 6326, "end_char_idx": 7364, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2396ab86-198f-41d8-b54d-de70f32e060a": {"__data__": {"id_": "2396ab86-198f-41d8-b54d-de70f32e060a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1849771f-6a25-4962-8a4b-c135165cff6f", "node_type": "1", "metadata": {}, "hash": "e313b7eb1c33e84c48dcdb7558532c2359cc925294bc9a40256fc4554fe99d54", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e23894c-7e85-4c3b-ba40-7234ea1060e7", "node_type": "1", "metadata": {}, "hash": "60dca613a3b2a964e60117f9968147b6e24b8edaa568d6a67d1935ed332f6905", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5\u00014.8\n3.8\u00012.3\n12.9\u00017.3\n9.3\u00014.7\n12.3\u00017.9\n12.0\u00018.3\nDay 1 Ongoing\n0\n0\n1.5\u00010.7\n1.3\u00010.6\n10.0\u00016.2\n9.5\u00016.5\nDay 5 Ongoing\n0\n0\n0.3\u00010.5\n0.5\u00010.5\n4.2\u00014.2\n5.3\u00015.7\nET count\n0\n0\n1.1\u00010.8\n0.7\u00010.6\n2.6\u00011.6\n1.3\u00011.8\nSA Initial Total Motile\n15.9\u000113.5\n9.5\u00015.6\n16.4\u000114.8\n11.6\u00017.9\n18.7\u000124.2\n15.8\u000122.5\nSA Initial Motility\n42.0\u00019.7\n40.8\u000112.4\n42.1\u000111.3\n11.6\u00017.9\n47.2\u000112.1\n40.4\u000114.6\nSA Initial Concentration\n57.2\u000129.7\n42.5\u000126.5\n59.8\u000131.9\n50.7\u000117.7\n60.2\u000123.3\n51.6\u000125.3\ne186\nASRM Abstracts\nVol. 106, No. 3, Supplement, September 2016\n9. Mansour, R., Fahmy, I., Tawab, N.A., et al.Electrical activation of oo-\ncytes after intracytoplasmic sperm injection: a controlled randomized\nstudy. Fertil. Steril., 2009;91:133-9.\n10. Terada, Y., Hasegawa, H., Takahashi, A., et al. Successful pregnancy\nafter oocyte activation by a calcium ionophore for a patient with recur-\nrent intracytoplasmic sperm injection failure, with an assessment of\noocyte activation and sperm centrosomal function using bovine eggs.-\nFertil. Steril., 2012;91:935 el1-el4.", "mimetype": "text/plain", "start_char_idx": 7317, "end_char_idx": 8325, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e23894c-7e85-4c3b-ba40-7234ea1060e7": {"__data__": {"id_": "0e23894c-7e85-4c3b-ba40-7234ea1060e7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2396ab86-198f-41d8-b54d-de70f32e060a", "node_type": "1", "metadata": {}, "hash": "e41c39a476911f39567dfa775b7e26771a83674c6d12a25b7ab94675a827ba96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f8cbd0b-56b9-4505-9e6f-6225e1ee004b", "node_type": "1", "metadata": {}, "hash": "3772709e7fb4627263e0490c2849a5acf4994a0372fdcc818058e34fd1a08574", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Steril., 2012;91:935 el1-el4.\n11. Montag, M., K\u20acoster, M., van der Ven, K., et al.The bene\ufb01t of arti\ufb01cial\noocyte activation is dependent on the fertilization rate in a previous\ntreatment cycle. Reprod. Biomed. Online, 2012;24:521-6.\n12. Vanden Meerschaut, F., Nikiforaki, D., De Gheselle, S., et al.Assisted\noocyte activation is not bene\ufb01cial for all patients with a suspected\noocyte-related activation de\ufb01ciency. Hum. Reprod., 2012;27:1977-\n84.\n13. Ebner, T., K\u20acoster, M., Shebl, O., et al. Application of a readyto-use\ncalcium ionophore increases rates of fertilization and pregnancy in se-\nvere male factor infertility.Fertil. Steril., 2012;98:1432-7.\n14. Eldar-Geva, T., Brooks, B., Margalioth, E.J., et al. Successful preg-\nnancy and delivery after calcium ionophore oocyte activation in a\nnormozoospermic patient with previous repeated failed fertilization\nafter intracytoplasmic sperm injection. Fertil. Steril., 2013;79 (Suppl\n3):1656-8.\nP-217 Tuesday, October 18, 2016\nTHE POLAR BODY DOES NOT ACCURATELY REPRESENT THE\nMITOCHONDRIAL MUTATIONAL LOAD WITHIN ITS CORRE-\nSPONDING OOCYTE.", "mimetype": "text/plain", "start_char_idx": 8296, "end_char_idx": 9387, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f8cbd0b-56b9-4505-9e6f-6225e1ee004b": {"__data__": {"id_": "9f8cbd0b-56b9-4505-9e6f-6225e1ee004b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e23894c-7e85-4c3b-ba40-7234ea1060e7", "node_type": "1", "metadata": {}, "hash": "60dca613a3b2a964e60117f9968147b6e24b8edaa568d6a67d1935ed332f6905", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4d699a46-bc37-404e-a0bf-9418362ac731", "node_type": "1", "metadata": {}, "hash": "8c6df082be875012b7685d05b63d29cf92004de6c4762ec2428c4cab40c6edac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "P-217 Tuesday, October 18, 2016\nTHE POLAR BODY DOES NOT ACCURATELY REPRESENT THE\nMITOCHONDRIAL MUTATIONAL LOAD WITHIN ITS CORRE-\nSPONDING OOCYTE.\nJ. Ko\ufb01nas,a\nL. Robinson,b\nM. Seth-Smith,c\nY. G. Kramer,d\nD. H. McCulloh,e\nF. Wang,b\nJ. Grifo,f\nD. L. Keefe.g\naDivision of Reproductive Endocrinology/Infertility, NYU, New York, NY;\nbDepartment of ObGyn, NYU, New York, NY; cNYU, New York, NY;\ndOBS-GYN, NYU Fertility Center, New York, NY; eObstetrics and Gynecol-\nogy, New York University Fertility Center, New York, NY; fNYU Langone\nMedical Center, New York, NY; gObGyn, New York University Langone\nMedical Center, New York, NY.\nOBJECTIVE: Mutations in mitochondrial DNA (mtDNA) cause a number\nof diseases in offspring. Since mtDNA mutations are transmitted exclusively\nthrough the oocyte, various manipulations of the oocyte cytoplasm have been\nproposed to prevent transmission of mtDNA diseases. A method to estimate\nmtDNA load at the oocyte level would help balance the risk/bene\ufb01t of oocyte\nmanipulations. We sought to determine whether polar bodies (PB) accurately\nrepresent the mitochondrial mutational load in their corresponding oocytes.\nDESIGN: Translational science research.\nMATERIALS AND METHODS: IRB approval was obtained for use of\nhuman discard material and a total of 10 oocyte-PB pairs were obtained.\nImmature oocytes received 2 hours post retrieval were placed in an incubator\nfor 48 hours and those that matured were subsequently frozen. Prior to\nfreezing, oocytes were processed with pronase and all excess cumulus cells\nwere removed. The PB was then removed mechanically and frozen sepa-\nrately from the oocyte in PBS solution. A real time PCR assay was developed\nto measure mitochondrial copy number and the presence or lack thereof of\nthe 4977 base pair common deletion (via the presence of the ND4 gene).", "mimetype": "text/plain", "start_char_idx": 9242, "end_char_idx": 11066, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4d699a46-bc37-404e-a0bf-9418362ac731": {"__data__": {"id_": "4d699a46-bc37-404e-a0bf-9418362ac731", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f8cbd0b-56b9-4505-9e6f-6225e1ee004b", "node_type": "1", "metadata": {}, "hash": "3772709e7fb4627263e0490c2849a5acf4994a0372fdcc818058e34fd1a08574", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab77ae80-5cb2-4b73-8e4b-f4f1d59a4f00", "node_type": "1", "metadata": {}, "hash": "1f792a4dc6bf865cadb7d3c7f581889bb38cc73a8349b8a2dd2eac69fe18651c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A real time PCR assay was developed\nto measure mitochondrial copy number and the presence or lack thereof of\nthe 4977 base pair common deletion (via the presence of the ND4 gene).\nThe absolute mtDNA copy number minus the ND4 gene copy number\ndivided by the absolute copy number yielded the deletion ratio. Paired\nt-test analysis was used for statistical analysis\nRESULTS: In all ten oocyte-PB pairs, the mutational load in the PB ex-\nceeded that in the associated oocyte. The mean deletion ratio in oocytes\nwas 30% and 61.8% in PBs (p\u00bc 0.001). The largest percent difference be-\ntween the oocyte and PB mtDNA deletion ratio was 76%. Prediction of\noocyte deletion ratio based on PB deletion ratio is shown with the equation\n[Oocyte deletion ratio\u00bc0.6064(PB deletion ratio) - 0.0708], however this\nrelationship did not reach statistical signi\ufb01cance.\nCONCLUSIONS: It has been suggested that the PB can be used to esti-\nmate mitochondrial mutational load. Here we show that the PB overestimates\nthe mutational load in the oocyte (as high as 76% in some cases). Higher\ndeletion ratios in PBs tended to correlate with higher deletion ratios in asso-\nciated oocytes. Larger numbers are needed for con\ufb01rmation, but even from\nthe sample size studied the PB deletion ratio clearly is not representative\nof its corresponding oocyte.\nP-218 Tuesday, October 18, 2016\nCYTOKINE ANTIBODYARRAY PROFILING IN HUMAN FOLLIC-\nULAR\nFLUID AS\nA\nPOTENTIAL\nMARKER\nFOR OOCYTE\nQUALITY.\nM. Pavone,a\nJ. M. Kelsh,b\nS. Malpani,c\nR. Con\ufb01no,a\nS. Jasti,b S. M. Briley,b J. X. Zhang,a F. E. Duncan.b aObstetrics and Gyne-\ncology, Northwestern, Chicago, IL; bAnatomy and Cell Biology, University\nof Kansas Medical Center, Kansas City, KS; cNorthwestern University, Chi-\ncago, IL.", "mimetype": "text/plain", "start_char_idx": 10887, "end_char_idx": 12628, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab77ae80-5cb2-4b73-8e4b-f4f1d59a4f00": {"__data__": {"id_": "ab77ae80-5cb2-4b73-8e4b-f4f1d59a4f00", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4d699a46-bc37-404e-a0bf-9418362ac731", "node_type": "1", "metadata": {}, "hash": "8c6df082be875012b7685d05b63d29cf92004de6c4762ec2428c4cab40c6edac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f9702b5-c6d8-46d1-85ee-abf1e28350b8", "node_type": "1", "metadata": {}, "hash": "86f4cda3e4dc59154939c0c08cf7dabf8f1e1dcac6abc21d8cce9ad386c55d53", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "OBJECTIVE: Advanced reproductive age and increased adiposity are\nassociated with negative in vitro fertilization (IVF) outcomes, but the under-\nlying mechanisms are unclear. The microenvironment in which an oocyte de-\nvelops can signi\ufb01cantly impact its quality. Therefore, the objectives of this\nstudy were to assess the cytokine pro\ufb01les of human follicular \ufb02uid and to\ndetermine how they change with age and body mass index (BMI).\nDESIGN: Translational.\nMATERIALS AND METHODS: Follicular \ufb02uid from the \ufb01rst follicle\nretrieved at the time of IVF from a total of 26 patients age 27-44 years\nwas run in duplicate on Human Cytokine C5 Antibody Arrays (Ray Biotech).\nProbed arrays were developed, intensities were quanti\ufb01ed, and data were\nnormalized and analyzed. Information including age, BMI, Anti-Mullerian\nhormone (AMH) levels, and infertility diagnosis was also collected.\nRESULTS: The mean age of participants was 35.6 \u0001 5 years, mean BMI\nwas 23.25 \u0001 2.9 kg/m2, and mean AMH was 2.66 \u0001 1.8 ng/ml. There was a\nsigni\ufb01cant negative linear correlation between age and AMH, but no relation-\nship between age and BMI was observed. 80 cytokines were analyzed, and 61\nhad intensity values above threshold. 39 cytokines showed a signi\ufb01cant in-\ncrease with age; these same cytokines showed a decrease with AMH, with\n12 reaching statistical signi\ufb01cance (MIP-1-beta, IL-3, IL-7, IL-12-P40,\nIL-15, TGFb1, TGFb3, VEGF, BDNF, Eotaxin2, PIGF, and Oncostatin M).\n4 cytokines had a signi\ufb01cant association with BMI; IL-8, MCP1, and Leptin\nwere increased, whereas HGF was decreased. Interestingly, the cytokines\nthat changed signi\ufb01cantly with BMI were distinct from those that changed\nwith age or AMH.", "mimetype": "text/plain", "start_char_idx": 12629, "end_char_idx": 14313, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5f9702b5-c6d8-46d1-85ee-abf1e28350b8": {"__data__": {"id_": "5f9702b5-c6d8-46d1-85ee-abf1e28350b8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab77ae80-5cb2-4b73-8e4b-f4f1d59a4f00", "node_type": "1", "metadata": {}, "hash": "1f792a4dc6bf865cadb7d3c7f581889bb38cc73a8349b8a2dd2eac69fe18651c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "697c1e5c-2be9-44c5-a14e-4c3a578417f9", "node_type": "1", "metadata": {}, "hash": "fcccc0d46cafb0ad237d952dee7267bb53e1ad9a6cd5e7fb9d5eb6a771c873c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Interestingly, the cytokines\nthat changed signi\ufb01cantly with BMI were distinct from those that changed\nwith age or AMH.\nCONCLUSIONS: Speci\ufb01c cytokine pro\ufb01les may be strong predictors of\nboth chronological and reproductive age. Obtaining this information is\nnon-invasive to the oocyte, and thus may have clinical utility. Studies are\nongoing to determine whether such cytokines are correlated with IVF out-\ncomes. Our \ufb01ndings also suggest that advanced reproductive age and\nincreased BMI are associated with unique follicular \ufb02uid microenvironments\nthat may negatively in\ufb02uence oocyte quality through different mechanisms.\nSupported by: Friends of Prentice, P50HD076188, KU Undergraduate\nResearch Award.\nP-219 Tuesday, October 18, 2016\nUNEARTHING\nANEUPLOIDY:\nINVESTIGATING\nDOUBLE-\nSTRAND\nBREAKS\nIN\nOOCYTES\nOF\nCAENORHABDITIS\nELEGANS.\nF. Balmir J. L. Yanowitz. Obstetrics, Gynecology, and Repro-\nductive Science, Magee-Womens Research Institute, Pittsburgh, PA.\nOBJECTIVE: To better understand the components of double-strand break\n(DSB) machinery, in order to gain insight into the \ufb01rst event in meiotic cross-\nover recombination.\nDESIGN: Basic research animal study of Caenorhabditis elegans.\nMATERIALS AND METHODS: We created double mutants and\nanalyzed a matrix of interactions between partial loss-of-function alleles of\ngenes involved in DSB formation in C. elegans. These include mutations\nin lin-35, cep-1, dsb-2, rec-1, him-17, him-5, parg-1, and mre-11.", "mimetype": "text/plain", "start_char_idx": 14195, "end_char_idx": 15654, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "697c1e5c-2be9-44c5-a14e-4c3a578417f9": {"__data__": {"id_": "697c1e5c-2be9-44c5-a14e-4c3a578417f9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Hebisha (2016).pdf", "node_type": "4", "metadata": {}, "hash": "1baa14739dc2902d5ecd5a4f32e29f464d5fa9a5408b69681c22ec81b5e691e8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f9702b5-c6d8-46d1-85ee-abf1e28350b8", "node_type": "1", "metadata": {}, "hash": "86f4cda3e4dc59154939c0c08cf7dabf8f1e1dcac6abc21d8cce9ad386c55d53", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These include mutations\nin lin-35, cep-1, dsb-2, rec-1, him-17, him-5, parg-1, and mre-11. We have\nanalyzed diakinesis oocytes by whole mount staining followed by confocal\nmicroscopy and 3D visualization allowing quanti\ufb01cation of crossover\nComparison of oocyte and PB deletion ratios\nOocyte Number\nOocyte deletion ratio\nPB deletion ratio\n1\n0.34\n0.62\n2\n0.45\n0.68\n3\n0.66\n0.90\n4\n0.57\n0.62\n5\n0.21\n0.97\n6\n0.06\n0.24\n7\n0.56\n0.64\n8\n0.15\n0.56\n9\n0.02\n0.62\n10\n0.02\n0.33\nFERTILITY & STERILITY\u0001\ne187", "mimetype": "text/plain", "start_char_idx": 15564, "end_char_idx": 16050, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30c63336-3aa1-4928-8c47-b6b36b839479": {"__data__": {"id_": "30c63336-3aa1-4928-8c47-b6b36b839479", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "McCormick (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d22e3443a06f699ceeb7903e753f3702d14bbea572b592db72ec02729df3854e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "85d9a67c-3d3b-43c0-b40a-0d0331570033", "node_type": "1", "metadata": {}, "hash": "3206c92180b8ee3017242c44217fe83f0c984cdd601cf16d583abf1663aaf41d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Moreover, a particular diacylglycerol (m/z697.6557) was downregulated in the\nstudy group. This lipidomic panel was associated with high-density lipoprotein,\ntriglyceride acyl-chain remodeling and canonical Wnt signaling pathway in\nenrichment analysis.\nCONCLUSIONS: Our data suggest that the identi\ufb01cation of lipids and\npathways correlated with in vitro fertilization may be used for the improve-\nment of current protocols of embryo culture. This study may contribute to\nfurther investigations, which aim to elucidate how in vitro culture, among\nother ART procedures, affects embryo development.\nSupported by: Conselho Nacional de Desenvolvimento Cient\u0001\u0131\ufb01co e Tec-\nnol\u0001ogico (CNPq).\nP-149 Tuesday, October 31, 2017\nDEVELOPMENT\nOF\nA\nCLINIC-SPECIFIC\nPRE-\nDICTIVE EMBRYOKINETIC MODEL IN AN ACA-\nDEMIC CENTER.\nL. Yang,a\nM. Peavey,a\nK. Kaskar,a\nN. R. Chappell,a\nL. Zhu,b\nD. Devlin,c\nC. T. Valdes,a\nT. L. Woodard,a P. W. Zarutskie,a W. E. Gibbons.a aDepartment of OB/\nGYN, Baylor College of Medicine, Houston, TX; bRice University, Houston,\nTX; cTranslational Bio & Mol Medicine, Baylor College of Medicine, Houston,\nTX.\nOBJECTIVE: Non-invasivetime-lapsemicroscopy(TLM) is usedtomonitor\nembryo development to assist embryo grading and transfer selection. Unfortu-\nnately, prior studies show con\ufb02icting morphokinetic parameters that predict clin-\nical pregnancy and thus, the development of clinic-speci\ufb01c embryo algorithms\nhave been proposed. This study examines the feasibility and development of a\nclinic-speci\ufb01c embryokinetic assay to predict clinical pregnancy rate.\nDESIGN: Retrospective cohort analysis of TLM of embryos that resulted\nin either 0 or 100% clinical pregnancy at an academic fertility center.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1705, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "85d9a67c-3d3b-43c0-b40a-0d0331570033": {"__data__": {"id_": "85d9a67c-3d3b-43c0-b40a-0d0331570033", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "McCormick (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d22e3443a06f699ceeb7903e753f3702d14bbea572b592db72ec02729df3854e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30c63336-3aa1-4928-8c47-b6b36b839479", "node_type": "1", "metadata": {}, "hash": "9d5a95cde2f650f78abf6937a7541d801a026bc9183ec9e3d88c69d677474793", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "80f68353-7385-4c48-9a92-37dfda339440", "node_type": "1", "metadata": {}, "hash": "8348f182547e5589e29b3dddc9c046e33aad9810987675bf7ffbaef5d9a25bcd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DESIGN: Retrospective cohort analysis of TLM of embryos that resulted\nin either 0 or 100% clinical pregnancy at an academic fertility center.\nMATERIALS AND METHODS: All embryos that underwent Embryo-\nScopeTM TLM and subsequent transfer with either clinical pregnancy\n(de\ufb01ned by fetal heart beat after 6 weeks) or no clinical pregnancy were\nincluded from 2014 to 2016. All morphokinetic parameters starting from\nfertilization to blastocyst formation were annotated. Demographics data\nincluded oocyte age, anti-M\u20acullerian hormone (AMH), peak estradiol, body\nmass index (BMI), and Society for Assisted Reproductive Technology diag-\nnosis. Data were analyzed by multivariate analysis of covariance, Fisher\u2019s\nexact, Chi-square tests, and binomial logistic regression with SPSS.\nRESULTS: A total of 215 embryos met inclusion criteria. Embryos that re-\nsulted in clinical pregnancy (n\u00bc94) in were faster in progression to 4-cell stage\n(37.8h vs 40.2h, p\u00bc0.057, OR 0.74), and advanced more slowly to the morula\nstage (64.3h vs 62.7h, p\u00bc 0.040, OR 1.113) compared to embryos that did not\nresult in clinical pregnancy (n\u00bc121). The logistic regression model (Chi\nsquare\u00bc26.3, p\u00bc0.010) correctly predicted 70% of clinical pregnancy (sensi-\ntivity of 79% and speci\ufb01city of 59%). A receiver operating characteristic\n(ROC) curvewasdeveloped andfound to besigni\ufb01cant withareaunder the curve\n0.757 (95% CI 0.667-0.848, p<0.001). As predicted, embryos that resulted in\npregnancy were associated with decreased oocyte age (35.0 vs 33.7yr,\np\u00bc0.0057) and higher AMH (4.78 vs. 3.5ng/mL, p\u00bc0.049); therefore, age and\nAMH were controlled for in the analysis. No difference was found between\nBMI, SART diagnosis, and the annotator of the morphokinetics.", "mimetype": "text/plain", "start_char_idx": 1564, "end_char_idx": 3292, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "80f68353-7385-4c48-9a92-37dfda339440": {"__data__": {"id_": "80f68353-7385-4c48-9a92-37dfda339440", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "McCormick (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d22e3443a06f699ceeb7903e753f3702d14bbea572b592db72ec02729df3854e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "85d9a67c-3d3b-43c0-b40a-0d0331570033", "node_type": "1", "metadata": {}, "hash": "3206c92180b8ee3017242c44217fe83f0c984cdd601cf16d583abf1663aaf41d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3f97893-3034-4229-b2a2-cbb0bdff8d4c", "node_type": "1", "metadata": {}, "hash": "62dee48a98558ba7d7843af517b2d9484bcb94cb3086d19f385f54de50913184", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3.5ng/mL, p\u00bc0.049); therefore, age and\nAMH were controlled for in the analysis. No difference was found between\nBMI, SART diagnosis, and the annotator of the morphokinetics.\nCONCLUSIONS: This study demonstrates the feasibility and develop-\nment of a clinic-speci\ufb01c embryokinetic assay and predictive model with as\nfew as 200 embryo outcomes. Shorter time to 4 cell and delayed morula\nappearance were predictive of clinical pregnancy rates, when age and\nAMH were controlled. Additional testing will be forthcoming and are needed\nto determine if the success of this model in prospective embryo selection.\nP-150 Tuesday, October 31, 2017\nCALCIUM IONOPHORE TREATMENT AFTER ICSI\nIMPROVES\nBLASTOCYST\nDEVELOPMENT\nFOR\nMALE FACTOR INDICATIONS AS WELL AS PATIENTS\nWITH ONLY A HISTORY OF POOR BLASTOCYST\nDEVELOPMENT.\nS.\nMcCormick,\nR.\nSmith,\nC.\nPospisil,\nN. I. McCubbin, W. B. Schoolcraft, M. Katz-Jaffe. Colorado Center for\nReproductive Medicine, Lone Tree, CO.\nOBJECTIVE: To determine whether calcium ionophore treatment after in-\ntracytoplasmic sperm injection (ICSI) can improve the blastocyst conversion\nrate in patients with male factor infertility or a history of poor blastocyst\ndevelopment whose partners have normal sperm parameters.\nDESIGN: Prospective intervention study.\nMATERIALS AND METHODS: Between January 2015 and December\n2016, patients with either male factor infertility (n\u00bc25) or only a history\nof poor blastocyst development whose partners have normal sperm parame-\nters (n\u00bc34), were recruited for oocyte splits and calcium ionophore treat-\nment. Immediately after ICSI, half of the metaphase 2 oocytes were\nrandomly selected and treated with calcium ionophore solution (Calcium\ngroup; A23187 calcimycin, Sigma) for 15 minutes followed by a three-\nstep washing protocol before in vitro culture. The remaining metaphase 2 sib-\nling oocytes were untreated and placed directly into in vitro culture (Control\ngroup). All normally fertilized zygotes from both groups were sequentially\ncultured to the blastocyst stage.", "mimetype": "text/plain", "start_char_idx": 3119, "end_char_idx": 5143, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3f97893-3034-4229-b2a2-cbb0bdff8d4c": {"__data__": {"id_": "c3f97893-3034-4229-b2a2-cbb0bdff8d4c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "McCormick (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d22e3443a06f699ceeb7903e753f3702d14bbea572b592db72ec02729df3854e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "80f68353-7385-4c48-9a92-37dfda339440", "node_type": "1", "metadata": {}, "hash": "8348f182547e5589e29b3dddc9c046e33aad9810987675bf7ffbaef5d9a25bcd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "94215def-a222-4251-94b5-57f30956123f", "node_type": "1", "metadata": {}, "hash": "717714b41b7637d9d2255ce028af4731e601402769801f734088460e9178ae5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The remaining metaphase 2 sib-\nling oocytes were untreated and placed directly into in vitro culture (Control\ngroup). All normally fertilized zygotes from both groups were sequentially\ncultured to the blastocyst stage. Transferable quality blastocysts were either\nbiopsied for comprehensive chromosome screening (CCS) and vitri\ufb01ed, or\nvitri\ufb01ed intact, for a future frozen embryo transfer (FET). Statistical analysis\nincluded Student\u2019s t-test, Fisher\u2019s Exact and Chi square test where appro-\npriate, with signi\ufb01cance at P<0.05.\nRESULTS: On average 21.2\u00028.5 oocytes were retrieved per IVF cycle with\nmean maternal and paternal age of 36.9\u00024.5 and 39.9\u00025.8 years, respectively.\nFertilization rates did not signi\ufb01cantly differ between the sibling oocyte groups\n(67% Calcium versus 74% Control; ns). Likewise, cleavage rates to the 6-8\ncell embryonic stage were comparable (97% with Calcium versus 96% Control;\nns). In contrast further development to the blastocyst stage was signi\ufb01cantly\nimproved in the calcium ionophore treatment group (48%) when compared to\ncontrols (39%; P<0.05). In addition, there was a trend towards more blastocysts\nformed on Day 5 of embryonic development (21% Calcium versus 16% Control;\nP\u00bc0.06). A total of 38 cycles included CCS with a 43% euploidy rate from sib-\nling oocytes treated with calcium ionophore compared to 44% euploidy rate for\nsibling oocyte untreated controls. To date, 29 patients have undergone an FET\n(n\u00bc12 SET Calcium group; n\u00bc12 SET Control group and n\u00bc5 DETs one blas-\ntocyst from each group) with an equivalent viable clinical pregnancy/live birth\nrate of 82.8% representing blastocysts from both groups.", "mimetype": "text/plain", "start_char_idx": 4925, "end_char_idx": 6577, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "94215def-a222-4251-94b5-57f30956123f": {"__data__": {"id_": "94215def-a222-4251-94b5-57f30956123f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "McCormick (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d22e3443a06f699ceeb7903e753f3702d14bbea572b592db72ec02729df3854e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3f97893-3034-4229-b2a2-cbb0bdff8d4c", "node_type": "1", "metadata": {}, "hash": "62dee48a98558ba7d7843af517b2d9484bcb94cb3086d19f385f54de50913184", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0b6d6391-8d0e-4ec4-999f-95e7c7c7f356", "node_type": "1", "metadata": {}, "hash": "87adcbe4c1ae50561c1185bf96500390b895e9fd4262f16b1687c25cad7e0ff7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CONCLUSIONS: In our study, calcium ionophore treatment after ICSI re-\nsulted in increased rates of blastocyst formation with no impact on chromo-\nsome constitution or clinical pregnancy/live birth rates for patients with male\nfactor infertility or a history of poor blastocyst development with normal\nsperm parameters.\nP-151 Tuesday, October 31, 2017\nHUMAN EMBRYO DEVELOPMENT CHARACTERIS-\nTICS MAY AFFECT LIVE BIRTH SEX RATIO: A\nTIME-LAPSE STUDY.\nB. Huang\nL. Jin. Reproductive\nMedical Center, Tongji Hospital, Wuhan, China.\nOBJECTIVE: There was few study reported the relationship between\nthese morphologic parameters and human embryo sex. Whether embryo\ndevelopment parameters affected the sex ratio or not is unclear. Nowadays,\nwe could obtain more information on morphokinetic parameters of the em-\nbryo and identify any sex-related differences by using time-lapse technology.\nAs far as we known, there were very few studies reported the relationship be-\ntween live birth gender and embryo development kinetics. Therefore, the pur-\npose of this study was to retrospectively analyze the time-lapse data from our\nIVF center and to determine whether implanted embryo development ki-\nnetics was associated with live birth gender.\nDESIGN: Retrospective observational cohort study.\nMATERIALS AND METHODS: The present research was conducted at\nReproductive Medicine Center of Tongji Hospital between Feb 2014 and\nDec 2015. A total of 743 patients were enrolled, and all patients gave written\ninformed consent. All patients in this study underwent routine clinical and\nlaboratory treatment at the center, and no additional intervention was per-\nformed. Embryos transfer resulted in <100% implantation or 100% im-\nplanted twins with two different genders (male/female) were excluded\nfrom the analysis. The precise timing of cell division and developmental pa-\nrameters were determined: time of extrusion of second polar body (2pb), time\nof PN appearance (PNA) and fading (PNF), time of cleavage to two-blasto-\nmere embryo (t2), t3-t8.", "mimetype": "text/plain", "start_char_idx": 6578, "end_char_idx": 8606, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0b6d6391-8d0e-4ec4-999f-95e7c7c7f356": {"__data__": {"id_": "0b6d6391-8d0e-4ec4-999f-95e7c7c7f356", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "McCormick (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d22e3443a06f699ceeb7903e753f3702d14bbea572b592db72ec02729df3854e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "94215def-a222-4251-94b5-57f30956123f", "node_type": "1", "metadata": {}, "hash": "717714b41b7637d9d2255ce028af4731e601402769801f734088460e9178ae5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Additionally, the time duration of events were also\ncalculated: PNA-PNF, PNF-t2, cc2 (t3-t2), s2 (t4-t2), cc3 (t5-t3), s3 (t8-t5).\nRESULTS: A total of 134 quali\ufb01ed patients with 100% implantation\nand known live birth information were included in the analysis. There\nwere 81 patients with 105 boys live birth (male embryos, n \u00bc 105) and\n53 patients with 69 girls live birth (female embryos, n \u00bc 69). The time\nparameters of t3 and t4 among male embryos were signi\ufb01cantly\n(p<0.05) earlier than those of female embryos. The time duration of\ncc2 in male embryos were signi\ufb01cantly (p<0.01) shorter than those of fe-\nmale embryos.\nCONCLUSIONS: Embryo development characteristics may be related\nwith live birth sex ratio.\ne164\nASRM Abstracts\nVol. 108, No. 3, Supplement, September 2017", "mimetype": "text/plain", "start_char_idx": 8607, "end_char_idx": 9384, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e6933cb5-f4e2-498e-a33e-8d9334d5dea8": {"__data__": {"id_": "e6933cb5-f4e2-498e-a33e-8d9334d5dea8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b05a6732-3698-4211-a0b0-cddf89225f55", "node_type": "1", "metadata": {}, "hash": "fd7732cdf90c7c6d3224b424aea43ea01a86b4ca724852d5b3b9d0af9f61bd9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Can calcium ionophore \u2018\u2018use\u2019\u2019 in\npatients with diminished ovarian\nreserve increase fertilization and\npregnancy rates? A randomized,\ncontrolled study\nPinar Caglar Aytac, M.D.,a Esra Bulgan Kilicdag, M.D.,a Bulent Haydardedeoglu, M.D.,a Erhan Simsek, M.D.,a\nTayfun Cok, M.D.,a and Huriye Ayse Parlakgumus, M.D.b\na Division of Reproductive Endocrinology and IVF Unit and b Division of Perinatology, Department of Obstetrics and\nGynecology, Faculty of Medicine, Baskent University, Adana, Turkey\nObjective: To determine whether calcium ionophore solution can improve the fertilization rate in patients with diminished ovarian\nreserve whose partners have normal sperm parameters.\nDesign: Between January 2014 and August 2014, patients with diminished ovarian reserve were randomized to make arti\ufb01cial oocyte\nactivation with calcium ionophore solution.\nSetting: University hospital.\nPatient(s): A total of 296 patients who had diminished ovarian reserve and partners with normal sperm parameters were included in the\nstudy.\nIntervention(s): Metaphase 2 oocytes were treated with calcium ionophore solution (GM508 Cult-Active) for 15 minutes just after\nintracytoplasmic sperm injection.\nMain Outcome Measure(s): Fertilization rate, implantation rate, clinical pregnancy rate, ongoing pregnancy rate.\nResult(s): Fertilization, implantation, pregnancy, and ongoing pregnancy rates for the calcium ionophore and control groups were\n60.7% and 55.4%, 12.8% and 10.7%, 21% and 12.8%, and 10.9% and 6.1%, respectively.\nConclusion(s): This is the \ufb01rst prospective, randomized, controlled study to analyze the effect of calcium ionophore solution on fertil-\nization rate in patients with diminished ovarian reserve. We did not observe any differences in fertilization, clinical pregnancy, or\nongoing pregnancy rates between the groups. We propose that fertilization ratios could not be\nincreased by arti\ufb01cial oocyte activation via application of calcium ionophore solution in patients\nwith diminished ovarian reserve.\nClinical Trial Registration Number: NCT02045914.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2050, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b05a6732-3698-4211-a0b0-cddf89225f55": {"__data__": {"id_": "b05a6732-3698-4211-a0b0-cddf89225f55", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e6933cb5-f4e2-498e-a33e-8d9334d5dea8", "node_type": "1", "metadata": {}, "hash": "a7cefddf0f5754a2503922a55218c0962b91d5eb624aab72e3172bdc0d202a42", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "92612b2a-ed10-4bb0-82b7-098ca4af519f", "node_type": "1", "metadata": {}, "hash": "8832ee06dd740661735321d65542f398778c5e39497929256e76e25c432d5e27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We propose that fertilization ratios could not be\nincreased by arti\ufb01cial oocyte activation via application of calcium ionophore solution in patients\nwith diminished ovarian reserve.\nClinical Trial Registration Number: NCT02045914. (Fertil Steril\u0001 2015;104:1168\u201374. \u00032015\nby American Society for Reproductive Medicine.)\nKey Words: Calcium ionophore, fertilization failure, diminished ovarian reserve, ICSI\nDiscuss: You can discuss this article with its authors and with other ASRM members at http://\nfertstertforum.com/aytacp-calcium-ionophore-dor/\nUse your smartphone\nto scan this QR code\nand connect to the\ndiscussion forum for\nthis article now.*\n* Download a free QR code scanner by searching for \u201cQR\nscanner\u201d in your smartphone\u2019s app store or app marketplace.\nA\nlthough success rates for IVF\nhave increased to nearly 70%\nusing\nthe\nintracytoplasmic\nsperm\ninjection\n(ICSI)\nmethod,\npersistent failures remain a problem\nfor a large proportion of couples (1).\nDuring IVF treatment after ovarian\nhyperstimulation,\nthe\nnumber\nof\noocytes collected during oocyte pickup\n(OPU) may be diminished owing to\nempty follicles, early rupture of folli-\ncles, or inadequate maturation of the\noocytes. This undesired drop in the\nnumber of oocytes after OPU becomes\nmore worrisome in cases of low oocyte\nfertilization (LF) or total fertilization\nfailure (TFF). Total fertilization failure\nis currently seen in approximately\nReceived April 1, 2015; revised July 9, 2015; accepted July 27, 2015; published online September 3,\n2015.\nP.C.A. has nothing to disclose. E.B.K. has nothing to disclose. B.H. has nothing to disclose. E.S. has\nnothing to disclose. T.C. has nothing to disclose. H.A.P. has nothing to disclose.\nReprint requests: Pinar Caglar Aytac, M.D., Faculty of Medicine, Division of Reproductive Endocri-\nnology and IVF Unit, Department of Obstetrics and Gynecology, Baskent University, Kazim Kar-\nabekir Mh.", "mimetype": "text/plain", "start_char_idx": 1820, "end_char_idx": 3720, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92612b2a-ed10-4bb0-82b7-098ca4af519f": {"__data__": {"id_": "92612b2a-ed10-4bb0-82b7-098ca4af519f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b05a6732-3698-4211-a0b0-cddf89225f55", "node_type": "1", "metadata": {}, "hash": "fd7732cdf90c7c6d3224b424aea43ea01a86b4ca724852d5b3b9d0af9f61bd9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "606103bd-a2f2-4427-8998-08fb804f2b11", "node_type": "1", "metadata": {}, "hash": "4d73d95e92a9ec4a60ffa1bb8dcfef0ce83e788dc3f5c3846384004b529ae69e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Gulhatmi cd. No: 37/A, Adana 01120, Turkey (E-mail: pinarcag1976@yahoo.com).\nFertility and Sterility\u00ae Vol. 104, No. 5, November 2015 0015-0282/$36.00\nCopyright \u00a92015 American Society for Reproductive Medicine, Published by Elsevier Inc.\nhttp://dx.doi.org/10.1016/j.fertnstert.2015.07.1163\n1168\nVOL. 104 NO. 5 / NOVEMBER 2015\n2%\u20133% of patients using the ICSI procedure (2), with our\nclinic reporting a failure rate of 4.3% (unpublished data).\nAnother distressing issue in IVF is the patients with dimin-\nished ovarian reserve (DOR), whereby patients exhibit low oo-\ncytes numbers after ovarian hyperstimulation, even in cases\nin which higher gonadotropin doses were used. Patients\nwith fewer oocytes per IVF/ICSI cycle exhibit lower fertiliza-\ntion rates (51%), along with higher rates of both fertilization\nfailure (16%) and cycle cancellation (24.6%) (3, 4). Within our\nclinic, cycle cancellation was more frequently observed in\npatients with DOR, resulting in TFF rates of up to 32.5%\n(unpublished data). Although signi\ufb01cant advances have\nbeen made in IVF therapy, many of the causes underlying\nfertilization\nfailure\nremain\npoorly\nunderstood,\nthereby\nlimiting\nthe\ntherapeutic\noptions\navailable\nfor\nthese\nindividuals.\nCalcium ionophore (CI) solution is used as an arti\ufb01cial\noocyte activator in infertile couples affected by TFF or LF,\nas well as male-speci\ufb01c factors, including teratozoospermia,\nazospermia, cryptozoospermia, or globozoospermia (5\u20138).\nHere, we sought to investigate the effects of arti\ufb01cial oocyte\nactivation (AOA) by CI after ICSI on the fertilization rate of\npatients with DOR. This study is the \ufb01rst to demonstrate the\neffect of CI on fertilization rates in patients with DOR.", "mimetype": "text/plain", "start_char_idx": 3721, "end_char_idx": 5418, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "606103bd-a2f2-4427-8998-08fb804f2b11": {"__data__": {"id_": "606103bd-a2f2-4427-8998-08fb804f2b11", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "92612b2a-ed10-4bb0-82b7-098ca4af519f", "node_type": "1", "metadata": {}, "hash": "8832ee06dd740661735321d65542f398778c5e39497929256e76e25c432d5e27", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbfb2218-7df1-4c3e-a460-c13ab87e0e9c", "node_type": "1", "metadata": {}, "hash": "a0e98f06769ed7da6aa84ad5c2ed0227f35a314bb06884611d9dd6c5fdc51777", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This study is the \ufb01rst to demonstrate the\neffect of CI on fertilization rates in patients with DOR.\nMATERIALS AND METHODS\nThis\nprospective,\nrandomized,\ncontrolled\nstudy\nwas\nconducted at Baskent University, Adana, Turkey, in the IVF\nunit of the Division of Reproductive Endocrinology, Depart-\nment of Obstetrics and Gynecology, between January and\nAugust 2014. All study-related protocols were approved by\nthe institutional review board of our university (approval\nno. KA13/191) before initiation of the trial. The clinical trial\nregistration number for this study is NCT02045914 (https://\nclinicaltrials.gov).\nStudy Design\nEligibility criteria for the study included DOR and partners\nwith normal sperm parameters. Diminished ovarian reserve\nwas de\ufb01ned according to the Bologna criteria for poor\novarian response (9). Participation was limited to patients\nwho met two of the three Bologna criteria (i.e., abnormal\novarian reserve tests such as bilateral antral follicle count\n<5 or antim\u20acullerian hormone (AMH) levels <0.5\u20131.1 ng/\nmL; poor ovarian response in the prior IVF cycle, de\ufb01ned\nas three or fewer retrieved follicles; and age R40 years).\nSperm parameters were assessed as normal according to\nthe World Health Organization criteria: sperm volume\n>1.5 mL, sperm pH >7.2, sperm count R15 \u0001 106/mL,\nand progressive sperm motility R32%. Patients with globo-\nzoospermia\nor\nmorphologically\npoor\nsperm\nwere\nnot\nincluded in the study. Sperm morphology was evaluated\naccording to Kruger's criteria, with morphology >4%\nregarded as normal (10). Patients who had experienced a\nprevious fertilization failure or who had a history of ovarian\nsurgery,\ngrade\n3\u20134\nendometriosis\nand\nendometrioma,\nadenomyomas, myomas, congenital uterine anomaly, and\ntubal pathology such as hydrosalphenx were excluded\nfrom the study.", "mimetype": "text/plain", "start_char_idx": 5319, "end_char_idx": 7126, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bbfb2218-7df1-4c3e-a460-c13ab87e0e9c": {"__data__": {"id_": "bbfb2218-7df1-4c3e-a460-c13ab87e0e9c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "606103bd-a2f2-4427-8998-08fb804f2b11", "node_type": "1", "metadata": {}, "hash": "4d73d95e92a9ec4a60ffa1bb8dcfef0ce83e788dc3f5c3846384004b529ae69e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b8abea5-1219-4fd3-ba8c-af723acf17f7", "node_type": "1", "metadata": {}, "hash": "123025f5964f0d8ab012916b18b8f16a19ca4119c09e631fe6517ea0ea90c22c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examination of 1,439 patients between January and\nAugust 2014 on the day of early follicular phase identi\ufb01ed\n408 patients with DOR (Fig. 1). Of these, 77 were excluded\nbecause\nof\naccompanying\nmale\ninfertility,\nwith\nan\nadditional 35 declining to participate in the study, resulting\nin a total of 296 patients. Informed consent was provided by\nall patients at the time of enrollment. Treatment protocols of\novarian hyperstimulation were then initiated, as described\nbelow. At the end of treatment, patient randomization was\nperformed by a single researcher on the day of OPU, just\nbefore the process of the OPU with the support of a\ncomputer-generated program. Arti\ufb01cial oocyte activation\nby CI was applied to the oocytes of 148 randomly selected\npatients just after ICSI (CI group); the remaining randomly\nselected 148 patients did not receive AOA so were regarded\nas the control group.\nOvarian Stimulation, OPU\nOvarian hyperstimulation was carried out according to the\nlong protocol, antagonist protocol, or clomiphene citrate\u2013\nfollicle stimulating hormone (CC-FSH) protocol. In the long\nprotocol, down-regulation was achieved by GnRH analogues\n(Lucrin,\nAbbott;\nGonapeptyl,\nFerring),\nfollowed\nby\nhyperstimulation with recombinant FSH (Puregon, Merck\nSharpe Dome; Gonal-f, MerckSerono). In the antagonist\nprotocol, FSH analogues were started on the third day of\nthe cycle, and GnRH antagonists (Orgalutran, Merck Sharpe\nDome; Cetrotide, MerckSerono) were added when the leading\nfollicles reached 12\u201313 mm in diameter or the E2 level\nexceeded 300 pg/mL on the \ufb01fth, sixth, or seventh day of\nthe cycle. In the CC-FSH protocol, clomiphene citrate (Klo-\nmen, Kocak) treatment at 50 mg twice daily was initiated\non the third day of the cycle, and FSH in planned doses was\nadded on the third day of CC treatment.", "mimetype": "text/plain", "start_char_idx": 7127, "end_char_idx": 8932, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3b8abea5-1219-4fd3-ba8c-af723acf17f7": {"__data__": {"id_": "3b8abea5-1219-4fd3-ba8c-af723acf17f7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbfb2218-7df1-4c3e-a460-c13ab87e0e9c", "node_type": "1", "metadata": {}, "hash": "a0e98f06769ed7da6aa84ad5c2ed0227f35a314bb06884611d9dd6c5fdc51777", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "39327f1d-7f04-40a9-b4a5-9c76b9f6685e", "node_type": "1", "metadata": {}, "hash": "3988f902b8944fe1569bbfcb494ea40d5ee3fe5af1ba1d5701d7f6f1b6065b8e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In all protocols,\novulation was induced using 250 mg recombinant hCG (Ovi-\ntrelle, MerckSereno) administered after the leading follicle\nreached a minimum of 17 mm in diameter. Oocyte retrieval\nwas performed 32\u201334 hours after hCG administration.\nOocytes were collected transvaginally under sedation\nanesthesia on the day of OPU. Metaphase I oocytes and\ngerminal vesicles were eliminated, and only metaphase II\n(MII) oocytes were prepared for the ICSI procedure.\nArti\ufb01cial Oocyte Activation\nArti\ufb01cial oocyte activation was performed as described\npreviously (7), unlikely with a lower concentration of CI so-\nlution. GM508 Cult-Active solution was incubated at 37\u0003C\nin 5%\u20137% CO2 for 4 hours before application. Following\nthe ICSI procedure, all injected MII oocytes were incubated\nin 50 mL GM508 Cult-Active (Gynemed) CI solution for\n15 minutes individually. Then, all oocytes were washed\nthree times in 500 mL culture medium, and each injected\noocyte was transferred into the culture medium and\nincubated for 16\u201320 hours until fertilization was achieved.\nVOL. 104 NO. 5 / NOVEMBER 2015\n1169\nFertility and Sterility\u00ae\nAn oocyte was accepted as fertilized when two pronuclei\nand two polar bodies were detected. The fertilization rate\nwas calculated as fertilized oocytes per number of MII\noocytes injected.\nEmbryo Grading, Transfer, and Pregnancy\nEmbryos were graded according to the number and equiva-\nlence of cells and the percentage of vacuoles formed around\nthem, the presence of multinucleation, and the status of the\nzona pellucida on the second and third days. Grades A, B, C,\nand D were assigned according to the Spanish Association of\nReproductive Biology (La Asociaci\u0002on para el Estudio de la\nBiolog\u00eda\nde\nla\nReproducci\u0002on)\nconsensus\nscoring\nof\ncleavage-stage embryos (11), and grade D embryos were\nexcluded from further use.", "mimetype": "text/plain", "start_char_idx": 8933, "end_char_idx": 10763, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39327f1d-7f04-40a9-b4a5-9c76b9f6685e": {"__data__": {"id_": "39327f1d-7f04-40a9-b4a5-9c76b9f6685e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b8abea5-1219-4fd3-ba8c-af723acf17f7", "node_type": "1", "metadata": {}, "hash": "123025f5964f0d8ab012916b18b8f16a19ca4119c09e631fe6517ea0ea90c22c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08524615-b70e-48db-95ab-e53b16248927", "node_type": "1", "metadata": {}, "hash": "a399c29996263cd691d1089e9d8bfe4282e5fbfef4c03d52c754886867ef7b00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Turkish law allows patients\nyounger than 35 years to receive only one embryo; two\nembryos can be transferred in patients aged 35 years and\nolder, as well as in patients who have already undergone\ntwo unsuccessful ICSI cycles. Thus, one or two embryos\nwere transferred on the third day after fertilization. All\npatients received luteal support with 90 mg/d P administered\nintravaginally (Crinone 8% gel, Serono) starting on the day\nof ET and continued for 12 days. Serum hCG levels were\nanalyzed on day 12, with levels >10 mIU/mL suggestive\nof pregnancy. Patients exhibiting a Rtwofold increase in\nhCG levels over the next 2 days were then examined by\ntransvaginal ultrasound to identify a gestational sac, a\nyolk sac, and the presence of a fetal heartbeat after 2 weeks.\nClinical pregnancy was accepted as positive if the fetal\ngestational sac was apparent and fetal heartbeat was re-\ncorded regularly. Implantation rate was calculated as the\nnumber of gestational sacs seen on transvaginal ultrasound\nper number of transferred embryos. Clinically pregnant\nFIGURE 1\nCONSORT statement \ufb02ow chart of the whole study population.\nCaglar Aytac. Calcium ionophore use in the patients with DOR. Fertil Steril 2015.\n1170\nVOL. 104 NO. 5 / NOVEMBER 2015\nORIGINAL ARTICLE: ASSISTED REPRODUCTION\npatients were followed up in the perinatology unit until the\nend of the second trimester (20 weeks' gestation). An\nongoing pregnancy rate was calculated for patients who\nprogressed beyond the end of the second trimester.\nCycle cancellation was performed in patients exhibiting\nno oocytes after OPU (empty follicle), TFF, P levels >1.5 ng/\nmL, endometrial thickness <7 mm, or arrest of cleavage.", "mimetype": "text/plain", "start_char_idx": 10764, "end_char_idx": 12441, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "08524615-b70e-48db-95ab-e53b16248927": {"__data__": {"id_": "08524615-b70e-48db-95ab-e53b16248927", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "39327f1d-7f04-40a9-b4a5-9c76b9f6685e", "node_type": "1", "metadata": {}, "hash": "3988f902b8944fe1569bbfcb494ea40d5ee3fe5af1ba1d5701d7f6f1b6065b8e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "804c1f32-bf75-4559-aac7-b06a8da77f8b", "node_type": "1", "metadata": {}, "hash": "498aba430850a173e4bc27e87b8a6b0fc62c3ff97b5107f0d083d72400ab22d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cycle cancellation was performed in patients exhibiting\nno oocytes after OPU (empty follicle), TFF, P levels >1.5 ng/\nmL, endometrial thickness <7 mm, or arrest of cleavage.\nPatient characteristics, including ages of the patients and\ntheir partners, duration of infertility, causes of infertility,\nnumber of previous IVF cycles, bilateral ovarian antral follicle\ncounts on the day of early follicular phase, AMH levels,\nsmoking history, body mass index (BMI), E2 and P levels\nand endometrial thickness on the day of hCG injection,\nduration of ovarian hyperstimulation, total dose and protocol\nof gonadotropin used for ovarian stimulation, number of\ncumulus\u2013oocyte complex (COC), number of MII oocytes\nobtained on the OPU day, number of two-pronuclei zygotes\nobtained after fertilization, cleavage ratio, grade of the\nembryos, and number of the transferred embryos were\nrecorded for each individual.\nStatistical Analysis\nThe fertilization rate in normoresponders was calculated as\n67% in our clinic (12). In the previous literature the fertiliza-\ntion rate was reported to be 51% in patients with fewer\noocytes retrieved in IVF (3). In our study, we aimed to increase\nthe fertilization rate from 51% to 67%\u201370% in patients with\nDOR. To this end, the estimated sample size calculated by\nthe PS-Power sample-size calculation program to achieve\n80% power (1 \u0004 b) and a type 1 error probability of 5% (a)\nwas 296 patients, divided evenly between groups.\nDemographic dataforeachgroupare presentedasthemean\n\u0005 SD, the median (range), or percentage values. A c2 test was\nused to compare categorical data, and the Mann-Whitney U\ntest was used to compare continuous variables that were non-\nnormally distributed. Student's t test was used to compare\nmeans of continuous data with normal distribution. P values\nof <.05 were considered statistically signi\ufb01cant. Data were\nanalyzed using SPSS version 18.0 for Windows.", "mimetype": "text/plain", "start_char_idx": 12268, "end_char_idx": 14172, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "804c1f32-bf75-4559-aac7-b06a8da77f8b": {"__data__": {"id_": "804c1f32-bf75-4559-aac7-b06a8da77f8b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08524615-b70e-48db-95ab-e53b16248927", "node_type": "1", "metadata": {}, "hash": "a399c29996263cd691d1089e9d8bfe4282e5fbfef4c03d52c754886867ef7b00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3f9c7ba5-b810-4eb5-b537-cb06104aee58", "node_type": "1", "metadata": {}, "hash": "528a379903e0efa4912be1f5afcf07d47918b95e4cf101619c98fc1892049f44", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "P values\nof <.05 were considered statistically signi\ufb01cant. Data were\nanalyzed using SPSS version 18.0 for Windows.\nRESULTS\nThe ages of patients and their partners, duration of infertility,\nBMI, smoking ratios, bilateral antral follicle counts, AMH\nlevels, E2 and P levels and endometrial thickness on the day\nof hCG injection, duration of hyperstimulation, total doses\nof gonadotropin used, numbers of COC and MII obtained on\nthe day of OPU, and the number of previous IVF cycles\nwere all similar between groups (Table 1). The majority of\npatients were experiencing their \ufb01rst IVF cycle (65.2%),\nwhereas 20.9% had previously undergone one, and 13.9%\nhad undergone two IVF cycles. Diagnosed causes of infertility\nbefore IVF included unexplained infertility (15%), tubal factor\n(6.3%), mild endometriosis (3.8%), and DOR (74.9%), which\nwere statistically similar between groups (P\u00bc.29). The\nnumbers of two-pronuclei zygotes, of oocytes that entered\ncleavage, of grades A, B, and C embryos, and of embryos\ntransferred after fertilization were also similar between\ngroups (Table 1).\nThe overall percentages of various ovarian stimulation\nprotocols included 16% long protocol, 48.5% antagonist pro-\ntocol, and 35.5% CC-FSH protocol. There were no signi\ufb01cant\ndifferences in terms of the frequency of the antagonist or CC-\nFSH protocols between groups; however, the frequency of the\nlong protocol was higher in the CI group (P\u00bc.004). Therefore,\nthe\ntotal\ndose\nof\ngonadotropin\nused\nduring\novarian\nstimulation in the CI group was slightly higher, though this\ndifference was not statistically signi\ufb01cant (P\u00bc.12).\nThe CI group exhibited a fertilization rate of 60.7% \u0005 4%,\ncompared with 55.4% for the control group (P\u00bc.26).", "mimetype": "text/plain", "start_char_idx": 14058, "end_char_idx": 15770, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3f9c7ba5-b810-4eb5-b537-cb06104aee58": {"__data__": {"id_": "3f9c7ba5-b810-4eb5-b537-cb06104aee58", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "804c1f32-bf75-4559-aac7-b06a8da77f8b", "node_type": "1", "metadata": {}, "hash": "498aba430850a173e4bc27e87b8a6b0fc62c3ff97b5107f0d083d72400ab22d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3308f05-ef22-46a4-b449-2ee592331ea9", "node_type": "1", "metadata": {}, "hash": "248670f0f3aafc699b72266384400f65b6bdde509ec8d8d3a991c03fee9b8b65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The CI group exhibited a fertilization rate of 60.7% \u0005 4%,\ncompared with 55.4% for the control group (P\u00bc.26). Cleavage\nrates were 93.8% for both the CI and control groups, and\nimplantation rates were 12.8% and 10.7%, respectively\n(P\u00bc.61). The pregnancy rate per cycle was 21% in the CI\ngroup compared with 12.8% in the control group (P\u00bc.60),\nwith per-transfer rates of 30.7% and 22.9%, respectively\n(P\u00bc.24). Clinical pregnancy rates were 13.6% per cycle and\n19.8% per transfer in the CI group, compared with 8.1% and\n10.9%, respectively, in the control group (P\u00bc.13). The\nongoing pregnancy rate per cycle was 10.9% in the CI group\nand 6.1% in the control group (P\u00bc.14); the ongoing\npregnancy rate per ET was 15.8% in the CI group and\n10.8% in the control group (P\u00bc.38).\nReasons for cycle cancellation included higher P levels\n(R1.5 ng/mL) on the day of hCG, empty follicle after OPU,\nthin endometrium on the day of ET, arrest of embryo cleav-\nage, and TFF. The cancellation rate for ET was signi\ufb01cantly\nlower in the CI group (31%) compared with the control group\n(43%; P\u00bc.05). This increased cancellation rate in the control\ngroup was found to be the result of higher empty follicle\ncounts, higher levels of P on the day of hCG, and the tendency\nfor more embryos to be frozen for other reasons. Therefore,\nthe number of ETs in the control group was lower than that\nin the CI group. Next, patients who had cycles cancelled\nbecause of TFF were categorized into subgroups according\nto the method of AOA. The subgroups were similar in terms\nof age, duration of infertility, bilateral antral follicle counts,\nsmoking rates, AMH levels, E2 and P levels on hCG day,\nduration of hyperstimulation, and oocyte number obtained\nafter OPU.", "mimetype": "text/plain", "start_char_idx": 15661, "end_char_idx": 17387, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3308f05-ef22-46a4-b449-2ee592331ea9": {"__data__": {"id_": "b3308f05-ef22-46a4-b449-2ee592331ea9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3f9c7ba5-b810-4eb5-b537-cb06104aee58", "node_type": "1", "metadata": {}, "hash": "528a379903e0efa4912be1f5afcf07d47918b95e4cf101619c98fc1892049f44", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d40c5c0c-73cd-4c54-a4fc-23d6a8e86c96", "node_type": "1", "metadata": {}, "hash": "cceccd807a54074ec91ae8215b468b4d1d6fd76fbc4dde388f6c4316358b6dd5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The TFF rates were 25% in the CI group compared\nwith 20.5% in the control group (P\u00bc.32; Table 2). Although\nthe TFF rate was a somewhat higher in the CI group, this\ndifference was not statistically signi\ufb01cant.\nDISCUSSION\nWe aimed to assess the effects of CI, a chemical oocyte\nactivator, on fertilization rates in patients with DOR after\nimplementation of the ICSI procedure. In this prospective,\nrandomized, controlled study, fertilization and cleavage rates\nwere similar in patients with DOR with or without AOA by CI\nafter ICSI. Implantation, pregnancy, and ongoing pregnancy\nrates were also similar between groups.\nThe study by Krog et al. (4) demonstrated higher rates of\nTFF in IVF in patients with fewer oocytes (fewer than four),\nregardless of the woman's chronological age. Here, we\nobserved TFF rates three times higher in patients with low\noocyte numbers (fewer than four) relative to those with\nnormal\noocyte\ncounts\n(41%\nvs.\n12%).\nAlthough\nwe\nVOL. 104 NO. 5 / NOVEMBER 2015\n1171\nFertility and Sterility\u00ae\nconsistently see fertilization rates of approximately 67% for\nnormo-responders in our clinic (12), the fertilization rate of\nthe patients with DOR described here was only 58%, with a\nsigni\ufb01cant decrease in overall fertility.\nDespite the critical role of oocyte numbers in TFF, the\nmost important reason for fertilization failure is a de\ufb01ciency\nin oocyte activation (13). The fertilization process begins\nwhen a sperm fuses with an oocyte that has arrested in MII.\nSperm-speci\ufb01c phospholipase C zeta (PCL zeta) is then\nsecreted to induce calcium oscillations in the cytoplasm\n(14). Calcium is provided by the endoplasmic reticulum via\ninositol triphosphate (15); inhibition of this calcium has\nbeen shown to inhibit cleavage of the embryo in Drosophila\nmelanogaster (16), indicating an essential role for calcium\nin oocyte activation.", "mimetype": "text/plain", "start_char_idx": 17388, "end_char_idx": 19236, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d40c5c0c-73cd-4c54-a4fc-23d6a8e86c96": {"__data__": {"id_": "d40c5c0c-73cd-4c54-a4fc-23d6a8e86c96", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3308f05-ef22-46a4-b449-2ee592331ea9", "node_type": "1", "metadata": {}, "hash": "248670f0f3aafc699b72266384400f65b6bdde509ec8d8d3a991c03fee9b8b65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f79ead76-1127-4389-8d44-fd7f60c20acc", "node_type": "1", "metadata": {}, "hash": "80c714bc274cbdbb7e676b4597b4ce7643a9f5fd0869182e9a4adb02b343918b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Calcium ionophore is a lipid-soluble\nmolecule that permits calcium transport across the cell\nmembrane, transiently increasing cytoplasmic calcium levels,\nthereby enabling oocyte activation and fertilization (17).\nTABLE 1\nDemographic characteristics of the two groups.\nCharacteristic\nCalcium ionophore cycle\nNo calcium ionophore\nP value\nPatients\nNo. of cycles\n148\n148\nFemale age (y)\n35 \u0005 4\n36 \u0005 4\nNS\nMale age (y)\n38 \u0005 6\n38 \u0005 6\nNS\nDuration of infertility (y)\n5.6 \u0005 4\n5.2 \u0005 4\nNS\nSmoking (%)\n14.9\n22.5\nNS\nBMI (kg/m2)\n23.9 \u0005 5\n24.8 \u0005 6\nNS\nAMH (ng/mL)\n0.4 (0.01\u20131.19)\n0.21 (0.01\u20131.10)\nNS\nAntral follicles (n)\n2.4 \u0005 1.4\n2.5 \u0005 1.7\nNS\nPrevious IVF cycles of patients (n)\n1.6 \u0005 1\n1.7 \u0005 1\nNS\nTreatment\nE2 level on hCG day (pg/mL)\n529 \u0005 377\n529 \u0005 394\nNS\nP level on hCG day (ng/mL)\n0.3 (0.1\u20137.6)\n0.3 (0.1\u20136.5)\nNS\nEndometrium thickness on hCG day (mm)\n9 \u0005 2\n9 \u0005 2\nNS\nCOH duration (d)\n8 \u0005 2\n8 \u0005 2\nNS\nTotal doses of gonadotropin (IU)\n2,350 (300\u20133,525)\n2,100 (300\u20134,125)\nNS\nCOC (n)\n2.4 \u0005 1\n2.3 \u0005 1\nNS\nMII oocyte (n)\n2 (1\u20134)\n2 (0\u20134)\nNS\nTotal oocytes treated with CI (n)\n429\n408\nNS\nAfter oocyte activation\nTwo pronuclei (n)\n1.5 \u0005 0.7\n1.4 \u0005 0.", "mimetype": "text/plain", "start_char_idx": 19237, "end_char_idx": 20360, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f79ead76-1127-4389-8d44-fd7f60c20acc": {"__data__": {"id_": "f79ead76-1127-4389-8d44-fd7f60c20acc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d40c5c0c-73cd-4c54-a4fc-23d6a8e86c96", "node_type": "1", "metadata": {}, "hash": "cceccd807a54074ec91ae8215b468b4d1d6fd76fbc4dde388f6c4316358b6dd5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a14bd87f-4676-47e0-a282-66da0f6db6ea", "node_type": "1", "metadata": {}, "hash": "79759774c4100bc78f4fe59e5434a88b824d394a8875204af6bb45c4590dda1b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5 \u0005 0.7\n1.4 \u0005 0.7\nNS\nCleavage (n)\n1.6 \u0005 0.7\n1.4 \u0005 0.6\nNS\nGrade A embryo (n)\n0.4 \u0005 0.6\n0.4 \u0005 0.5\nNS\nGrade B embryo (n)\n0.8 \u0005 0.6\n0.9 \u0005 0.6\nNS\nGrade C embryo (n)\n0.009 \u0005 0.9\n0.2 \u0005 0.1\nNS\nNo. of transferred embryos\n1.3 \u0005 0.4\n1.3 \u0005 0.4\nNS\nNote: Values are presented as mean \u0005 SD or median (range), unless otherwise noted. COH \u00bc controlled ovarian hyperstimulation; NS \u00bc not signi\ufb01cant.\nCaglar Aytac. Calcium ionophore use in the patients with DOR. Fertil Steril 2015.\nTABLE 2\nIVF outcomes of the two groups.", "mimetype": "text/plain", "start_char_idx": 20344, "end_char_idx": 20847, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a14bd87f-4676-47e0-a282-66da0f6db6ea": {"__data__": {"id_": "a14bd87f-4676-47e0-a282-66da0f6db6ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f79ead76-1127-4389-8d44-fd7f60c20acc", "node_type": "1", "metadata": {}, "hash": "80c714bc274cbdbb7e676b4597b4ce7643a9f5fd0869182e9a4adb02b343918b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74cce886-989a-45d5-a98d-da614d33b14d", "node_type": "1", "metadata": {}, "hash": "274167b83149f747447838fde84a101db166d3c23e085ebc8ab2d83fd2a43f4e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Caglar Aytac. Calcium ionophore use in the patients with DOR. Fertil Steril 2015.\nTABLE 2\nIVF outcomes of the two groups.\nOutcome\nCalcium ionophore (D)\nCalcium ionophore (L)\nP value\nFertilization rate (%), mean \u0005 SD (n)a\n60.7 \u0005 4 (147)\n55.4 \u0005 3.9 (142)\nNS\nCleavage ratea\n93.8 (106/113)\n93.8 (106/113)\nNS\n_Implantation rate/transfera\n12.8\n10.7\nNS\nPregnancy rateb\n21 (31/148)\n12.8 (19/148)\nNS\nPregnancy rate/transferb\n30.7 (31/101)\n22.9 (19/83)\nNS\nClinical pregnancy rate/cycleb\n13.6 (20/148)\n8.1 (12/148)\nNS\nClinical pregnancy rate/transferb\n19.8 (20/101)\n14.5 (12/83)\nNS\nOngoing pregnancy rate/cycleb\n10.9 (16/125)\n6.1 (9/143)\nNS\nOngoing pregnancy rate/transferb\n15.8 (16/101)\n10.8 (9/83)\nNS\nTotal fertilization failureb\n25 (37/147)\n20.4 (29/142)\nNS\nNote: Values are presented as percentage (number), unless otherwise noted.\na Mann-Whitney U test for non-normally distributed quantitative data.\nb P values according to the c2 test for categorical data.\nCaglar Aytac. Calcium ionophore use in the patients with DOR. Fertil Steril 2015.\n1172\nVOL. 104 NO. 5 / NOVEMBER 2015\nORIGINAL ARTICLE: ASSISTED REPRODUCTION\nPrevious studies of couples who had experienced fertil-\nization failures in previous ICSI cycles revealed better fertil-\nization rates using CI for oocyte activation in subsequent\ncycles, regardless of male factors (5, 18).", "mimetype": "text/plain", "start_char_idx": 20726, "end_char_idx": 22060, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "74cce886-989a-45d5-a98d-da614d33b14d": {"__data__": {"id_": "74cce886-989a-45d5-a98d-da614d33b14d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a14bd87f-4676-47e0-a282-66da0f6db6ea", "node_type": "1", "metadata": {}, "hash": "79759774c4100bc78f4fe59e5434a88b824d394a8875204af6bb45c4590dda1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75f03b61-9693-417b-bcba-b7f750de4fbf", "node_type": "1", "metadata": {}, "hash": "1f5013a924f0a0db58b45e3b261671e183f509d9f82230a79e635414202446f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Similar effects\nwere also seen in patients exhibiting infertility due to male\nfactors such as azospermia or cryptozoospermia, with the\naddition of CI resulting in better fertilization rates in\nsubsequent ICSI cycles (7). In all of these studies, patients\nhad experienced fertilization failure due to male and/or\nfemale factors in previous ICSI cycles. However, in one\nstudy, nearly a quarter of patients with TFF reported one or\nmore previous pregnancies, suggesting that TFF is not\nindicative of de\ufb01nite infertility but may instead represent\nan episodic situation (4). Because neither TFF nor LF rates\ncan be predicted using existing methodologies, we sought to\nlower the frequency of TFF and increase fertilization rates\nin patients with DOR in their speci\ufb01c cycle.\nThe treatment protocols for both groups were similar,\nwith the exception of the long protocol, which was used\nmore frequently in the CI group (P\u00bc.004). However, because\nthe difference in treatment protocols in patients with DOR was\nshown to have no effect on live birth rates (19), we assumed\nthat the difference in the use of the long protocol seen here\nwould not affect ongoing pregnancy rates.\nIn the study by Ebner et al. (20), CI treatment during ICSI\nfailed to improve fertilization rates of the embryos, but\ninstead, amelioration was seen on the number of embryos\ngoing to the blastula formation in patients with previous\nembryo development problems. In our study, all embryos\nwere transferred at cleavage stage, with no statistical differ-\nences observed in terms of the number of embryos of each\ngrade. If we had followed the embryos to the point of blastula\nor morula formation, rather than the cleavage stage, we may\nhave been able to better assess the effects of calcium on\nembryo quality.\nThe main concern in using CI as an oocyte activator in\nIVF cycles is the possibility of unknown effects on the em-\nbryos, with potential long-term consequences for the new-\nborns\nthemselves.\nTwo\nrecent\nstudies\nrevealed\nno\nchromosomal abnormalities in implanted embryos after IVF\nin which CI was used as an arti\ufb01cial oocyte activator, with\nno perinatal morbidities or mortalities evident in these\npatients (21, 22).", "mimetype": "text/plain", "start_char_idx": 22061, "end_char_idx": 24245, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "75f03b61-9693-417b-bcba-b7f750de4fbf": {"__data__": {"id_": "75f03b61-9693-417b-bcba-b7f750de4fbf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74cce886-989a-45d5-a98d-da614d33b14d", "node_type": "1", "metadata": {}, "hash": "274167b83149f747447838fde84a101db166d3c23e085ebc8ab2d83fd2a43f4e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "12d265fa-ca7e-4cf2-9759-bc96e6cc84e3", "node_type": "1", "metadata": {}, "hash": "d33e51f45b18a198295fea6a37838c8a4140f79b9d8fb56b1815a4c3e5e7adde", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Similar results have also been seen in\nchildren 3\u201310 years of age who were born after ICSI cycles\nwith AOA via CI, with no differences seen in terms of\nneonatal, neurologic, or language development relative to\ntheir peers (23\u201325). Initial results from our study failed to\nidentify any abnormality associated with this therapy,\nalthough ongoing monitoring continues. One report by\nEbner et al. (26) described a case of anal atresia, a major\nmalformation, in a baby conceived after an ICSI cycle with\nCI application; however, the gastrointestinal abnormality\nrates in babies born after CI application were found to be\nconsistent with those in babies conceived using traditional\nICSI.\nAs with all studies, this work is not without limitations.\nIdeally, it would have been better to split oocytes into two\ngroups for use as CI and controls for each individual cycle;\nhowever, because of the low number of oocytes recovered\nin this cohort (four or fewer), this option was not feasible.\nFurthermore, although we selected patients exhibiting normal\nsperm parameters, the possibility of latent loss of sperm-\nactivating capacity cannot be excluded. Such a possibility\nmay have affected patient outcomes; however, this difference\nwould have applied to both groups.\nIn conclusion, AOA by CI was not shown to affect fertil-\nization rates in patients with DOR after ICSI. Similarly, AOA\nwith CI did not decrease TFF rates in this population. Taken\ntogether, these results suggest that routine use of CI to\nincrease fertilization, pregnancy, and ongoing pregnancy\nrates is not appropriate for patients with DOR.\nAcknowledgments:\nThe\nauthors\nthank\nall\nof\nthe\nembryologists who contributed to this study for their help\nand thoroughness.\nREFERENCES\n1.\nKim JY, Kim JH, Jee BC, Lee JR, Suh CS, Kim SH. Can intracytoplasmic sperm\ninjection prevent total fertilization failure and enhance embryo quality in pa-\ntients with non-male factor infertility? Eur J Obstet Gynecol Reprod Biol\n2014;178:188\u201391.\n2.\nVan Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, et al.", "mimetype": "text/plain", "start_char_idx": 24246, "end_char_idx": 26302, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "12d265fa-ca7e-4cf2-9759-bc96e6cc84e3": {"__data__": {"id_": "12d265fa-ca7e-4cf2-9759-bc96e6cc84e3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75f03b61-9693-417b-bcba-b7f750de4fbf", "node_type": "1", "metadata": {}, "hash": "1f5013a924f0a0db58b45e3b261671e183f509d9f82230a79e635414202446f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "14f33a2f-a793-4d14-827b-c05d6bfeb6e6", "node_type": "1", "metadata": {}, "hash": "187ba5e47f7e446eb756b5182e9919e45fa9af8d2be72601bfcbccc0837247ad", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.\nVan Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, et al. High\nfertilization and implantation rates after intracytoplasmic sperm injection.\nHum Reprod 1993;8:1061\u20136.\n3.\nLuna M, Bigelow C, Duke M, Ruman J, Sandler B, Grunfeld L, et al. Should\nICSI be recommended routinely in patients with four or fewer oocytes\nretrieved? J Assist Reprod Genet 2011;28:911\u20135.\n4.\nKrog M, Prior M, Carlsen E, Loft A, Forman J, Pinborg A, et al. Fertilization\nfailure after IVF in 304 couples\u2014a case-control study on predictors and\nlong-term prognosis. Eur J Obstet Gynecol Reprod Biol 2015;184:32\u20137.\n5.\nMontag M, K\u20acoster M, van der Ven K, Bohlen U, van der Ven H. The bene\ufb01t of\narti\ufb01cial oocyte activation is dependent on the fertilization rate in a previous\ntreatment cycle. Reprod Biomed Online 2012;24:521\u20136.\n6.\nNasr-Esfahani MH, Deemeh MR, Tavalaee M. Arti\ufb01cial oocyte activation and\nintracytoplasmic sperm injection. Fertil Steril 2010;94:520\u20136.\n7.\nEbner T, K\u20acoster M, Shebl O, Moser M, Van der Ven H, Tews G, et al. Appli-\ncation of a ready-to-use calcium ionophore increases rates of fertilization\nand pregnancy in severe male factor infertility. Fertil Steril 2012;98:\n1432\u20137.\n8.\nHeindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option\nfor sperm-or oocyte-related fertilization failure: assisted oocyte activa-\ntion following diagnostic heterologous ICSI. Hum Reprod 2005;20:\n2237\u201341.\n9.", "mimetype": "text/plain", "start_char_idx": 26228, "end_char_idx": 27634, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14f33a2f-a793-4d14-827b-c05d6bfeb6e6": {"__data__": {"id_": "14f33a2f-a793-4d14-827b-c05d6bfeb6e6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "12d265fa-ca7e-4cf2-9759-bc96e6cc84e3", "node_type": "1", "metadata": {}, "hash": "d33e51f45b18a198295fea6a37838c8a4140f79b9d8fb56b1815a4c3e5e7adde", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ce8c62d5-4b05-4c10-9ae6-c31be3a54069", "node_type": "1", "metadata": {}, "hash": "4f93409ad09b69f3af79dc7dddac99ce3a4496f8c64aff18e3ce6a359992c26a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Reprod 2005;20:\n2237\u201341.\n9.\nFerraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L. ESHRE\nconsensus on the de\ufb01nition of \u2018poor response\u2019to ovarian stimulation for\nin vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616\u201324.\n10.\nMurray KS, James A, McGeady JB, Reed ML, Kuang WW, Nangia AK. The\neffect of the new 2010 World Health Organization criteria for semen ana-\nlyses on male infertility. Fertil Steril 2012;98:1428\u201331.\n11.\nBalaban B, Brison D, Calder\u0002on G, Catt J, Conaghan J, Cowan L, et al. The\nIstanbul consensus workshop on embryo assessment: proceedings of an\nexpert meeting. Hum Reprod 2011;26:1270\u201383.\n12.\nKilic\u00b8dag EB, Haydardedeoglu B, Cok T, Hacivelioglu SO, Bagis T. Premature\nprogesterone elevation impairs implantation and live birth rates in GnRH-\nagonist IVF/ICSI cycles. Arch Gynecol Obstet 2010;281:747\u201352.\n13.\nJiaen L, Zsolt N, Hubert J, Herman T, Johan S, Michel C, et al. Analysis of 76\ntotal fertilization failure cycles out of 2732 intracytoplasmic sperm injection\ncycles. Hum Reprod 1995;10:2630\u20136.\n14.\nSaunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM, et al.\nPLCz: a sperm-speci\ufb01c trigger of Ca(2\u00fe) oscillations in eggs and embryo\ndevelopment. Development 2002;129:3533\u201344.\n15.\nWakai T, Fissore RA. Ca(2\u00fe) homeostasis and regulation of ER Ca(2\u00fe) in\nmammalian oocytes/eggs. Cell Calcium 2013;53:63\u20137.\nVOL. 104 NO.", "mimetype": "text/plain", "start_char_idx": 27603, "end_char_idx": 28995, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ce8c62d5-4b05-4c10-9ae6-c31be3a54069": {"__data__": {"id_": "ce8c62d5-4b05-4c10-9ae6-c31be3a54069", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "14f33a2f-a793-4d14-827b-c05d6bfeb6e6", "node_type": "1", "metadata": {}, "hash": "187ba5e47f7e446eb756b5182e9919e45fa9af8d2be72601bfcbccc0837247ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "235a2b10-c7c1-4512-add5-377ce660f8a8", "node_type": "1", "metadata": {}, "hash": "0f2b3f5e86c110ce702094bf196081177637b0f43321f4c6c1ac8bfc858a118d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cell Calcium 2013;53:63\u20137.\nVOL. 104 NO. 5 / NOVEMBER 2015\n1173\nFertility and Sterility\u00ae\n16.\nWong R, Hadjiyanni I, Wei HC, Polevoy G, McBride R, Sem KP, et al. PIP2 hy-\ndrolysis and calcium release are required for cytokinesis in Drosophila sper-\nmatocytes. Curr Biol 2005;15:1401\u20136.\n17.\nMeerschaut FV, Nikiforaki D, Heindryckx B, De Sutter P. Assisted oocyte acti-\nvation following ICSI fertilization failure. Reprod Biomed Online 2014;28:\n560\u201371.\n18.\nYoon HJ, Bae IH, Kim HJ, Jang JM, Hur YS, Kim HK, et al. Analysis of clin-\nical outcomes with respect to spermatozoan origin after arti\ufb01cial oocyte\nactivation with a calcium ionophore. J Assist Reprod Genet 2013;30:\n1569\u201375.\n19.\nPolyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, et al. Live\nbirth rates in Bologna poor responders treated with ovarian stimulation for\nIVF/ICSI. Reprod Biomed Online 2014;28:469\u201374.\n20.\nEbner T, Oppelt P, W\u20acober M, Staples P, Mayer R, Sonnleitner U, et al. Treat-\nment with Ca2\u00fe ionophore improves embryo development and outcome in\ncases with previous developmental problems: a prospective multicenter\nstudy. Hum Reprod 2015;30:97\u2013102.\n21.\nLu Q, Chen X, Shen H, Zhang X, Li Y, Liyang R, et al. No genetic alter-\nations in infants from intracytoplasmic sperm injection in combination\nwith arti\ufb01cial oocyte activation: a pilot study. Chin Med J (Engl) 2014;\n127:383\u20135.\n22.", "mimetype": "text/plain", "start_char_idx": 28956, "end_char_idx": 30325, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "235a2b10-c7c1-4512-add5-377ce660f8a8": {"__data__": {"id_": "235a2b10-c7c1-4512-add5-377ce660f8a8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "Caglar Aytac (2015).pdf", "node_type": "4", "metadata": {}, "hash": "85f26f5d98c0b621b3c16418e347f1abd58c96df6bff77300ee1af3d1b540ee1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ce8c62d5-4b05-4c10-9ae6-c31be3a54069", "node_type": "1", "metadata": {}, "hash": "4f93409ad09b69f3af79dc7dddac99ce3a4496f8c64aff18e3ce6a359992c26a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Chin Med J (Engl) 2014;\n127:383\u20135.\n22.\nNakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M, Aono T.\nEffect of activation with Ca ionophore A23187 and puromycin on the devel-\nopment of human oocytes that failed to fertilize after intracytoplasmic\nsperm injection. Fertil Steril 2001;76:148\u201352.\n23.\nMeerschaut FV, D\u2019Haeseleer E, Gysels H, Thienpont Y, Dewitte G,\nHeindryckx B, et al. Neonatal and neurodevelopmental outcome of children\naged 3\u201310 years born following assisted oocyte activation. Reprod Biomed\nOnline 2014;28:54\u201363.\n24.\nD'haeseleer E, Vanden Meerschaut F, Bettens K, Luyten A, Gysels H,\nThienpont Y, et al. Language development of children born following intra-\ncytoplasmic sperm injection (ICSI) combined with assisted oocyte activation\n(AOA). Int J Lang Commun Disord 2014;49:702\u20139.\n25.\nDeemeh MR, Tavalaee M, Nasr-Esfahani MH. Health of children born\nthrough arti\ufb01cial oocyte activation: a pilot study. Reprod Sci 2015;22:\n322\u20138.\n26.\nEbner T, Montag M, Montag M, Van der Ven K, Van der Ven H, Ebner T, et al.\nLive birth after arti\ufb01cial oocyte activation using a ready-to-use ionophore: a\nprospective multicentre study. Reprod Biomed Online 2015;30:359\u201365.\n1174\nVOL. 104 NO. 5 / NOVEMBER 2015\nORIGINAL ARTICLE: ASSISTED REPRODUCTION", "mimetype": "text/plain", "start_char_idx": 30287, "end_char_idx": 31539, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/metadata": {"69c282a1-fb15-4b35-abde-72f13c724a32": {"doc_hash": "f8c9c5265f8122576140d9202894b61e386b93cda27e6fb08068077ad3f80783", "ref_doc_id": "Ebner (2004).pdf"}, "5b27c940-f4e5-4bec-9b9d-a6f03bdebab8": {"doc_hash": "b8b134b5ddc8a560d699c9755450303b6fe112c1ec886ead6558469d9c4b5292", "ref_doc_id": "Ebner (2004).pdf"}, "e66dfbeb-b6b5-41f2-bbc0-dc271d3ba486": {"doc_hash": "a25778cf58a8f108a03a86ee0ad72745904df8f075b7a66b970859047be1eb9b", "ref_doc_id": "Ebner (2004).pdf"}, "a2ab8ad1-3de6-47ab-9195-b6fab1655249": {"doc_hash": "ccb7f8a16ac3c742faa28bdbf41570c7713da79f4215df1d0f17be0abe507e27", "ref_doc_id": "Ebner (2004).pdf"}, "8d4c2fdc-774f-40a3-ab88-6349f7521ed2": {"doc_hash": "a7bb26fe4fcf13868896a8c72979575f86df7d6507804e1cfb1d89c5bf23e207", "ref_doc_id": "Ebner (2004).pdf"}, "dfdb4dee-1cea-4ada-9e45-246ce22679a3": {"doc_hash": "d7a41bae187ebdb19d79ae6d5a27fc8ec06de81f0d58094d4e75f73ff4a5b4d2", "ref_doc_id": "Ebner (2004).pdf"}, "22f950e8-96aa-44db-8f2d-9064b09f3238": {"doc_hash": "18b4f26f868177e6af49cc0721393a3bcedb88a48929483d3fc0b0e0976e4a3c", "ref_doc_id": "Ebner (2004).pdf"}, "9127de41-169c-44c0-bb99-52552eb02d47": {"doc_hash": "57844f9fc4bd890f31f85e35b890e8474cc783ec866362424aabcd649aa8d022", "ref_doc_id": "Ebner (2004).pdf"}, "313092a6-84e7-4afa-8cc2-765cfc933e7e": {"doc_hash": "c07f903e2d4d8463224bb8e8e55a565ba1865e9786a8c8805ce91228f207cec3", "ref_doc_id": "Ebner (2004).pdf"}, "ed0c1021-ee70-49c6-ba2b-6e7f2f54239b": {"doc_hash": "158a57f78671b3b386222546011fd07779b561cdad5104ed9d0a6eea04344f7c", "ref_doc_id": "Ebner (2004).pdf"}, "414ef5b0-c94e-417f-a3b3-0b36c2bf27f5": {"doc_hash": "f918afa12bf5e9b9812d391e6b949b5554111276c95d13a7103f83911d50786f", "ref_doc_id": "Ebner (2004).pdf"}, "077bfbfb-a750-4d40-8b7f-e924c0fca8ef": {"doc_hash": "680d577072bfc88d612dd7290f238e65c69d7ee3b42ef4ecbc4fe043946af835", "ref_doc_id": "Ebner (2004).pdf"}, "e2cffb51-6705-45a5-8c71-300537442fc5": {"doc_hash": "69387985a201c2e06c4353a0a2cef6228913f754147ea1f9725054263ef1725f", "ref_doc_id": "Ebner (2004).pdf"}, "379a9310-5e98-4b2f-ae48-0445af362347": {"doc_hash": "b2d4539b3e08cf1767a03ac13c4ca96ef7b51996289b36b788360a85073ddfed", "ref_doc_id": "Ebner (2004).pdf"}, "6c9ecd9e-f8c2-4149-ad2a-89586ba81f78": {"doc_hash": "3988073230a48c09d79efb4348a8cd2ff7f091f7428a4da98d4702bd0a96b73f", "ref_doc_id": "Ebner (2004).pdf"}, "4556a9c6-e12f-431a-8f42-f10218602d30": {"doc_hash": "729877181817ee206b5ff2a16205dbf831634f058879e4fa7054daed9558d2ba", "ref_doc_id": "Ebner (2004).pdf"}, "dfbafac1-47dc-49d4-856b-d18e0c6cf151": {"doc_hash": "0a6be7eadadd013b16a3348a513b1e4e9daea3c4cd414790f9c9736a58b61bff", "ref_doc_id": "Ebner (2004).pdf"}, "d0443bed-a471-4bba-9f65-453c6d965e51": {"doc_hash": "7191b0caab0f55cfa74e5f5436861ea4f3dd85b13629d1fb2c0747f4ac519f0e", "ref_doc_id": "Ebner (2004).pdf"}, "28a7fb70-a880-47ab-a0b9-3704cdf20754": {"doc_hash": "81abb5aaac263fac654817a291feea8d3e6d0dc756cf3ad375f6125f07450343", "ref_doc_id": "Ebner (2004).pdf"}, "9d74a9ed-13b3-4c0f-ad72-11d74f83b371": {"doc_hash": "4eef9566d374bc84a6f6b5a24ef72af96953326447c703df81f3c6888a3beeb6", "ref_doc_id": "Ebner (2004).pdf"}, "f9e7d081-4d2e-4cad-bcfa-55c630269e65": {"doc_hash": "f21238277c6d53100e2fade0ca413dcbdd6b713bb0dffd6d75a80e30dfa94719", "ref_doc_id": "Ebner (2004).pdf"}, "125ed0df-0871-4111-9472-447f458f1959": {"doc_hash": "3cd2b54abd402e9c60f3c4c0520ed2f7315a8b5e822609e73694b1d2b640eb8c", "ref_doc_id": "Ebner (2004).pdf"}, "6d9bdb48-1770-495d-ad8a-b424674f1e8d": {"doc_hash": "2f6639bab6e476c83cdb87059caf5c5e0be15eef29a8e1afb04f5cb9a18d9ea9", "ref_doc_id": "Ebner (2004).pdf"}, "d4322125-12ef-4859-a757-44962fa1d4e8": {"doc_hash": "f11714c577c7434b4064cc7707734df28ca4c9a8a30d9b8b15840aaf503867f3", "ref_doc_id": "Ebner (2004).pdf"}, "8c2b9d7d-16a5-4164-a233-bae304d3829a": {"doc_hash": "fc5c0321ee113960ba245e2b97e5add833e59e31f51254c798cfb80eeb5bc51e", "ref_doc_id": "Ebner (2004).pdf"}, "3a8e8a9e-42ad-474e-bda9-68abc4364850": {"doc_hash": "3c846f4d1254783a2f0f6cb9c7d74e8acd1771b018a17edda5d6d021e7476d1d", "ref_doc_id": "Ebner (2004).pdf"}, "ee1c34f8-f078-44ea-9049-7b9e0bb54e1c": {"doc_hash": "68c403f284cadbc4f5b6a3ed59f74b58b45a90d103ba4a9ef6bf265485e4d8e7", "ref_doc_id": "Ebner (2004).pdf"}, "250ffe8d-017a-47da-b440-3bdeb2faf3ac": {"doc_hash": "c066fb1ab19d20c3bd7407e2a47522cd0b25d647de245c2a088c1e56ea865528", "ref_doc_id": "Ebner (2004).pdf"}, "2724d647-5b6a-4b3b-9b98-8f518e8d11d7": {"doc_hash": "8f15ed3bc99623d3c321d4fe10951580ce15f7a91c287ff5439b20b81069eb2d", "ref_doc_id": "Ebner (2004).pdf"}, "b178f845-2267-44fa-a1ac-3cd03cb59397": {"doc_hash": "3d13fcc8a0b3ffb029ca6c493101909e134676a7efbc3bc1eb6f80592248cf4b", "ref_doc_id": "Ebner (2004).pdf"}, "2d028516-59a7-40b6-bf83-6df150680417": {"doc_hash": "0449614766c3e220d9f1c41fd0af3af658956a45ff725ed2c6f06055bb160224", "ref_doc_id": "Mateizel (2022).pdf"}, "7ea66c1a-91b3-4442-9f5e-fc78966c9ca7": {"doc_hash": "00b1ce219f19d790f3c3eac2a852d8add5776ef48e82749e245a37988c82d8ec", "ref_doc_id": "Mateizel (2022).pdf"}, "ccade27f-a9d5-44bd-b5cc-439350da0245": {"doc_hash": "5df1adea3d4dedd72307f71b61708ca1adf3765888ac3abde26c59906e5363f8", "ref_doc_id": "Mateizel (2022).pdf"}, "dc9d926e-b13a-4130-b44b-72f8a883bd72": {"doc_hash": "ad37175222b592593b31c8a94274750e42442250db36345f2abd10ea44531b64", "ref_doc_id": "Mateizel (2022).pdf"}, "92c3cc89-4e8f-4c44-9843-381553d9b8f7": {"doc_hash": "22e70c0a3f2c7a108544796a351e79f5eb10c507a7c00b67f20f1fa1d0b324df", "ref_doc_id": "Mateizel (2022).pdf"}, "38ddb3f4-a255-491a-9f3d-09bbc8cb50ad": {"doc_hash": "49db64ecfe668e563ec354c2b88d21880fefe176247aa8fe182ed3fd33e9375c", "ref_doc_id": "Mateizel (2022).pdf"}, "742cb966-58c8-4dca-8664-567488fadda6": {"doc_hash": "6b8bab730ea0daa7918dc7f35e6ec2959e0d4acb176f637c46a6a34199deb3c3", "ref_doc_id": "Mateizel (2022).pdf"}, "0c864224-e32a-40ae-94e7-f2890c44213b": {"doc_hash": "552e10ca4e6aa77c7f29abf58d38712903034b39ae25554c55158ba820fe6694", "ref_doc_id": "Mateizel (2022).pdf"}, "810af72d-1fdc-4708-912c-df80f4d07f96": {"doc_hash": "971ccdb77ab8200dfececb248a1d9228033b75bcaca89c4aaf16b54466b4460f", "ref_doc_id": "Mateizel (2022).pdf"}, "1d749b2d-ca04-4e8d-8ee1-a08241d44271": {"doc_hash": "ddfc4d7e6c27c7bf80922ab15ed8b7849b8a86640fde317e517fe90371b9f0c9", "ref_doc_id": "Mateizel (2022).pdf"}, "73cfdaac-2817-44d3-88ca-5cb100cd4607": {"doc_hash": "670987858b1e116514eea9671683e7f961eb1557d1ff782e1ae24973363dc33f", "ref_doc_id": "Mateizel (2022).pdf"}, "37ef2460-25ca-480c-bebc-7854784c7e25": {"doc_hash": "e49ac8fc855080e1496f052b986f5bccbfe8b507bd7a6310685fb4209e2eb6d2", "ref_doc_id": "Mateizel (2022).pdf"}, "61c9b673-6b4d-42fc-aed0-f09247eccfbc": {"doc_hash": "1fde3675be667bbfe74acc8514496a02f4f77d041368f21be8b74fe1584a57cb", "ref_doc_id": "Mateizel (2022).pdf"}, "5312a7ad-636c-4078-af63-39f3029a489f": {"doc_hash": "72626177ba1cf100a8b10a34a955fac363713c6aaff455a08f09daf06982158c", "ref_doc_id": "Mateizel (2022).pdf"}, "be4e86ba-4445-4e41-aeef-b2dc7b8e4bb9": {"doc_hash": "d1a70c9bbb633464f497e6590acb54c114044b5eee6c4112a89236643151b5ed", "ref_doc_id": "Mateizel (2022).pdf"}, "b86abf3e-2938-4a17-8ec1-1536958dc992": {"doc_hash": "22a4e363a1f8c4b8e326cb9f8ec1115555a80843415f90a9beda8075f671ae71", "ref_doc_id": "Mateizel (2022).pdf"}, "5d797fbb-abfe-4f1d-b653-f6daa4b72e96": {"doc_hash": "5905ab8354017b82127b510448c9d1a68942291dc564524006d691e1d2b09856", "ref_doc_id": "Mateizel (2022).pdf"}, "0ba2cd55-02f4-497a-b257-f653fa5534a7": {"doc_hash": "b7df18a966bb8138f8a4b03f26f7cda755887d1be2bc80dc6f30f47b54e726e9", "ref_doc_id": "Mateizel (2022).pdf"}, "9511df57-7527-409c-bf41-71f91c4acfcd": {"doc_hash": "1c2b3070f4d90d456e5bfbb92c8b43908af11512a1f8a8981f12eb0f1c2e4d9b", "ref_doc_id": "Mateizel (2022).pdf"}, "c8d95f87-9983-4190-8f04-e6a3383aef78": {"doc_hash": "a7c49d0ee6dad7257b4d2ec513655dd553d4530b5c8091cbe89877b373393252", "ref_doc_id": "Mateizel (2022).pdf"}, "d55f06d0-be41-4ce7-b7c3-d262425ecf5c": {"doc_hash": "7c3e8c9f39fb71e7a235d42524a92fcb3c48fc06f5d3af2282dab847e7d154ab", "ref_doc_id": "Mateizel (2022).pdf"}, "f832c886-a6df-4832-95bc-0064c562b0e6": {"doc_hash": "b1e2da354980861b181b74c8ccc2c7e36bdf45552f38185537d04fb07c3205dd", "ref_doc_id": "Mateizel (2022).pdf"}, "503863d1-7df0-47a8-b10d-abfd5e9778fc": {"doc_hash": "ebc62abb15c8b0e35c32af1d5db7942504a073c1daa4f3a11e865e5030fb90e2", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "91e8f0e6-bf46-483c-a399-3d5c0176a3c3": {"doc_hash": "e445e42363e0c11e07490464acafaef9ab986cb289be035caeb926dd33b560c9", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "b6c9359e-e0bb-4edc-9fcb-0bbc95b72897": {"doc_hash": "104befb894d484952a69cbc636f186d7603fac9afa6a0e9042d58e93b17f1474", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "974739ea-45fd-4a59-8e36-0ccf64d95e9a": {"doc_hash": "2bb8b69d92f5f3aa3ad972ad5f15b61c8da5df33dbcc55d94710487ff6fe23e3", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "efc9f392-1475-43b0-8278-fec560307071": {"doc_hash": "1989ffdbb0d1a204c082718e3815342d8e94a851aa2025282e5eb4ae84c9f44e", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "26a2a009-eee8-4aae-a523-6aed3180ace2": {"doc_hash": "87fd947d18ff198a387f5e18e811f8c80f330a8af1ce59f608c7535aaeb23906", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "ada4a161-18bb-43b4-8389-4aecbcb5272b": {"doc_hash": "259b61a42833cbe0139bce4a98ad014ea8dabb0aacf5dd48be5be8e10299ce19", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "41c7cc37-9e2c-4399-9756-576f752db2b2": {"doc_hash": "3b8b66ba46cd85b5d59275d4d6468aba68a16f4c9a018717bd1c7f246dcd2f5c", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "a13aff0d-bdfe-4bd9-ae63-74a5b03e906d": {"doc_hash": "b405c5ac96e9da205c8da8d4dafe9ae67c9bbbf275f2028b0f15afff716deccc", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "21fd8d04-e738-42b2-9895-3495f2019d60": {"doc_hash": "0ebed2ecc7a5297beb50c19c0bdc242add0268683c81c33f8f5277061d829b7d", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "15a7e983-14ef-4d0e-a5ea-1c0eea2d0a2e": {"doc_hash": "350d3f92cd633b59253f960047df8a67e70b91d43881ba6fb683efef6c02dd14", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "a8b5af39-dbfa-41be-9c26-8b3e490104d6": {"doc_hash": "683e28a7b5573667ebeeaf739a4effb31e45e5f31c6d8582a9a3109809bfa0f8", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "e4db23bb-cdaa-42e8-80d8-679cb2508099": {"doc_hash": "e3d78d5f15fe2cebd3c101b4c0c8678b4c2915aa77153110013cb7bca84037e9", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "257b4fd6-7cf7-4fbe-a994-0f43548a5b5e": {"doc_hash": "c521e25d824f6aebf2c9e1b4b60bba4ac3d6bff616d0b3f86f76e89ffd2543ad", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "ab806ebb-2f6c-42ce-a8dc-f9e84b7471c3": {"doc_hash": "eb9167461f99038cd18173f178ee252c34c025f5f426d293c36f66a786ff22c8", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "9f125168-ec69-4b27-8e4c-845e000b0df6": {"doc_hash": "772ea7582ce688278d9d54b4eea190a83162cb35a728260ec3f219c2cb5919a1", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "19de532f-e3f6-4a90-947d-4fe34bbf3894": {"doc_hash": "f1cfcf4c2a4e36bafb995ae7c1439db670fec6fbd65f3ce36b8a3317e3f2e068", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "20e9e856-9dd9-4ed5-879b-70f8d40a6b14": {"doc_hash": "ea78a72082a78b57e5725b95a80b7e4a28db90a555f382e1e84334051fa5a0ea", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "6a266794-ccd2-4c05-bd9e-073cae5896e3": {"doc_hash": "045ea79514703e737bc9c33f1d41d8032977aa01df50d45614d3b18979fd14e7", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "e09ab81a-5916-491b-aaba-a7d786f75136": {"doc_hash": "1a34b4ee107cc06a26c582cb61a1ba798969628ec489b5f3ef581cbc4a1b0ba8", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "28790530-8cfd-486c-97cc-646a7bafdb95": {"doc_hash": "1a7bfff9b8d388b0a377bb80125828996e0e24d442daeaaa5bf123af8c3e7e6d", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "005be17c-41f3-418e-9823-d272d8fa2301": {"doc_hash": "2625a155b4d2a4c795da66f7ac074553f7ae808f37114c80f9dee280d09c953f", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "e9b3e9e4-408c-4f03-8644-b09f80acea30": {"doc_hash": "e528d0e3783b13603cd978ddba179f43d7beacb1b3e5a79263a94a95db57989f", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "9b381b44-201f-475e-b7e9-9a57c2e0ae7e": {"doc_hash": "e0baf5843e3ff8bdb9bfe5a372b952250c69596e6e6e2176ec48bf11bd4a384b", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "98eb7538-8674-447b-870d-ae84f61e9a6a": {"doc_hash": "b094efbb8a588b96d2dd9c221f7fde8d8f44d3818ef0aa9af38670fb590833f1", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "ab93033e-461b-4706-b732-b164bf0f5345": {"doc_hash": "1b2fea1af41b265484e49cb71333ddd244a0bc560800f96b881974798fd24a08", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "4e3ca5cb-ad5d-423f-8e36-0df355c6cc08": {"doc_hash": "7de7719e1ba87676fd569eaee36173250397f96276c9ba3678aa7718dea50a77", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "87c0e0f3-ad99-40a6-bdde-5539cad7bc11": {"doc_hash": "283133cf5d138efc13e16c79f43e3a3475b6683486dd51d0b3aa7cb475f0ad43", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "cf206f45-989f-4f91-b6d8-0df21a1c5c59": {"doc_hash": "29e221d4cbd08fc74bf4f4ae033edc0e48044f8dac3611aad165d304d7c85efd", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "c2331340-209a-4f5b-adcc-dbdca8245cf2": {"doc_hash": "738949a620bbf2a7eab57b76b81434b4c81b49612bfeffb87ead57acb4e47f15", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "e19dbd15-3045-4302-8ab3-ee2079af1bcc": {"doc_hash": "588086a7fc5f896541f17ef5e4f6d379cb8fa77e546c2d13eda7099a0659180c", "ref_doc_id": "Vanden Meerschaut (2012).pdf"}, "5d9d063c-dadd-4e36-942e-071b19931274": {"doc_hash": "b966f9421223740bf3804fc66774e646f90baf3a6a747b1062048ef3654b0586", "ref_doc_id": "Mansour (2009).pdf"}, "6d366835-0c97-4361-beaf-71904242ae16": {"doc_hash": "5ec70508fb28eff91a79a5698ff7b3a32f3dd98059f63e9e82565d7a5fd42ff8", "ref_doc_id": "Mansour (2009).pdf"}, "4dbd1651-884e-41b5-af0a-efa81493cfe7": {"doc_hash": "2502309fced8936398cc2957d7af410080873b07edab48f6e449184359f01dab", "ref_doc_id": "Mansour (2009).pdf"}, "2e3adca0-6c18-4e3b-a913-a3e4e1e0b1e6": {"doc_hash": "e9cb70770c995cd9c0185c942458bd14b51c14ecbe0686ec98cce88a180db8bf", "ref_doc_id": "Mansour (2009).pdf"}, "08293380-7604-46b1-9a55-a24d65a6bbb4": {"doc_hash": "e19f255625b0df8ee1751a9fac02a56af75e03e23edcd04418a782d36d00f7b4", "ref_doc_id": "Mansour (2009).pdf"}, "57bba814-fe83-4229-b517-e5e4ecfa1620": {"doc_hash": "b638d8b86a856745a58c04a2a52f15afebbf70da4ccde11fdbe64941b9c41b4f", "ref_doc_id": "Mansour (2009).pdf"}, "1ce3b3dc-c52b-495d-8f9b-c2b941bf28c1": {"doc_hash": "c6ee2378c944460789c18f1d3844f890886d2a30fa851679856227d38f5c0a14", "ref_doc_id": "Mansour (2009).pdf"}, "570b37d3-6ab5-4f79-976a-222310c1aed3": {"doc_hash": "5de88235bf4bb385f129a5461ef2847690789d7be09c5a89e6caf765083583c4", "ref_doc_id": "Mansour (2009).pdf"}, "ad9f4738-8fc1-4028-83f2-f71f1e0feca4": {"doc_hash": "e79fb671c3dd454b87c15b271aa9a04a577978f866ce93a4308a0c18de53df0c", "ref_doc_id": "Mansour (2009).pdf"}, "c141dfa2-8669-4a93-8e90-e99c2a158d54": {"doc_hash": "71fbe05beeb9d436af4d17ac70adb0f116a33613db342246db9ca5b1a9867981", "ref_doc_id": "Mansour (2009).pdf"}, "40f7bf3f-181b-4c8f-819e-192d895ea9a3": {"doc_hash": "7b9028a99851a64b93e83b59ccb235486ce9548f01090057a49a34635fd84d81", "ref_doc_id": "Mansour (2009).pdf"}, "c0bf827b-d55b-4f97-835d-ebf7e2f28b1c": {"doc_hash": "bf60008d6047d4b6e61c4d22646d2758ce93ef46ecc67dc1c1b96ab1d0d03a51", "ref_doc_id": "Mansour (2009).pdf"}, "fffa90b7-9352-444c-925d-cc1399a044a0": {"doc_hash": "9baf01773415ef019daadf1daa0cbdc82265042a9265e22a376971096e4f80e5", "ref_doc_id": "Mansour (2009).pdf"}, "66c8321b-d12c-4101-b9aa-0e8c68e6667b": {"doc_hash": "13deadfc99dae5010e54b7a85acf89644a6c76914adac94cb82b40c21c429792", "ref_doc_id": "Mansour (2009).pdf"}, "84fd64f4-eeab-4cda-ab4e-c8e7e785eb39": {"doc_hash": "56353a9b68791601f27e7e0d3c03e07af67ea50cf0ee499ee1b1086baefbee21", "ref_doc_id": "Mansour (2009).pdf"}, "74b7913b-c171-4fdb-bc36-3fb16c035b9d": {"doc_hash": "0587440c6679e99681bb2496b7c1c2e48adc689e91fac4d312399059d236d576", "ref_doc_id": "Mansour (2009).pdf"}, "7ba002c1-2745-4f98-be54-d765fc863b3a": {"doc_hash": "a795288217997054166b48683113e99aa5f2c4f9d259241629ffc7a3d8f337b3", "ref_doc_id": "Mansour (2009).pdf"}, "187b57f3-d373-4183-a564-d57f20338df6": {"doc_hash": "7f1fd5aff6002b71876eecd9aa873e168863977ff5fbcf7fd65e750ba2ebbd7c", "ref_doc_id": "Mansour (2009).pdf"}, "70e1f38d-4626-4321-849a-2836ecc9d719": {"doc_hash": "d65d75ce1a085b8103f8327d7388144d7ac601683893de52baa3cdf77188ad9a", "ref_doc_id": "Mansour (2009).pdf"}, "6c3ca4d1-d3e3-4ba8-9dbf-33242f07acc4": {"doc_hash": "3a239bb11d8158c9c4faaac352e57359bbd85550fda9f15301246e77a5b67aac", "ref_doc_id": "Mansour (2009).pdf"}, "9af22841-94a2-47ca-ae52-faf0272e41c1": {"doc_hash": "527f649e726d18ba7dd9d7d5f1994d8275e5b0bb33721d72e260973844692b5b", "ref_doc_id": "Mansour (2009).pdf"}, "ce3b33df-8057-483f-a3b2-5b9a90150d20": {"doc_hash": "86c8cdbe453579412303834f3d917363a0d8eee767e2d96bba332aeb07961f15", "ref_doc_id": "Mansour (2009).pdf"}, "a4cdaf9a-b225-4456-8edf-280f55d3cd87": {"doc_hash": "f083166a6245050610a251febed7bfdfadde710269fd5948b04f0d4bba9c3d1c", "ref_doc_id": "Aydinuraz (2016).pdf"}, "8ed8c110-e654-40e2-baed-2c215a3340d7": {"doc_hash": "df272f2f5b1168b41fc63a00b7b10fb0c851d6892e42f7a24dd7e90ab31d0118", "ref_doc_id": "Aydinuraz (2016).pdf"}, "9a81ce77-0635-4121-b553-b3642bf3fd0d": {"doc_hash": "851031999f57f3564e4969a5a1466d2eec7e7275872fc7388657a3826f78ee3b", "ref_doc_id": "Aydinuraz (2016).pdf"}, "13427dda-901c-4e2e-b099-b8d9775a6756": {"doc_hash": "efd8e82ffc8e15790642d79dc02f05de5adb77205c6a7490414a793efc98ae30", "ref_doc_id": "Aydinuraz (2016).pdf"}, "511dffa4-e6ee-4134-8452-e96175da66c0": {"doc_hash": "8e4e26c00c63679da45cb188a07fafb5770fd3ebdc09a7ddfe39b96b174f4597", "ref_doc_id": "Aydinuraz (2016).pdf"}, "6ea5923d-d5ff-44a0-9d68-71b73e7e93c5": {"doc_hash": "c234954c7808d55dc7736373f29b39cf471a611a8af9b4d91d5c5db284db373b", "ref_doc_id": "Aydinuraz (2016).pdf"}, "db34c9f5-1b6d-450e-8a00-86a3a61043f6": {"doc_hash": "35654f7d6cbb2ee643afc4f46714c6a7bb230dfe52de5c662ee2797fdb7392c0", "ref_doc_id": "Aydinuraz (2016).pdf"}, "05f91917-a900-4f3e-8374-df0e76ac9787": {"doc_hash": "293269f0991b27e4a59feb80de50721333355c2b5cd51f68ef200c6ce4ad7662", "ref_doc_id": "Aydinuraz (2016).pdf"}, "b24e6465-fdd4-4936-a5d5-ff08956a189b": {"doc_hash": "a80d3221af84afe239e256f2b2a05c966e490618c732e41d3242aaeb202ee332", "ref_doc_id": "Aydinuraz (2016).pdf"}, "cc60321a-a95c-4874-9566-624cc6e617da": {"doc_hash": "28ab0b2e9d3b4a48c5541a8ce8281be7bc6ac0f26413c92ca67bf8724032010e", "ref_doc_id": "Aydinuraz (2016).pdf"}, "0f80ea38-2872-4c09-a77e-26ee9404f77a": {"doc_hash": "08c55cd0bd33eae03ac361f5c5b75d66963087ad4f8f67bb63337a5c08cb6cfb", "ref_doc_id": "Aydinuraz (2016).pdf"}, "097992a6-44e4-435e-a4ed-b09e227516c3": {"doc_hash": "803f37639f84151949d35b2a922e808ef9d58c5421f02a514be82c5808e96523", "ref_doc_id": "Aydinuraz (2016).pdf"}, "d97eca6a-e5f6-4282-9aac-62ec73791ede": {"doc_hash": "414726d18ea473f5161aa9bd5a21e95f56814015acd855d5d8e6870e9dc99bf9", "ref_doc_id": "Aydinuraz (2016).pdf"}, "122081d6-cfc6-4c96-a229-a2e69c93da33": {"doc_hash": "de6c7dbb12d2844c49d320b1bfc11d4b1c7464cef00baa7bfa09493da1166b5b", "ref_doc_id": "Aydinuraz (2016).pdf"}, "6ca93689-131f-4173-8c35-2a8cd7d1f61d": {"doc_hash": "b5e08b909ccd23ae96c24bb112d4ec5ada6f49c9c8fcfe07937952c70e785a65", "ref_doc_id": "Aydinuraz (2016).pdf"}, "7dd94584-3d5c-4971-890d-7380e58afb79": {"doc_hash": "05d95b8e1859f82cb9ef88bbadd3665236fce1052578ecabade0dc972e871187", "ref_doc_id": "Aydinuraz (2016).pdf"}, "6c05d35a-3965-4c10-954a-74a414a0b0b0": {"doc_hash": "b96fd289191295c1e894643c41795542bf7e60087d113b2cf47456b9ddd3b1b2", "ref_doc_id": "Aydinuraz (2016).pdf"}, "cdb10ca3-018a-47b5-8628-a73550becd2b": {"doc_hash": "11344f1f291ef7c45f5501b3992f7099a8d8c6acce35de73f3a894baf2ba6a3f", "ref_doc_id": "Aydinuraz (2016).pdf"}, "7e9ab3e5-6a63-4d83-aa97-95948be1b0b7": {"doc_hash": "2deda1cf7652f653a3462e4db633e0076b0812954a9427b5687909abf6498db7", "ref_doc_id": "Aydinuraz (2016).pdf"}, "760d7fcc-b4c4-47ac-b0d0-56682dbe5540": {"doc_hash": "1aa462ddfd9b12c08247daaabda5cd0301cc7ca2cf6067bfbd8f04a95ef11d4c", "ref_doc_id": "Aydinuraz (2016).pdf"}, "57c7d7ab-6658-43f1-a935-4e4765d59736": {"doc_hash": "027f36be1c95b1412d9a8ded0a3faaf8ddd52c89f8e3c4e01a30f353c0b8dd3f", "ref_doc_id": "Aydinuraz (2016).pdf"}, "b88dc522-2fa4-4515-a233-a5b5f68245bf": {"doc_hash": "2f84eea14ae2a3181eb7885d59ad7bfa945c22b6db4d608b45e4b2c18f40bc22", "ref_doc_id": "Aydinuraz (2016).pdf"}, "aa0d4463-c02c-4410-9e89-ba1ab63832ce": {"doc_hash": "77c39aabe11d6914358645cf62ef813d466aecf480f5e4a142fd2b90fd09345e", "ref_doc_id": "Aydinuraz (2016).pdf"}, "24c1e624-b5f5-4aae-9efd-120d8a6b3386": {"doc_hash": "5f997f0ab8749bd3ace50bc046829462afdd79f15f1469259ac210623768b97c", "ref_doc_id": "Aydinuraz (2016).pdf"}, "98560698-244d-405d-a578-aa4e48279c41": {"doc_hash": "8ec3b422975d734cf8b123989d32b567ae3ebc207732967fbd00dcd063a87f41", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "d45f7025-aa09-4dbb-b6bd-d58a513f39ac": {"doc_hash": "413a9c70028591230ca0112405c37763f4741684b5d44d1b8b9ab40b8e4e0161", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "32c9bc69-c52e-4098-8ec4-d71ad4e017ff": {"doc_hash": "6e9370decd690030932b2cd834e66f05b589262ade8d01733168a0aef6d0a72e", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "a900225e-8ac4-4158-9735-961ac8ae897c": {"doc_hash": "cb4d37a0babd57b9d9e3244c9f2ee4fff972e10219fead50d253dd2218025ad0", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "a0b9ec3f-9c3d-4006-9ec1-5e2a6a043fe0": {"doc_hash": "e7fe6d263efdc7e1dd7e34cbc872dfa0acc7f6a3fda51829a1aa5d08f36b09d5", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "6d9911a0-9a4e-4ad6-ba79-cb4c11abcb65": {"doc_hash": "efc4b05bcf95d09317b34c7f70762a7ae252824819817930185061c60b7ce709", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "433d41ab-90d1-445e-9645-52fc2e75e240": {"doc_hash": "9c3b20c61b7a7358abf112bad3567dd0b8139a27788012da1374c10fee18d503", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "12ebc7e7-beea-4c7f-8b26-de66e9bfbda9": {"doc_hash": "8458ddc385c08c0e01aaef59c602a48f027ff81acbb95a912cc42709ed633cc5", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "b1bb3dd0-959f-4eed-963f-14d10908ac4d": {"doc_hash": "c912b98022a4e998844909b7393d53bc4580828d81a5be6f3bd2d92d4ddf575d", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "34e9fc3f-7bf3-4ea5-9b92-88fd30fa2118": {"doc_hash": "2656f8462d186011d0ab34647c7db20d136d3226b7c14d9f99778d783720288e", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "cb128918-799a-4925-b6c1-9abd76867000": {"doc_hash": "a0c156eb6fe886db37f1b6c241a414079ecb7e94e36d5300c524abcf712934f7", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "3d8d8555-dc03-4fb6-87f0-1c3b390f4b04": {"doc_hash": "b81db9932728422759af20d0ab4933ad7f0d4d1687147a06f37eabbcfe8c3693", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "ad881b08-387d-44c1-b119-b264d87effc9": {"doc_hash": "fa8ef110f56d2f9ae9f40fcfff77daa5b82f0a22b640d30a1cc1cab073d905b5", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "c75e8929-eaba-4d5f-b7b0-854f726311cc": {"doc_hash": "1347a85f73b0781605c8e019a0e989a970ad6b8cac57dcf8d5ad13b52f1ca75e", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "0e79e415-4e4a-43ac-b442-01f445634ee5": {"doc_hash": "9deb5ae1e7bbd73b842a81546e9af489c6ec0e51b01f2471e1c8e3ae0499d8e9", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "675b6243-3f2f-4fe7-ac8f-8a9f6d99c4d3": {"doc_hash": "3c4fdccf4f1664b5eab7d13c7bb22955cb142e10693cea83481c338d5c2c8978", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "b3efffaa-0611-481b-a447-da839eb98abc": {"doc_hash": "3ee30d1ff0dc46e223b0c9dfea38716b43c5ec66cf39bf0fde1d476396446557", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "9660842f-f2c2-4ef8-945b-9c0b16ab640a": {"doc_hash": "ecacdbea8b266af230a7f59954231ddeb121d335902c43288d052a1aaa9497be", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "c49a36f1-40e8-4e3d-9b1e-7627eb67aff6": {"doc_hash": "ce5f9db5960bdad2c19cb025f943d93f049283f57d0c6901f7fe941100a8c9a9", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "579c0bf3-c572-4b86-addc-f1d85cb49d6f": {"doc_hash": "db35b7fc2f0a1ea5259cdcc0bf25ddc297beb8a8e107a79c1e9054a83082dd7b", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "73bd7ce1-4760-4efb-ab70-61cb406ef000": {"doc_hash": "fb5459c9e613a1afcfaf0cbaffda7e4ed98a8ef3dc0ef195c5063d8f21f8b73c", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "10935ce3-303d-411c-b447-ac80e0e2b509": {"doc_hash": "6c17efcdcbde72ad06ae801a5e0725c5551c0844f9feac6e7e65209b93c521d7", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "2240faf3-9f26-4f02-a03f-c87a29cf3586": {"doc_hash": "9417451965d7c00152ae7b59fa3662bbe87f0f31e4df31939626f5959a02be53", "ref_doc_id": "Nasr\u2010Esfahani (2008).pdf"}, "9b45649c-df98-48a6-b7ac-1269fa75e562": {"doc_hash": "ebd1e900e9e292eceaede56148d8f1acfd1033e9e9fe164f2b56d88963cb252a", "ref_doc_id": "Nazarian (2018).pdf"}, "b1bd25c9-b5a4-4e75-9b96-2cec78d4fc23": {"doc_hash": "35fc42b7f48ac0e3d5e3f279228eb4202b29fe084b7256b10000454885179981", "ref_doc_id": "Nazarian (2018).pdf"}, "4de88f85-cec6-478a-9b51-360978159647": {"doc_hash": "b25cf7685c1f514a75f6ca2a8483810b06a6243ea3a48a2421b90ca7065a51ec", "ref_doc_id": "Nazarian (2018).pdf"}, "39ddf46d-77be-4c2a-9f49-8c02d81c55c4": {"doc_hash": "011eec39df0c58b39d4f31bb323e0bcc297931944ca4b6d2bc4b3971fb3d8e1c", "ref_doc_id": "Nazarian (2018).pdf"}, "3ffcf484-5737-4b51-8e63-f349c48397a9": {"doc_hash": "d69c5b57322b9b4893f13aa22a8edc9bb807d8ed01a5c4d90bc3509b6fc6a9b7", "ref_doc_id": "Nazarian (2018).pdf"}, "502055fc-5e5a-438a-8cbc-226d90982deb": {"doc_hash": "ed00f61091e357292fb8991c410fd99d66ab1dfb435ece6f6a502999097a8674", "ref_doc_id": "Nazarian (2018).pdf"}, "424c2355-74b1-4a22-9baf-aeaac67bad4b": {"doc_hash": "f8489b54997fdc1f267d4c79b44b860c09bdfacedd2bce3cbfa1857237ed3483", "ref_doc_id": "Nazarian (2018).pdf"}, "f326ec05-a2d0-44fa-83e5-d977a41f816f": {"doc_hash": "176e726c1f01e1298906628dde09461f8e7eff3d0db80d65be49abd25692fd60", "ref_doc_id": "Nazarian (2018).pdf"}, "0d69da79-e85a-4c5a-905e-fe594ae0199e": {"doc_hash": "5133b43ae4c6ffeb2d80ae10c0759a110caa9a37e59c5cbecdd57275db138438", "ref_doc_id": "Nazarian (2018).pdf"}, "27c8f3f4-d006-4ad1-a2c5-c1fff2108b5e": {"doc_hash": "eaf9d2c116aea85096e45d9156dee4406fec8f320033f0c45d6acb7fb0df491d", "ref_doc_id": "Nazarian (2018).pdf"}, "c63544bc-16a3-4dc9-873c-0752b9dbffcc": {"doc_hash": "48e5f368f92d3621eaf1b8b1065d9e75aa08d9613fd00457c9c537d9e1031798", "ref_doc_id": "Nazarian (2018).pdf"}, "3e6ef68a-6f6f-4c1b-937d-bac3106b2bee": {"doc_hash": "719e1d1d742be56fe981fe11ae36300e13ef6e1446a62c5eb5ee984e5ce84d99", "ref_doc_id": "Nazarian (2018).pdf"}, "887d3d28-96fe-41ea-94cd-28f393d6cff5": {"doc_hash": "5d1411cfd36296fbb8b4259827336cae4fb09bd38a5298834ae37edfefd7d419", "ref_doc_id": "Nazarian (2018).pdf"}, "00a26eac-43ff-4374-8daf-60b6c9eeb79f": {"doc_hash": "1c165d45d130818c579c6a472cb68052c14d7617eb99dd467f446cff62896811", "ref_doc_id": "Nazarian (2018).pdf"}, "f3438acf-34a2-43df-91e8-4c656042cc04": {"doc_hash": "ca1f8d1a0e91d1ba2e763c6ed718a6de3e9f3007dbe98beed742a493c3e5d93f", "ref_doc_id": "Nazarian (2018).pdf"}, "c3b8818e-a77f-418c-a315-157aa1989e31": {"doc_hash": "b6de62273fb2546e1477f10e6c6e3be981941b75a1d3bc9645cf421deabf11e1", "ref_doc_id": "Nazarian (2018).pdf"}, "5c149f51-8202-4839-b399-df40b0ebe323": {"doc_hash": "b169c7a251dc1d76df56e82ad2bcce8a6020e275bef483dbe23ef43cd83b4d49", "ref_doc_id": "Nazarian (2018).pdf"}, "9889ecd1-3dd1-4a1a-bb44-17fdf99d938b": {"doc_hash": "0d4d01ca77218d1aac941db25039bf942a354505d77365beec98c64967f369cd", "ref_doc_id": "Nazarian (2018).pdf"}, "0842cf97-fb33-4f6d-8457-41a929f3c5af": {"doc_hash": "23f8971b09309bbbde07d4c1947b2d050d522c1f95c00ad9155247518ac086a2", "ref_doc_id": "Nazarian (2018).pdf"}, "d1e34a1d-e107-4a11-83a5-722ccaa2c0b5": {"doc_hash": "3521a35ae5782fc6a845e7b48344784ee8e05aef7ed33b1092b7509ec54f4f58", "ref_doc_id": "Nazarian (2018).pdf"}, "2a2c6d77-22cf-4858-87d9-ab17d2427306": {"doc_hash": "6a0338da7e5bc2a65cc89361bfc5a950286af249f1342d38f70f7999a41e2d27", "ref_doc_id": "Nazarian (2018).pdf"}, "5e463115-2b22-4110-b039-caf0eec60127": {"doc_hash": "401557d82aeede2be1ed085d0509e434fb96c28f8a744e6781b8f1fb980c6c7f", "ref_doc_id": "Okuyama (2019).pdf"}, "c7b65309-6163-4163-b7f5-22ad8f5bc740": {"doc_hash": "ff7d97117bdacc358621521099c86e8e57851aad05823523f2433458ec0c5371", "ref_doc_id": "Okuyama (2019).pdf"}, "34b050d2-36e3-4344-8cae-229cc065a8ff": {"doc_hash": "425508e607503dbb69d1d19666dc9f090af8990fc3b8b5aa24cf4c82c13fb098", "ref_doc_id": "Okuyama (2019).pdf"}, "65d31939-9391-4a0c-aea8-d28b804ebab4": {"doc_hash": "6346541dedc884111cb6970982b5a17dc031493beac089a4aef7d1bfed58418f", "ref_doc_id": "Okuyama (2019).pdf"}, "26e01579-6891-488c-ba07-508bee9ade1f": {"doc_hash": "3439f271d472f4bf1912fdc22711e78ad17c5bfad08ecd816f71baf32e6cd53a", "ref_doc_id": "Okuyama (2019).pdf"}, "bf72e3ca-1814-421b-a0d1-86da4cee2a5e": {"doc_hash": "3e9610b29f1662276375b3b511c9cd79e66221f882d49aa7d99edf0b492c0958", "ref_doc_id": "Okuyama (2019).pdf"}, "8fe5dc88-e38e-441c-a398-fe068c827d06": {"doc_hash": "0b673fc8e93b9b47c164855c1059c52881ef1347b62ccac8e26591a35af0abab", "ref_doc_id": "Okuyama (2019).pdf"}, "5370834e-f927-4713-b100-00b9527155ac": {"doc_hash": "c79451d79e22328e41616cd02056c142a285eaff555f35c3079be53a0b9c29c6", "ref_doc_id": "Okuyama (2019).pdf"}, "f48423e0-9804-488f-be81-e4f9b4d3487d": {"doc_hash": "e086db4c2177564cc67fc2e1bd0847c8b4e3eccd908f93f93b1dd0821a8a8d59", "ref_doc_id": "Okuyama (2019).pdf"}, "ee91883c-f070-413c-8d84-447440864936": {"doc_hash": "f78817666253abd4f93db294d6388b8f9a99b5294ee3291132f740da0831ae93", "ref_doc_id": "Okuyama (2019).pdf"}, "b687125c-07dd-4940-887a-400f034f89e4": {"doc_hash": "7fd0a175a975646beb74ef5f6ab8cade4ac8f9b13b9caea26920cda60c07bd13", "ref_doc_id": "Okuyama (2019).pdf"}, "f51a1a32-ce47-4b4e-882f-3461e5377732": {"doc_hash": "09edbbbb0708cc74585495e23f0e301f0264a4f6dcbdd04803e14816eea146e6", "ref_doc_id": "Okuyama (2019).pdf"}, "dcfaddf2-45b7-45a4-8d27-f2ef202217fd": {"doc_hash": "f8c9c5265f8122576140d9202894b61e386b93cda27e6fb08068077ad3f80783", "ref_doc_id": "Fawzy (2018).pdf"}, "7941db33-a293-4bf8-8019-94787b226219": {"doc_hash": "b8b134b5ddc8a560d699c9755450303b6fe112c1ec886ead6558469d9c4b5292", "ref_doc_id": "Fawzy (2018).pdf"}, "dd9043ab-a3a3-4b4f-ac90-50dfc0084e23": {"doc_hash": "a25778cf58a8f108a03a86ee0ad72745904df8f075b7a66b970859047be1eb9b", "ref_doc_id": "Fawzy (2018).pdf"}, "78410b94-8da7-494d-881d-f354469491a6": {"doc_hash": "ccb7f8a16ac3c742faa28bdbf41570c7713da79f4215df1d0f17be0abe507e27", "ref_doc_id": "Fawzy (2018).pdf"}, "ff9b4900-ff68-4df1-a32f-842f539fae3c": {"doc_hash": "a7bb26fe4fcf13868896a8c72979575f86df7d6507804e1cfb1d89c5bf23e207", "ref_doc_id": "Fawzy (2018).pdf"}, "0f00be8b-452b-46c5-9597-4b90469385f5": {"doc_hash": "d7a41bae187ebdb19d79ae6d5a27fc8ec06de81f0d58094d4e75f73ff4a5b4d2", "ref_doc_id": "Fawzy (2018).pdf"}, "ae5cdbe6-c6c7-4d4b-8bac-109a089e67fe": {"doc_hash": "18b4f26f868177e6af49cc0721393a3bcedb88a48929483d3fc0b0e0976e4a3c", "ref_doc_id": "Fawzy (2018).pdf"}, "e1e4a91b-eba7-4532-8dd3-52be9c907e41": {"doc_hash": "57844f9fc4bd890f31f85e35b890e8474cc783ec866362424aabcd649aa8d022", "ref_doc_id": "Fawzy (2018).pdf"}, "c5ae8542-e65c-4448-ade8-8062fc4be831": {"doc_hash": "c07f903e2d4d8463224bb8e8e55a565ba1865e9786a8c8805ce91228f207cec3", "ref_doc_id": "Fawzy (2018).pdf"}, "0ac23d77-5341-4cac-9702-70b39483f26d": {"doc_hash": "158a57f78671b3b386222546011fd07779b561cdad5104ed9d0a6eea04344f7c", "ref_doc_id": "Fawzy (2018).pdf"}, "7861ad15-19aa-4e5a-8ea5-4165a8b88c66": {"doc_hash": "f918afa12bf5e9b9812d391e6b949b5554111276c95d13a7103f83911d50786f", "ref_doc_id": "Fawzy (2018).pdf"}, "9b3f4512-26b0-424b-ae07-d3c1ff4155af": {"doc_hash": "680d577072bfc88d612dd7290f238e65c69d7ee3b42ef4ecbc4fe043946af835", "ref_doc_id": "Fawzy (2018).pdf"}, "74382c08-8a9d-49b1-8fda-3f0973f6236a": {"doc_hash": "69387985a201c2e06c4353a0a2cef6228913f754147ea1f9725054263ef1725f", "ref_doc_id": "Fawzy (2018).pdf"}, "005e3249-f08a-44d9-acc4-03097c443d0e": {"doc_hash": "b2d4539b3e08cf1767a03ac13c4ca96ef7b51996289b36b788360a85073ddfed", "ref_doc_id": "Fawzy (2018).pdf"}, "5c43adef-6e44-46f8-a632-d0d2c08038de": {"doc_hash": "3988073230a48c09d79efb4348a8cd2ff7f091f7428a4da98d4702bd0a96b73f", "ref_doc_id": "Fawzy (2018).pdf"}, "f821a1d9-6560-41f8-9cbd-209ee42143d0": {"doc_hash": "729877181817ee206b5ff2a16205dbf831634f058879e4fa7054daed9558d2ba", "ref_doc_id": "Fawzy (2018).pdf"}, "0b421b3c-492c-4566-8d97-ea6eb9673d1f": {"doc_hash": "0a6be7eadadd013b16a3348a513b1e4e9daea3c4cd414790f9c9736a58b61bff", "ref_doc_id": "Fawzy (2018).pdf"}, "191647a6-0b01-4147-a00d-55e78411dd2a": {"doc_hash": "7191b0caab0f55cfa74e5f5436861ea4f3dd85b13629d1fb2c0747f4ac519f0e", "ref_doc_id": "Fawzy (2018).pdf"}, "97161929-0471-494b-b339-c1b80b59b21a": {"doc_hash": "81abb5aaac263fac654817a291feea8d3e6d0dc756cf3ad375f6125f07450343", "ref_doc_id": "Fawzy (2018).pdf"}, "05826b2d-9b29-4b70-b8be-47668cf5bf3c": {"doc_hash": "4eef9566d374bc84a6f6b5a24ef72af96953326447c703df81f3c6888a3beeb6", "ref_doc_id": "Fawzy (2018).pdf"}, "f20a94ab-395d-4887-bab6-2c27c5ccf15e": {"doc_hash": "f21238277c6d53100e2fade0ca413dcbdd6b713bb0dffd6d75a80e30dfa94719", "ref_doc_id": "Fawzy (2018).pdf"}, "0cc4b88c-f74b-4dd0-8290-a4095af61cad": {"doc_hash": "3cd2b54abd402e9c60f3c4c0520ed2f7315a8b5e822609e73694b1d2b640eb8c", "ref_doc_id": "Fawzy (2018).pdf"}, "89468b73-294a-43ca-90c0-47117aac2e45": {"doc_hash": "2f6639bab6e476c83cdb87059caf5c5e0be15eef29a8e1afb04f5cb9a18d9ea9", "ref_doc_id": "Fawzy (2018).pdf"}, "1cacdca8-7f0c-4c68-915c-338c09bd9b1f": {"doc_hash": "f11714c577c7434b4064cc7707734df28ca4c9a8a30d9b8b15840aaf503867f3", "ref_doc_id": "Fawzy (2018).pdf"}, "deeea9ab-855c-481d-bf4e-d5d543700ef1": {"doc_hash": "fc5c0321ee113960ba245e2b97e5add833e59e31f51254c798cfb80eeb5bc51e", "ref_doc_id": "Fawzy (2018).pdf"}, "b8b94a20-68ba-4654-9466-862e59c1467f": {"doc_hash": "3c846f4d1254783a2f0f6cb9c7d74e8acd1771b018a17edda5d6d021e7476d1d", "ref_doc_id": "Fawzy (2018).pdf"}, "45d7ce31-3546-4430-be49-3fbc8a79fa51": {"doc_hash": "68c403f284cadbc4f5b6a3ed59f74b58b45a90d103ba4a9ef6bf265485e4d8e7", "ref_doc_id": "Fawzy (2018).pdf"}, "d4218994-bd60-49e3-852a-c3bf55dc3356": {"doc_hash": "c066fb1ab19d20c3bd7407e2a47522cd0b25d647de245c2a088c1e56ea865528", "ref_doc_id": "Fawzy (2018).pdf"}, "e8809a3e-d4f3-4c9b-9582-0f2e909f293f": {"doc_hash": "8f15ed3bc99623d3c321d4fe10951580ce15f7a91c287ff5439b20b81069eb2d", "ref_doc_id": "Fawzy (2018).pdf"}, "f524e131-1259-448b-85ba-6407783fcc76": {"doc_hash": "3d13fcc8a0b3ffb029ca6c493101909e134676a7efbc3bc1eb6f80592248cf4b", "ref_doc_id": "Fawzy (2018).pdf"}, "fa948224-a4b2-4f78-b7f5-42ae3633b934": {"doc_hash": "b116840525a1d196a28f2c52b22abd401a2e07957931566639a214c2375a2b5a", "ref_doc_id": "Takahashi (2015).pdf"}, "fd55de99-473e-484c-a651-afb3f541aba0": {"doc_hash": "916f4242e139acaaf00d983c483b45e80f8320e3c30ef576178a2573544a1819", "ref_doc_id": "Takahashi (2015).pdf"}, "a241af33-0aa0-4474-86a1-ce94c3ab99a7": {"doc_hash": "c3c1ccf4f60d37918076408309adf8bd1cfba22967655ef257f04fde01100c00", "ref_doc_id": "Takahashi (2015).pdf"}, "71c02030-ced9-4e75-a916-086926ae1850": {"doc_hash": "7339202c07b1d7ec78c953614c0368af2d5872dfad0d0ee90dc6bd7ab6452ce5", "ref_doc_id": "Takahashi (2015).pdf"}, "d3f004d9-158b-4a7f-adc1-93271e83d62f": {"doc_hash": "9031ed14643553b62c3656bc8121375ce4d0d366630a639236a61b9dbd7cf60a", "ref_doc_id": "Takahashi (2015).pdf"}, "9ef54e7b-7006-4dcc-9b81-cf18576b516f": {"doc_hash": "cac2ff1dd1bb269e800de804783bd8f72fe51d896f078eb47e48700c99e61de8", "ref_doc_id": "Takahashi (2015).pdf"}, "d34908ed-3a24-450d-962e-3eb6c346fa78": {"doc_hash": "9e39e082be19507b0a2bf635cd66c878e38d4fe2f70e4a429c1bc798623a1b93", "ref_doc_id": "Hebisha (2016).pdf"}, "253ccfd6-43a9-4fbb-bf49-d69d1633373d": {"doc_hash": "3b30f6be57eee83118b7e06884345b8266df0f2720fc6dac6dc09ea1ab4b86ac", "ref_doc_id": "Hebisha (2016).pdf"}, "eae26353-8dfe-40db-bd02-b560358048d4": {"doc_hash": "fd107509c09517a57ac86f03f812435cc6abcc418d153245917d4e6fd902d6d0", "ref_doc_id": "Hebisha (2016).pdf"}, "1f208597-d38a-4650-92ca-958a4e3b8d56": {"doc_hash": "483b2a4b713b44df448498f235a64e1b47f57384b0ae016cef26efaa22dd6e8e", "ref_doc_id": "Hebisha (2016).pdf"}, "1849771f-6a25-4962-8a4b-c135165cff6f": {"doc_hash": "e313b7eb1c33e84c48dcdb7558532c2359cc925294bc9a40256fc4554fe99d54", "ref_doc_id": "Hebisha (2016).pdf"}, "2396ab86-198f-41d8-b54d-de70f32e060a": {"doc_hash": "e41c39a476911f39567dfa775b7e26771a83674c6d12a25b7ab94675a827ba96", "ref_doc_id": "Hebisha (2016).pdf"}, "0e23894c-7e85-4c3b-ba40-7234ea1060e7": {"doc_hash": "60dca613a3b2a964e60117f9968147b6e24b8edaa568d6a67d1935ed332f6905", "ref_doc_id": "Hebisha (2016).pdf"}, "9f8cbd0b-56b9-4505-9e6f-6225e1ee004b": {"doc_hash": "3772709e7fb4627263e0490c2849a5acf4994a0372fdcc818058e34fd1a08574", "ref_doc_id": "Hebisha (2016).pdf"}, "4d699a46-bc37-404e-a0bf-9418362ac731": {"doc_hash": "8c6df082be875012b7685d05b63d29cf92004de6c4762ec2428c4cab40c6edac", "ref_doc_id": "Hebisha (2016).pdf"}, "ab77ae80-5cb2-4b73-8e4b-f4f1d59a4f00": {"doc_hash": "1f792a4dc6bf865cadb7d3c7f581889bb38cc73a8349b8a2dd2eac69fe18651c", "ref_doc_id": "Hebisha (2016).pdf"}, "5f9702b5-c6d8-46d1-85ee-abf1e28350b8": {"doc_hash": "86f4cda3e4dc59154939c0c08cf7dabf8f1e1dcac6abc21d8cce9ad386c55d53", "ref_doc_id": "Hebisha (2016).pdf"}, "697c1e5c-2be9-44c5-a14e-4c3a578417f9": {"doc_hash": "fcccc0d46cafb0ad237d952dee7267bb53e1ad9a6cd5e7fb9d5eb6a771c873c7", "ref_doc_id": "Hebisha (2016).pdf"}, "30c63336-3aa1-4928-8c47-b6b36b839479": {"doc_hash": "9d5a95cde2f650f78abf6937a7541d801a026bc9183ec9e3d88c69d677474793", "ref_doc_id": "McCormick (2017).pdf"}, "85d9a67c-3d3b-43c0-b40a-0d0331570033": {"doc_hash": "3206c92180b8ee3017242c44217fe83f0c984cdd601cf16d583abf1663aaf41d", "ref_doc_id": "McCormick (2017).pdf"}, "80f68353-7385-4c48-9a92-37dfda339440": {"doc_hash": "8348f182547e5589e29b3dddc9c046e33aad9810987675bf7ffbaef5d9a25bcd", "ref_doc_id": "McCormick (2017).pdf"}, "c3f97893-3034-4229-b2a2-cbb0bdff8d4c": {"doc_hash": "62dee48a98558ba7d7843af517b2d9484bcb94cb3086d19f385f54de50913184", "ref_doc_id": "McCormick (2017).pdf"}, "94215def-a222-4251-94b5-57f30956123f": {"doc_hash": "717714b41b7637d9d2255ce028af4731e601402769801f734088460e9178ae5a", "ref_doc_id": "McCormick (2017).pdf"}, "0b6d6391-8d0e-4ec4-999f-95e7c7c7f356": {"doc_hash": "87adcbe4c1ae50561c1185bf96500390b895e9fd4262f16b1687c25cad7e0ff7", "ref_doc_id": "McCormick (2017).pdf"}, "e6933cb5-f4e2-498e-a33e-8d9334d5dea8": {"doc_hash": "a7cefddf0f5754a2503922a55218c0962b91d5eb624aab72e3172bdc0d202a42", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "b05a6732-3698-4211-a0b0-cddf89225f55": {"doc_hash": "fd7732cdf90c7c6d3224b424aea43ea01a86b4ca724852d5b3b9d0af9f61bd9b", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "92612b2a-ed10-4bb0-82b7-098ca4af519f": {"doc_hash": "8832ee06dd740661735321d65542f398778c5e39497929256e76e25c432d5e27", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "606103bd-a2f2-4427-8998-08fb804f2b11": {"doc_hash": "4d73d95e92a9ec4a60ffa1bb8dcfef0ce83e788dc3f5c3846384004b529ae69e", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "bbfb2218-7df1-4c3e-a460-c13ab87e0e9c": {"doc_hash": "a0e98f06769ed7da6aa84ad5c2ed0227f35a314bb06884611d9dd6c5fdc51777", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "3b8abea5-1219-4fd3-ba8c-af723acf17f7": {"doc_hash": "123025f5964f0d8ab012916b18b8f16a19ca4119c09e631fe6517ea0ea90c22c", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "39327f1d-7f04-40a9-b4a5-9c76b9f6685e": {"doc_hash": "3988f902b8944fe1569bbfcb494ea40d5ee3fe5af1ba1d5701d7f6f1b6065b8e", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "08524615-b70e-48db-95ab-e53b16248927": {"doc_hash": "a399c29996263cd691d1089e9d8bfe4282e5fbfef4c03d52c754886867ef7b00", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "804c1f32-bf75-4559-aac7-b06a8da77f8b": {"doc_hash": "498aba430850a173e4bc27e87b8a6b0fc62c3ff97b5107f0d083d72400ab22d5", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "3f9c7ba5-b810-4eb5-b537-cb06104aee58": {"doc_hash": "528a379903e0efa4912be1f5afcf07d47918b95e4cf101619c98fc1892049f44", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "b3308f05-ef22-46a4-b449-2ee592331ea9": {"doc_hash": "248670f0f3aafc699b72266384400f65b6bdde509ec8d8d3a991c03fee9b8b65", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "d40c5c0c-73cd-4c54-a4fc-23d6a8e86c96": {"doc_hash": "cceccd807a54074ec91ae8215b468b4d1d6fd76fbc4dde388f6c4316358b6dd5", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "f79ead76-1127-4389-8d44-fd7f60c20acc": {"doc_hash": "80c714bc274cbdbb7e676b4597b4ce7643a9f5fd0869182e9a4adb02b343918b", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "a14bd87f-4676-47e0-a282-66da0f6db6ea": {"doc_hash": "79759774c4100bc78f4fe59e5434a88b824d394a8875204af6bb45c4590dda1b", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "74cce886-989a-45d5-a98d-da614d33b14d": {"doc_hash": "274167b83149f747447838fde84a101db166d3c23e085ebc8ab2d83fd2a43f4e", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "75f03b61-9693-417b-bcba-b7f750de4fbf": {"doc_hash": "1f5013a924f0a0db58b45e3b261671e183f509d9f82230a79e635414202446f3", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "12d265fa-ca7e-4cf2-9759-bc96e6cc84e3": {"doc_hash": "d33e51f45b18a198295fea6a37838c8a4140f79b9d8fb56b1815a4c3e5e7adde", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "14f33a2f-a793-4d14-827b-c05d6bfeb6e6": {"doc_hash": "187ba5e47f7e446eb756b5182e9919e45fa9af8d2be72601bfcbccc0837247ad", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "ce8c62d5-4b05-4c10-9ae6-c31be3a54069": {"doc_hash": "4f93409ad09b69f3af79dc7dddac99ce3a4496f8c64aff18e3ce6a359992c26a", "ref_doc_id": "Caglar Aytac (2015).pdf"}, "235a2b10-c7c1-4512-add5-377ce660f8a8": {"doc_hash": "0f2b3f5e86c110ce702094bf196081177637b0f43321f4c6c1ac8bfc858a118d", "ref_doc_id": "Caglar Aytac (2015).pdf"}}, "docstore/ref_doc_info": {"Ebner (2004).pdf": {"node_ids": ["69c282a1-fb15-4b35-abde-72f13c724a32", "5b27c940-f4e5-4bec-9b9d-a6f03bdebab8", "e66dfbeb-b6b5-41f2-bbc0-dc271d3ba486", "a2ab8ad1-3de6-47ab-9195-b6fab1655249", "8d4c2fdc-774f-40a3-ab88-6349f7521ed2", "dfdb4dee-1cea-4ada-9e45-246ce22679a3", "22f950e8-96aa-44db-8f2d-9064b09f3238", "9127de41-169c-44c0-bb99-52552eb02d47", "313092a6-84e7-4afa-8cc2-765cfc933e7e", "ed0c1021-ee70-49c6-ba2b-6e7f2f54239b", "414ef5b0-c94e-417f-a3b3-0b36c2bf27f5", "077bfbfb-a750-4d40-8b7f-e924c0fca8ef", "e2cffb51-6705-45a5-8c71-300537442fc5", "379a9310-5e98-4b2f-ae48-0445af362347", "6c9ecd9e-f8c2-4149-ad2a-89586ba81f78", "4556a9c6-e12f-431a-8f42-f10218602d30", "dfbafac1-47dc-49d4-856b-d18e0c6cf151", "d0443bed-a471-4bba-9f65-453c6d965e51", "28a7fb70-a880-47ab-a0b9-3704cdf20754", "9d74a9ed-13b3-4c0f-ad72-11d74f83b371", "f9e7d081-4d2e-4cad-bcfa-55c630269e65", "125ed0df-0871-4111-9472-447f458f1959", "6d9bdb48-1770-495d-ad8a-b424674f1e8d", "d4322125-12ef-4859-a757-44962fa1d4e8", "8c2b9d7d-16a5-4164-a233-bae304d3829a", "3a8e8a9e-42ad-474e-bda9-68abc4364850", "ee1c34f8-f078-44ea-9049-7b9e0bb54e1c", "250ffe8d-017a-47da-b440-3bdeb2faf3ac", "2724d647-5b6a-4b3b-9b98-8f518e8d11d7", "b178f845-2267-44fa-a1ac-3cd03cb59397"], "metadata": {}}, "Mateizel (2022).pdf": {"node_ids": ["2d028516-59a7-40b6-bf83-6df150680417", "7ea66c1a-91b3-4442-9f5e-fc78966c9ca7", "ccade27f-a9d5-44bd-b5cc-439350da0245", "dc9d926e-b13a-4130-b44b-72f8a883bd72", "92c3cc89-4e8f-4c44-9843-381553d9b8f7", "38ddb3f4-a255-491a-9f3d-09bbc8cb50ad", "742cb966-58c8-4dca-8664-567488fadda6", "0c864224-e32a-40ae-94e7-f2890c44213b", "810af72d-1fdc-4708-912c-df80f4d07f96", "1d749b2d-ca04-4e8d-8ee1-a08241d44271", "73cfdaac-2817-44d3-88ca-5cb100cd4607", "37ef2460-25ca-480c-bebc-7854784c7e25", "61c9b673-6b4d-42fc-aed0-f09247eccfbc", "5312a7ad-636c-4078-af63-39f3029a489f", "be4e86ba-4445-4e41-aeef-b2dc7b8e4bb9", "b86abf3e-2938-4a17-8ec1-1536958dc992", "5d797fbb-abfe-4f1d-b653-f6daa4b72e96", "0ba2cd55-02f4-497a-b257-f653fa5534a7", "9511df57-7527-409c-bf41-71f91c4acfcd", "c8d95f87-9983-4190-8f04-e6a3383aef78", "d55f06d0-be41-4ce7-b7c3-d262425ecf5c", "f832c886-a6df-4832-95bc-0064c562b0e6"], "metadata": {}}, "Vanden Meerschaut (2012).pdf": {"node_ids": ["503863d1-7df0-47a8-b10d-abfd5e9778fc", "91e8f0e6-bf46-483c-a399-3d5c0176a3c3", "b6c9359e-e0bb-4edc-9fcb-0bbc95b72897", "974739ea-45fd-4a59-8e36-0ccf64d95e9a", "efc9f392-1475-43b0-8278-fec560307071", "26a2a009-eee8-4aae-a523-6aed3180ace2", "ada4a161-18bb-43b4-8389-4aecbcb5272b", "41c7cc37-9e2c-4399-9756-576f752db2b2", "a13aff0d-bdfe-4bd9-ae63-74a5b03e906d", "21fd8d04-e738-42b2-9895-3495f2019d60", "15a7e983-14ef-4d0e-a5ea-1c0eea2d0a2e", "a8b5af39-dbfa-41be-9c26-8b3e490104d6", "e4db23bb-cdaa-42e8-80d8-679cb2508099", "257b4fd6-7cf7-4fbe-a994-0f43548a5b5e", "ab806ebb-2f6c-42ce-a8dc-f9e84b7471c3", "9f125168-ec69-4b27-8e4c-845e000b0df6", "19de532f-e3f6-4a90-947d-4fe34bbf3894", "20e9e856-9dd9-4ed5-879b-70f8d40a6b14", "6a266794-ccd2-4c05-bd9e-073cae5896e3", "e09ab81a-5916-491b-aaba-a7d786f75136", "28790530-8cfd-486c-97cc-646a7bafdb95", "005be17c-41f3-418e-9823-d272d8fa2301", "e9b3e9e4-408c-4f03-8644-b09f80acea30", "9b381b44-201f-475e-b7e9-9a57c2e0ae7e", "98eb7538-8674-447b-870d-ae84f61e9a6a", "ab93033e-461b-4706-b732-b164bf0f5345", "4e3ca5cb-ad5d-423f-8e36-0df355c6cc08", "87c0e0f3-ad99-40a6-bdde-5539cad7bc11", "cf206f45-989f-4f91-b6d8-0df21a1c5c59", "c2331340-209a-4f5b-adcc-dbdca8245cf2", "e19dbd15-3045-4302-8ab3-ee2079af1bcc"], "metadata": {}}, "Mansour (2009).pdf": {"node_ids": ["5d9d063c-dadd-4e36-942e-071b19931274", "6d366835-0c97-4361-beaf-71904242ae16", "4dbd1651-884e-41b5-af0a-efa81493cfe7", "2e3adca0-6c18-4e3b-a913-a3e4e1e0b1e6", "08293380-7604-46b1-9a55-a24d65a6bbb4", "57bba814-fe83-4229-b517-e5e4ecfa1620", "1ce3b3dc-c52b-495d-8f9b-c2b941bf28c1", "570b37d3-6ab5-4f79-976a-222310c1aed3", "ad9f4738-8fc1-4028-83f2-f71f1e0feca4", "c141dfa2-8669-4a93-8e90-e99c2a158d54", "40f7bf3f-181b-4c8f-819e-192d895ea9a3", "c0bf827b-d55b-4f97-835d-ebf7e2f28b1c", "fffa90b7-9352-444c-925d-cc1399a044a0", "66c8321b-d12c-4101-b9aa-0e8c68e6667b", "84fd64f4-eeab-4cda-ab4e-c8e7e785eb39", "74b7913b-c171-4fdb-bc36-3fb16c035b9d", "7ba002c1-2745-4f98-be54-d765fc863b3a", "187b57f3-d373-4183-a564-d57f20338df6", "70e1f38d-4626-4321-849a-2836ecc9d719", "6c3ca4d1-d3e3-4ba8-9dbf-33242f07acc4", "9af22841-94a2-47ca-ae52-faf0272e41c1", "ce3b33df-8057-483f-a3b2-5b9a90150d20"], "metadata": {}}, "Aydinuraz (2016).pdf": {"node_ids": ["a4cdaf9a-b225-4456-8edf-280f55d3cd87", "8ed8c110-e654-40e2-baed-2c215a3340d7", "9a81ce77-0635-4121-b553-b3642bf3fd0d", "13427dda-901c-4e2e-b099-b8d9775a6756", "511dffa4-e6ee-4134-8452-e96175da66c0", "6ea5923d-d5ff-44a0-9d68-71b73e7e93c5", "db34c9f5-1b6d-450e-8a00-86a3a61043f6", "05f91917-a900-4f3e-8374-df0e76ac9787", "b24e6465-fdd4-4936-a5d5-ff08956a189b", "cc60321a-a95c-4874-9566-624cc6e617da", "0f80ea38-2872-4c09-a77e-26ee9404f77a", "097992a6-44e4-435e-a4ed-b09e227516c3", "d97eca6a-e5f6-4282-9aac-62ec73791ede", "122081d6-cfc6-4c96-a229-a2e69c93da33", "6ca93689-131f-4173-8c35-2a8cd7d1f61d", "7dd94584-3d5c-4971-890d-7380e58afb79", "6c05d35a-3965-4c10-954a-74a414a0b0b0", "cdb10ca3-018a-47b5-8628-a73550becd2b", "7e9ab3e5-6a63-4d83-aa97-95948be1b0b7", "760d7fcc-b4c4-47ac-b0d0-56682dbe5540", "57c7d7ab-6658-43f1-a935-4e4765d59736", "b88dc522-2fa4-4515-a233-a5b5f68245bf", "aa0d4463-c02c-4410-9e89-ba1ab63832ce", "24c1e624-b5f5-4aae-9efd-120d8a6b3386"], "metadata": {}}, "Nasr\u2010Esfahani (2008).pdf": {"node_ids": ["98560698-244d-405d-a578-aa4e48279c41", "d45f7025-aa09-4dbb-b6bd-d58a513f39ac", "32c9bc69-c52e-4098-8ec4-d71ad4e017ff", "a900225e-8ac4-4158-9735-961ac8ae897c", "a0b9ec3f-9c3d-4006-9ec1-5e2a6a043fe0", "6d9911a0-9a4e-4ad6-ba79-cb4c11abcb65", "433d41ab-90d1-445e-9645-52fc2e75e240", "12ebc7e7-beea-4c7f-8b26-de66e9bfbda9", "b1bb3dd0-959f-4eed-963f-14d10908ac4d", "34e9fc3f-7bf3-4ea5-9b92-88fd30fa2118", "cb128918-799a-4925-b6c1-9abd76867000", "3d8d8555-dc03-4fb6-87f0-1c3b390f4b04", "ad881b08-387d-44c1-b119-b264d87effc9", "c75e8929-eaba-4d5f-b7b0-854f726311cc", "0e79e415-4e4a-43ac-b442-01f445634ee5", "675b6243-3f2f-4fe7-ac8f-8a9f6d99c4d3", "b3efffaa-0611-481b-a447-da839eb98abc", "9660842f-f2c2-4ef8-945b-9c0b16ab640a", "c49a36f1-40e8-4e3d-9b1e-7627eb67aff6", "579c0bf3-c572-4b86-addc-f1d85cb49d6f", "73bd7ce1-4760-4efb-ab70-61cb406ef000", "10935ce3-303d-411c-b447-ac80e0e2b509", "2240faf3-9f26-4f02-a03f-c87a29cf3586"], "metadata": {}}, "Nazarian (2018).pdf": {"node_ids": ["9b45649c-df98-48a6-b7ac-1269fa75e562", "b1bd25c9-b5a4-4e75-9b96-2cec78d4fc23", "4de88f85-cec6-478a-9b51-360978159647", "39ddf46d-77be-4c2a-9f49-8c02d81c55c4", "3ffcf484-5737-4b51-8e63-f349c48397a9", "502055fc-5e5a-438a-8cbc-226d90982deb", "424c2355-74b1-4a22-9baf-aeaac67bad4b", "f326ec05-a2d0-44fa-83e5-d977a41f816f", "0d69da79-e85a-4c5a-905e-fe594ae0199e", "27c8f3f4-d006-4ad1-a2c5-c1fff2108b5e", "c63544bc-16a3-4dc9-873c-0752b9dbffcc", "3e6ef68a-6f6f-4c1b-937d-bac3106b2bee", "887d3d28-96fe-41ea-94cd-28f393d6cff5", "00a26eac-43ff-4374-8daf-60b6c9eeb79f", "f3438acf-34a2-43df-91e8-4c656042cc04", "c3b8818e-a77f-418c-a315-157aa1989e31", "5c149f51-8202-4839-b399-df40b0ebe323", "9889ecd1-3dd1-4a1a-bb44-17fdf99d938b", "0842cf97-fb33-4f6d-8457-41a929f3c5af", "d1e34a1d-e107-4a11-83a5-722ccaa2c0b5", "2a2c6d77-22cf-4858-87d9-ab17d2427306"], "metadata": {}}, "Okuyama (2019).pdf": {"node_ids": ["5e463115-2b22-4110-b039-caf0eec60127", "c7b65309-6163-4163-b7f5-22ad8f5bc740", "34b050d2-36e3-4344-8cae-229cc065a8ff", "65d31939-9391-4a0c-aea8-d28b804ebab4", "26e01579-6891-488c-ba07-508bee9ade1f", "bf72e3ca-1814-421b-a0d1-86da4cee2a5e", "8fe5dc88-e38e-441c-a398-fe068c827d06", "5370834e-f927-4713-b100-00b9527155ac", "f48423e0-9804-488f-be81-e4f9b4d3487d", "ee91883c-f070-413c-8d84-447440864936", "b687125c-07dd-4940-887a-400f034f89e4", "f51a1a32-ce47-4b4e-882f-3461e5377732"], "metadata": {}}, "Fawzy (2018).pdf": {"node_ids": ["dcfaddf2-45b7-45a4-8d27-f2ef202217fd", "7941db33-a293-4bf8-8019-94787b226219", "dd9043ab-a3a3-4b4f-ac90-50dfc0084e23", "78410b94-8da7-494d-881d-f354469491a6", "ff9b4900-ff68-4df1-a32f-842f539fae3c", "0f00be8b-452b-46c5-9597-4b90469385f5", "ae5cdbe6-c6c7-4d4b-8bac-109a089e67fe", "e1e4a91b-eba7-4532-8dd3-52be9c907e41", "c5ae8542-e65c-4448-ade8-8062fc4be831", "0ac23d77-5341-4cac-9702-70b39483f26d", "7861ad15-19aa-4e5a-8ea5-4165a8b88c66", "9b3f4512-26b0-424b-ae07-d3c1ff4155af", "74382c08-8a9d-49b1-8fda-3f0973f6236a", "005e3249-f08a-44d9-acc4-03097c443d0e", "5c43adef-6e44-46f8-a632-d0d2c08038de", "f821a1d9-6560-41f8-9cbd-209ee42143d0", "0b421b3c-492c-4566-8d97-ea6eb9673d1f", "191647a6-0b01-4147-a00d-55e78411dd2a", "97161929-0471-494b-b339-c1b80b59b21a", "05826b2d-9b29-4b70-b8be-47668cf5bf3c", "f20a94ab-395d-4887-bab6-2c27c5ccf15e", "0cc4b88c-f74b-4dd0-8290-a4095af61cad", "89468b73-294a-43ca-90c0-47117aac2e45", "1cacdca8-7f0c-4c68-915c-338c09bd9b1f", "deeea9ab-855c-481d-bf4e-d5d543700ef1", "b8b94a20-68ba-4654-9466-862e59c1467f", "45d7ce31-3546-4430-be49-3fbc8a79fa51", "d4218994-bd60-49e3-852a-c3bf55dc3356", "e8809a3e-d4f3-4c9b-9582-0f2e909f293f", "f524e131-1259-448b-85ba-6407783fcc76"], "metadata": {}}, "Takahashi (2015).pdf": {"node_ids": ["fa948224-a4b2-4f78-b7f5-42ae3633b934", "fd55de99-473e-484c-a651-afb3f541aba0", "a241af33-0aa0-4474-86a1-ce94c3ab99a7", "71c02030-ced9-4e75-a916-086926ae1850", "d3f004d9-158b-4a7f-adc1-93271e83d62f", "9ef54e7b-7006-4dcc-9b81-cf18576b516f"], "metadata": {}}, "Hebisha (2016).pdf": {"node_ids": ["d34908ed-3a24-450d-962e-3eb6c346fa78", "253ccfd6-43a9-4fbb-bf49-d69d1633373d", "eae26353-8dfe-40db-bd02-b560358048d4", "1f208597-d38a-4650-92ca-958a4e3b8d56", "1849771f-6a25-4962-8a4b-c135165cff6f", "2396ab86-198f-41d8-b54d-de70f32e060a", "0e23894c-7e85-4c3b-ba40-7234ea1060e7", "9f8cbd0b-56b9-4505-9e6f-6225e1ee004b", "4d699a46-bc37-404e-a0bf-9418362ac731", "ab77ae80-5cb2-4b73-8e4b-f4f1d59a4f00", "5f9702b5-c6d8-46d1-85ee-abf1e28350b8", "697c1e5c-2be9-44c5-a14e-4c3a578417f9"], "metadata": {}}, "McCormick (2017).pdf": {"node_ids": ["30c63336-3aa1-4928-8c47-b6b36b839479", "85d9a67c-3d3b-43c0-b40a-0d0331570033", "80f68353-7385-4c48-9a92-37dfda339440", "c3f97893-3034-4229-b2a2-cbb0bdff8d4c", "94215def-a222-4251-94b5-57f30956123f", "0b6d6391-8d0e-4ec4-999f-95e7c7c7f356"], "metadata": {}}, "Caglar Aytac (2015).pdf": {"node_ids": ["e6933cb5-f4e2-498e-a33e-8d9334d5dea8", "b05a6732-3698-4211-a0b0-cddf89225f55", "92612b2a-ed10-4bb0-82b7-098ca4af519f", "606103bd-a2f2-4427-8998-08fb804f2b11", "bbfb2218-7df1-4c3e-a460-c13ab87e0e9c", "3b8abea5-1219-4fd3-ba8c-af723acf17f7", "39327f1d-7f04-40a9-b4a5-9c76b9f6685e", "08524615-b70e-48db-95ab-e53b16248927", "804c1f32-bf75-4559-aac7-b06a8da77f8b", "3f9c7ba5-b810-4eb5-b537-cb06104aee58", "b3308f05-ef22-46a4-b449-2ee592331ea9", "d40c5c0c-73cd-4c54-a4fc-23d6a8e86c96", "f79ead76-1127-4389-8d44-fd7f60c20acc", "a14bd87f-4676-47e0-a282-66da0f6db6ea", "74cce886-989a-45d5-a98d-da614d33b14d", "75f03b61-9693-417b-bcba-b7f750de4fbf", "12d265fa-ca7e-4cf2-9759-bc96e6cc84e3", "14f33a2f-a793-4d14-827b-c05d6bfeb6e6", "ce8c62d5-4b05-4c10-9ae6-c31be3a54069", "235a2b10-c7c1-4512-add5-377ce660f8a8"], "metadata": {}}}}